U.S and Trans-Border Securities Regulation
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. - International Business Law<br />
July/August 2013<br />
Michael Krebs<br />
JD, Boston University School of Law 1985<br />
Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />
Tel. 617.439.2288 email: mkrebs@nutter.com<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Course Objective<br />
General survey of primary U.S. securities laws <strong>and</strong> the domestic<br />
<strong>and</strong> trans-border business contexts in which they are relevant.<br />
Particular emphasis will be placed on<br />
<strong>Securities</strong> Act of 1933 (the “<strong>Securities</strong> Act”)<br />
<strong>Securities</strong> Exchange Act of 1934 (the “Exchange Act”),<br />
Role of the <strong>Securities</strong> Exchange Commission (the “SEC”),<br />
Impact of the Sarbanes-Oxley Act of 2002,<br />
Impact of 2010 Dodd-Frank Act<br />
Impact of 2012 JOBS Act<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. in International Business Law<br />
Session 1 – July 22, 2013<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 1 Agenda<br />
Overarching concepts<br />
<strong>Securities</strong> Act overview<br />
Definition of a “security”<br />
<strong>Securities</strong> exempt from §5<br />
registration requirements<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Overarching concepts<br />
1) “Issuer” or “Registrant”<br />
2) “Interstate commerce”<br />
3) “Materiality”<br />
4) “GAAP” (vs. “IFRS”)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
“Issuer” <strong>and</strong> “Registrant”<br />
“Issuer” is the company or other<br />
entity that issues securities<br />
“Registrant” is an issuer that has<br />
filed a registration statement with<br />
the SEC (pronounced “S-É-C”)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Interstate Commerce<br />
Within U.S.?<br />
In offshore transactions?<br />
Reg. S<br />
F 3 or “F-cubed”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Interstate Commerce (cont’d)<br />
Underlying the Federal securities laws is the concept that the<br />
U.S. Congress may regulate securities matters only to the<br />
extent that they involve “interstate commerce.”<br />
For example, the registration requirement under Section 5 of<br />
the <strong>Securities</strong> Act is predicated on<br />
[making] use of any means or instruments of transportation or<br />
communication in interstate commerce or of the mails to sell<br />
such security . . . or [carrying or causing] to be carried through<br />
the mails or in interstate commerce, by any means or<br />
instruments of transportation, any such security for the<br />
purpose of sale or for delivery after sale.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Interstate Commerce (cont’d)<br />
Similarly, the anti-fraud provisions in Section 17 of<br />
the <strong>Securities</strong> Act <strong>and</strong> in Section 10(b) of the<br />
Exchange Act require an interstate commerce<br />
nexus.<br />
Liability under Section 10(b), for example, is<br />
predicated on the<br />
“use of any means or instrumentality of interstate<br />
commerce or of the mails, or of any facility of any<br />
national securities exchange. . . .”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Interstate Commerce (cont’d)<br />
Reg. S (<strong>Securities</strong> Act Rules 901-905)<br />
Rule 901:<br />
For the purposes only of section 5 of the Act , the<br />
terms offer, offer to sell, sell, sale, <strong>and</strong> offer to buy<br />
shall be deemed to include offers <strong>and</strong> sales that<br />
occur within the United States <strong>and</strong> shall be deemed<br />
not to include offers <strong>and</strong> sales that occur outside the<br />
United States.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Interstate Commerce (cont’d)<br />
Reg. S (<strong>Securities</strong> Act Rules 901-905)<br />
Rule 902(h):<br />
Definition of “offshore transaction”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Interstate Commerce (cont’d)<br />
F 3 or “F-cubed”<br />
Issuer is foreign<br />
Plaintiffs are foreign<br />
Fraudulent purchase or sale of securities<br />
occurred in foreign country<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Interstate Commerce (cont’d)<br />
F3 or “F-cubed” (cont’d)<br />
In the 2010 Morrison v. National Australian Bank<br />
decision, the Supreme Court reasoned:<br />
It is a rare case of prohibited extraterritorial application<br />
that lacks all contact with United States territory. The<br />
Exchange Act’s focus is not on the place where the<br />
deception originated, but on purchases <strong>and</strong> sales of<br />
securities in the United States. Section 10(b) applies<br />
only to transactions in securities listed on domestic<br />
exchanges <strong>and</strong> domestic transactions in other<br />
securities” [emphasis added]<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Materiality<br />
An omitted fact will be deemed material if the fact<br />
“would have assumed actual significance in the<br />
deliberations of the reasonable shareholder. Put<br />
another way, there must be a substantial likelihood<br />
that the disclosure of the omitted fact would have<br />
been viewed by the reasonable investor as having<br />
significantly altered the "total mix" of<br />
information made available.”<br />
TSC v. Northway (1976)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Materiality (cont’d)<br />
Basic v. Levinson (1988)<br />
Claim based upon misleading statement<br />
regarding ongoing merger discussions.<br />
Supreme Court adopts<br />
magnitude/probability test for materiality.<br />
Court endorsed “no comment” protocol.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Materiality (cont’d)<br />
Matrixx Initiatives v. Siracusano (2011)<br />
Matrixx, a drug company, argued that “adverse<br />
event reports that do not reveal a statistically<br />
significant increased risk of adverse events from<br />
product use are [never] material information.”<br />
The Supreme Court declined to adopt the<br />
categorical statistical significance test.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Materiality (cont’d)<br />
Matrixx Initiatives (2011) (cont’d)<br />
“The mere existence of reports of adverse events—which says<br />
nothing in <strong>and</strong> of itself about whether the drug is causing the<br />
adverse events—will not satisfy [the 10b-5 pleading st<strong>and</strong>ard].<br />
Something more is needed, but that something more is not<br />
limited to statistical significance <strong>and</strong> can come from the<br />
source, content, <strong>and</strong> context of the reports. This contextual<br />
inquiry may reveal in some cases that reasonable investors<br />
would have viewed reports of adverse events as material<br />
even though the reports did not provide statistically<br />
significant evidence of a causal link” [emphasis added]<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
GAAP (vs. IFRS)<br />
GAAP – “Generally Accepted Accounting<br />
Principles”<br />
As interpreted by SEC <strong>and</strong> FASB<br />
(Financial Accounting St<strong>and</strong>ards Board)<br />
Extremely important to issuer SEC filings<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
GAAP (vs. IFRS)<br />
IFRS – “International Financial Reporting St<strong>and</strong>ards”<br />
In 2008, SEC proposed a “roadmap” for the potential use in SEC<br />
filings of financial statements prepared in accordance IFRS.<br />
In 2010, SEC requested public comment on three specific topics<br />
related to its ongoing consideration of incorporating IFRS into<br />
financial reporting system for U.S. issuers known as<br />
“convergence”.<br />
November 2011 SEC released a staff study titled “A Comparison<br />
of U.S. GAAP <strong>and</strong> IFRS”<br />
July 13, 2012, the staff of the SEC's Office of the Chief<br />
Accountant published its final report (the “2013 Staff report") on<br />
its IFRS Work Plan.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
IFRS – Continued<br />
GAAP (vs. IFRS)<br />
The 2013 Staff report does not include a final policy decision, or<br />
even a recommendation, as to whether IFRS should be<br />
incorporated into the US financial reporting system, or how such<br />
incorporation should occur.<br />
The 2013 Staff report indicates that IFRS is generally perceived<br />
to be of high quality. However, it notes that there are areas where<br />
gaps remain, <strong>and</strong> inconsistencies exist in the application of IFRS<br />
globally.<br />
The Staff also believes that improvements can be made to the<br />
IFRS interpretative process <strong>and</strong> the enforcement <strong>and</strong><br />
coordination activities of regulators across territories.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
<strong>Securities</strong> Act Overview<br />
How would you describe the<br />
<strong>Securities</strong> Act to a foreign<br />
colleague who is unfamiliar with<br />
U.S. securities laws?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
<strong>Securities</strong> Act Overview<br />
(cont’d)<br />
Core Principles:<br />
1. Each <strong>and</strong> every offer <strong>and</strong> sale of a<br />
security – whether by an issuer or by a<br />
previous purchaser of that security – must<br />
be registered with the SEC, unless either<br />
the security or the particular transaction<br />
(i.e., an “offer” <strong>and</strong> “sale”) specifically is<br />
exempt by statute or regulation from<br />
registration.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
<strong>Securities</strong> Act Overview<br />
(cont’d)<br />
Core Principles:<br />
2. If a transaction is to be registered with the<br />
SEC, the issuer – <strong>and</strong> ONLY the issuer –<br />
must file the registration statement with the<br />
SEC.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
<strong>Securities</strong> Act Overview<br />
(cont’d)<br />
Core Principles:<br />
3. If a transaction is registered with the SEC,<br />
the issuer has an affirmative obligation to<br />
disclose in the registration statement all<br />
information regarding the issuer <strong>and</strong> the<br />
security that is “material” to that investment<br />
decision.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
<strong>Securities</strong> Act Overview<br />
(cont’d)<br />
More specifically:<br />
<strong>Securities</strong> Act primarily regulates<br />
“distributions” (i.e., public offerings) of<br />
securities by an “issuer”<br />
Also applies to offers <strong>and</strong> sales that are<br />
not public offerings<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
<strong>Securities</strong> Act Overview<br />
(cont’d)<br />
Establishes “prospectus” <strong>and</strong> “registration<br />
statement” as key disclosure documents<br />
Prospectus, which is a subpart of the registration<br />
statement, includes material information regarding<br />
Issuer's properties <strong>and</strong> business;<br />
Security offered for sale;<br />
Issuer’s management <strong>and</strong> principal shareholders;<br />
Issuer’s financial statements, as audited <strong>and</strong><br />
“certified” by issuer’s independent accountants; <strong>and</strong><br />
Material risks associated with issuer <strong>and</strong> security<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
<strong>Securities</strong> Act Overview<br />
(cont’d)<br />
<strong>Securities</strong> Act imposes accountability<br />
through administrative, civil <strong>and</strong> potentially<br />
criminal liability for:<br />
Failure to register sale of securities<br />
when required<br />
Materially false or misleading<br />
statements in a registration<br />
statement or prospectus<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Key Provisions of the<br />
<strong>Securities</strong> Act of 1933<br />
Section 5 – Registration requirements<br />
Section 2 – Definition of “security”<br />
Section 3 – <strong>Securities</strong> exempt from Section 2<br />
definition<br />
Section 4 – <strong>Trans</strong>actions exempt from Section 5<br />
registration<br />
Sections 11, 12, 17 <strong>and</strong> 24 – Civil/Criminal<br />
Liability<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Section 5<br />
§5(c) It is unlawful … to offer to sell or<br />
offer to buy … any “security,”<br />
unless a registration statement has<br />
been filed as to such security.<br />
§5(a) It is unlawful to sell a “security,”<br />
unless a registration statement is<br />
“in effect” as to such security.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved.
Section 2(a)(1)<br />
§2(a)(1) - "security" means any [promissory]<br />
note, stock… bond… evidence of<br />
indebtedness … investment contract… any<br />
put, call, … option, on any security… or, in<br />
general, any interest or instrument commonly<br />
known as a "security”… or warrant or right to<br />
subscribe to or purchase … any of the<br />
foregoing.<br />
(c) 2005-2010 Michael K. Krebs. All<br />
Rights Reserved.
Stocks<br />
Key Components of §2(a)(1)<br />
Promissory Notes/Bonds<br />
Options<br />
Index or Group of <strong>Securities</strong><br />
“Investment Contracts”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Section 3(a)<br />
§3(a) contains a lengthy list of securities not<br />
covered by the definition in §2(a)(1) <strong>and</strong><br />
therefore not covered by the provisions of the<br />
<strong>Securities</strong> Act (except the anti-fraud<br />
provisions of §17).<br />
(c) 2005-2010 Michael K. Krebs. All<br />
Rights Reserved.
Section 4<br />
§4 exempts some transactions from the §5<br />
registration requirements, including:<br />
§4(a)(1) – <strong>Trans</strong>actions by a person other than an Issuer,<br />
Underwriter, or Dealer.<br />
§4(a)(2) – <strong>Trans</strong>actions by an issuer not involving a<br />
“public offering” – the so-called “private placement”<br />
exemption<br />
Portions of §3(a) also exempt certain transactions from the<br />
§5 registration requirements. See, e.g., §3(a)(9); §3(a)(10);<br />
§3(a)(11)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Civil <strong>and</strong> Criminal Liabilities<br />
§11 – Creates civil liability for false or misleading registration<br />
statements <strong>and</strong> provides for the award of damages<br />
§12 – Allows rescission of an offer or sale in violation of §5 or<br />
through the use of a materially false or misleading<br />
prospectus<br />
§17 – Makes it unlawful for any person to make fraudulent<br />
offer or sale of a security (applies even to exempt<br />
securities)<br />
§24 – Provides criminal fines <strong>and</strong> prison terms for securities<br />
law violations<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
What is a “Security”?<br />
Very broadly defined. Includes:<br />
Equity investments, such as common or preferred stock,<br />
issued by a business enterprise, whether organized as a<br />
corporation, limited liability company, or limited<br />
partnership (LLCs <strong>and</strong> LPs – but not corporations –<br />
analyzed under “investment contract” test)<br />
Often includes debt instruments, such as a bond or<br />
promissory note issued by a business enterprise or by a<br />
state, municipality or quasi-governmental entity, <strong>and</strong><br />
Includes interests in a pool of stocks or bonds, such as<br />
shares of a mutual fund<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
What is a “Security”?<br />
Promissory Notes<br />
When is a promissory note not<br />
considered a security for purposes<br />
of the <strong>Securities</strong> Act?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Section 2(a) of the ’33 Act<br />
§2(a) – DEFINITIONS.—When used in this<br />
title [i.e., the <strong>Securities</strong> Act], unless<br />
the context otherwise requires—<br />
(1) The term "security" means any note…<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Promissory Notes<br />
Section 2(a)(1) defines a “security” to<br />
include “any note”<br />
Interpretative issue:<br />
Does “any” mean “every”?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Promissory Notes<br />
Many extensions of credit do not have the<br />
typical attributes of an investment so . . .<br />
“the context otherwise requires” that<br />
some promissory notes not be treated as a<br />
security for purposes of the <strong>Securities</strong> Act.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
“Unless the context otherwise<br />
requires…”<br />
Provides an important basis for judicial discretion<br />
concerning the proper scope of the securities laws:<br />
Is every promissory “note” really a security?<br />
What “profit sharing agreements” are securities?<br />
Are general partnership interests securities? Limited<br />
partnership interests? Limited liability companies?<br />
Should distinctions be drawn between the stock of<br />
publicly held <strong>and</strong> that of a closely held corporation<br />
(i.e., one the is not publicly traded)?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reves v. Ernst & Young,<br />
494 U.S. 56 (1990)<br />
Supreme Court establishes the “family<br />
resemblance” test for determining whether or not a<br />
promissory note is a security.<br />
Every note is presumed to be a security, unless it<br />
falls into a category of instruments that are not<br />
securities.<br />
Notes used in consumer lending, notes secured by a<br />
mortgage on a home, <strong>and</strong> short-term notes secured<br />
by the assignment of accounts receivable are in the<br />
“family” of nonsecurities.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
What is a “Security”?<br />
Loan Participation Interests<br />
Could a loan participation interest<br />
be considered a security for<br />
purposes of the <strong>Securities</strong> Act?<br />
[Consider Module 2 Discussion Question]<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
What is a “Security”?<br />
Loan Participation Interests<br />
Promissory notes to several lender banks<br />
“It is well-settled that certificates<br />
evidencing loans by commercial banks to<br />
their customers for use in the customers'<br />
current operations are not securities.”<br />
Security Pacific Bank (2 nd Cir. 1992)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
What is a “Security”?<br />
Loan Participation Interests<br />
“However, . . . a [loan] participation might in<br />
some circumstances be considered a security even<br />
where the instrument itself is not . . . .”<br />
Who are the participants?<br />
What are the purposes of the purchasers or<br />
participants?<br />
What are the promotional bases used in<br />
marketing the loan notes?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
What is a “Security”?<br />
Loan Participation Interests<br />
“While banks are subjected to risks of<br />
misinformation, their ability to verify<br />
representations <strong>and</strong> take supervisory <strong>and</strong><br />
corrective actions places them in a<br />
significantly different posture than the<br />
investors sought to be protected through the<br />
securities acts.”<br />
Western Bank & Trust v. Kotz, 532 F.2d 1252<br />
(9th Cir. 1976) quoted approvingly in Security<br />
Pacific Bank dissent.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
What is a “Security”?<br />
Loan Participation Interests<br />
“Potential purchasers were not presented<br />
with one loan <strong>and</strong> asked if they wanted to<br />
participate in it, but were solicited, often on<br />
a daily basis, <strong>and</strong> offered a range of<br />
investment options involving different<br />
issuers with different maturities <strong>and</strong> interest<br />
rates.”<br />
Security Pacific Bank dissent<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
What is a “Security”?<br />
Loan Participation Interests<br />
Has any court adopted the arguments<br />
made in the Security Pacific Bank<br />
dissent?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
What is a “Security”?<br />
Loan Participation Interests<br />
Pollack v. Laidlaw Holdings, 27 F.3d 808 (2d Cir. 1994)<br />
The 2 nd Circuit reversed District’s Court’s dismissal, concluding that under the<br />
Reves factors the mortgage participations purchased <strong>and</strong> sold by Laidlaw<br />
Holdings were "securities" under federal securities law.<br />
In examining the Reves factors, the Court took particular interest in<br />
distinguishing BancoEspanol. The Laidlaw court found that the defendant was<br />
raising funds for its general business activities of making <strong>and</strong> servicing<br />
mortgages. The court also explained that the marketing scheme in<br />
BancoEspanol was more analogous to a group of highly sophisticated<br />
commercial entities engaging in short-term commercial financing arrangements<br />
than to the securities markets. In Laidlaw, by contrast, the trial court found that<br />
the purchasers of these mortgage instruments were unsophisticated, passive<br />
investors who had simply placed their money in discretionary accounts with<br />
instructions to make conservative investments.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
What is a “Security”?<br />
Loan Participation Interests<br />
In April 1997 the federal banking regulators issued an<br />
“Interagency Statement on Sales of 100% Loan<br />
Participations.”<br />
Citing Banco Espanol, the regulators emphasized that<br />
the court cautioned that the holding was specific to the<br />
facts of the case <strong>and</strong> that even if an underlying<br />
instrument is not a security, the manner in which<br />
participations in that instrument are used, pooled or<br />
marketed might establish that such participations are<br />
securities.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
What is a “Security”?<br />
Investment Contracts<br />
What is an “investment contract”<br />
for purposes of the <strong>Securities</strong> Act?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Howey Test for Investment<br />
Contracts as a “Security”<br />
In Howey, the Supreme Court defined an<br />
“investment contract” as any transaction in<br />
which<br />
1) a person invests money,<br />
2) in a common enterprise, <strong>and</strong><br />
3) is led to expect profits,<br />
4) solely from the efforts of others.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Howey Test – Up Close<br />
1. Investment: The investment, which can be cash or noncash<br />
consideration, is expected to produce income or profit; the investor is not<br />
buying a consumable commodity or service.<br />
2. Commonality: Multiple investors have interrelated interests in a<br />
common scheme – horizontal commonality. For some courts, it is<br />
sufficient to have vertical commonality – a single investor has a common<br />
interest with the manager of his investment.<br />
3. Profits: The expected return must come from earnings of the enterprise,<br />
not merely additional contributions, <strong>and</strong> this return must be the principal<br />
motivation for the investment.<br />
4. Efforts of others: Investor’s efforts in the common enterprise may<br />
contribute to profits, but the efforts of the managers must be predominant;<br />
the investors must be mostly passive.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Howey Test – Applied:<br />
SEC v. ETS Payphones et al.<br />
What did the 11 th Circuit rule <strong>and</strong> why?<br />
Do you agree with the decision?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Howey Test – Applied:<br />
SEC v. ETS Payphones et al.<br />
11 th Circuit ruled that contractual payphone<br />
arrangement was NOT a security, because:<br />
Howey test requires that an investment contract<br />
either provide for capital appreciation or a<br />
participation in earnings, <strong>and</strong> thus excludes<br />
schemes offering a fixed rate of return.<br />
Howey’s requirement that return on investment be<br />
"derived solely from the efforts of others" was not<br />
satisfied when purchasers had a contractual<br />
entitlement to return.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Howey Test – Applied:<br />
SEC v. Edwards<br />
What does SEC v. Edwards teach us<br />
about the “investment contract” test?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Howey Test – Applied:<br />
SEC v. Edwards<br />
In 2004, Supreme Court unanimously reversed the 11 th Circuit,<br />
ruling that the contractual arrangement of the ETS Payphones<br />
structure was a “security,” because<br />
The term “profits" is used in Howey in the sense of<br />
income or return, <strong>and</strong> includes dividends, other periodic<br />
payments, or increased value of investment, <strong>and</strong><br />
Howey test does not distinguish between a promise of<br />
fixed return <strong>and</strong> promise of variable return. That investors<br />
have bargained for fixed return on investment does not<br />
mean the return is not also expected to come “solely from<br />
efforts of others.”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
The Reves Test compared to the Howey<br />
Test<br />
Reves<br />
1. Motivation of seller <strong>and</strong><br />
buyer.<br />
2. Plan of distribution.<br />
3. Reasonable expectations<br />
of investing public.<br />
4. Other factors reduce risk.<br />
(c) 2005-2010 Michael K. Krebs. All<br />
Rights Reserved.<br />
Howey<br />
1. Investment of Money<br />
2. In a Common<br />
Enterprise<br />
3. With an expectation<br />
of profit from the<br />
efforts of others
Howey vs. Reves<br />
The two tests can be viewed as two ends of<br />
the same filter. Howey allows items into the<br />
“security” box, while Reves allows items not<br />
to be characterized as securities <strong>and</strong> therefore<br />
to pass out of the “security” box.<br />
For public policy reasons, the Howey filter is<br />
the more porous filter, allowing more in than<br />
the Reves filter allows out.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Partnership <strong>and</strong> LLC Interests<br />
Involves a particular application of the Howey test:<br />
Investor’s efforts in common enterprise may contribute to<br />
profits, but efforts of the managers must be predominant.<br />
Courts will look at the totality of circumstances<br />
surrounding the transaction, <strong>and</strong> not simply accept a literal<br />
reading of the written agreement between the parties.<br />
Courts will look at actual involvement contemplated by<br />
parties, evidence of such involvement (or lack of<br />
involvement), <strong>and</strong> anything else that can be gleaned from<br />
factual circumstances surrounding the investment.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Partnership <strong>and</strong> LLC Interests<br />
Interests of general partners typically are<br />
not securities, but interests of limited<br />
partners typically are.<br />
Interests in LLCs may be securities<br />
depending on circumstances.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
What is a “Security”?<br />
Common Stock<br />
Under what circumstances, if any, is<br />
common stock not considered a<br />
security for purposes of the<br />
<strong>Securities</strong> Act?<br />
Why not analyze common stock as<br />
an LLC interest?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Stock in Closely Held<br />
Businesses<br />
The Supreme Court has emphasized that<br />
definition of a security must reflect “economic<br />
reality.”<br />
In some instances, transactions in corporate<br />
stock involve – in “economic reality” – the<br />
transfer of small business assets from one<br />
owner/manager to another owner/manager,<br />
neither of whom is expecting profits “solely<br />
from the efforts of others.”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Stock in Closely Held<br />
Businesses<br />
Prior to 1985, under the “sale of business” doctrine, lower<br />
courts looked to the Howey test’s emphasis on<br />
management to conclude that sale of a majority equity<br />
interest passes complete control to purchaser, who should<br />
be viewed as an entrepreneur, not an investor.<br />
L<strong>and</strong>reth Timber Co. v. L<strong>and</strong>reth, 471 U.S. 681 (1985),<br />
resolved the issue with a literal interpretation of Section<br />
2. In a sale of “stock,” the Supreme Court refused to<br />
consider the “economic substance” of the transaction or to<br />
assume that federal securities laws apply only to passive<br />
investors.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Compare Reves with L<strong>and</strong>reth<br />
Why did the Supreme Court in the subsequent<br />
Reves decision not take a literal approach?<br />
Why did the Supreme Court in L<strong>and</strong>reth not rely on<br />
introductory clause (i.e., “unless the context<br />
otherwise requires”)?<br />
Is the Supreme Court’s treatment of bank<br />
certificates of deposit consistent with L<strong>and</strong>reth?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Guarantees as <strong>Securities</strong><br />
§2(a)1- “The term "security" “means …<br />
any…guarantee of…any of the foregoing”<br />
Guarantors are treated as issuers only if<br />
guarantees are incorporated into securities being<br />
distributed to investors.<br />
In other words, if guarantee <strong>and</strong> security are<br />
“bundled,” then guarantor is an issuer of a<br />
security.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Swap Agreements<br />
Note that prior to the 2010 Dodd-Frank Act, the<br />
definition of "security" in section 2(a)(1) did not<br />
include either of the following:<br />
any non-security-based swap agreement (as<br />
defined in the Gramm-Leach-Bliley Act); or<br />
any security-based swap agreement (as defined in<br />
the Gramm-Leach-Bliley Act).<br />
The Dodd-Frank Act completely changed the scheme<br />
for the regulation of swaps.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Dodd-Frank Act<br />
(July 2010)<br />
Changes to <strong>Securities</strong> Act include<br />
Adding “security-based swap” to definition of<br />
“security”<br />
Providing that any offer or sale of a securitybased<br />
swap by or on behalf of an issuer of the<br />
referenced securities constitutes a contract for<br />
the sale or offer of the sale of the referenced<br />
securities, <strong>and</strong> subjects the security-based swap<br />
to registration requirements of <strong>Securities</strong> Act<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
<strong>Securities</strong> exempt from §5<br />
registration requirements<br />
§3(a) of the <strong>Securities</strong> Act<br />
Creates exemptions for certain<br />
instruments that, based upon a strict<br />
reading of §2(a)(1), would<br />
otherwise be considered securities<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
<strong>Securities</strong> exempt from §5<br />
registration requirements<br />
Examples?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Government <strong>Securities</strong> §3(a)2<br />
“Any security issued or guaranteed by the United States<br />
or … by any State of the United States, or by any<br />
political subdivision of a State…, or by any public<br />
instrumentality of one or more States . . . .”<br />
Federal government<br />
State governments<br />
“Political subdivision” (e.g., a city)<br />
“Public instrumentality” (e.g., public agency, such as<br />
a regional water authority or a turnpike authority)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Government <strong>Securities</strong> §3(a)2<br />
Important Caveat - §17(c)<br />
SEC. 17. FRAUDULENT INTERSTATE TRANSACTIONS<br />
(a) It shall be unlawful for any person in the offer or<br />
sale of any securities . . . by the use of any means or instruments of . . .<br />
interstate commerce or by use of the mails, directly or indirectly—<br />
(1) to employ any device, scheme, or artifice to defraud, or<br />
(2) to obtain money or property by means of any untrue statement<br />
of a material fact or any omission to state a material fact<br />
necessary in order to make the statements made, in light of the<br />
circumstances under which they were made, not misleading;<br />
* * *<br />
(c) The exemptions provided in section 3 shall not apply to the<br />
provisions of this section.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Government <strong>Securities</strong> §3(a)2<br />
Important Caveat – Rule 10b-5<br />
Recent SEC Enforcement Action<br />
On May 6, 2013, the SEC charged the City of Harrisburg, PA with securities fraud for its<br />
misleading public statements when its financial condition was deteriorating <strong>and</strong> financial<br />
information available to municipal bond investors was either incomplete or outdated.<br />
In a related SEC “Report of Investigation”, the SEC notes that public officials should be<br />
mindful that their written or oral public statements may affect the “total mix of<br />
information available to investors” <strong>and</strong> that this could result in anti-fraud liability under<br />
the federal securities laws for the public officials making such statements if they are<br />
materially misleading or omit material information.<br />
The report said that public officials should consider adopting policies <strong>and</strong> procedures that<br />
are reasonably designed to result in accurate, timely, <strong>and</strong> complete public disclosures;<br />
identifying those persons involved in the disclosure process; evaluating other public<br />
disclosures including financial information made by the municipal issuer; <strong>and</strong> assuring<br />
that responsible individuals receive adequate training about their obligations under the<br />
federal securities laws.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Commercial Paper -- §3(a)3<br />
“Any note, draft, bill of exchange, or banker's<br />
acceptance which arises out of a current<br />
transaction or the proceeds of which have<br />
been or are to be used for current transactions,<br />
<strong>and</strong> which has a maturity at the time of<br />
issuance of not exceeding nine months,<br />
exclusive of days of grace, or any renewal<br />
thereof the maturity of which is likewise<br />
limited.” (Emphasis added.)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Exempt Bank <strong>Securities</strong><br />
§3(a)2 “any security issued or guaranteed by<br />
any bank”<br />
§3(a)5 “Any security issued… by a savings <strong>and</strong><br />
loan association, cooperative bank, or<br />
similar institution, which is<br />
supervised <strong>and</strong> examined by State or<br />
Federal authority having supervision over<br />
any such institution…”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Exempt Bank <strong>Securities</strong> (cont’d)<br />
Two important caveats:<br />
1. Federal or state bank regulators may<br />
impose requirements similar to ’33<br />
Act.<br />
2. Exemption does not apply to securities<br />
issued by a bank holding company,<br />
savings <strong>and</strong> loan holding company,<br />
etc.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 1 – What is a Security<br />
for Purposes of the <strong>Securities</strong> Act?<br />
Study Problem 1.1<br />
Pennypincher <strong>and</strong> 14 of her closest (but not very wealthy) friends from all over<br />
New Engl<strong>and</strong> want to organize a commercial bank under Massachusetts law.<br />
Pennypincher <strong>and</strong> her friends do not want to bear all the risk of forming the new<br />
bank.<br />
Instead, they recruit 10 wealthy friends to share the expenses, including the cost<br />
of preparing regulatory applications for FDIC <strong>and</strong> Massachusetts approvals.<br />
Together they will contribute $1 million.<br />
If <strong>and</strong> when the bank opens for business, the bank will exchange common stock<br />
for the $1 million at a price per share equal to 90% of the price paid in the $10<br />
million offering. If the bank does not open, the balance of the $1 million, if<br />
any, remaining after expenses will be returned.<br />
Would the $1 million investment in connection with the bank’s organization be<br />
subject to §5 of the <strong>Securities</strong> Act?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Limits on Bank <strong>Securities</strong><br />
Exemption<br />
Important: §3(a)2 <strong>and</strong> §3(a)5 do not<br />
apply to the pre-organization<br />
investment in Study Problem 1.1<br />
because investment is not contingent<br />
upon receipt of regulatory approvals<br />
<strong>and</strong> commencement of a banking<br />
business<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. in International Business Law<br />
Session 2 – June 26, 2012<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Private Placements §4(2), §3(b)<br />
Session 2 Agenda<br />
• <strong>Regulation</strong> D – primarily Rules 506 <strong>and</strong> 504<br />
• Accredited investor test – Rule 501(a)<br />
• General conditions – Rule 502<br />
“Crowdfunding”<br />
Equity awards to employees of privately held companies –<br />
Rule 701<br />
Exchange offers – §3(a)(9)<br />
Intrastate offerings – §3(a)(11), Rule 147<br />
Reg. S<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
But first, some context<br />
When does an “offer” occur?<br />
What is a “sale” of a security?<br />
What are the implications of<br />
registering a sale of a security<br />
with the SEC?<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Basic Principle Underlying<br />
the <strong>Securities</strong> Act of 1933<br />
Unless an exemption is available,<br />
Each <strong>and</strong> every offer or sale of a security<br />
must be registered with the SEC, <strong>and</strong><br />
In the registration statement (which<br />
includes the prospectus), all information<br />
material to that investment decision must<br />
be disclosed.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
What is an “offer”?<br />
2(a)(3) –"offer to sell", "offer for sale", or<br />
"offer"<br />
Includes every attempt or offer to dispose of, or<br />
solicitation of an offer to buy, a security or<br />
interest in a security, for value.<br />
Exception: “preliminary negotiations or<br />
agreements between an issuer . . . <strong>and</strong> any<br />
underwriter . . . .”<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
What is a “sale”?<br />
§ 2(a)(3) –"sale" or "sell"<br />
Every contract of sale or disposition of<br />
a security or interest in a security, for<br />
value.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
What is a “sale”?<br />
Special Situations – Rule 145<br />
Mergers, Sale of Assets, Reclassifications of <strong>Securities</strong><br />
Original SEC “no sale” theory<br />
Superseded by Rule 145: an offer, offer to sell, offer for<br />
sale, or sale occurs when there is submitted to<br />
security holders for a vote or consent a plan or<br />
agreement pursuant to which such holders are required<br />
to make an investment decision, whether to accept a<br />
new or different security in exchange for their existing<br />
security<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
What is a “sale”?<br />
Special Situations – Spin Offs<br />
Policy Consideration:<br />
Legitimate dividend vs. problematic distribution<br />
Legal Issue:<br />
Is disposition “for value” within the meaning of §2(a)(3)?<br />
SEC position is that lack of monetary consideration for<br />
the shares does not mean that the disposition was not for<br />
value.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Considerations:<br />
What is a “sale”?<br />
Spin Offs (cont’d)<br />
Legitimate business purpose?<br />
Adequacy of public information about the spun off<br />
securities <strong>and</strong> their issuer?<br />
Do parent shareholders provide consideration for the<br />
spun-off shares?<br />
Is spin-off pro-rata to the parent shareholders?<br />
If the parent spins-off “restricted securities,” has it held<br />
those securities for at least two years?<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
What is a “sale”?<br />
Special Situation – Free Stock<br />
Phenomenon of early Internet era<br />
Legal Issue: Similar to Spin Off<br />
SEC takes the position that a “gift” of stock is a sale “for<br />
value” when the purpose of the “gift” is to advance the<br />
donor's economic objectives rather than to make a gift for<br />
simple reasons of generosity.<br />
Attracting additional people to the web site.<br />
Increasing advertising revenue<br />
Generating general interest in the company <strong>and</strong> its br<strong>and</strong><br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Back to Basics . . .<br />
Unless an exemption is available,<br />
Each <strong>and</strong> every offer or sale of a security<br />
must be registered with the SEC, <strong>and</strong><br />
In the registration statement (which<br />
includes the prospectus), all information<br />
material to that investment decision must be<br />
disclosed.<br />
(c) 2005-2010 Michael K. Krebs. All<br />
Rights Reserved.
Implications of SEC<br />
registration?<br />
What are the implications of<br />
registering a sale of a security<br />
with the SEC, especially an<br />
IPO?<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
What does “registration” entail?<br />
1. Preparation of registration statement<br />
For companies that are not WKSIs or other<br />
publicly traded companies, registration will<br />
entail<br />
Significant expense (typically >$500,000)<br />
Significant delay (typically > four months)<br />
Public disclosures that may benefit<br />
competitors<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Lessons from Facebook IPO<br />
1. Preparation of registration statement<br />
Example of delay (not atypical)<br />
Facebook probably began working on<br />
IPO in late 2011<br />
Facebook first filed with SEC on<br />
February 1, 2012<br />
Facebook completed IPO on May 17,<br />
2012<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
What does “registration”<br />
entail? (cont’d)<br />
1. Preparation of registration statement<br />
2. Potential ’33 Act Liability<br />
Potential strict liability for issuer for<br />
materially false or misleading<br />
registration statement<br />
Potential liability for directors <strong>and</strong><br />
certain executive officers<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Lessons from Facebook IPO<br />
2. Potential ’33 Act Liability<br />
Example of litigation (atypical)<br />
According to media reports, various civil<br />
lawsuits have been filed against Facebook,<br />
Mark Zuckerberg <strong>and</strong> underwriters<br />
At least one such lawsuit alleges that the<br />
defendants concealed a weakened growth<br />
forecast prior to the IPO<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
What does “registration”<br />
entail? (cont’d)<br />
1. Preparation of registration statement<br />
2. Potential ’33 Act Liability<br />
3. Subsequent ’34 Act Reporting<br />
Audited annual financial statements<br />
Audit of internal controls (for larger<br />
companies)<br />
Quarterly <strong>and</strong> periodic reporting<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Exempt <strong>Trans</strong>actions<br />
How do “start-ups” <strong>and</strong> other small<br />
companies raise capital if they wish to<br />
avoid the time <strong>and</strong> expense of an IPO?<br />
Do mature companies raise capital other<br />
than in a registered public offering?<br />
(To be discussed in subsequent session)<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Basic Principle Underlying the<br />
<strong>Securities</strong> Act of 1933<br />
“Unless an exemption is available, . . .”<br />
Some exemptions focus on the type of<br />
security being offered – Refer to Session 1<br />
Other exemptions focus on the nature of the<br />
transaction in which the offer <strong>and</strong> sale is to<br />
occur.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Exempt <strong>Trans</strong>actions<br />
Private placements –<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved<br />
4(2) <strong>and</strong> Rule 506;<br />
Certain small offerings – 3(b), 4(6) (<strong>and</strong><br />
Rules 504 <strong>and</strong> 505), Reg. CE, Rule 701;<br />
Intrastate offerings –<br />
Exchanges by the issuer –<br />
Fairness Hearings –<br />
<br />
3(a)(11) <strong>and</strong> Rule 147;<br />
3(a)(10);<br />
3(a)(9);<br />
4(1) <strong>and</strong> Rule 144 – IUD (i.e., sales not by an<br />
Issuer, Underwriter or Dealer)<br />
Reg. S
Rule 506<br />
Exempt <strong>Trans</strong>actions<br />
JOBS Act Changes<br />
More flexibility in communicating<br />
regarding private placement<br />
“Crowdfunding”<br />
<strong>Regulation</strong>s not issued yet<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Our Focus in Session 2<br />
Private placements –<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved<br />
4(2) <strong>and</strong> Rule 506<br />
Certain small offerings – 3(b), 4(6) (<strong>and</strong> Rules 504<br />
<strong>and</strong> 505), “crowdfunding” <strong>and</strong> Reg. CE, Rule 701<br />
Intrastate offerings –<br />
Exchanges by the issuer –<br />
Fairness Hearings –<br />
3(a)(11) <strong>and</strong> Rule 147<br />
3(a)(10)<br />
3(a)(9)<br />
Secondary trading – 4(1) <strong>and</strong> Rules 144 (i.e., sales not<br />
by an Issuer, Underwriter or Dealer) (this will be<br />
covered in a later Session)<br />
Reg. S (this will be covered in a later Session)
Exempt <strong>Trans</strong>actions –<br />
Key Principle #1<br />
<strong>Securities</strong> offered <strong>and</strong> sold in an exempt<br />
transaction do not thereby become exempt<br />
securities.<br />
For each <strong>and</strong> every subsequent “offer”/<br />
“sale” of those securities, seller must either<br />
register the offer/sale with SEC or then<br />
qualify for an exemption from registration.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Funding Start-Ups<br />
Study Problem No. 2.1<br />
BeanTown Biosystems, Inc. sells 10,000 shares of common<br />
stock for $600,000 to the parents of the company’s four<br />
founders, who are recent graduates from BC, BU, Harvard<br />
<strong>and</strong> MIT, respectively.<br />
In total, four parents will own in total 40% of Biosystems<br />
immediately after the investment. Each founder will own<br />
15%.<br />
Must Biosystems register under 5 of the <strong>Securities</strong> Act the<br />
sale of stock to the founders’ parents?<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Funding Start-Ups<br />
Study Problem No. 2.2<br />
Two months after the parents’ investment, BeanTown<br />
Biosystems, Inc. files a patent for medical diagnostic<br />
device.<br />
Very Confident VC Investment Fund wants to invest<br />
$4.5 million cash in Biosystems in exchange for<br />
Series A preferred stock, representing a 40% equity<br />
interest in Biosystems after the investment.<br />
Must Biosystems register under 5 of the <strong>Securities</strong><br />
Act the sale of the Series A Preferred Stock to Very<br />
Confident?<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
4(2) –<br />
Private Placements<br />
transactions by an issuer not<br />
involving any public offering<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Private Placements<br />
Interpretative issue:<br />
What is a “public offering”<br />
within the meaning of<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved<br />
4(2)?
4(2) Analysis<br />
1953 Ralston Purina Supreme Court Decision:<br />
Burden is on the issuer<br />
Offeree must be able to fend for himself<br />
Access to the “kind of information which registration<br />
under 5 would disclose”<br />
1962 SEC Release No. 4,552:<br />
“Coming to Rest” – Restrictions on transfer<br />
Integration – Five factors<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
4(2) Analysis (cont’d)<br />
1975 ABA Position Paper:<br />
Offeree qualification (i.e., offeree must be able<br />
to fend for himself)<br />
Access to information material to investment<br />
decision<br />
Manner of offering (i.e., no public advertising)<br />
Safeguards against redistribution (i.e., “coming<br />
to rest”)<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Private Placements –<br />
<strong>Regulation</strong> D<br />
1982 SEC Adopts Regulatory “Safe Harbor”<br />
<strong>Regulation</strong> D (Limited Offers)<br />
Rule 501 (Categories of accredited investors)<br />
Rule 502 (General conditions to be met)<br />
BUT remember JOBS Act<br />
Rule 506 (Sales without regard to offering size)<br />
Rule 505 (Offerings not exceeding $5 million)<br />
Rule 504 (Offerings not exceeding $1 million)<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Private Placements –<br />
<strong>Regulation</strong> D<br />
General conditions to be met – Rule 502<br />
No integration problem – Rule 502(a)<br />
Required disclosure, if any, provided – Rule 502(b)<br />
No general solicitation or general advertising – Rule 502(c)<br />
But keep in mind JOBS Act Change (see next slide)<br />
Limitations on resale – Rule 502(d)<br />
Notice of sale – Rule 503<br />
Must file Form D with the SEC no later than 15 calendar days<br />
after the first sale of securities in the offering<br />
No disqualification – Rule 507<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
<strong>Regulation</strong> D –<br />
Important JOBS Act Change<br />
JOBS Act limits prohibition on general solicitation or<br />
general advertising – Rule 502(c)<br />
JOBS Act requires the SEC, not later than July 4, 2012, to<br />
revise <strong>Regulation</strong> D to provide that prohibitions against<br />
general solicitation or general advertising contained in<br />
Rule 502(c) shall not apply to offers <strong>and</strong> sales of securities<br />
made pursuant to Rule 506 provided that all purchasers<br />
of the securities are accredited investors.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Private Placements –<br />
<strong>Regulation</strong> D<br />
Accredited investor test – “Rules of Thumb”<br />
Entities:<br />
Total assets > $5 million <strong>and</strong> not formed for the<br />
purpose of the investment<br />
Individuals:<br />
Income for last two years – <strong>and</strong> expected income for<br />
current year – is > $200,000 ($300,000 married<br />
couple)<br />
Net worth – excluding equity in primary residence –<br />
> $1,000,000 (with or without spouse)<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Private Placements –<br />
<strong>Regulation</strong> D<br />
How many investors may<br />
purchase securities in a Reg. D<br />
offering?<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Private Placements –<br />
<strong>Regulation</strong> D<br />
Practice points in dealing with non-accredited<br />
investors<br />
Rules 506 <strong>and</strong> 505 seem to cap at 35 the number of<br />
investors in an offering<br />
But Rule 501(e), which has special counting rules,<br />
excludes accredited investors from that 35 investor<br />
limit<br />
Beware: the inclusion of even one non-accredited<br />
investor triggers the information disclosure rules<br />
for 506 <strong>and</strong> 505 offerings. Rule 502(b)(1).<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Private Placements –<br />
“Crowdfunding” §4(6)<br />
JOBS Act added §4(6) to the <strong>Securities</strong> Act<br />
Exempts from registration securities sold by a closely held<br />
company raising up to $1 million within any given 12‐month<br />
period, provided that:<br />
1. The amount purchased by an investor in the transaction<br />
does not exceed the maximum investment amount (see<br />
subsequent slide);<br />
2. The transaction is conducted through a broker or “funding<br />
portal;” <strong>and</strong><br />
3. The private company provides certain descriptive<br />
information to the funding portal <strong>and</strong> the SEC.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
“Crowdfunding” – Investor Cap<br />
During any 12-month period, the aggregate amount sold to any<br />
investor by an issuer, including in reliance on §4(6), may<br />
not exceed —<br />
(1) Greater of $2,000 or 5 percent of the annual income or net<br />
worth of such investor, as applicable, if either the annual<br />
income or the net worth of the investor is less than $100,000;<br />
<strong>and</strong><br />
(2) 10 percent of the annual income or net worth of such<br />
investor, as applicable, not to exceed a maximum aggregate<br />
amount sold of $100,000, if either the annual income or net<br />
worth of the investor is equal to or more than $100,000<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Crowdfunding Portal<br />
A funding portal is defined as a crowdfunding intermediary that does<br />
not:<br />
1. offer investment advice or recommendations;<br />
2. solicit purchases, sales, or offers to buy securities offered or<br />
displayed on its website or portal;<br />
3. compensate employees, agents, or others persons for such<br />
solicitation or based on the sale of securities displayed or<br />
referenced on its website or portal;<br />
4. hold, manage, possess, or otherwise h<strong>and</strong>le investor funds or<br />
securities; or<br />
5. engage in such other activities as the SEC, by rule, determines<br />
appropriate.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Funding Start-Ups<br />
Study Problem No. 2.1<br />
BeanTown Biosystems, Inc. sells 10,000 shares of common<br />
stock for $600,000 to the parents of the company’s four<br />
founders, who are recent graduates from BC, BU, Harvard<br />
<strong>and</strong> MIT, respectively.<br />
In total, four parents will own in total 40% of Biosystems<br />
immediately after the investment. Each founder will own<br />
15%.<br />
Must Biosystems register under 5 of the <strong>Securities</strong> Act<br />
the sale of stock to the founders’ parents?<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Funding Start-Ups<br />
Study Problem No. 2.1 – Analysis<br />
Biosystems’s sale of stock to founders’ parents would<br />
be exempt from registration.<br />
Rule 504 (< $1 million) or 4(2)<br />
Size <strong>and</strong> nature of investor group would likely not<br />
raise concern under 4(2)<br />
One would expect that the parents would have<br />
access to all material information<br />
Investor “sophistication” (or “purchaser<br />
representative”) not required under Rule 504<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Funding Start-Ups<br />
Study Problem No. 2.1 – Analysis (cont’d)<br />
Rule 504 (< $1 million) (relies on Section 3(b) of <strong>Securities</strong> Act)<br />
Biosystems does not fall within one of the categories of issuers that<br />
may not use Rule 504. Those excluded issuers include:<br />
Issuer subject to Exchange Act reporting requirements of section<br />
13 or 15(d);<br />
Investment companies; or<br />
Development stage company that either has no specific business<br />
plan or purpose or has indicated that its business plan is to engage<br />
in a merger or acquisition with an unidentified company or<br />
companies, or other entity or person<br />
Investor “sophistication” (or “purchaser representative”) not required<br />
under Rule 504<br />
Issuer not required to furnish specific information under Rule 504.<br />
See Rule 502(b)(1).<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Funding Start-Ups<br />
Study Problem No. 2.1 – Analysis (cont’d)<br />
Either<br />
4(2) or Rule 504 Require Resale Restrictions<br />
See, for example, Rule 502(d):<br />
The issuer shall exercise reasonable care to assure that purchasers of securities are not<br />
underwriters within the meaning of Section 2(a)(11), which reasonable care may be<br />
demonstrated by:<br />
Reasonable inquiry to determine if purchaser is acquiring securities for himself or<br />
for other persons [this usually is satisfied by an investor representation in<br />
purchase agreement; see sample purchase agreement];<br />
Written disclosure to each purchaser prior to sale that securities have not been<br />
registered under the Act <strong>and</strong>, therefore, cannot be resold unless they are registered<br />
under the Act or unless an exemption from registration is available [this usually is<br />
satisfied by an investor representation in purchase agreement whereby investor<br />
acknowledges that she underst<strong>and</strong>s these restrictions]; <strong>and</strong><br />
Placement of a legend on the certificate or other document that evidences securities,<br />
stating that securities have not been registered under the Act <strong>and</strong> setting forth or<br />
referring to restrictions on transferability <strong>and</strong> sale of the securities [see slide with<br />
sample restrictive legend].”<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Sample Subscription<br />
Agreement<br />
In a private placement, the agreement whereby the investor<br />
agrees to purchase, <strong>and</strong> the issuer agrees to sell, the<br />
restricted securities sometimes is referred to as the<br />
“subscription agreement.”<br />
Excerpts from a model subscription agreement for a private<br />
placement by a limited liability company (LLC) is posted<br />
on the course Web site under the Session 2 reading<br />
materials.<br />
The highlighted sections are the investor representations<br />
intended to satisfy Rule 502(d).<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Sample Restrictive Legend<br />
THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE<br />
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF<br />
1933, AS AMENDED, OR QUALIFIED UNDER ANY STATE<br />
SECURITIES LAWS. THE SECURITIES MAY NOT BE<br />
OFFERED, SOLD, TRANSFERRED OR OTHERWISE<br />
DISPOSED OF WITHOUT SUCH REGISTRATION OR THE<br />
DELIVERY TO THE CORPORATION OF WRITTEN NOTICE<br />
AND, IF REQUESTED BY THE CORPORATION, AN OPINION<br />
OF COUNSEL, REASONABLY SATISFACTORY TO THE<br />
CORPORATION, THAT AN EXEMPTION FROM<br />
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS<br />
AMENDED, AND FROM QUALIFICATION UNDER SUCH<br />
STATE SECURITIES LAW IS THEN AVAILABLE.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Funding Start-Ups<br />
Study Problem No. 2.2<br />
Two months after the parents’ investment, BeanTown<br />
Biosystems, Inc. files a patent for medical diagnostic<br />
device.<br />
Very Confident VC Investment Fund wants to invest<br />
$4.5 million cash in Biosystems in exchange for<br />
Series A preferred stock, representing a 40% equity<br />
interest in Biosystems after the investment.<br />
Must Biosystems register under 5 of the<br />
<strong>Securities</strong> Act the sale of the Series A Preferred<br />
Stock to Very Confident?<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Funding Start-Ups<br />
Study Problem No. 2.2 – Analysis<br />
Biosystems’s sale of stock to Very Confident VC Investment Fund<br />
would be exempt from registration.<br />
Rule 506 or Rule 505 (< $5 million) or<br />
4(2)<br />
Facts suggest investor is both “accredited” <strong>and</strong> “sophisticated”<br />
Such an investor would likely not raise a concern under 4(2)<br />
Also, Rules 505 <strong>and</strong> 506 could be used:<br />
Issuer not required to furnish specific information to<br />
accredited investor. See Rule 502(b)(1).<br />
Facts do not indicate any impermissible “general<br />
solicitation or general advertising.” See Rule 502(c).<br />
No integration with $600,000 investment by parents<br />
Either 4(2), Rule 505 or Rule 506 require resale restrictions<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Excerpts from Sample Venture<br />
Capital Purchase Agreement<br />
In the venture capital context, the agreement whereby the<br />
investor agrees to purchase, <strong>and</strong> the issuer agrees to sell,<br />
the restricted securities is sometimes referred to as a “stock<br />
purchase agreement.”<br />
Excerpts from a model stock purchase agreement for an<br />
initial round of venture capital investment is posted on the<br />
course Web site under the Session 2 reading materials.<br />
The highlighted sections are the investor representations<br />
intended to satisfy Rule 502(d).<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Funding Start-Ups<br />
Study Problem No. 2.3<br />
Assume BeanTown Biosystems does not obtain funding from Very Confident.<br />
Five months after the parents invest $600,000, 28 friends of the Biosystems<br />
founders want to invest a total of $4.6 million in Biosystems common stock.<br />
Each of those friends is very knowledgeable about Biosystems’s technology, but<br />
only four have had significant financial success. None has had any prior<br />
involvement with Biosystems.<br />
Each of the four financially successful investors intends to invest $1,000,000;<br />
each of the other 24 investors plans to invest $25,000.<br />
Could Biosystems structure the investment to avoid registration under 5<br />
of the <strong>Securities</strong> Act? If so, how? Do you need additional information?<br />
What if another 10 friends of modest means want to invest $10,000 each as part<br />
of the same offering? What if one of the $1 million investors was identified<br />
by a “finder.”<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Funding Start-Ups<br />
Study Problem No. 2.3 – Analysis<br />
Biosystems could structure the investment to avoid registration under<br />
of the <strong>Securities</strong> Act, possibly with some changes.<br />
4(2) vs. Rule 506 vs. Rule 505<br />
Size <strong>and</strong> nature of investor group raises concern under<br />
Cannot have more than 35 non-accredited investors under either Rule 505 or Rule<br />
506<br />
For non-accredited investors, investor “sophistication” (or “purchaser<br />
representative”) required under 506(b)(2)(ii) . . . If not possible, consider Rule<br />
505<br />
BUT Rule 505 raises “integration” concerns with the parents’ investment five<br />
months earlier . . .<br />
ALSO substantial disclosure would be required because of non-accredited<br />
investors (Rule 502(b) for both Rules 505 <strong>and</strong> 506) . . . so consider whether<br />
burden is warranted for the $600,000 of incremental financing from nonaccredited<br />
investors<br />
Adding another 10 presumably non-accredited investors would preclude reliance<br />
on Rule 506.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved<br />
4(2)<br />
5
Session 2 – Exempt <strong>Trans</strong>actions<br />
Funding Start-Ups<br />
Study Problem No. 2.3 – Analysis (cont’d)<br />
Important: Biosystem’s reliance on Rule 506 would<br />
provide ancillary benefits under state securities laws<br />
(also known as “blue sky” laws) as a result of the<br />
National <strong>Securities</strong> Markets Improvement Act of 1996<br />
("NSMIA"), which amended Section 18 of the<br />
<strong>Securities</strong> Act. [See next slide re NSMIA]<br />
Adding another 10 investors would preclude reliance<br />
on Rule 506, if, as it seems they are non-accredited.<br />
Biosystems’s use of a finder could cause many<br />
complications [See subsequent slide]<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Funding Start-Ups<br />
A Few Words About NSMIA<br />
NSMIA, which is codified in Section 18 of the <strong>Securities</strong><br />
Act, creates a class of securities - referred to as "covered<br />
securities" - the offer <strong>and</strong> sale of which are no longer<br />
subject to state securities law registration requirements.<br />
Covered securities include: securities listed (or approved<br />
for listing) on the NYSE <strong>and</strong> NASDAQ; certain securities<br />
exempt under Section 3(a) of the Act (including<br />
government or municipal securities, bank securities <strong>and</strong><br />
commercial paper); <strong>and</strong> securities exempt from<br />
registration under the Act if sold in transactions<br />
complying with Rule 506 of <strong>Regulation</strong> D.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Funding Start-Ups<br />
A Few More Words About NSMIA<br />
As a result of NSMIA, states may no longer require the registration<br />
of covered securities.<br />
States may, as permitted under NSMIA, require filings <strong>and</strong> the<br />
payment of fees for offers <strong>and</strong> sales in their state of covered<br />
securities other than those which are listed.<br />
Additionally, since NSMIA only preempts state securities<br />
registration requirements, broker-dealer <strong>and</strong> agent/salesperson<br />
registration requirements (applicable to individuals engaged in the<br />
offer <strong>and</strong> sale of covered securities) must still be examined to<br />
determine whether action is required to be taken in connection with a<br />
particular offering or transaction.<br />
Although NSMIA preempts state securities registration requirements,<br />
NSMIA preserves the right of the states to investigate <strong>and</strong> prosecute<br />
fraud.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Funding Start-Ups<br />
A Few Words About “Finders”<br />
Finders, mergers <strong>and</strong> acquisitions advisors <strong>and</strong> institutional<br />
private placement practitioners often are collectively referred to<br />
as Private Placement Broker-Dealers (“PPBDs”).<br />
Many finders <strong>and</strong> other PPBDs are not registered with the SEC<br />
as “broker-dealers.”<br />
The SEC takes the position that a finder or other PPBD whose<br />
compensation for participation in the transaction depends upon<br />
the amount or outcome of the transaction – which the SEC<br />
refers to as “transaction-based compensation” – is acting as a<br />
broker <strong>and</strong> therefore should register as such.<br />
The SEC <strong>and</strong> the states frequently bring enforcement actions<br />
against unlicensed PPBDs.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Funding Start-Ups<br />
A Few More Words About “Finders”<br />
Why should an issuer care if a PPBD is an unregistered broker?<br />
Issuers must disclose on Form D payments to brokers <strong>and</strong> finders.<br />
Under state law, payment of a commission to an unregistered broker<br />
may preclude a state exemption if Rule 506 is not used <strong>and</strong> therefore<br />
NSMIA preemption does not apply.<br />
Depending on the nature of the finder’s marketing efforts, the activities<br />
may constitute general solicitation.<br />
Commentators have argued that if an unregistered PPBD engaged in a<br />
sale of a security to an investor, that investor may be able to “void” or<br />
rescind the investment contract because Section 29(b) of the Exchange<br />
Act provides that contracts in violation of that Act are void.<br />
Good secondary source: Report <strong>and</strong> Recommendation of the Task Force on<br />
Private Placement Broker- Dealers, 60 Business Lawyer 959 (May 2005).<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Mergers Involving Emerging Companies<br />
Study Problem No. 2.4<br />
[Assume transaction in Problem 2.2 did occur but the transaction in Problem 2.3 did not.]<br />
Five months after Very Confident’s $4.5 million investment, Biosystems wants to acquire<br />
Great Genome Solutions, Inc. a biotech company located in northern California. Genome is 60<br />
percent controlled by two friends of Biosystems’s founders.<br />
Biosystems will acquire Genome by merging a newly formed Biosystems subsidiary with <strong>and</strong><br />
into Genome, resulting in Genome becoming a wholly owned subsidiary of Biosystems (this is<br />
a conventional merger structure known as a “reverse triangular merger”). Genome<br />
stockholders will receive only shares of Biosystems common stock (assuming none exercises<br />
appraisal rights under applicable state corporate law).<br />
In addition to Genome’s founders, it has 20 other stockholders, some of whom are employees<br />
<strong>and</strong> others are relatives of the founders. Aside from the founders, none of Genome’s<br />
stockholders is very sophisticated regarding corporate finance matters. The founders would<br />
enter into a customary voting agreement, agreeing to vote their shares in favor of the merger.<br />
Must Biosystems file a registration statement with the SEC in order to acquire Genome?<br />
Assume the acquisition is valued at $3.5 million? What if Genome is valued at $7.0<br />
million? What if Genome has 60 stockholders <strong>and</strong> most are not Genome employees?<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Mergers Involving Emerging Companies<br />
Study Problem No. 2.4 – Analysis<br />
Biosystems’s issuance of stock to Genome stockholders need<br />
not be registered under 5 of the <strong>Securities</strong> Act, because<br />
Biosystems’s common stock clearly is a “security” under<br />
the Act <strong>and</strong> is not an exempt security under 3(a).<br />
The merger will involve a “sale” of a security under the<br />
Act (since 1972).<br />
2(a)(3) – “Sale” includes every . . . disposition of a<br />
security for value”<br />
See Rule 145 – especially the Preliminary Note<br />
Voting agreement by control stockholders does not change<br />
analysis.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Mergers Involving Emerging Companies<br />
Study Problem No. 2.4 – Analysis (Cont’d)<br />
Biosystems’s issuance of stock to Genome stockholders in the merger could qualify<br />
as an exempt transaction.<br />
4(2) vs. Rule 506 vs. Rule 505<br />
Size <strong>and</strong> nature of stockholder group raises concerns about relying solely on<br />
4(2)<br />
Merger will not raise “integration” concerns under Rule 505 with recent $4.5<br />
million Very Confident investment, because<br />
The two transactions were not part of a single plan of financing<br />
Biosystems received very different consideration in each (Genome stock<br />
vs. cash)<br />
<strong>Trans</strong>action would involve less than 35 non-accredited investors, so either<br />
Rule 505 or 506 is possible<br />
Investor “sophistication” (or purchaser representative) not required under 505<br />
but would be required under 506(b)(2)(ii)<br />
Rule 505 exemption therefore probably is the best alternative if acquisition is<br />
valued at $3.5 million<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Mergers Involving Emerging Companies<br />
Study Problem No. 2.4 – Analysis (Cont’d)<br />
If Genome is valued at $7.0 million?<br />
Biosystems would rely on Rule 506 (not Rule 505)<br />
Investor “sophistication” (or purchaser representative) is<br />
required under 506(b)(2)(ii)<br />
What if Genome has 60 stockholders <strong>and</strong> most are not<br />
Genome employees?<br />
Rule 506 available if not more than 35 non-accredited<br />
investors, <strong>and</strong><br />
Unsophisticated investors need a purchaser representative<br />
under 506(b)(2)(ii) or, alternatively, Biosystems might<br />
consider a 3(a)(10) “fairness hearing” in California<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Fairness Hearings –<br />
3(a)(10)<br />
©2012 Michael K. Krebs<br />
All Rights Reserved<br />
3(a)(10)<br />
any security . . . issued in exchange for one or more<br />
bona fide outst<strong>and</strong>ing securities… after a hearing upon<br />
the fairness of such terms <strong>and</strong> conditions … by any<br />
court, or by any official or agency of the United States,<br />
or by any State or Territorial banking or insurance<br />
commission or other governmental authority expressly<br />
authorized by law to grant such approval<br />
Additional guidance provided in SEC Staff Legal<br />
Bulletin regarding 3(a)(10) (not required reading)
Session 2 – Exempt <strong>Trans</strong>actions<br />
Emerging Companies <strong>and</strong> Warrants<br />
Study Problem No. 2.5<br />
[Assume Genome acquisition occurred valued at $3.5 million]<br />
In the year following the Great Genome acquisition, BeanTown Biosystems’s<br />
business exp<strong>and</strong>s significantly, <strong>and</strong> it wants to borrow $1 million each from Very<br />
Confident <strong>and</strong> the two Genome founders.<br />
The promissory notes evidencing the borrowing will be secured by a lien on all of<br />
Biosystems’s No’s tangible <strong>and</strong> intangible assets <strong>and</strong> payable in three years or, if<br />
earlier, upon the completion of an IPO of Biosystems.<br />
Each lender will receive a warrant to purchase from Biosystems 100,000 shares of<br />
Biosystems common stock at a price per share of $10, which is 25% above the $8<br />
price at which Biosystems common stock was valued in the Genome acquisition.<br />
The warrant expires in ten years <strong>and</strong> is exercisable only after 12 months or upon the<br />
completion of an IPO, whichever is earlier. The warrant includes a customary “net<br />
exercise” provision.<br />
Are the notes securities? Are the warrants securities? Must Biosystems file a<br />
registration statement with the SEC in connection with this financing?<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Emerging Companies <strong>and</strong> Warrants<br />
Study Problem No. 2.5 – Analysis<br />
The notes are not securities. See 2(a)(1) <strong>and</strong> Reves v. Ernst & Young - “Unless the context<br />
otherwise requires” in preamble to § 2(a).<br />
Reves: family resemblance test.<br />
• Every “note” is presumed to be security unless it bears a strong resemblance (in terms<br />
of four factors) to one of the categories of instruments listed by the court that are not<br />
securities.<br />
• Plan of distribution is not to general public; note is secured by all-assets lien, reducing<br />
the risks to note holders; <strong>and</strong> therefore better view is that Very Confident <strong>and</strong><br />
Genome’s two founders thought they were making a commercial loan, not<br />
purchasing a security.<br />
• Short-term note secured by assets of a small business is an example cited in Reves of<br />
a promissory note that is not a security<br />
• Therefore, the Biosystems promissory notes are more analogous to category of loans<br />
issued to commercial banks in a conventional lending transactions <strong>and</strong> do not fall<br />
within statutory definition of "notes" that are "securities."<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Emerging Companies <strong>and</strong> Warrants<br />
Study Problem No. 2.5 – Analysis (cont’d)<br />
The warrants clearly are securities.<br />
See § 2(a)(1): “warrant” to purchase stock is specifically<br />
identified as a security<br />
The offer <strong>and</strong> sale of the warrants likely is exempt under<br />
any of several exemptions, including Rule 506.<br />
Size <strong>and</strong> nature of warrant holder group may justify<br />
reliance solely on §4(2).<br />
Therefore, Biosystems does not have to file a registration<br />
statement in connection with the $3 million borrowing or the<br />
warrants.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Emerging Companies/Employee Stock Awards<br />
Study Problem No. 2.6<br />
[Assume Genome acquisition occurred ]<br />
BeanTown Biosystems’s main office is in Massachusetts <strong>and</strong><br />
some development work will take place in at the former<br />
Genome facility in California.<br />
Biosystems has 40 employees <strong>and</strong> would like to offer them<br />
stock options as an inducement for them to accept less cash<br />
compensation than they would earn at many other companies.<br />
None of the employees qualifies as an accredited investor.<br />
Must Biosystems register under §5 of the <strong>Securities</strong> Act the<br />
grant of the options? What about the sale of stock upon<br />
exercise of the options? What if Biosystems had not<br />
acquired Genome?<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Intrastate Offerings –<br />
<strong>and</strong> Rule 147<br />
Resale restrictions<br />
©2012 Michael K. Krebs<br />
All Rights Reserved<br />
3(a)(11)<br />
For nine months after the offering is complete, purchasers may<br />
not resell securities to any non-resident of the state<br />
Offering size<br />
No maximum offering amount<br />
Pitfalls for the unwary<br />
Many<br />
Exemption not available if any purchaser, or any offeree!!, is<br />
not a resident of the state<br />
Restrictions on use of an underwriter not located in the state
Session 2 – Exempt <strong>Trans</strong>actions<br />
Emerging Companies/Employee Stock Awards<br />
Study Problem No. 2.6 – Analysis<br />
Biosystems will likely not be required to register under 5 of the<br />
<strong>Securities</strong> Act the offer or sale of the stock options to the employees.<br />
<br />
4(2) may be available BUT rather risky given size of group<br />
Rule 504 might be available<br />
<br />
3(a)(11)/Rule 147 not available if grants made to employees<br />
who live in California<br />
MOST IMPORTANT – Rule 701 will likely be available.<br />
Rule 701 will also exempt the issuance of Biosystems stock<br />
upon the exercise of the option.<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Rule 701<br />
Rule 701 (Benefit Plans/Contracts Relating to<br />
Compensation)<br />
Only for issuers that do not file periodic reports with<br />
SEC under Exchange Act<br />
Must be a written compensatory benefit plan (or written<br />
compensation contract)<br />
Only for sales to insiders or near-insiders, such as<br />
directors, officers, employees, <strong>and</strong> consultants or other<br />
advisors<br />
BUT . . . aggregate annual sales limits . . . See Rule<br />
701(d)(2)<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Rule 701 (cont’d)<br />
Rule 701(d):<br />
No limit on offers<br />
Aggregate sales price during any consecutive 12month<br />
period must not exceed the greatest of the<br />
following:<br />
$1,000,000;<br />
15% of the total assets;<br />
15% of the outst<strong>and</strong>ing amount of the class of<br />
securities being offered.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Rule 701 (cont’d)<br />
Value of options for 701 purposes is<br />
based upon option exercise price<br />
No integration with other offerings<br />
Limited disclosure required unless<br />
amount during any 12-month period<br />
exceeds $5 million<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Exempt <strong>Trans</strong>actions<br />
Google Pre-IPO Private Placements<br />
SEC Form S-1, Part II, Item 15. Recent Sales of Unregistered<br />
<strong>Securities</strong><br />
Furnish information required by Item 701 of <strong>Regulation</strong> S-K<br />
SEC Reg. S-K Item 701:<br />
Furnish the following information as to all securities sold by registrant<br />
within the past three years which were not registered under <strong>Securities</strong><br />
Act.<br />
Include sales of reacquired securities, as well as new issues, securities<br />
issued in exchange for property, services, or other securities<br />
Indicate the section of <strong>Securities</strong> Act or SEC rule under which<br />
exemption from registration was claimed <strong>and</strong> state briefly facts relied<br />
upon to make exemption available<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Private Placements<br />
Google Pre-IPO Private Placements<br />
Google April 2004 Form S-1, Part II, Item 15. Recent Sales of<br />
Unregistered <strong>Securities</strong>:<br />
The following sets forth information regarding securities sold by the<br />
registrant since January 1, 2001.<br />
1. In January 2001, Google sold 9,000 shares of Series C preferred stock<br />
for cash consideration of $21,083 to an accredited investor.<br />
* * *<br />
5. Since January 2001, the registrant has issued to directors, officers,<br />
employees <strong>and</strong> consultants options to purchase 63,230,957 shares of<br />
common stock with an aggregate exercise price of $118,292,482, <strong>and</strong><br />
has issued 42,013,513 shares of common stock for an aggregate<br />
purchase price of $27,123,241 upon exercise of such options.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Private Placements<br />
Google Pre-IPO Private Placements<br />
Google April 2004 Form S-1, Part II, Item 15. Recent Sales of<br />
Unregistered <strong>Securities</strong>:<br />
“Except as noted below, the issuance of securities described above<br />
were deemed to be exempt from registration under the <strong>Securities</strong><br />
Act in reliance on Section 4(2) . . . as transactions by an issuer not<br />
involving any public offering. The recipients of securities in each<br />
such transaction represented their intention to acquire the securities<br />
for investment only <strong>and</strong> not with a view to or for sale in connection<br />
with any distribution thereof <strong>and</strong> appropriate legends were affixed<br />
to the share certificates <strong>and</strong> other instruments issued in such<br />
transactions. The sale of these securities were made without<br />
general solicitation or advertising.”<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 2 – Private Placements<br />
Google Pre-IPO Private Placements<br />
Google July 2004 Amendment No. 4 to Form S-1, Part II, Item 15.<br />
Recent Sales of Unregistered <strong>Securities</strong>:<br />
“The option grants <strong>and</strong> stock issuances described in paragraph 5 above include the issuance<br />
of 37,099,623 options <strong>and</strong> 23,702,819 shares of our common stock that may not have been<br />
exempt from registration or qualification requirements under federal or state securities laws,<br />
<strong>and</strong> we have not registered or qualified all of these shares under these laws. Consequently,<br />
certain of the options we granted <strong>and</strong> the shares issued upon exercise of these options may<br />
have been issued in violation of federal or state securities laws, or both, <strong>and</strong> may be subject<br />
to rescission. In order to address this issue, we intend to make a rescission offer soon after<br />
the effective date of this offering to all holders of any outst<strong>and</strong>ing options <strong>and</strong> shares<br />
subject to rescission, pursuant to which we will offer to repurchase these options <strong>and</strong> shares<br />
then outst<strong>and</strong>ing from the holder. If our rescission offer is accepted by all offerees, we<br />
could be required to make an aggregate payment to the holders of these options <strong>and</strong> shares<br />
of up to approximately $25.9 million, which includes statutory interest. There are no<br />
assurances that we will not be subject to penalties or fines relating to these issuances. We<br />
believe our anticipated rescission offer could provide us with additional meritorious<br />
defenses against any future claims relating to these shares.”<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Rule 701 <strong>and</strong> JOBS Act<br />
§501 of JOBS Act amended §12(g)(1)(A) of Exchange<br />
Act to increase “holder of record” threshold to<br />
2,000 persons, or<br />
500 persons who are not accredited investors<br />
BUT §502 of JOBS Act provides that employees who<br />
receive securities in an exempt offering, which would<br />
include a 701 offering, are excluded from both “holder of<br />
record” tests.<br />
If these provisions had been in effect, would Facebook<br />
have gone public?<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. - International Business Law<br />
June/July 2012<br />
Michael Krebs<br />
JD, Boston University School of Law 1985<br />
Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />
Tel. 617.439.2288 email: mkrebs@nutter.com<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. in International Business Law<br />
Session 3 – June 27, 2012<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 Agenda<br />
Planning for an Initial Public Offering or IPO –<br />
Underst<strong>and</strong>ing the “gun jumping” rules<br />
What is a “WKSI”? How are the gun jumping rules different<br />
for a WKSI?<br />
What are the other categories of issuers under the <strong>Securities</strong><br />
Act? How are the gun jumping rules different for them?<br />
How does the JOBS Act change the gun jumping rules?<br />
Civil <strong>and</strong> Criminal Liability under the <strong>Securities</strong> Act<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Basic Principles Underlying the<br />
<strong>Securities</strong> Act of 1933<br />
Unless an exemption is available,<br />
1. Every offer or sale of a security must be<br />
registered with the SEC under § 5 of the<br />
<strong>Securities</strong> Act, <strong>and</strong><br />
2. In the registration statement (which<br />
includes the prospectus), all information<br />
material to that investment decision must<br />
be disclosed.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Planning for an IPO<br />
Restrictions on communications during<br />
“registration”?<br />
• When is a company deemed to be “in registration”?<br />
• What is an “offer”?<br />
• What is a “prospectus”?<br />
• What are the restrictions on company<br />
communications while it is in registration?<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Section 5 Rubric<br />
Three distinct phases of “registration”<br />
Pre-Filing<br />
Waiting Period<br />
Post-Effective<br />
(c) 2012 Michael K. Krebs. All<br />
Rights Reserved.
Section 5 Rubric<br />
5(c) It is unlawful to offer to sell a “security” before a<br />
registration statement is on file with the SEC with<br />
respect to such transaction.<br />
5(b)(1) It is unlawful to make use of a prospectus relating to<br />
a transaction for which a registration statement has<br />
been filed unless the prospectus meets the<br />
requirements of 10(a).<br />
5(a) It is unlawful to sell a security unless a registration<br />
statement is “in effect” [i.e., has been declared<br />
effective] with respect to such transaction.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
What constitutes an “offer”?<br />
The “Gun Jumping” Doctrine<br />
But first, some context!<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During<br />
“Registration”?<br />
Study Problem 3.1<br />
Two years after its formation, BeanTown Biosystems’s prototype medical<br />
diagnostic device is receiving rave reviews in beta testing, <strong>and</strong> Biosystems<br />
launches a publicity campaign aimed at building market dem<strong>and</strong> for its product<br />
<strong>and</strong> begins planning for the construction of a $75 million manufacturing facility<br />
that would allow Biosystems to meet anticipated dem<strong>and</strong> for the diagnostic<br />
device <strong>and</strong> accelerate its ongoing research <strong>and</strong> development efforts.<br />
The Biosystems board approves the recommendation of the company’s four<br />
founders, Rachel, Monica, Phoebe <strong>and</strong> Emma, that should Biosystems should<br />
“go public” by selling $100 million of common stock in an underwritten<br />
offering <strong>and</strong> use the proceeds to fund its manufacturing facility, to accelerate<br />
R&D, <strong>and</strong> to provide additional working capital for raw material <strong>and</strong> inventory.<br />
Might the marketing campaign create problems under the <strong>Securities</strong> Act for the<br />
proposed public offering if the campaign began 25 days before the registration<br />
statement was filed? What if it began 45 days before?<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During<br />
“Registration”?<br />
Study Problem 3.1 — Pre Dec. 1, ’05 Analysis<br />
Biosystems will likely be considered to be in the “pre-filing” stage of a<br />
“registration,” because its board has determined to sell securities in a<br />
registered offering (even though the facts do not indicate whether it has<br />
selected a lead underwriter), but it has not filed a registrations statement.<br />
So, Section 5(c) applies.<br />
Whether the marketing campaign constitutes an “offer” in violation of<br />
Section 5(c) depends upon how the campaign is conducted.<br />
Biosystems should not engage in conduct that conditions the market (i.e.,<br />
arouses public interest in the company or the securities of the company)<br />
by initiating publicity when in registration, but it may continue to<br />
advertise products <strong>and</strong> services.<br />
For pre-December 1, 2005 analysis, See <strong>Securities</strong> Act Release No. 5180<br />
(August 16, 1971).<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During<br />
“Registration”?<br />
Study Problem 3.1 — Pre-Dec. 1 ’05 Analysis<br />
Ordinary <strong>and</strong> customary advertisements aimed at<br />
building market dem<strong>and</strong> for Biosystems’s product<br />
would not likely violate Section 5.<br />
By comparison, forward-looking valuation information<br />
– especially a prediction, projection, forecast, estimate<br />
or opinion concerning, among other things, sales <strong>and</strong><br />
earnings <strong>and</strong> value of Biosystem’s securities – may be<br />
considered to be conditioning the market, <strong>and</strong> therefore<br />
deemed to be an “offer” in violation of Section 5(c).<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 –What Can Be Done During<br />
“Registration”?<br />
Study Problem 3.2<br />
Same facts as Study Problem 3.1.<br />
To coincide with the most important annual trade show in the medical device<br />
industry that will begin around the time Biosystems plans to file its IPO registration<br />
statement, Biosystems dramatically steps up its marketing campaign, extolling what<br />
it characterizes as the “revolutionary” virtues of the diagnostic device.<br />
Contemporaneously, the four founders give extensive interviews with various<br />
technology <strong>and</strong> business magazines covering the trade show.<br />
Might Biosystems’s trade show-related activity create problems under the <strong>Securities</strong><br />
Act for the proposed public offering if the trade show activity occurs after<br />
Biosystems chooses its lead underwriter but before it files its IPO registration<br />
statement?<br />
What if the interviews were given 35 days before Biosystems files its registration<br />
statement but published only 5 days before the registration statement was filed?<br />
What if the trade show occurred, or the interviews were published, after the<br />
registration statement was filed but before it was declared effective?<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During<br />
“Registration”?<br />
Study Problem 3.2 — Pre-Dec. 1, ’05 Analysis<br />
Whether the trade-show activity violates<br />
Section 5 depends upon how <strong>and</strong> when it is<br />
conducted.<br />
If trade-show activity occurred before S-1<br />
filing, Biosystems must be concerned about<br />
whether its activities may be conditioning the<br />
market for its IPO, <strong>and</strong> thus constitute a prefiling<br />
“offer” in violation of Section 5(c).<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During<br />
“Registration”?<br />
Study Problem 3.2 — Pre-Dec. 1, ’05 Analysis<br />
As regards trade show appearances <strong>and</strong> interviews published<br />
after the registration statement is filed, Biosystems must consider<br />
whether any statement made or material distributed in<br />
connection with the trade show, including any article that results<br />
from the interviews, may be deemed to be a “prospectus.”<br />
See Rule 134 (for post-filing, non-prospectus<br />
communications)<br />
See Google Inc. August 18, 2004 Prospectus: “Risk Factors –<br />
Risks Related to Our Offering” (1st paragraph) (p. 21); <strong>and</strong><br />
See Excerpt from Lexar Media, Inc.'s August 18, 2000 Post<br />
Effective Amendment (Risk of Illegal Prospectus)<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During<br />
“Registration”?<br />
Study Problem 3.2 — Pre-Dec. 1, ’05 Analysis<br />
Statements about future possibilities of the company<br />
may be deemed a prospectus that does not satisfy the<br />
requirements of Section 10.<br />
Important facts are that Biosystems<br />
“dramatically” increased its marketing campaign<br />
<strong>and</strong> characterized its product as “revolutionary”.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During Registration”?<br />
Study Problem 3.1<br />
(Applying 2005 Offering Reforms)<br />
Two years after its formation . . . Biosystems launches a publicity<br />
campaign aimed at building market dem<strong>and</strong> for its product <strong>and</strong><br />
begins planning for the construction of a $75 million<br />
manufacturing facility . . . .<br />
The Biosystems board approves the recommendation of the<br />
company’s four founders . . . that should Biosystems “go public”.<br />
. .<br />
Might the marketing campaign create problems under the<br />
<strong>Securities</strong> Act for the proposed public offering if the campaign<br />
began 25 days before the registration statement was filed? What<br />
if it began 45 days before?<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During<br />
“Registration”?<br />
Study Problem 3.1 — Post Dec. 1, ’05 Analysis<br />
Effective December 1, 2005, the SEC’s “Offering Reform”<br />
<strong>Regulation</strong>s (the “2005 Offering Reforms”) provide a “safe<br />
harbor” regarding pre-registration publicity<br />
The 2005 Offering Reforms involve three main areas:<br />
Communications related to registered securities offerings;<br />
Registration <strong>and</strong> other procedures in the offering <strong>and</strong><br />
capital formation processes; <strong>and</strong><br />
Delivery of information to investors, including delivery<br />
through access <strong>and</strong> notice, <strong>and</strong> timeliness of that delivery.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During “Registration”?<br />
Study Problem 3.1 — Post Dec. 1, ’05 Analysis<br />
Under Rule 163A, communications of any type by all issuers<br />
more than 30 days prior to filing a registration statement are<br />
not considered prohibited “gun-jumping” offers but only if<br />
the communication does not reference a registered securities<br />
offering, <strong>and</strong><br />
reasonable steps are taken to prevent distribution or<br />
republication of the communication during the 30-day period<br />
prior to filing the registration statement.<br />
Such communications are excluded from the definition of “offer”<br />
for purposes of Section 5(c).<br />
NB. Rule 163A is a non-exclusive safe harbor.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During “Registration”?<br />
Study Problem 3.1 — Post Dec. 1, ’05 Analysis<br />
For example, an IPO issuer may participate in industry<br />
conferences <strong>and</strong> similar events held more than 30 days before<br />
filing of the registration statement without gun-jumping<br />
concerns, so long as no registered securities offering is<br />
discussed.<br />
BUT safe harbor is available only to issuer <strong>and</strong> persons acting<br />
on behalf of an issuer.<br />
Safe harbor is not available to underwriters or dealers. Thus, it<br />
is not available to assist underwriters or dealers in testing the<br />
waters for the offering.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During “Registration”?<br />
Study Problem 3.2<br />
(Applying 2005 Offering Reforms)<br />
To coincide with the most important annual trade show in the medical device industry<br />
that will begin around the time of the S-1 filing, BeanTown Biosystems dramatically<br />
steps up its marketing campaign, extolling what it characterizes as the “revolutionary”<br />
virtues of the diagnostic device, <strong>and</strong> the four founders give extensive interviews with<br />
various technology <strong>and</strong> business magazines covering the trade show.<br />
Might Biosystems’s trade show-related activity create problems under the <strong>Securities</strong><br />
Act for the proposed public offering if the trade show activity occurred after<br />
Biosystems chose its lead underwriter but before it filed its registration statement?<br />
What if the interviews were given 35 days before Biosystems files its registration<br />
statement but published only 5 days before the registration statement was filed?<br />
What if the trade show occurred, or the interviews were published, after the<br />
registration statement was filed but before it was declared effective?<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During “Registration”?<br />
Study Problem 3.2 — Post Dec. 1, ’05 Analysis<br />
What if the interviews were given 35 days before<br />
Biosystems files its registration statement but published<br />
only 5 days before the registration statement was filed?<br />
Under 2005 Offering Reforms, during the 30 days<br />
before the registration statement is filed, the IPO issuer<br />
will be in a “quiet period.”<br />
However, as was the case prior to the 2005 Offering<br />
Reforms, the issuer is permitted to make a very limited<br />
announcement of its intention to conduct a registered<br />
offering of securities, without naming any underwriters.<br />
Rule 135.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During “Registration”?<br />
Study Problem 3.2 — Post Dec. 1, ’05 Analysis<br />
In addition, in reliance on the non-exclusive safe harbor under Rule 169,<br />
IPO issuers may continue publishing, during 30-day quiet period <strong>and</strong> at any<br />
other time during the offering, factual business information intended to<br />
be used by persons other than in their capacity as investors or potential<br />
investors.<br />
Fact that a customer or other person to whom a factual business<br />
communication is made may be a potential investor does not affect the<br />
availability of the safe harbor.<br />
The manner <strong>and</strong> timing of the communication must be similar to the<br />
issuer’s historic practice.<br />
The same issuer employees who have historically been responsible for<br />
providing information to customers <strong>and</strong> suppliers must make the<br />
communications for which safe harbor protection is sought.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During “Registration”?<br />
Study Problem 3.2 — Post Dec. 1, ’05 Analysis<br />
Even if the safe harbor in Rule 169 is not available, the issuer<br />
retains the ability available prior to the 2005 Reforms to rely on a<br />
facts <strong>and</strong> circumstances analysis in addressing the question of<br />
whether a communication is an offer.<br />
The safe harbor for factual business information excludes<br />
information released as part of the offering activities in the<br />
registered offering.<br />
For example, the safe harbor is not available for a copy of a<br />
prior press release that originally had been regularly released<br />
in accordance with the safe harbor but later is specifically<br />
provided to investors or potential investors as part of offering<br />
activities.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During “Registration”?<br />
Study Problem 3.3<br />
June 30, 2010 – Forbes Magazine reported:<br />
In January 2010, General Motors Vice Chairman Bob Lutz told Forbes that a<br />
2010 IPO was a possibility, but only after a laundry list of criteria were checked<br />
off, including turning a profit, generating solid cash flow <strong>and</strong> having a<br />
compelling story to tell investors.<br />
August 5, 2010 – Bloomberg Businessweek reported:<br />
The White House’s senior advisor to the Task Force on the Auto Industry said<br />
that he believed it was likely that General Motors would have an initial public<br />
offering sometime in 2010 . . . . [The U.S. government then owned a majority<br />
interest in GM.]<br />
Ron Bloom, speaking at an auto industry conference . . . said the U.S.<br />
government would unwind its stakes in the automakers “as soon as is<br />
practicable,” echoing a comment made by President Obama.<br />
Do the comments of Mr. Lutz or Mr. Bloom raise any issue under the <strong>Securities</strong> Act?<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During<br />
“Registration”?<br />
Study Problem 3.4<br />
Same facts as Study Problem 3.3.<br />
On August 16, 2010 – Bloomberg reported:<br />
Wall Street banks led by JPMorgan Chase & Co. <strong>and</strong> Morgan Stanley st<strong>and</strong> to make<br />
a combined $120 million on General Motors Co.’s initial public offering. If it<br />
weren’t for Goldman Sachs Group Inc., they could have made four times as much.<br />
In a pitch to the U.S. Treasury in May, Goldman Sachs offered to accept a fee of<br />
0.75 percent, according to people with direct knowledge of the matter. That’s a<br />
fraction of the 3 percent banks typically charge on the largest IPOs <strong>and</strong> well below<br />
the 2 percent offered by Bank of America Corp. <strong>and</strong> other banks that presented to<br />
Treasury, said the people, speaking anonymously because the matter is private.<br />
GM filed the registration statement for its IPO on August 18, 2010.<br />
Does the reporting on the proposed underwriting terms for the expected GM IPO raise<br />
any issue under the <strong>Securities</strong> Act?<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 Agenda<br />
Planning for an Initial Public Offering or IPO –<br />
Underst<strong>and</strong>ing the “gun jumping” rules<br />
What is a “WKSI”? How are the gun jumping rules<br />
different for a WKSI?<br />
What are the other categories of issuers under the <strong>Securities</strong><br />
Act? How are the gun jumping rules different for them?<br />
How did the JOBS Act change the gun jumping rules?<br />
Civil <strong>and</strong> Criminal Liability under the <strong>Securities</strong> Act<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
How are the rules different<br />
for a WKSI?<br />
An extremely important aspect of the SEC’s<br />
2005 Offering Reforms was the introduction<br />
of special class of issuers designated:<br />
“Well known seasoned issuers” or “WKSIs”<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
How are the rules different<br />
for a WKSI?<br />
What is a “WKSI”? - See Rule 405<br />
Meets all requirements of General Instruction I.A.<br />
of Form S–3 or Form F–3 [see subsequent slide]<br />
<strong>and</strong> either:<br />
(1) As of a date within 60 days of “determination<br />
date,” has a worldwide market value of its<br />
outst<strong>and</strong>ing voting <strong>and</strong> non-voting common equity<br />
held by non-affiliates of $700 million or more; or<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
How are the rules different<br />
for a WKSI?<br />
What is a “WKSI”? - See Rule 405<br />
Alternative Test:<br />
(2) As of a date within 60 days of determination<br />
date, has issued in the last three years at least<br />
$1 billion aggregate principal amount of nonconvertible<br />
securities, other than common equity,<br />
in primary offerings for cash registered under the<br />
Act<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
WSKI S-3 Eligibility<br />
Why does S-3 eligibility matter?<br />
What is the public policy rationale for<br />
treating WKSIs differently?<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
WSKI S-3 Eligibility<br />
General Instruction I.A. of Form S–3 requires:<br />
1. Registrant is organized under laws of U.S. or any<br />
state, etc. <strong>and</strong> has its principal business operations in<br />
U.S. or its territories.<br />
2. Registrant has a class of securities registered pursuant<br />
to Section 12(b) of the Exchange Act or a class of<br />
equity securities registered pursuant to Section 12(g)<br />
of the Exchange Act or is required to file reports<br />
pursuant to Section 15(d) of the Exchange Act.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
WSKI S-3 Eligibility (cont’d)<br />
3. Registrant has been subject to the requirements of Section<br />
12 or 15(d) of the Exchange Act <strong>and</strong> has filed all the<br />
material required to be filed pursuant to Section 13, 14 or<br />
15(d) for a period of at least twelve calendar months<br />
immediately preceding the filing of the registration<br />
statement.<br />
4. Registrant has filed in a timely manner all reports<br />
required to be filed during the twelve calendar months<br />
<strong>and</strong> any portion of a month immediately preceding<br />
filing of registration statement, other than certain 8-K<br />
filings.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
WSKI S-3 Eligibility (cont’d)<br />
5. Neither the registrant nor any of its consolidated or<br />
unconsolidated subsidiaries has, since the end of the last<br />
fiscal year for which certified financial statements of the<br />
registrant <strong>and</strong> its consolidated subsidiaries were included<br />
in a report filed pursuant to Section 13(a) or 15(d) of the<br />
Exchange Act: (a) failed to pay any dividend or sinking<br />
fund installment on preferred stock; or (b) defaulted (i)<br />
on any installment or installments on indebtedness for<br />
borrowed money, or (ii) on any rental on one or more<br />
long term leases, which defaults in the aggregate are<br />
material to the financial position of the registrant.<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
How are the rules different<br />
for a WKSI?<br />
Section 5 framework for WKSIs<br />
WKSI may file “automatic shelf registration<br />
statement” on Form S–3 or Form F–3.<br />
Rule 405<br />
Automatic shelf registration statement is<br />
immediately effective upon filing with the<br />
SEC. Rule 462(e)<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
How are the rules different<br />
for a WKSI?<br />
Gun jumping rules do not apply to WKSIs!<br />
Rule 163:<br />
In an offering by or on behalf of WKSI that will be<br />
or is at the time intended to be registered under the<br />
<strong>Securities</strong> Act, an offer by or on behalf of such<br />
issuer is exempt from the prohibitions in § 5(c)<br />
on offers before a registration statement has been<br />
filed, provided conditions of Rule 163 are satisfied.<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 Agenda<br />
Planning for an Initial Public Offering or IPO –<br />
Underst<strong>and</strong>ing the “gun jumping” rules<br />
What is a “WKSI”? How are the gun jumping rules different<br />
for a WKSI?<br />
What are the other categories of issuers under the<br />
<strong>Securities</strong> Act? How are the gun jumping rules<br />
different for them?<br />
How did the JOBS Act change the gun jumping rules?<br />
Civil <strong>and</strong> Criminal Liability under the <strong>Securities</strong> Act<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
Other Categories of Issuers<br />
under <strong>Securities</strong> Act<br />
Four basic categories of issuers (prior to JOBS Act):<br />
1. WKSIs<br />
2. Issuers that are not WKSIs but still file periodic reports<br />
(10-Ks, 10-Qs, 8-Ks) with the SEC under the Exchange<br />
Act, usually because the issuer previously conducted a<br />
public offering of securities or has securities listed on an<br />
exchange;<br />
3. Foreign private issuers (which may also qualify as<br />
WKSIs); <strong>and</strong><br />
4. Issuers that do not file periodic reports with the SEC.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Another Category of Issuers –<br />
Emerging Growth Company<br />
JOBS Act adds a fifth over-arching category:<br />
The "emerging growth company" is able to take<br />
advantage of new scaled disclosure, governance <strong>and</strong><br />
accounting requirements.<br />
An "emerging growth company" (EGC) is an issuer<br />
that, for its most recently completed fiscal year, had<br />
total annual gross revenues of less than $1 billion.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Emerging Growth Companies<br />
An issuer's status as an EGC will continue until the earliest of the<br />
following:<br />
The last day of the issuer's fiscal year during which its gross<br />
revenues ≥ $1 billion;<br />
The last day of the issuer's fiscal year following the fifth<br />
anniversary of its IPO;<br />
The date on which the issuer has, during the previous three-year<br />
period, issued > $1 billion in non-convertible debt; or<br />
The date on which the issuer is deemed to be a "large accelerated<br />
filer," which generally is comparable to a WKSI.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
How are gun jumping rules different for<br />
“reporting companies” that are not<br />
WKSIs?<br />
For non-WKSI reporting companies <strong>and</strong><br />
certain foreign private issuers:<br />
Rule 168 permits the regular release or<br />
dissemination of communications containing<br />
factual business information or forwardlooking<br />
information, if the other conditions of<br />
Rule 168 are satisfied.<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
What is a Foreign Private Issuer?<br />
A foreign issuer (other than a foreign government) except an issuer<br />
meeting the following conditions:<br />
(i) > 50 percent of the outst<strong>and</strong>ing voting securities of such issuer are<br />
directly or indirectly owned of record by residents of the United<br />
States; <strong>and</strong><br />
(ii) Any of the following:<br />
(A) Majority of issuer’s executive officers or directors are U.S.<br />
citizens or residents;<br />
(B) >50 percent of issuer’s assets are located in U.S.; or<br />
(C) The issuer’s business is administered principally in U.S..<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Other Categories of Issuers<br />
under <strong>Securities</strong> Act<br />
Effective in January 2008, the SEC amended<br />
the eligibility requirements for the use of Form<br />
S-3 <strong>and</strong> Form F-3 registration statements.<br />
Previously, an issuer could use S-3 only if it<br />
had a “float” of $75 million or more. (The<br />
term “float” means the aggregate market value<br />
of the voting <strong>and</strong> non-voting common equity<br />
held by non-affiliates of the issuer.)<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Other Categories of Issuers<br />
under <strong>Securities</strong> Act<br />
Current S-3 Eligibility: If Float ≥ $75 million<br />
If issuer has a “float” of $75 million or more<br />
<strong>and</strong> satisfies other S-3 eligibility criteria:<br />
Issuer can sell an unlimited amount of<br />
securities under an S-3 registration statement.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Other Categories of Issuers<br />
under <strong>Securities</strong> Act<br />
Current S-3 Eligibility: If Float < $75 million<br />
If issuer has a “float” of less than $75 million, the issuer<br />
can use S-3 if the issuer:<br />
1. Satisfies the other S-3 eligibility criteria;<br />
2. Has a class of common equity securities listed on a<br />
national securities exchange; <strong>and</strong><br />
3. Does not sell more than the equivalent of one-third<br />
of its public float in primary offerings over any<br />
period of 12 calendar months.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
How are gun jumping rules different for<br />
EGCs after the JOBS Act?<br />
“Test the Waters” Communications<br />
During the quiet period, non-WKSIs that meet<br />
the criteria for EGCs may discuss a possible<br />
offering of securities to institutions that are<br />
accredited investors (which includes Qualified<br />
Institutional Buyers or “QIBs”).<br />
Communications may occur prior to or after<br />
filing a registration statement<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
EGCs – “Test the Waters” Communications<br />
The JOBS Act added Section 5(d):<br />
An ECG or any person authorized to act on behalf of<br />
an ECG may engage in oral or written<br />
communications with potential investors that are<br />
qualified institutional buyers or institutions that are<br />
accredited investors, to determine whether such<br />
investors might have an interest in a contemplated<br />
securities offering, either prior to or following the date<br />
of filing of a registration statement, subject to the<br />
requirement of Section 5(b)(2).<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During “Registration”?<br />
Overview of Restrictions on Communications<br />
The following is a summary of the restrictions on<br />
communications while an issuer is “in registration:”<br />
1. Well-known seasoned issuers (“WKSIs”) are permitted to<br />
engage at any time in oral <strong>and</strong> written communications,<br />
including use at any time of a free writing prospectus,<br />
subject to enumerated conditions (including, in specified<br />
cases, filing with SEC).<br />
2. All reporting issuers are permitted, at any time, to continue<br />
to publish regularly released factual business information<br />
<strong>and</strong> forward-looking information under Rule 168.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During “Registration”?<br />
Overview of Restrictions on Communications<br />
3. Non-reporting issuers are permitted, at any time, to<br />
continue to publish regularly released factual business<br />
information that is intended for use by persons other than<br />
in their capacity as investors or potential investors under<br />
new Rule 169.<br />
4. ECGs are permitted to engage in “test the water”<br />
communications with QIBs <strong>and</strong> institutional accredited<br />
investors per new §5(d)<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During “Registration”?<br />
Overview of Restrictions on Communications<br />
5. Other communications by non-WKSI issuers (i.e.,<br />
communications not sanctioned by new §5(d) ) made<br />
more than 30 days before filing a registration statement<br />
are not prohibited offers so long as they do not reference<br />
a securities offering that is or will be the subject of a<br />
registration statement.<br />
6. All issuers <strong>and</strong> offering participants are permitted to use<br />
“free writing prospectuses” after the filing of the<br />
registration statement, subject to enumerated conditions<br />
(including, in specified cases, filing with SEC).<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During “Registration”?<br />
Overview of Restrictions on Communications<br />
7. Procedural matters, such as communications about the<br />
schedule for an offering or about account-opening<br />
procedures, are excluded from the definition of<br />
“prospectus.”<br />
8. Exemptions for research reports are exp<strong>and</strong>ed. Importantly,<br />
the JOBS Act amended the definition of “offer” in §2(3) to<br />
exclude broker-dealer research reports about any ECG.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 – What Can Be Done During “Registration”?<br />
More about research report exemption<br />
The JOBS Act amended the definition of “offer” in §2(3) to<br />
provide:<br />
The publication or distribution by a broker or dealer of a<br />
research report about an [ECG] that is the subject of a<br />
proposed public offering of the common equity securities of<br />
such [ECG] pursuant to a registration statement that the issuer<br />
proposes to file, or has filed, or that is effective shall be<br />
deemed for purposes of §2(10) <strong>and</strong> §5(c) not to constitute an<br />
offer for sale or offer to sell a security, even if the broker or<br />
dealer is participating or will participate in the registered<br />
offering of the securities of the issuer.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Session 3 Agenda<br />
Planning for an Initial Public Offering or IPO<br />
What is a “WKSI”? How are these rules different for a<br />
WKSI?<br />
What are the other categories of issuers under the<br />
<strong>Securities</strong> Act?<br />
Civil <strong>and</strong> Criminal Liability under the <strong>Securities</strong><br />
Act<br />
(c) 2012 Michael K. Krebs<br />
All Rights Reserved
The “Elephant in the Corner” –<br />
Liability under the <strong>Securities</strong> Act <strong>and</strong><br />
How it Shape the Registration Statement<br />
• What typically gives rise to liability? Who may be liable?<br />
• What is the “due diligence defense,” when is it available,<br />
<strong>and</strong> who may assert it?<br />
• Who is a “control person” <strong>and</strong> when might they be<br />
vicariously liable for the acts of others?<br />
• What gives rise to aiding <strong>and</strong> abetting claims? How did<br />
Dodd-Frank change scope of “aiding <strong>and</strong> abetting”<br />
liability?<br />
• When is indemnification or contribution permitted?<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
What typically gives rise to<br />
liability? Who may be liable?<br />
Three principal types of civil liability<br />
under the <strong>Securities</strong> Act:<br />
1. Rescission rights under §12(a)(1)<br />
2. Strict liability for registration<br />
statements under §11.<br />
3. Prospectus liability under §12(a)(2)<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Rescission rights under<br />
Section 12(a)(1)<br />
Strict liability: No scienter, reliance, causation<br />
Sales of unregistered securities; illegal offer<br />
Consideration paid (i.e., rescission) or damages if<br />
security previously sold<br />
Rescission right is effectively a “put” right<br />
1. Investor may recover only if in privity with person<br />
(i.e., “seller”) who violated §12(a)(1) BUT Pinter<br />
case defines seller broadly.<br />
2. Statute of limitations – three years. §13<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Rescission rights under<br />
Section 12(a)(1)<br />
Persons liable:<br />
Party who passed title, or<br />
Any person who solicited the purchaser if<br />
person was motivated by<br />
his own financial interests or<br />
those of the securities owner<br />
Pinter v. Dahl<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Strict liability under Section 11<br />
Strict liability for materially false or misleading<br />
statements in registration statement:<br />
Strict liability: Plaintiff does not have to prove<br />
Reliance (some exceptions)<br />
Scienter (some exceptions)<br />
Causation<br />
Joint <strong>and</strong> several liability<br />
Scope?<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Section 11 Liability (cont’d)<br />
What statements are covered?<br />
Any materially false or misleading statement included<br />
(or deemed to be included) in an effective registration<br />
statement<br />
Includes definitive prospectus filed after registration<br />
statement is declared effective<br />
Does not include “free writing prospectus” (See SEC<br />
Rule 433(d)(1) – “The free writing prospectus filed<br />
for purposes of this section will not be filed as part of<br />
the registration statement . . . .”)<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Section 11 Plaintiffs<br />
Who may sue under § 11:<br />
Anyone who purchased part of securities covered by<br />
registration statement<br />
Whether or not purchased in initial distribution or<br />
“after-market”<br />
But must be able to “trace” shares back to<br />
registration statement<br />
But not purchaser of shares outst<strong>and</strong>ing prior to the<br />
offering (i.e., shares that can not be traced)<br />
Not sellers who were motivated by misleadingly<br />
pessimistic information in registration statement<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Section 11 Defendants<br />
What categories of persons are<br />
subject to § 11 strict liability?<br />
What is the public policy rationale<br />
for exposing them to strict<br />
liability?<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Section 11 Defendants<br />
Scope of joint <strong>and</strong> several liability:<br />
Issuer<br />
CEO, CFO, CAO<br />
Directors at time of filing (whether or not<br />
signatories to registration statement)<br />
All underwriters<br />
All experts who consent to inclusion of their<br />
opinion (but only as to information certified<br />
by expert)<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Section 11 Defenses<br />
Due diligence<br />
Not for issuer; extremely limited for executive officers.<br />
Discussed in subsequent slides.<br />
Negative causation<br />
Defendant proves that plaintiff’s damages actually resulted<br />
from factors other than the materially false or misleading<br />
statement in the registration statement<br />
Statute of limitations<br />
One year after “discovery” of materially false or misleading<br />
statement BUT not later than three years after there is a bona<br />
fide offering of the security to the public in that transaction<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Section 11 Defenses (cont’d)<br />
Outside director is proportionately liable<br />
Unless there is a finding that director knowingly<br />
violated the securities law §11(f)(2)(A)<br />
No liability for forward-looking statement<br />
For existing SEC reporting companies only<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Section 11 Defenses (cont’d)<br />
Reliance must be shown if security purchased<br />
after issuer releases earnings report covering<br />
a period of at least twelve months beginning<br />
after the effective date of the registration<br />
statement – § 11(a)<br />
BUT investor need not actually have read the<br />
registration statement to prove reliance. It would<br />
be sufficient if investor relied on secondary<br />
sources that repeated the materially false or<br />
misleading statement<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Section 11 Due Diligence Defense<br />
What is the “due diligence” defense?<br />
When is it available?<br />
Who may assert it?<br />
What is the public policy rationale for<br />
the defense?<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Section 11 Due Diligence<br />
Defense (cont’d)<br />
Rule 176 (rather vague)<br />
Two leading cases:<br />
BarChris Construction (1968)<br />
WorldCom (2004)<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
BarChris<br />
Section 11 Due Diligence<br />
Defense (cont’d)<br />
The greater the involvement of a defendant, <strong>and</strong> the more<br />
senior the defendant’s position with the issuer, the more<br />
due diligence a court expects<br />
Underwriters conducting a due diligence investigation<br />
must obtain corroborating evidence <strong>and</strong> not rely merely on<br />
statements from the issuer’s executives or counsel<br />
“Trust, but verify.” (Russian proverb famously quoted by<br />
U.S. President Ronald Regan)<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
WorldCom<br />
Section 11 Due Diligence<br />
Defense (cont’d)<br />
1. What constitutes a red flag?<br />
Question of fact<br />
For example, any information causing an<br />
underwriter to lose confidence in the<br />
accuracy of any portion of a registration<br />
statement, including “expertized” audited<br />
financials.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Section 11 Due Diligence<br />
Defense (cont’d)<br />
WorldCom (cont’d)<br />
1. What constitutes a red flag? (cont’d)<br />
Deeper inquiry – including retention of<br />
accountants – may be warranted by discovery of<br />
“aggressive or unusual accounting strategies<br />
regarding significant issues.”<br />
In a competitive industry, any meaningful<br />
superiority of one company over another in any<br />
financial category could raise a red flag.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Section 11 Due Diligence<br />
Defense (cont’d)<br />
WorldCom (cont’d)<br />
2. Must underwriters retain their own accounting<br />
experts to investigate the accuracy of financial<br />
statements?<br />
WorldCom opinion disclaims any such requirement,<br />
yet acknowledges that underwriters may wish to<br />
retain accountants as a matter of prudence.<br />
Underwriters may also, or alternatively, include on<br />
the due diligence team personnel with accounting<br />
backgrounds.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Section 11 Due Diligence<br />
Defense (cont’d)<br />
WorldCom (cont’d)<br />
3. “Comfort letter” insufficient by itself to<br />
establish a due diligence defense <strong>and</strong> thus<br />
will need supplementation.<br />
Consider: if that supplementation is effectively<br />
a mini-audit, conducted on a quarterly basis,<br />
then the mini-audit may simply supplant, rather<br />
than supplement, the comfort letter.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Section 11 Due Diligence<br />
Defense (cont’d)<br />
WorldCom (cont’d)<br />
4. How can underwriters document their<br />
diligence?<br />
If you are an underwriter, you want the<br />
document to memorialize beyond doubt<br />
that you participated fully in all phases of<br />
diligence.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Section 11 Due Diligence<br />
Defense (cont’d)<br />
WorldCom (cont’d)<br />
5. Nature of Due Diligence Calls, Especially<br />
in Shelf Registration Context<br />
WorldCom court excoriated the underwriters<br />
for asking too few <strong>and</strong> too general questions,<br />
for passively accepting conclusory <strong>and</strong> nonresponsive<br />
answers, <strong>and</strong> for failing to ask<br />
tough follow-up questions.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Section 11 Due Diligence<br />
Defense (cont’d)<br />
WorldCom (cont’d)<br />
6. After WorldCom, how should co-managing<br />
underwriters (i.e., non-lead underwriters)<br />
participate in diligence?<br />
Until WorldCom, non-lead members of underwriting<br />
syndicate often did not participate in diligence <strong>and</strong><br />
simply relied on diligence performed by the lead.<br />
Post-WorldCom, the non-lead underwriter who remains<br />
uninvolved in the diligence investigation – for example,<br />
by relying on the lead, who in turn relies on the auditor –<br />
has a double risk of losing its diligence defense.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
What about Section 12(a)(2)?<br />
Establishes liability for:<br />
An offer/sale of a security by means of a<br />
prospectus or oral communication, which<br />
includes a materially false or misleading<br />
statement of a material fact, if the defendant does<br />
not sustain the burden of proof that he did not<br />
know, <strong>and</strong> in the exercise of reasonable care<br />
could not have known, of such untruth or<br />
omission<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Was Gustafson v. Alloyd Co.<br />
correctly decided?<br />
According to the dissent in Gustafson:<br />
Commentators writing shortly after passage of the <strong>Securities</strong> Act understood §12(2)<br />
to cover resales <strong>and</strong> private sales, as well as public offerings. Felix Frankfurter,<br />
organizer of the team that drafted the statute, firmly stated this view: The <strong>Securities</strong><br />
Act “seeks to terminate the facilities of the mails <strong>and</strong> of interstate commerce for<br />
dishonest or unfair dealings in the sale of all private or foreign government<br />
securities, new or old” (emphasis added).<br />
Most subsequent commentators have agreed that §12(2), like §17(a), is not confined<br />
to public offerings.<br />
“Every Court of Appeals to consider the issue ruled that private placements are<br />
subject to §12(2).” See, e.g., Pacific Dunlop Holdings Inc. v. Allen & Co. Inc., 993<br />
F. 2d 578 (1993)(the inclusion of the term "communication" in the Act's definition<br />
of prospectus meant that the term prospectus was defined "very broadly" to include<br />
all written communications that offered the sale of a security).<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Was Gustafson v. Alloyd Co.<br />
correctly decided?<br />
513 U.S. 561 (1995) – Majority:<br />
“In light of the care that Congress took to justify the imposition of liability<br />
without proof of either fraud or reliance on "those whose moral<br />
responsibility to the public is particularly heavy” – the "originators of<br />
securities“ – we can not conclude that Congress would have extended that<br />
liability to every private or secondary sale without a whisper of<br />
explanation.”<br />
“In sum, the word ‘prospectus’ is a term of art referring to a document<br />
that describes a public offering of securities by an issuer or controlling<br />
shareholder. The contract of sale, <strong>and</strong> its recitations, were not held out<br />
to the public <strong>and</strong> were not a prospectus as the term is used in the 1933<br />
Act.”<br />
Compare with 1985 L<strong>and</strong>reth Timber decision.<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Gustafson v. Alloyd Co. (cont’d)<br />
Dissent (Ginsburg, with Breyer joining) :<br />
“The Court presents impressive policy reasons for its construction, but<br />
drafting history <strong>and</strong> the longst<strong>and</strong>ing scholarly <strong>and</strong> judicial underst<strong>and</strong>ing of<br />
§12(2) caution against judicial resistance to the statute's defining text. I<br />
would leave any alteration to Congress.”<br />
“The House Conference Report, which explains the Act in its final form,<br />
describes §12(2) in broad terms, <strong>and</strong> nowhere suggests that the provision is<br />
limited to public offerings:<br />
‘The House bill (sec. 12) imposes civil liability for using the mails or the facilities of<br />
interstate commerce to sell securities (including securities exempt, under section 3, from<br />
other provisions of the bill) by means of representations which are untrue or are<br />
misleading by reason of omissions of material facts.’<br />
“In light of the text, drafting history, <strong>and</strong> longst<strong>and</strong>ing scholarly <strong>and</strong> judicial<br />
underst<strong>and</strong>ing of §12(2), I conclude that §12(2) applies to a private resale of<br />
securities.”<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
When might control persons be<br />
vicariously liable for acts of others?<br />
Affiliates = Control Persons<br />
See § 15 of <strong>Securities</strong> Act<br />
See p. 117 of Soderquist<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
“Aiding <strong>and</strong> Abetting”<br />
Liability under <strong>Securities</strong> Act<br />
Evolution of theories of liability for<br />
secondary parties (accountants,<br />
lawyers, etc.)<br />
Central Bank of Denver (1994)<br />
Stoneridge Investment Partners<br />
(2008)<br />
Pacific Investment Co. v. Mayer<br />
Brown LLP (7 th Cir. April 27, 2010)<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
“Aiding <strong>and</strong> Abetting” (cont’d)<br />
Central Bank of Denver (1994)<br />
Private plaintiff may not maintain aiding <strong>and</strong><br />
abetting suit under Exchange Act 10(b)<br />
Per Supreme Court: 10(b) prohibits only<br />
making of a material misstatement (or<br />
omission) or commission of a manipulative<br />
act, <strong>and</strong> does not reach those who aid <strong>and</strong> abet<br />
a violation.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
“Aiding <strong>and</strong> Abetting” (cont’d)<br />
Stoneridge Investment Partners (2008)<br />
Vendors <strong>and</strong> customers could not be<br />
liable as primary actors under 10(b)<br />
under so-called “scheme” liability<br />
theory.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
“Aiding <strong>and</strong> Abetting” (cont’d)<br />
Pacific Investment Co. v. Mayer Brown LLP<br />
(7 th Cir. April 27, 2010)<br />
“After Stoneridge, it is somewhat unclear how . . .<br />
deceptive conduct of a secondary actor could be<br />
communicated to the public <strong>and</strong> yet remain<br />
‘deceptive.’ ”<br />
The mere fact that the ultimate result of a secondary<br />
actor's deceptive course of conduct is<br />
communicated to the public through a company's<br />
financial statements is insufficient to show reliance<br />
on the secondary actor's own deceptive conduct.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
“Aiding <strong>and</strong> Abetting” (cont’d)<br />
How did Dodd-Frank change the scope of<br />
liability for “aiding <strong>and</strong> abetting” claims?<br />
Dodd-Frank establishes a more modest<br />
“recklessness” st<strong>and</strong>ard of proof for SEC aiding<br />
<strong>and</strong> abetting claims.<br />
In 1995, Private <strong>Securities</strong> Litigation Reform<br />
Act gave SEC the right to bring claims for<br />
aiding <strong>and</strong> abetting violations of the <strong>Securities</strong><br />
Exchange Act of 1934 but required “knowing”<br />
misconduct.<br />
©-2012 Michael K. Krebs<br />
All Rights Reserved
“Aiding <strong>and</strong> Abetting” (cont’d)<br />
How did Dodd-Frank change the scope of<br />
liability for “aiding <strong>and</strong> abetting” claims?<br />
(cont’d)<br />
Since PSLRA was passed, several courts have held<br />
that actual knowledge must be shown for aiding <strong>and</strong><br />
abetting liability, <strong>and</strong> that recklessness is<br />
insufficient.<br />
With passage of Dodd-Frank Act, mere<br />
“recklessness” will be sufficient to establish the<br />
requisite state of mind for SEC aiding <strong>and</strong> abetting<br />
claims.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Indemnification or Contribution<br />
under <strong>Securities</strong> Act<br />
SEC position against indemnification<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
Indemnification or Contribution<br />
under <strong>Securities</strong> Act<br />
SEC requires the following statement in each<br />
registration statement filed under the ’33 Act:<br />
“Insofar as indemnification for liabilities arising<br />
under the <strong>Securities</strong> Act of 1933 may be<br />
permitted to directors, officers <strong>and</strong> controlling<br />
persons of the registrant . . . , the registrant has<br />
been advised that in the opinion of the <strong>Securities</strong><br />
<strong>and</strong> Exchange Commission such indemnification<br />
is against public policy as expressed in the Act<br />
<strong>and</strong> is, therefore, unenforceable. “<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Indemnification or Contribution<br />
under <strong>Securities</strong> Act<br />
SEC position against indemnification (cont’d)<br />
“In the event that a claim for indemnification against such<br />
liabilities (other than the payment by the registrant of<br />
expenses incurred or paid by a director, officer or<br />
controlling person of the registrant in the successful<br />
defense of any action, suit or proceeding) is asserted . . . in<br />
connection with the securities being registered, the<br />
registrant will, unless in the opinion of its counsel the<br />
matter has been settled by controlling precedent, submit to<br />
a court of appropriate jurisdiction the question whether<br />
such indemnification by it is against public policy as<br />
expressed in the Act <strong>and</strong> will be governed by the final<br />
adjudication of such issue.”<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Criminal Liability<br />
Under the <strong>Securities</strong> Act<br />
Criminal liability --<br />
24:<br />
What constitutes willfulness?<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Litigation concerning violations<br />
of law in IPOs of late ’90s<br />
Please note:<br />
The following slides regarding the<br />
so-call “Initial Public Offering<br />
<strong>Securities</strong> Litigation” <strong>and</strong> related<br />
antitrust litigation are optional<br />
background material.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved.
Litigation concerning violations<br />
of law in IPOs of late ’90s<br />
During the dot-com boom of the late 1990s, the stock of<br />
many technology <strong>and</strong> telecommunications companies<br />
were publicly launched in high-stakes IPOs.<br />
The so-call “Initial Public Offering <strong>Securities</strong><br />
Litigation” consisted of 309 class actions filed<br />
throughout 2001, involving more than 300 IPOs<br />
marketed between 1998 <strong>and</strong> 2000. The cases were<br />
coordinated before U.S. District Court Judge Shira A.<br />
Scheindlin in the Southern District of New York.<br />
The case is formally known as “In re Initial Public<br />
Offering <strong>Securities</strong> Litigation.”<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
IPO <strong>Securities</strong> Litigation<br />
(cont’d)<br />
Plaintiffs: investors who purchased high-tech<br />
companies’ stock in after-market of IPOs<br />
Defendants: 55 IPO underwriters, 300 issuing<br />
companies, individual company directors <strong>and</strong><br />
officers<br />
Alleged misconduct<br />
Tie-in agreements/laddering<br />
Undisclosed Compensation<br />
Improper use of analysts to inflate stock prices<br />
& analyst conflicts of interest<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
IPO <strong>Securities</strong> Litigation<br />
(cont’d)<br />
Specifically, plaintiff alleged three fraudulent<br />
devices used by the underwriters.<br />
First, they allege that the underwriters<br />
conditioned allocations of shares at the offer<br />
price on agreements to purchase shares in the<br />
aftermarket (the "Tie-in Agreements").<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
IPO <strong>Securities</strong> Litigation<br />
(cont’d)<br />
Specifically, plaintiff alleged three fraudulent devices used<br />
by the underwriters.<br />
Second, they allege that the underwriters also required<br />
customers who received allocations of shares at the<br />
offer price to pay three forms of "Undisclosed<br />
Compensation" to the underwriters: (1) paying inflated<br />
brokerage commissions, (2) paying commissions on<br />
churned transactions in unrelated securities, <strong>and</strong> (3)<br />
purchasing other unwanted securities from the<br />
underwriters.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
IPO <strong>Securities</strong> Litigation<br />
(cont’d)<br />
Specifically, plaintiff alleged three fraudulent devices used by the<br />
underwriters.<br />
Third, Plaintiffs allege that underwriters used their analysts<br />
in several improper ways: (1) setting unrealistic price targets,<br />
(2) promising a "hot" analyst to an issuer in exchange for<br />
underwriting the IPO, (3) tying analyst compensation to<br />
performance of the investment banking division, (4) allowing<br />
analysts to own shares of stocks they were touting, <strong>and</strong> (5)<br />
failing to disclose these conflicts of interest.<br />
Plaintiffs also alleged that underwriters facilitated receipt of<br />
quick profits by insiders of defendant issuers <strong>and</strong> that the<br />
issuers "participated in <strong>and</strong> benefitted from" the underwriters'<br />
misconduct.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
IPO <strong>Securities</strong> Litigation<br />
Alleged <strong>Securities</strong> Law Violations<br />
Section 11 of the <strong>Securities</strong> Act<br />
Failure to disclose tie-in agreements <strong>and</strong> compensation<br />
arrangements in the registration statement<br />
Derivative liability under §15 for directors<br />
Section 10(b) of the Exchange Act<br />
Engaging in manipulative or deceptive practices as part<br />
of a scheme to defraud investors<br />
False or misleading statements concerning publicly<br />
traded securities<br />
Derivative liability under §20(a) for directors<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
IPO <strong>Securities</strong> Litigation<br />
Refusal to Certify Plaintiffs as a Class<br />
In October 2004, Judge Scheindlin issued an<br />
order granting in part <strong>and</strong> denying in part the<br />
Plaintiffs' motions for class certification in the<br />
six focus cases.<br />
On appeal, the Second Circuit reversed, denying<br />
class certification. Miles v. Merrill Lynch & Co.<br />
(In re Initial Public Offering <strong>Securities</strong><br />
Litigation), 471 F.3d 24 (2d Cir. 2006)<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
IPO <strong>Securities</strong> Litigation<br />
Refusal to Certify Plaintiffs as a Class<br />
Individual questions predominated over<br />
common questions as to:<br />
Reliance on misrepresentations<br />
Class could not rely on fraud-on-the-market doctrine<br />
because market for IPO shares is not efficient<br />
Knowledge of the misrepresentations<br />
Exclusion from class based on payment of<br />
undisclosed compensation to underwriter<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
IPO <strong>Securities</strong> Litigation<br />
2009 Settlement<br />
After a long period of mediation the<br />
parties reached a $586 million cash<br />
settlement.<br />
Investment banks <strong>and</strong> issuers denied<br />
wrongdoing.<br />
Important: FINRA Rule 5131 now<br />
prohibits certain preferential<br />
allocations of “new issues”<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Please note:<br />
IPO Antitrust Case<br />
The following slides regarding the<br />
related antitrust litigation are<br />
optional background material.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved.
Related Antitrust Case<br />
Contemporaneously with the In re Initial Public<br />
Offering Litigation, another putative (i.e.,<br />
proposed) class action was filed in the U.S.<br />
District Court for the Southern District of New<br />
York by investors who purchased shares of<br />
stock in certain technology related companies<br />
through IPOs or in the aftermarket immediately<br />
following IPOs during the late 1990s.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Related Antitrust Case<br />
The complaint charged ten investment banks,<br />
including Morgan Stanley, Goldman Sachs,<br />
Lehman Brothers, Credit Suisse First Boston,<br />
<strong>and</strong> JPMorgan Chase, along with a number of<br />
institutional investors, with conspiring illegally<br />
to artificially inflate the aftermarket prices of<br />
some 900 internet <strong>and</strong> technology stocks sold in<br />
those IPOs.<br />
The plaintiffs sought treble (i.e., triple) damages<br />
under federal antitrust laws.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
Alleged Antitrust Law<br />
Violations<br />
Sherman Act, Clayton Act <strong>and</strong> Robinson-Patman<br />
Act<br />
Unlawful agreement by underwriters to refuse to<br />
sell shares unless investors agreed to:<br />
Buy additional shares at escalating prices<br />
Pay high commissions on subsequent purchases<br />
Purchase other less desirable securities from<br />
underwriter<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
U.S. Supreme Court Rules<br />
<strong>Securities</strong> Laws Preclude Antitrust<br />
Claims<br />
In June 2007, the U.S. Supreme Court ruled in<br />
Credit Suisse First Boston v. Glen Billing (“IPO<br />
Antitrust Litigation”) that certain long-st<strong>and</strong>ing<br />
securities industry practices in the issuance of<br />
IPOs are impliedly immune from antitrust<br />
challenges on the ground that the regulation of<br />
such conduct is within the sole purview of the<br />
securities laws <strong>and</strong> the SEC.<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
U.S. Supreme Court Rules<br />
<strong>Securities</strong> Laws Preclude Antitrust<br />
Claims<br />
The Court ruled that no antitrust liability could arise<br />
from:<br />
(1) “laddering” agreements whereby investors<br />
were required to promise to place bids in the aftermarket<br />
at prices above the IPO price;<br />
(2) “tying” arrangements whereby investors<br />
commit to purchase other, less attractive securities; <strong>and</strong><br />
(3) other allegedly excessive commissions,<br />
including for the purchase of an issuer’s shares in<br />
follow-up or secondary public offerings (for which the<br />
underwriters would earn underwriting discounts).<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
U.S. Supreme Court Rules<br />
<strong>Securities</strong> Laws Preclude Antitrust<br />
Claims<br />
Court looked at 4 factors in determining “clear<br />
repugnancy” between antitrust laws <strong>and</strong> securities law:<br />
Efforts to jointly sell <strong>and</strong> market IPO securities is central to<br />
functioning of well-regulated market<br />
SEC maintained authority to enforce all challenged activity<br />
Evidence that SEC actively exercised that authority<br />
Fine line separating permissible from impermissible activity<br />
best drawn by those with expertise in securities<br />
©2012 Michael K. Krebs<br />
All Rights Reserved
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. - International Business Law<br />
June/July 2012<br />
Michael Krebs<br />
JD, Boston University School of Law 1985<br />
Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />
Tel. 617.439.2288 email: mkrebs@nutter.com<br />
© 2012 Michael K. Krebs<br />
All Rights Reserved
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. in International Business Law<br />
Session 4<br />
July 25, 2013
Session 4 Agenda<br />
How does a company register its IPO?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
2
Case Studies<br />
LinkedIn – November 16, 2011 IPO<br />
Facebook – May 17, 2012 IPO<br />
bluebird bio, Inc. – June 24, 2013 IPO<br />
Noodles & Company – June 28, 2013 IPO<br />
Grana y Montero Corp. – July 24, 2013 IPO<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
3
Basic Principles Underlying the<br />
<strong>Securities</strong> Act of 1933<br />
Unless an exemption is available,<br />
1. Every offer or sale of a security must be<br />
registered with the SEC under § 5 of the<br />
<strong>Securities</strong> Act, <strong>and</strong><br />
2. In the registration statement (which includes<br />
the prospectus), all information regarding<br />
the issuer <strong>and</strong> the security that is material to<br />
that investment decision must be disclosed.
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
How did Facebook <strong>and</strong> the other case<br />
study companies know what to<br />
disclose in their IPO registration<br />
statement?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
5
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
What disclosure does the <strong>Securities</strong><br />
Act itself specify?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
6
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
Not Important:<br />
§ 7 <strong>and</strong> Schedule A of the <strong>Securities</strong> Act<br />
EXCEPT: See § 7(a)(2) regarding financial<br />
statements<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
7
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
Very Important:<br />
SEC Form S-1 (or F-1)<br />
SEC <strong>Regulation</strong> S-K<br />
SEC <strong>Regulation</strong> S-X<br />
SEC “Industry Guides” (if applicable)<br />
SEC <strong>Regulation</strong> C (Rules 400 et seq.)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
8
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
<strong>Regulation</strong> C (Rules 400 et seq.), especially:<br />
Rule 421(d) (“plain English” rules)<br />
Rule 408 (additional material information)<br />
Rule 418 (SEC authority to request<br />
“supplemental” information)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
9
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
But first, some context!<br />
Prior to JOBS Act<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
10
Session 4<br />
Life Cycle of a Typical IPO<br />
1. Company tentatively decides to raise capital<br />
2. Company, after consultation with counsel,<br />
concludes than none of the exemptions from § 5<br />
registration will likely be available<br />
3. Company counsel advises management regarding<br />
compliance with “gun jumping” rules<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
11
Session 4<br />
Life Cycle of a Typical IPO<br />
4. Company contacts one or more investment<br />
banking firms to ascertain interest in acting as<br />
managing underwriter or co-managing<br />
underwriter in public offering<br />
5. Company selects one or more managing<br />
underwriters <strong>and</strong> may issue press release,<br />
especially if company is publicly traded.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
12
Session 4<br />
Life Cycle of a Typical IPO (cont’d)<br />
6. Managing underwriter, underwriter’s counsel <strong>and</strong> company<br />
counsel conduct due diligence review of company’s<br />
business, financial condition, results of operations, <strong>and</strong><br />
prospects, including interviews with senior management<br />
7. Company <strong>and</strong> company counsel prepare registration<br />
statement (including underlying prospectus) in collaboration<br />
with managing underwriter, underwriter’s counsel<br />
NB. Company’s independent accountants are involved<br />
but typically keep their distance from the prospectus<br />
drafting but review in connection with their “comfort<br />
letter” due diligence<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
13
Session 4<br />
Life Cycle of a Typical IPO (cont’d)<br />
8. Managing underwriter has preliminary discussions with other<br />
members of underwriting “syndicate” (those underwriters who<br />
will be parties to the underwriting agreement <strong>and</strong> therefore in<br />
“privity” of contract with the company)<br />
Prior to JOBS Act, underwriters did NOT have discussions<br />
at this stage with “dealers” who often will purchase stock<br />
directly from the underwriters in the offering<br />
NB. JOBS Act – namely, §5(d) – allows written or oral<br />
“test the waters” communications with “qualified<br />
institutional buyers [QIBs] or institutions that are<br />
accredited investors”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
14
Session 4<br />
Life Cycle of a Typical IPO (cont’d)<br />
9. Managing underwriter has preliminary discussions with<br />
company’s independent registered public accounting firm<br />
regarding scope of “comfort” letter that accounting firm will<br />
provide with respect to financial data in prospectus that is derived<br />
from company’s financial statements. The comfort letter will be a<br />
part of due diligence defense for §11 <strong>and</strong> §12(a)(2) purposes.<br />
10. Company files registration statement with SEC electronically<br />
via EDGAR system. The registration statement includes a<br />
“delaying amendment.” More about that later.<br />
11. Company typically issues a press release. If so, the Company<br />
likely would uses the safe harbor in Rule 134, so press release is<br />
not a prospectus<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
15
Session 4<br />
Life Cycle of a Typical IPO (cont’d)<br />
12. The SEC’s Division of Corporation Finance (or “Corp<br />
Fin”) reviews all IPO registration statements. Corp Fin<br />
assigns accounting <strong>and</strong> non-accounting reviewers from<br />
one of 12 Offices organized by industry. (In a non-IPO,<br />
Corp Fin makes a threshold decision whether to review<br />
registration statement.) See<br />
http://sec.gov/divisions/corpfin/cffilingreview.htm for the<br />
SEC’s summary of the review process.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
16
Session 4<br />
Life Cycle of a Typical IPO (cont’d)<br />
13. The lead non-accountant Corp Fin reviewer assigned to<br />
the registration statement contacts Company counsel. In<br />
the case of a non-IPO registration, Corp Fin will inform<br />
Company counsel whether registration statement is being<br />
reviewed <strong>and</strong>, if so, which of the three levels of review the<br />
registration statement will receive:<br />
Full Review – a “cover-to-cover” review of the registration<br />
statement in which the staff will examine the entire filing<br />
(including exhibits) for compliance with the applicable<br />
disclosure requirements of the federal securities laws <strong>and</strong><br />
regulations – all IPO registration statements receive full<br />
review;<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
17
Session 4<br />
Life Cycle of a Typical IPO (cont’d)<br />
Financial Statement Review – The staff will examine<br />
the financial statements <strong>and</strong> related disclosure, such as<br />
MD&A, for compliance with the applicable accounting<br />
st<strong>and</strong>ards <strong>and</strong> SEC disclosure requirements; or<br />
Targeted Review – The staff will examine the filing<br />
for one or more specific items of disclosure for<br />
compliance with the applicable accounting st<strong>and</strong>ards<br />
<strong>and</strong>/or other disclosure requirements.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
18
Session 4<br />
Life Cycle of a Typical IPO (cont’d)<br />
14. In the case of an IPO registration statement, or a non-IPO registration<br />
receiving a “full review,” the first round of staff comments likely will<br />
be received within 30 to 40 days of initial filing.<br />
15. During waiting period, underwriters begin to contact dealers <strong>and</strong><br />
customers. NB. JOBS Act allows discussions with QIBs <strong>and</strong><br />
institutions that are accredited investors<br />
16. Company receives comments from SEC staff regarding registration<br />
statement<br />
17. Company <strong>and</strong> company counsel revise registration statement<br />
(including underlying prospectus) in collaboration with managing<br />
underwriter, underwriter’s counsel <strong>and</strong> company’s independent<br />
accountants<br />
18. Company files amendment to registration statement<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
19
Session 4<br />
Life Cycle of a Typical IPO (cont’d)<br />
19. Company receives one or more additional rounds of comments<br />
from SEC regarding registration statement<br />
20. Steps 15 – 17 repeated, as necessary (often the Company will<br />
file multiple amendments)<br />
21. Company counsel <strong>and</strong> underwriter’s counsel negotiate form of<br />
underwriting agreement. NB. This often occurs before the<br />
initial registration filing.<br />
22. Underwriter’s counsel has detailed discussions with the<br />
company’s independent registered public accounting firm<br />
regarding the scope of “comfort” letter the accounting firm will<br />
provide when the offering closes. NB. This often occurs before<br />
the initial registration filing.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
20
Session 4<br />
Life Cycle of a Typical IPO (cont’d)<br />
23. Company <strong>and</strong> managing underwriters conclude that the<br />
Company has addressed all of the SEC staff’s substantive<br />
comments, the prospectus is in substantially final form,<br />
<strong>and</strong> SEC staff would be willing to cause the registration<br />
statement to be declared “effective” upon request. A<br />
Company typically will wait until the staff informs<br />
Company counsel that the staff “has no further<br />
comments.”<br />
24. Underwriters distribute “preliminary prospectus” (which<br />
is often referred to as a “red herring” because of the red<br />
“Subject to completion” legend on the cover page of the<br />
prospectus)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
21
Session 4<br />
Life Cycle of a Typical IPO (cont’d)<br />
25. Company (CEO <strong>and</strong> CFO) <strong>and</strong> managing underwriters<br />
go on “road show.” (Lawyers stay home.)<br />
26. Underwriters solicit offers to purchase from dealers <strong>and</strong><br />
other prospective purchasers<br />
27. Managing underwriters obtain “lock-up” agreements<br />
from Company insiders, whereby the agree not to sell<br />
stock for a specified period after the effective date<br />
(typically 90 days to one year; in the Facebook IPO,<br />
the lock-up periods ranged from 91 days to 366<br />
days with 211 days Mr. Zuckerberg<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
22
Session 4<br />
Life Cycle of a Typical IPO (cont’d)<br />
28. When managing underwriters believe the offering is<br />
sufficiently oversubscribed, the Company files “acceleration<br />
request” with SEC staff<br />
29. Company <strong>and</strong> managing underwriters have final discussions<br />
regarding offering price of securities. Per FINRA Rule 5131,<br />
book-running lead manager provides to issuer a report of<br />
indications of interest, including names of interested<br />
institutional investors <strong>and</strong> number of shares indicated by each,<br />
<strong>and</strong> a report of aggregate dem<strong>and</strong> from retail investors.<br />
30. SEC declares registration statement effective<br />
31. Company <strong>and</strong> managing underwriters execute<br />
underwriting agreement<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
23
Session 4<br />
Life Cycle of a Typical IPO (cont’d)<br />
32. Underwriters electronically send confirmations of orders<br />
to dealers <strong>and</strong> other purchaser with link to “final”<br />
prospectus, which includes pricing info (More about this<br />
later)<br />
33. Company files definitive prospectus under Rule 424(b)<br />
34. Closing or settlement usually occurs on the third business<br />
day after price (T+3) when underwriters receive funds from<br />
purchasers <strong>and</strong> deliver funds to company<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
24
Session 4<br />
Life Cycle of a Typical IPO (cont’d)<br />
35. After IPO settlement date, book-running lead manager<br />
provides to issuer, per FINRA Rule 5131, a report of the<br />
final allocation of shares<br />
36. 2 business days before release of lock-up, the book-running<br />
lead manager must announce the impending release or<br />
waiver through a major news service. Per FINRA Rule 5131<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
25
Session 4<br />
Life Cycle of A123 Systems, Inc.<br />
A very protracted IPO<br />
A123 Systems, Inc. designs, develops, manufactures <strong>and</strong> sells<br />
advanced, rechargeable lithium-ion batteries <strong>and</strong> battery<br />
systems.<br />
“Our batteries <strong>and</strong> battery systems provide a combination of<br />
power, safety <strong>and</strong> life that we believe no other commercially<br />
available battery provides.”<br />
“We believe that lithium-ion batteries will play an increasingly<br />
important role in facilitating a shift toward cleaner forms of<br />
energy. Using our innovative approach to materials science <strong>and</strong><br />
battery engineering . . . , we have developed a broad family of<br />
high-power lithium-ion batteries <strong>and</strong> battery systems.”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
26
Timeline<br />
Session 4<br />
Life Cycle of A123 Systems IPO<br />
Filed registration statement in August ‘08 covering the<br />
offer <strong>and</strong> sale of approximately $175 million of common<br />
stock.<br />
Multiple amendments (3x) filed in fall ’08<br />
April 2009: Sells $70 million of equity in Rule 506 private<br />
placement<br />
June 2009: Files Amend. No. 4 to registration statement<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
27
Timeline (cont’d)<br />
Session 4<br />
Life Cycle of A123 Systems, Inc.<br />
2009 IPO<br />
September 23, 2009: SEC issues an order granting confidential<br />
treatment for certain portions of exhibits filed with a registration<br />
statement<br />
September 23, 2009: SEC declares registration statement effective<br />
September 24, 2009: Files definitive prospectus under Rule 424(b)<br />
$380 million offering of common stock<br />
A123 Systems, Inc. offering 27,500,000 shares of common stock<br />
“Selling stockholders” identified in prospectus, which include<br />
members of senior management, offering an additional 680,501<br />
shares<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
28
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
Now, back to case study issuers<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
29
Basic Principle Underlying the<br />
<strong>Securities</strong> Act of 1933<br />
Disclosure regime vs. merit review
What did<br />
Noodles & Company Disclose?<br />
Noodles & Company’s definitive prospectus filed under Rule 424(b)<br />
contained the following statements:<br />
The <strong>Securities</strong> <strong>and</strong> Exchange Commission <strong>and</strong> state securities regulators have<br />
not approved or disapproved these securities, or determined if this prospectus<br />
is truthful or complete. Any representation to the contrary is a criminal<br />
offense.<br />
You should rely only on the information contained in this prospectus or in any<br />
free-writing prospectus we may authorize to be delivered or made available to<br />
you. We have not, <strong>and</strong> the underwriters have not, authorized anyone to<br />
provide you with additional or different information. * * * The information<br />
in this prospectus or any free-writing prospectus is accurate only as of its date,<br />
regardless of its time of delivery or of any sale of shares of our Class A<br />
common stock. Our business, financial condition, results of operations <strong>and</strong><br />
prospects may have changed since that date.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
31
Session 4 – Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
Study Problem 4.1<br />
Within a month after the BeanTown Biosystems board authorizes the<br />
IPO, Biosystems chooses the investment banking firm Morgan<br />
Stanley to serve as the lead underwriter, <strong>and</strong> Biosystems <strong>and</strong> its<br />
counsel begin to prepare the registration statement that Biosystems<br />
expects to file with the SEC within the next 30 days for a public<br />
offering of 10,000,000 shares at a estimated offering price of<br />
$10/share.<br />
Biosystems is incorporated in Delaware. Its principal office is in<br />
Massachusetts.<br />
What registration form would Biosystems file with the SEC for<br />
its IPO?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
32
Session 4 –Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
Study Problem 4.1 – Analysis<br />
What registration form would Biosystems file with<br />
the SEC?<br />
Form S-1<br />
©2013 Michael K. Krebs<br />
All Rights Reserved
Session 4 –Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
Study Problem 4.1 – Analysis<br />
Form S-1 is the “default” form for nongovernmental<br />
U.S. issuers:<br />
Eligibility Requirements for Use of Form S-1<br />
“This Form shall be used for the registration under the .<br />
. . <strong>Securities</strong> Act of securities of all registrants for<br />
which no other form is authorized or prescribed, except<br />
that this Form shall not be used for securities of foreign<br />
governments or political subdivisions thereof.”<br />
©2013 Michael K. Krebs<br />
All Rights Reserved
Session 4 – Case Studies<br />
Study Problem 4.2<br />
What registration form did the following<br />
issuers file?<br />
LinkedIn<br />
Facebook<br />
bluebird bio, Inc.<br />
Noodles & Company<br />
Grana y Montero Corp.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
35
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
How did Facebook know what to<br />
disclose in its IPO registration<br />
statement?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
36
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
Form S-1 Framework<br />
II. Application of General Rules <strong>and</strong> <strong>Regulation</strong>s<br />
A. Attention is directed to the General Rules <strong>and</strong> <strong>Regulation</strong>s under<br />
the <strong>Securities</strong> Act, particularly those comprising <strong>Regulation</strong> C.<br />
That <strong>Regulation</strong> contains general requirements regarding the<br />
preparation <strong>and</strong> filing of the registration statement.<br />
B. Attention is directed to <strong>Regulation</strong> S-K for the requirements<br />
applicable to the content of the non-financial statement portions<br />
of registration statements under the <strong>Securities</strong> Act. Where this<br />
Form directs the registrant to furnish information required by<br />
<strong>Regulation</strong> S-K <strong>and</strong> the item of <strong>Regulation</strong> S-K so provides,<br />
information need only be furnished to the extent appropriate.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
37
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
Form S-1 Framework (cont’d)<br />
Item 4. Use of Proceeds.<br />
Furnish the information required by Item 504 of<br />
<strong>Regulation</strong> S-K<br />
Item 6. Dilution.<br />
Furnish the information required by Item 506 of<br />
<strong>Regulation</strong> S-K<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
38
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
What is SEC <strong>Regulation</strong> S-K?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
39
SEC <strong>Regulation</strong> S-K<br />
Reg. S-K, Rule 10 – The “Rosetta Stone”<br />
Reg. S-K states the requirements applicable to the content of the nonfinancial<br />
statement portions of:<br />
1. Registration statements under the <strong>Securities</strong> Act to the extent<br />
provided in the forms to be used for registration under such Act; <strong>and</strong><br />
2. Registration statements under Exchange Act (“EA”) Section 12,<br />
annual or other reports under EA Sections 13 <strong>and</strong> 15(d), goingprivate<br />
transaction statements under EA Section 13, tender offer<br />
statements under EA Sections 13 <strong>and</strong> 14, proxy <strong>and</strong> information<br />
statements under EA section 14, <strong>and</strong> any other documents required to<br />
be filed under the EA to the extent provided in the forms <strong>and</strong> rules<br />
under that Act.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
40
SEC <strong>Regulation</strong> S-K<br />
Example of Reg. S-K Disclosure Requirements:<br />
Item 504 -- Use of Proceeds<br />
State the principal purposes for which the net<br />
proceeds to the registrant from the securities to be<br />
offered are intended to be used <strong>and</strong> the approximate<br />
amount intended to be used for each such purpose.<br />
Where registrant has no current specific plan . . . so<br />
state <strong>and</strong> discuss the principal reasons for the offering.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
41
Don’t Forget <strong>Regulation</strong> C!<br />
For example, Rule 421(a) directs:<br />
The information required in a prospectus need not follow<br />
the order of the items or other requirements in the form.<br />
Such information shall not, however, be set forth in such<br />
fashion as to obscure any of the required information or<br />
any information necessary to keep the required<br />
information from being incomplete or misleading. Where<br />
an item requires information to be given in a prospectus in<br />
tabular form it shall be given in substantially the tabular<br />
form specified in the item.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
42
<strong>Regulation</strong> C (cont’d)<br />
In addition, Rule 408(a) specifies:<br />
“In addition to the information expressly required to be<br />
included in a registration statement, there shall be added<br />
such further material information, if any, as may be<br />
necessary to make the required statements, in the light of<br />
the circumstances under which they are made, not<br />
misleading.”<br />
Sound familiar?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
43
What did Facebook Disclose?<br />
USE OF PROCEEDS<br />
We estimate that our net proceeds from the sale of the Class A common stock . .<br />
. will be approximately $6.8 billion, or approximately $6.9 billion if the<br />
underwriters exercise in full their right to purchase additional shares to cover<br />
over-allotments, based on the initial public offering price of $38.00 per share,<br />
after deducting underwriting discounts <strong>and</strong> commissions <strong>and</strong> estimated offering<br />
expenses payable by us.<br />
The principal purposes of our initial public offering are to create a public market<br />
for our Class A common stock <strong>and</strong> thereby enable future access to the public<br />
equity markets by us <strong>and</strong> our employees, obtain additional capital, <strong>and</strong> facilitate<br />
an orderly distribution of shares for the selling stockholders. We intend to use<br />
the net proceeds to us from our initial public offering for working capital <strong>and</strong><br />
other general corporate purposes; however, we do not currently have any<br />
specific uses of the net proceeds planned. * * *<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
44
What did Facebook Disclose?<br />
USE OF PROCEEDS (continued)<br />
* * * Additionally, we may use a portion of the proceeds to us for<br />
acquisitions of complementary businesses, technologies, or other assets.<br />
However, we have no commitments to use the proceeds from this<br />
offering for any such acquisitions or investments at this time.<br />
Pending other uses, we intend to invest the proceeds to us in investmentgrade,<br />
interest-bearing securities * * * Our management will have<br />
broad discretion in the application of the net proceeds we receive from<br />
our initial public offering, <strong>and</strong> investors will be relying on the judgment<br />
of our management regarding the application of the net proceeds.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
45
What did bluebird bio<br />
Disclose?<br />
USE OF PROCEEDS<br />
We estimate that the net proceeds from the sale of 5,941,176 shares of common<br />
stock in this offering will be approximately $90.9 million based on the initial public<br />
offering price of $17.00 per share, after deducting underwriting discounts <strong>and</strong><br />
commissions <strong>and</strong> estimated offering expenses payable by us. * * *<br />
We are undertaking this offering in order to access the public capital markets <strong>and</strong> to<br />
increase our liquidity. We intend to use the net proceeds of this offering as follows:<br />
Approximately $11.8 million to fund direct research <strong>and</strong> development expenses for<br />
our ALD-102 Study, a Phase II/III clinical study of Lenti-D * * *<br />
The remainder for general <strong>and</strong> administrative expenses (including personnelrelated<br />
costs), potential future development programs, early-stage research <strong>and</strong><br />
development, capital expenditures <strong>and</strong> working capital <strong>and</strong> other general corporate<br />
purposes.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
46
What did Noodles &<br />
Company Disclose?<br />
USE OF PROCEEDS<br />
The net proceeds we receive from this offering will be approximately $87.0<br />
million based on the initial public offering price of $18.00 per share, after<br />
deducting the underwriting discounts <strong>and</strong> commissions <strong>and</strong> estimated offering<br />
expenses payable by us. If the underwriters' option to purchase additional shares<br />
in this offering from us is exercised, our net proceeds will be approximately<br />
$100.4 million after deducting the underwriting discounts <strong>and</strong> commissions <strong>and</strong><br />
estimated offering expenses payable by us.<br />
We intend to use approximately $85.9 million of the net proceeds we receive<br />
from this offering to repay borrowings under our credit facility, which has a<br />
maturity date of August 1, 2017 <strong>and</strong> had an outst<strong>and</strong>ing balance of<br />
approximately $100.3 million as of April 2, 2013. * * * We intend to use any<br />
remaining proceeds for working capital <strong>and</strong> other general corporate purposes.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
47
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
What is SEC <strong>Regulation</strong> S-X?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
48
SEC <strong>Regulation</strong> S-X<br />
Same concept as Reg. S-K, but applicable to financial statements<br />
Reg. S-X (together with the SEC’s Financial Reporting Releases)<br />
sets forth the form <strong>and</strong> content of <strong>and</strong> requirements for financial<br />
statements required to be filed as a part of:<br />
1. Registration statements under the <strong>Securities</strong> Act, except as<br />
otherwise specifically provided in the applicable form;<br />
2. Registration statements under EA Section 12, annual or<br />
other reports under EA Sections 13 <strong>and</strong> 15(d) <strong>and</strong> proxy<br />
<strong>and</strong> information statements under EA Section 14 except as<br />
otherwise specifically provided in the applicable form;<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
49
What did LinkedIn Disclose?<br />
LINKEDIN CORPORATION<br />
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS<br />
Report of Independent Registered Public Accounting Firm (F-2 )<br />
Consolidated Balance Sheets (F-3)<br />
Consolidated Statements of Operations (F-4)<br />
Consolidated Statements of Redeemable Convertible Preferred Stock,<br />
Stockholders’ Equity <strong>and</strong> Comprehensive Income (Loss) (F-5)<br />
Consolidated Statements of Cash Flows ( F-7 )<br />
Notes to Consolidated Financial Statements (F-8)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
50
What did LinkedIn Disclose?<br />
LINKEDIN CORPORATION<br />
Report of Independent Registered Public Accounting Firm<br />
States that Deloitte & Touche audited the accompanying consolidated<br />
financial statements of LinkedIn <strong>and</strong> subsidiaries<br />
Notes, as is customary, that the financial statements are LinkedIn’s<br />
responsibility, not Deloitte’s<br />
Opines that the consolidated financial statements present fairly, in all<br />
material respects, the financial position of LinkedIn as of December 31,<br />
2009 <strong>and</strong> 2010, <strong>and</strong> the results of operations <strong>and</strong> cash flows for each of<br />
the three years in the period ended December 31, 2010, in conformity<br />
with accounting principles generally accepted in the United States of<br />
America.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
51
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
How did JOBS Act affect<br />
<strong>Regulation</strong> S-X?<br />
Did §7(a)(2) affect the financial<br />
statements included in the Noodles<br />
prospectus?<br />
What about the bluebird bio prospectus?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
52
luebird bio Disclosure regarding<br />
Emerging Growth Company Status<br />
In “Risk Factors” section of definitive prospectus, bluebird bio<br />
disclosed:<br />
“We are an “emerging growth company,” <strong>and</strong> we cannot be certain if<br />
the reduced reporting requirements applicable to emerging growth<br />
companies will make our common stock less attractive to investors.<br />
“We are an “emerging growth company” * * * For as long as we continue<br />
to be an emerging growth company, we may take advantage of exemptions<br />
from various reporting requirements * * * including not being required to<br />
comply with the auditor attestation requirements of Section 404 of the<br />
Sarbanes-Oxley Act of 2002 * * * We cannot predict if investors will find<br />
our common stock less attractive because we may rely on these<br />
exemptions.”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
53
luebird bio Disclosure regarding<br />
Emerging Growth Company Status<br />
Risk Factor disclosure (cont’d):<br />
“Under the JOBS Act, emerging growth companies can also delay<br />
adopting new or revised accounting st<strong>and</strong>ards until such time as<br />
those st<strong>and</strong>ards apply to private companies. We have irrevocably<br />
elected not to avail ourselves of this exemption from new or revised<br />
accounting st<strong>and</strong>ards <strong>and</strong>, therefore, will be subject to the same new<br />
or revised accounting st<strong>and</strong>ards as other public companies that are<br />
not emerging growth companies.” [Emphasis added.]<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
54
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
What are the SEC “Industry Guides”?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
55
What did Graña y Montero<br />
Disclose?<br />
What industry guide, if any, is applicable to<br />
Graña y Montero S.A.A.’s registration<br />
statement?<br />
Hint: See first page of the section of financial<br />
statements titled:<br />
“Supplementary Data (Unaudited)”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
56
SEC Industry Guides<br />
http://www.sec.gov/about/forms/industryguides.pdf<br />
Disclosure of oil <strong>and</strong> gas operations<br />
Statistical disclosure by bank holding companies<br />
Prospectus relating to interests in oil <strong>and</strong> gas programs<br />
Registration of interests in real estate limited partnerships<br />
Disclosures concerning unpaid claims <strong>and</strong> claim adjustment<br />
expenses of property-casualty insurance underwriters<br />
Description of property by issuers engaged or to be engaged<br />
in significant mining operations<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
57
Another Overarching Principle –<br />
Integrated Disclosure Under <strong>Securities</strong><br />
Act <strong>and</strong> Exchange Act<br />
Integrated Disclosure<br />
Forms S-1, S-3, S-4, S-8, etc.<br />
Reg. S-K, Reg. S-X<br />
SEC “Industry Guides”<br />
Risk Factors<br />
MD&A or “Management’s Discussion <strong>and</strong><br />
Analysis of Financial Condition <strong>and</strong> Results of<br />
Operations”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
58
Objectives of Integrated Disclosure<br />
System:<br />
No. 1 – St<strong>and</strong>ardize ’33 Act/’34 Act<br />
Disclosure<br />
St<strong>and</strong>ardize categories of information<br />
required in SEC filings <strong>and</strong> investor<br />
documents under both the <strong>Securities</strong> Act<br />
<strong>and</strong> the Exchange Act<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
59
“Three Amigos” of Integrated<br />
Disclosure<br />
<strong>Regulation</strong> S-K<br />
Disclosures Other Than Financial Statements<br />
<strong>Regulation</strong> S-X (supplemented by Industry Guides)<br />
Form <strong>and</strong> Content of Financial Statements<br />
Industry Guides require supplemental statistical<br />
disclosure for certain industries<br />
<strong>Regulation</strong> M-A<br />
M&A/Tender Offer Disclosure<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
60
Objectives of Integrated Disclosure<br />
System:<br />
No. 2 – Incorporation by Reference<br />
Permit various information to be<br />
incorporated by reference from the<br />
issuer’s other ‘34 Act reports or ‘33 Act<br />
registration statements<br />
previously filed, or<br />
subsequently filed<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
61
Primary ’33 Act Examples of<br />
Incorporation by Reference<br />
S-3 Registration Statement<br />
S-4 Registration Statement<br />
S-8 Registration Statement<br />
More about this in Session 5<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
62
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
What is meant by the phrase<br />
“plain English”?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
63
What is meant by the phrase<br />
“plain English”?<br />
Rule 421(d) – known as the “Plain English Rule”<br />
Issuers must use plain English principles in the<br />
organization, language, <strong>and</strong> design of these sections<br />
of the prospectus:<br />
front <strong>and</strong> back cover pages,<br />
summary, <strong>and</strong><br />
risk factors section.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
64
“Plain English” (cont’d)<br />
For those sections where plain English in required by Rule 421(d)<br />
[see preceding slide], the following principles apply:<br />
Short sentences;<br />
Definite, concrete, everyday words;<br />
Active voice;<br />
Tabular presentation or bullet lists for complex<br />
material, whenever possible;<br />
No legal jargon or highly technical business terms; <strong>and</strong><br />
No multiple negatives.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
65
“Plain English” (cont’d)<br />
In designing these sections specified by Rule 421(d) (or other<br />
sections of the prospectus,) you may include pictures, logos,<br />
charts, graphs, or other design elements so long as the design is<br />
not misleading <strong>and</strong> the required information is clear.<br />
Issuers are encouraged to use tables, schedules, charts <strong>and</strong><br />
graphic illustrations of the results of operations, balance sheet,<br />
or other financial data that present the data in an<br />
underst<strong>and</strong>able manner.<br />
See generally <strong>Securities</strong> Act Release No. 33–7497 (January<br />
28, 1998) for information on plain English principles<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
66
What did LinkedIn Disclose?<br />
Risks Related to Our Business<br />
We have a short operating history in a new <strong>and</strong> unproven market, which makes it difficult to<br />
evaluate our future prospects <strong>and</strong> may increase the risk that we will not be successful.<br />
We have a short operating history in a new <strong>and</strong> unproven market that may not develop as<br />
expected, if at all. This short operating history makes it difficult to effectively assess our future<br />
prospects. You should consider our business <strong>and</strong> prospects in light of the risks <strong>and</strong> difficulties<br />
we encounter in this rapidly evolving market. These risks <strong>and</strong> difficulties include our ability to,<br />
among other things:<br />
• increase our number of registered members <strong>and</strong> member engagement;<br />
• avoid interruptions or disruptions in our service or slower than expected website load<br />
times;<br />
• develop a scalable, high-performance technology infrastructure that can efficiently<br />
<strong>and</strong> reliably h<strong>and</strong>le increased member usage globally, as well as the deployment of<br />
new features <strong>and</strong> products; * * *<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
67
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
Who must sign a registration<br />
statement?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
68
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
Who must consent to the filing<br />
of a registration statement?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
69
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
What is a delaying amendment?<br />
Why is it relevant?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
70
Why Do Issuers use a<br />
Delaying Amendment?<br />
Consider § 8(a) of the<br />
<strong>Securities</strong> Act<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
71
What did Grana y Montero<br />
Corp. Do?<br />
Grana y Montero Corp.’s initial F-1 filing on June 4, 2013<br />
contains the following statement toward the bottom of the<br />
registration statement cover page:<br />
The Registrant hereby amends this Registration Statement on<br />
such date or dates as may be necessary to delay its effective date<br />
until the Registrant shall file a further amendment which<br />
specifically states that this Registration Statement shall thereafter<br />
become effective in accordance with Section 8(a) of the <strong>Securities</strong><br />
Act, or until this Registration Statement shall become effective on<br />
such date as the Commission, acting pursuant to said Section 8(a),<br />
may determine.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
72
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
Must a company file an IPO<br />
registration statement electronically<br />
with the SEC?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
73
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
May a company file an IPO registration<br />
statement confidentially with the SEC?<br />
What did the following issuers do?<br />
bluebird bio, Inc.<br />
Noodles & Company<br />
Grana y Montero Corp.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
74
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
What is a “free writing prospectus”?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
75
A Few Words About “Free Writing”<br />
The 2005 Offering Reforms permit the use of a category of<br />
written offering material known as “free writing prospectuses.”<br />
A free writing prospectus is any written communication that<br />
constitutes an offer to sell (or solicitation of an offer to buy)<br />
securities that are or will be the subject of a registered offering<br />
<strong>and</strong> that is not a statutory prospectus or other written<br />
communication permitted or exempted under other provisions<br />
of the securities laws.<br />
See SEC Rules 164 <strong>and</strong> 433 (<strong>and</strong> 405).<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
76
“Free Writing” (cont’d)<br />
The term “free writing” includes offering-related emails,<br />
faxes, term sheets <strong>and</strong> other written <strong>and</strong> prerecorded<br />
electronic communications.<br />
Free writing prospectuses are permitted to be used<br />
after a registration statement has been filed with the<br />
SEC upon satisfaction of certain conditions, including<br />
filing in some cases.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
77
“Free Writing” (cont’d)<br />
In connection with IPOs <strong>and</strong> offerings by other “unseasoned<br />
issuers,”<br />
a free writing prospectus may be used only if it is<br />
accompanied or preceded by a preliminary prospectus<br />
(which, in the IPO context, must include a price range).<br />
In the case of electronic communications, a hyperlink to<br />
the preliminary prospectus would satisfy this delivery<br />
requirement.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
78
“Free Writing” (cont’d)<br />
The free writing prospectus is subject to prospectus liability<br />
under <strong>Securities</strong> Act Section 12(a)(2) for the user.<br />
But the free writing prospectus is not deemed part of the<br />
registration statement <strong>and</strong>, accordingly, does not carry<br />
<strong>Securities</strong> Act Section 11 cross-liability for all underwriters.<br />
The rules also clarify that an underwriter generally is not<br />
liable under Section 12(a)(2) for another person’s free writing<br />
prospectuses so long as the underwriter does not use or refer to<br />
that writing.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
79
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
What is a road show?<br />
Does it involve a “prospectus”?<br />
Is it live or recorded?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
80
Road Shows<br />
Fidelity Investment’s IPO glossary defines a Road Show<br />
as follows:<br />
Also called the 'Dog <strong>and</strong> Pony Show'. A tour taken by a<br />
company preparing for an IPO in order to attract interest in<br />
its securities. Attended by potential buyers, including<br />
institutional investors, analysts, <strong>and</strong> money managers by<br />
invitation only. Members of the media are forbidden to<br />
attend.<br />
For non-WSKIs, occurs only after registration statement is<br />
on file, but this may change as a result of new §5(d).<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
81
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
SEC View of Electronic Communications<br />
Essentially all pre-recorded electronic communications are treated as<br />
written communications, rather than as oral communications. Therefore,<br />
they are subject to filing if prepared or used by the issuer or if they<br />
otherwise meet the criteria for filing of free writing prospectuses.<br />
Live, real-time communications to a live audience are considered oral,<br />
<strong>and</strong> thus not an illegal prospectus or subject to filing, even if<br />
communicated by electronic means.<br />
Television <strong>and</strong> radio broadcasts continue to be treated as written<br />
communications, however, as specifically required by the <strong>Securities</strong> Act.<br />
An issuer must remain as cautious about information posted to its web<br />
site or hyperlinked on its web site to a third-party web site. 2005<br />
Offering Reforms treat these links generally as free writing prospectuses<br />
of the issuer to the extent they are deemed offers.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
82
Electronic Road Shows<br />
A road show, graphically transmitted in real-time to a live audience,<br />
including “live” conferences with investors, live road shows, <strong>and</strong> road<br />
shows webcast in real-time, as well as any slides or other visual aids<br />
provided or transmitted as part of the road show, will not be a written<br />
communication or a free writing prospectus, although it is subject to the<br />
liability provisions of the federal securities laws.<br />
Electronic road shows that are neither live nor transmitted in real time are<br />
considered free writing prospectuses, although permitted if the rules for free<br />
writing prospectuses are satisfied.<br />
Electronic road shows that qualify as free writing prospectuses that are<br />
used in an initial public offering of common or convertible equity securities<br />
must comply with the filing conditions unless the issuer makes a version<br />
readily available without restriction electronically to any potential investor.<br />
Electronic road shows for other offerings generally do not need to be<br />
filed.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
83
After the Road Show . . .<br />
Do underwriters have a “market out”<br />
under the typical underwriting<br />
agreement?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
84
After the Road Show . . .<br />
What is the “Green Shoe”?<br />
(Also known as the underwriters’<br />
over-allotment option)<br />
Why is it necessary?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
85
After the Road Show . . .<br />
The “Green Shoe” or “over-allotment” option<br />
is an option in the typical underwriting<br />
agreement that grants the underwriters a 30-day<br />
option to purchase up to 15% more of the<br />
securities being underwritten.<br />
Term is derived from an offering by the Green<br />
Shoe Company (predecessor of Stride Rite) in<br />
which the over-allotment option first was used.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
86
What did LinkedIn Do?<br />
LinkedIn’s definitive prospectus filed under Rule 424(b)<br />
contained the following statement under the caption<br />
“Underwriting”:<br />
“We have granted to the underwriters an option, exercisable for 30<br />
days from the date of this prospectus, to purchase up to 1,176,000<br />
additional shares of Class A common stock at the public offering<br />
price listed on the cover page of this prospectus, less underwriting<br />
discounts <strong>and</strong> commissions. The underwriters may exercise this<br />
option solely for the purpose of covering over-allotments, if any,<br />
made in connection with the offering of the shares of Class A<br />
common stock offered by this prospectus. * * * ”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
87
Underst<strong>and</strong>ing SEC<br />
Disclosure Regime for IPOs<br />
When <strong>and</strong> how must a<br />
prospectus be delivered?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
88
Section 5 Framework<br />
After effective date of the registration statement, a<br />
written communication that confirms the sale of a<br />
security may be provided only if a final prospectus is<br />
sent or given previously or at the same time.<br />
Otherwise, such a communication is a prospectus <strong>and</strong><br />
may not be provided unless it meets the requirements<br />
of Section 10(a).<br />
As written confirmations are not designed to meet<br />
those requirements, a final prospectus must<br />
accompany or precede a written confirmation.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
89
When/how must a prospectus be<br />
delivered?<br />
How must a prospectus be delivered?<br />
Rules 172 <strong>and</strong> 173: Access = Delivery<br />
SEC concluded, as part of 2005 Offering Reforms, that Internet<br />
usage then was sufficiently broad to allow adoption of a<br />
prospectus delivery model that relies on timely access to filed<br />
information <strong>and</strong> documents.<br />
This generally is referred to as the “access equals delivery”<br />
model, which enables issuers, brokers, <strong>and</strong> dealers to satisfy<br />
their final prospectus delivery obligations if a final prospectus<br />
is or will be on file within the time required by the new rules,<br />
including a cure period.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
90
When/how must a prospectus<br />
be delivered? (cont’d)<br />
Rules 172 <strong>and</strong> 173: Access = Delivery<br />
Final prospectus will be deemed to precede or<br />
accompany a security for sale as long as final<br />
prospectus meeting requirements of <strong>Securities</strong> Act<br />
Section 10(a) is filed, or issuer makes a good faith <strong>and</strong><br />
reasonable effort to timely file final prospectus with<br />
SEC.<br />
Delivery of preliminary prospectus in IPOs continues<br />
to be required.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
91
When/how must a prospectus<br />
be delivered?<br />
Rule 173: Access = Delivery<br />
Sales by an issuer or underwriter to a purchaser<br />
Purchaser must be provided, not later than two<br />
business days after completion of the sale, either a<br />
copy of the final prospectus or a notice providing that<br />
the sale was made pursuant to a registration statement<br />
or in a transaction in which a final prospectus would<br />
have been required to have been delivered in the<br />
absence of the Rule 172.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
92
When/how must a prospectus<br />
be delivered?<br />
Rule 173: Access = Delivery<br />
For sales by an issuer or underwriter to a purchaser<br />
The investor may request a final prospectus, but the<br />
issuer <strong>and</strong> underwriter need not provide before<br />
settlement.<br />
Written confirmations <strong>and</strong> notices of allocation,<br />
including e-mail notifications to inform investors of<br />
their allocations, may be sent after effectiveness of the<br />
registration statement without being accompanied by a<br />
final prospectus.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
93
When/how must a prospectus<br />
be delivered?<br />
For how long after the effective date of the<br />
registration statement does a “dealer” have an<br />
obligation to deliver a prospectus?<br />
Rule 174 (whereby SEC shortened timeframe<br />
under Section 4(a)(3))<br />
25 days for “dealers” in typical IPO (see Rule<br />
174(d))<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
94
What did LinkedIn Disclose?<br />
LinkedIn’s definitive prospectus filed under Rule 424(b)<br />
contained the following statements after the table of contents:<br />
“Through <strong>and</strong> including June 12, 2012 (the 25th day after the date of<br />
this prospectus), all dealers that effect transactions in these securities,<br />
whether or not participating in this offering, may be required to<br />
deliver a prospectus. This is in addition to the dealers’ obligation to<br />
deliver a prospectus when acting as underwriters <strong>and</strong> with respect to<br />
their unsold allotments or subscriptions. ”<br />
“The information contained in this prospectus is accurate only as of<br />
the date of this prospectus, regardless of the time of delivery of this<br />
prospectus, or of any sale of our Class A common stock.”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
95
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. - International Business Law<br />
July/August 2013<br />
Michael Krebs<br />
JD, Boston University School of Law 1985<br />
Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />
Tel. 617.439.2288 email: mkrebs@nutter.com
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. in International Business Law<br />
Session 5 – July 26, 2013<br />
Preview Slides<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 5 Agenda<br />
How does a company register securities<br />
after its IPO?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
2
Basic Principle Underlying the<br />
<strong>Securities</strong> Act of 1933<br />
Unless an exemption is available,<br />
1. Every offer or sale of a security must be<br />
registered with the SEC under § 5 of the<br />
<strong>Securities</strong> Act, <strong>and</strong><br />
2. In the registration statement (which<br />
includes the prospectus), all information<br />
material to that investment decision must<br />
be disclosed.
Session 5 – Underst<strong>and</strong>ing SEC Registration<br />
Regime for Reporting Companies<br />
Study Problem 5.1<br />
Jumbo Corp., a NYSE-listed company that has been<br />
publicly traded for the past 15 years, seeks to raise $300<br />
million in debt financing by selling ten-year senior notes<br />
in an underwritten offering primarily to institutional<br />
investors. The notes would not be “investment grade.”<br />
Jumbo’s common equity float is $50 million.<br />
What form of registration statement would Jumbo Corp<br />
file with the SEC?<br />
What if Jumbo’s common equity float is $500 million?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
4
Underst<strong>and</strong>ing SEC Registration<br />
Regime for Reporting Companies<br />
How does an “S-3 registration<br />
statement” differ from an “S-1<br />
registration statement”?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
5
Review of S-3 Eligibility<br />
Why does S-3 eligibility matter?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
6
S-3 Eligibility (cont’d)<br />
General Instruction I.A. of Form S–3 requires:<br />
1. Registrant is organized under laws of U.S. or any<br />
state, etc. <strong>and</strong> has its principal business operations in<br />
U.S. or its territories.<br />
2. Registrant has a class of securities registered pursuant<br />
to Section 12(b) of the Exchange Act or a class of<br />
equity securities registered pursuant to Section 12(g)<br />
of the Exchange Act or is required to file reports<br />
pursuant to Section 15(d) of the Exchange Act.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
7
S-3 Eligibility (cont’d)<br />
3. Registrant has been subject to the requirements of Section<br />
12 or 15(d) of the Exchange Act <strong>and</strong> has filed all the<br />
material required to be filed pursuant to Section 13, 14 or<br />
15(d) for a period of at least twelve calendar months<br />
immediately preceding the filing of the registration<br />
statement.<br />
4. Registrant has filed in a timely manner all reports<br />
required to be filed during the twelve calendar months<br />
<strong>and</strong> any portion of a month immediately preceding<br />
filing of registration statement, other than certain 8-K<br />
filings.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
8
S-3 Eligibility (cont’d)<br />
5. Neither the registrant nor any of its consolidated or<br />
unconsolidated subsidiaries has, since the end of the last<br />
fiscal year for which certified financial statements of the<br />
registrant <strong>and</strong> its consolidated subsidiaries were included<br />
in a report filed pursuant to Section 13(a) or 15(d) of the<br />
Exchange Act: (a) failed to pay any dividend or sinking<br />
fund installment on preferred stock; or (b) defaulted (i)<br />
on any installment or installments on indebtedness for<br />
borrowed money, or (ii) on any rental on one or more<br />
long term leases, which defaults in the aggregate are<br />
material to the financial position of the registrant.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
9
S-3 Eligibility (cont’d)<br />
Current S-3 Eligibility: If Float < $75 million<br />
If issuer has a “float” of less than $75 million, the issuer<br />
can use S-3 if the issuer:<br />
1. Satisfies the other S-3 eligibility criteria;<br />
2. Has a class of common equity securities listed on a<br />
national securities exchange; <strong>and</strong><br />
3. Does not sell more than the equivalent of one-third<br />
of its public float in primary offerings during any<br />
12-month period.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
10
S-3 Eligibility (cont’d)<br />
Current S-3 Eligibility: If Float ≥ $75 million<br />
If issuer has a “float” of $75 million or more<br />
<strong>and</strong> satisfies other S-3 eligibility criteria:<br />
Issuer can sell an unlimited amount of<br />
securities under an S-3 registration statement.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
11
Underst<strong>and</strong>ing SEC Registration<br />
Regime for Reporting Companies<br />
What is meant by “incorporation<br />
by reference”?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
12
Review of Overarching Principle –<br />
Integrated Disclosure Under <strong>Securities</strong><br />
Act <strong>and</strong> Exchange Act<br />
Integrated Disclosure<br />
Forms S-1, S-3, S-4, S-8, etc.<br />
Reg. S-K, Reg. S-X<br />
SEC “Industry Guides”<br />
Risk Factors<br />
MD&A or “Management’s Discussion <strong>and</strong><br />
Analysis of Financial Condition <strong>and</strong> Results of<br />
Operations”<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
13
Objectives of Integrated Disclosure<br />
System:<br />
No. 1 – St<strong>and</strong>ardize ’33 Act/’34 Act<br />
Disclosure<br />
St<strong>and</strong>ardize categories of information<br />
required in SEC filings <strong>and</strong> investor<br />
documents under both the <strong>Securities</strong> Act<br />
<strong>and</strong> the Exchange Act<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
14
“Three Amigos” of Integrated<br />
Disclosure<br />
<strong>Regulation</strong> S-K<br />
Disclosures Other Than Financial Statements<br />
<strong>Regulation</strong> S-X (supplemented by Industry Guides)<br />
Form <strong>and</strong> Content of Financial Statements<br />
Industry Guides require supplemental statistical<br />
disclosure certain industries<br />
<strong>Regulation</strong> M-A<br />
M&A/Tender Offer Disclosure<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
15
Review of <strong>Regulation</strong> S-K<br />
Reg. S-K, Rule 10 – The “Rosetta Stone”<br />
Reg. S-K states the requirements applicable to the content of the nonfinancial<br />
statement portions of:<br />
1. Registration statements under the <strong>Securities</strong> Act to the extent<br />
provided in the forms to be used for registration under such Act; <strong>and</strong><br />
2. Registration statements under Exchange Act (“EA”) Section 12,<br />
annual or other reports under EA Sections 13 <strong>and</strong> 15(d), goingprivate<br />
transaction statements under EA Section 13, tender offer<br />
statements under EA Sections 13 <strong>and</strong> 14, proxy <strong>and</strong> information<br />
statements under EA section 14, <strong>and</strong> any other documents required to<br />
be filed under the EA to the extent provided in the forms <strong>and</strong> rules<br />
under that Act.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
16
Review of <strong>Regulation</strong> S-X<br />
Same concept as Reg. S-K, but applicable to financial statements<br />
Reg. S-X (together with the SEC’s Financial Reporting Releases)<br />
sets forth the form <strong>and</strong> content of <strong>and</strong> requirements for financial<br />
statements required to be filed as a part of:<br />
1. Registration statements under the <strong>Securities</strong> Act, except as<br />
otherwise specifically provided in the applicable form;<br />
2. Registration statements under EA Section 12, annual or<br />
other reports under EA Sections 13 <strong>and</strong> 15(d) <strong>and</strong> proxy<br />
<strong>and</strong> information statements under EA Section 14 except as<br />
otherwise specifically provided in the applicable form;<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
17
Objectives of Integrated Disclosure<br />
System:<br />
No. 2 – Incorporation by Reference<br />
Permit various information to be<br />
incorporated by reference from the<br />
issuer’s other ‘34 Act reports or ‘33 Act<br />
registration statements<br />
previously filed, or<br />
subsequently filed<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
18
Primary ’33 Act Examples of<br />
Incorporation by Reference<br />
S-3 Registration Statement<br />
S-4 Registration Statement<br />
S-8 Registration Statement<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
19
Primary ’33 Act Examples of<br />
Incorporation by Reference<br />
S-3 Registration Statement<br />
Item 12. Incorporation of Certain<br />
Information<br />
(a) The documents listed . . . below shall be<br />
specifically incorporated by reference<br />
into the prospectus . . . :<br />
(1) annual report on Form 10-K . . . which<br />
contains financial statements for the latest<br />
fiscal year . . . .<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
20
Primary ’33 Act Examples of<br />
Incorporation by Reference<br />
S-3 Registration Statement<br />
Item 12. Incorporation of Certain<br />
Information<br />
(b) “[a]ll documents subsequently filed . . .<br />
pursuant to Sections 13(a), 13(c), 14 or<br />
15(d) of the Exchange Act, prior to the<br />
termination of the offering, shall be<br />
deemed to be incorporated by reference<br />
into the prospectus.”<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
21
10-K Disclosure: Geography<br />
Part I: Business Info<br />
Form 10-K Filing<br />
Part II: Financial Statements <strong>and</strong> Related Info<br />
Form 10-K or Annual Report to Stockholders<br />
Part III: Insider Info<br />
Proxy Statement (<strong>and</strong> 10-K)<br />
Part IV: Exhibits, Etc.<br />
Form 10-K Filing<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
22
10-K Disclosure: Geography<br />
Part II: MD&A (Item 303 of Reg. S-K)<br />
Liquidity<br />
Capital resources<br />
Operating results, including<br />
o Unusual/infrequent events, transactions<br />
o Known trends/uncertainties that registrant<br />
reasonably expects will have a material<br />
favorable or unfavorable impact<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
23
10-K Disclosure: MD&A<br />
Objective of MD&A:<br />
“To provide, in one section of a filing,<br />
material historical <strong>and</strong> prospective textual<br />
disclosure enabling investors . . . to assess<br />
the financial condition <strong>and</strong> results of<br />
operations of the registrant, with particular<br />
emphasis on the registrant's prospects for the<br />
future.” (SEC 1989 Release)<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
24
10-K Disclosure: MD&A<br />
MD&A will be addressed in more<br />
detail in Session 7<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
25
Underst<strong>and</strong>ing SEC Registration Regime<br />
for Reporting Companies<br />
What form of registration statement<br />
would a publicly traded company file<br />
when it grants stock options or<br />
restricted stock?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
26
Session 5 – Underst<strong>and</strong>ing SEC Registration<br />
Regime for Reporting Companies<br />
Study Problem 5.2<br />
Biosystems completed its IPO two years ago <strong>and</strong> now would<br />
like to grant stock options to all of its approximately 1,000<br />
employees, as well as its non-employee directors.<br />
Each option will entitle the recipient to purchase shares of<br />
Biosystems common stock at price equal to the market value<br />
of Biosystems common stock on the date of grant. Each<br />
option will vest in four annual installments beginning on the<br />
first anniversary of the grant date.<br />
Must Biosystems file a registration statement to register<br />
the common stock issuable upon exercise of the option?<br />
What did bluebird bio do?<br />
If so, when must the registration be filed?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
27
Underst<strong>and</strong>ing SEC Registration<br />
Regime for Reporting Companies<br />
S-8 Registration Statement<br />
For securities to be issued to its employees or employees of its<br />
subsidiaries or parents<br />
Equity Benefit Plans, include<br />
Stock Option Plans<br />
Employee Stock Purchase Plans, etc.<br />
“Employee” is defined to include<br />
Any employee, director, or officer, <strong>and</strong> certain consultants or<br />
advisors.<br />
Form S-8 is available for the issuance of securities to<br />
consultants or advisors only if services are not in connection<br />
with the offer or sale of securities in a capital-raising<br />
transaction, <strong>and</strong> do not directly or indirectly promote or<br />
maintain a market for the registrant’s securities. (Similar to<br />
Rule 701.)<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
28
Underst<strong>and</strong>ing SEC Registration Regime<br />
for Reporting Companies<br />
What form of registration statement<br />
would a company file when it acquires<br />
another publicly traded company?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
29
Session 5 – Underst<strong>and</strong>ing SEC Registration<br />
Regime for Reporting Companies<br />
Study Problem 5.3<br />
Two years after Gee Whiz completes its IPO, Gee Whiz<br />
decides it wants to acquire the technology of the Next Big<br />
Thing Corp. (NBT). Gee Whiz is willing to acquire NBT by<br />
merger. NBT shareholders will receive $5.00 in cash <strong>and</strong> 0.25<br />
shares of Gee Whiz common stock for each share of NBT<br />
stock.<br />
NBT is a corporation organized under Delaware law that has its<br />
only office <strong>and</strong> facility in Massachusetts. NBT completed its<br />
IPO four years ago <strong>and</strong> has 600 stockholders.<br />
Will Gee Whiz have to file a registration under the <strong>Securities</strong><br />
Act? If so, what form of registration statement will it file?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
30
Underst<strong>and</strong>ing SEC Registration<br />
Regime for Reporting Companies<br />
S-4 Registration Statement<br />
M&A <strong>Trans</strong>actions<br />
Incorporation by reference for S-3<br />
eligible issuers<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
31
Underst<strong>and</strong>ing SEC Registration Regime<br />
for Reporting Companies<br />
What is a “shelf registration statement”?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
32
Shelf Registrations under Rule 415<br />
“Shelf registration” or “shelf offering” are terms used<br />
for offerings under SEC Rule 415, which allows<br />
permits companies to file a registration statement<br />
covering one or more types of financings that it<br />
expects to complete within two years.<br />
For non-WKSIs, having a registration “on the shelf”<br />
allows the issuer to market quickly when conditions<br />
become favorable.<br />
[See web site for “Primer on Shelf Registrations”<br />
under Session 5 reading material.]<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
33
Shelf Registrations <strong>and</strong> Due<br />
Diligence after Worldcom<br />
What are the implications of the<br />
WorldCom decision [Session 3]<br />
for shelf registration statements?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
34
Shelf Registrations <strong>and</strong> Due Diligence<br />
after Worldcom<br />
Interplay between ’34 Act Filings <strong>and</strong><br />
“Due Diligence” review for ’33 Act<br />
registration statement<br />
Lessons from WorldCom shareholder<br />
litigation<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
35
Shelf Registrations <strong>and</strong> Due Diligence<br />
after Worldcom<br />
Lessons from WorldCom litigation:<br />
Under a short-form registration (i.e., S-<br />
3), the time needed to prepare the<br />
registration statement is reduced<br />
sharply because of issuer’s ability to<br />
incorporate by reference prior ’34 Act<br />
disclosures.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
36
Shelf Registrations <strong>and</strong> Due Diligence<br />
after Worldcom<br />
Lessons from WorldCom litigation:<br />
SEC has acknowledged that different<br />
due diligence methods are necessary<br />
"in view of the compressed preparation<br />
time <strong>and</strong> the volatile nature of the<br />
capital markets."<br />
Nonetheless, such techniques must be<br />
"equally thorough."<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
37
Shelf Registrations <strong>and</strong> Due Diligence<br />
after Worldcom<br />
Lessons from WorldCom litigation:<br />
Among the strategies recommended by the SEC were<br />
the development of a "reservoir of knowledge about<br />
the companies that may select the underwriter to<br />
distribute their securities registered on short form<br />
registration statements" through a "careful review of<br />
[periodic Exchange Act] filings on an ongoing basis,"<br />
consultation of analysts' reports, <strong>and</strong> active<br />
participation in the issuer's investor relations<br />
program, especially analysts <strong>and</strong> brokers meetings.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
38
Shelf Registrations <strong>and</strong> Due Diligence<br />
after Worldcom<br />
Lessons from WorldCom litigation:<br />
The SEC also approvingly noted the following practices:<br />
designating of one law firm to act as underwriters' counsel,<br />
which "facilitates continuous due diligence by ensuring ongoing<br />
access to the registrant on the underwriters' behalf";<br />
holding "Exchange Act report 'drafting sessions,' " which<br />
allow underwriters "to participate in the drafting <strong>and</strong> review<br />
of periodic disclosure documents before they are filed"; <strong>and</strong><br />
conducting "periodic due diligence sessions," such as<br />
meetings between prospective underwriters, their counsel,<br />
<strong>and</strong> management shortly after the release of quarterly<br />
earnings.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
39
Shelf Registrations <strong>and</strong> Due Diligence<br />
after Worldcom<br />
Lessons from WorldCom litigation (cont’d):<br />
While an underwriter is not "expected to possess<br />
the intimate knowledge of corporate affairs of<br />
inside directors," his obligation is to conduct a<br />
meaningful investigation, not merely to listen to<br />
management's explanations of the company's<br />
affairs.<br />
“Tacit reliance on management assertions is<br />
unacceptable; the underwriters must play devil's<br />
advocate.”<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
40
Shelf Registrations <strong>and</strong> Due Diligence<br />
after Worldcom<br />
Lessons from WorldCom litigation (cont’d):<br />
There are questions of fact as to whether the Underwriter<br />
Defendants conducted a reasonable investigation:<br />
the limited number of conversations with the WorldCom<br />
or its auditor,<br />
the cursory nature of the inquiries,<br />
the failure to go behind any of the almost formulaic<br />
answers given to questions,<br />
<strong>and</strong> the failure to inquire into issues of particular<br />
prominence in the Underwriter Defendants’ own internal<br />
evaluations of the financial condition of the WorldCom or<br />
in the financial press.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
41
Shelf Registrations <strong>and</strong> Due Diligence<br />
after Worldcom<br />
Lessons from WorldCom litigation (cont’d):<br />
In particular with respect to 2001, having<br />
internally downgraded WorldCom's credit rating<br />
<strong>and</strong> having taken steps to limit their exposure as<br />
WorldCom creditors, the Underwriter Defendants<br />
were well aware that WorldCom was in a<br />
deteriorating financial position in a troubled<br />
industry<br />
A reasonable investigation would have entailed a<br />
more searching inquiry than that undertaken by<br />
the Underwriter Defendants.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
42
Shelf Registrations <strong>and</strong> Due Diligence<br />
after Worldcom<br />
Lessons from WorldCom litigation (cont’d):<br />
To succeed with a due diligence defense, the<br />
Underwriter Defendants will have to show that they<br />
conducted a reasonable investigation of the nonexpertised<br />
portions of the Registration Statements <strong>and</strong><br />
thereafter had reasonable ground to believe that the<br />
interim financial statements were true.<br />
In assessing the reasonableness of the investigation,<br />
the Underwriter Defendants’ receipt of “comfort<br />
letters” from WorldCom’s auditors will be important<br />
evidence, BUT it is insufficient by itself to establish<br />
the defense.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
43
Underst<strong>and</strong>ing SEC Registration Regime<br />
for Reporting Companies<br />
The 2005 Offering Reforms<br />
Establish automatically effective shelf<br />
registration for WKSIs – or “Well Known<br />
Seasoned Issuers”, <strong>and</strong><br />
Significantly modify shelf registration<br />
procedures for WKSIs<br />
[Refer to Session 3 slides for more details.]<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
44
Underst<strong>and</strong>ing SEC Registration<br />
Regime for Reporting Companies<br />
S-3 Registration Statement for WKSIs allows<br />
“On-Dem<strong>and</strong>” SEC registration through an<br />
“automatic shelf registration statement.”<br />
Guarantees no SEC review<br />
Effectiveness upon filing<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
45
A Few Words About the Automatic<br />
Shelf Registration Statement<br />
Automatic shelf registration provides WKSIs with<br />
significant flexibility beyond that provided to non-<br />
WKSI seasoned issuers, permitting WKSIs:<br />
To take advantage of market windows,<br />
To structure terms of securities on a real-time basis<br />
to accommodate investor dem<strong>and</strong>, <strong>and</strong><br />
To determine or change the plan of distribution in<br />
response to changing market conditions.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
46
Underst<strong>and</strong>ing SEC Registration<br />
Regime for Reporting Companies<br />
Are there offering techniques<br />
available to non-WKSI publicly<br />
traded issuers that approximate the<br />
advantages of an automatic shelf<br />
registration statement?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
47
Underst<strong>and</strong>ing SEC Registration<br />
Regime for Reporting Companies<br />
Increasingly, public offerings are becoming<br />
less “public”<br />
Due to market developments, such as<br />
heightened volatility <strong>and</strong> concerns about<br />
investor front-running, fewer public offerings<br />
involve traditional marketing<br />
Most public offerings begin as confidentially<br />
marketed public offerings<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
48
Underst<strong>and</strong>ing SEC Registration<br />
Regime for Reporting Companies<br />
“Registered direct offering”<br />
“Confidentially marketed public offering”<br />
“At-the-market offering”<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
49
“Registered Direct Offering”<br />
A registered direct offering is a public offering that is<br />
sold by a placement agent on an agency, or “best<br />
efforts,” basis (rather than a firm commitment<br />
underwriting).<br />
Much like a PIPE (private investment in publicly traded<br />
equity – to be discussed in Session 6), a registered direct<br />
offering is marketed <strong>and</strong> sold to a selected number of<br />
accredited <strong>and</strong> institutional investors.<br />
They often are referred to as “registered PIPEs.”<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
50
What are the advantages of a<br />
“registered direct offering”?<br />
There are two principal advantages:<br />
1. Confidential marketing is<br />
permitted;<br />
2. Pricing for the issuer will likely be<br />
better than a PIPE<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
51
Advantages of a<br />
“registered direct offering” (cont’d)<br />
Confidentiality<br />
Issuers that want to test the market or conduct an offering without<br />
attracting publicity find that a registered direct offering is a good choice.<br />
When an issuer has an effective shelf registration statement, the<br />
placement agent may market a potential registered direct offering<br />
as it would a PIPE transaction — by obtaining confidentiality<br />
undertakings until such time as an actual transaction is announced.<br />
This permits an issuer to “test” the market for a potential offering,<br />
without a public announcement that might affect the issuer’s stock price,<br />
while complying with Reg. FD [to be discussed in Session 7]. The issuer<br />
typically announces the transaction immediately prior to pricing or at<br />
pricing.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
52
Advantages of a<br />
“registered direct offering”? (cont’d)<br />
Pricing<br />
An issuer that is deciding between a PIPE<br />
transaction <strong>and</strong> a registered direct offering may<br />
choose a registered direct offering for pricing<br />
reasons.<br />
Typically, a PIPE offering will be subject to some<br />
liquidity discount that will not affect a registered<br />
public offering. [More about this in Session 6.]<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
53
“Confidentially Marketed Public<br />
Offering”<br />
Confidentially marketed public offerings – or “CMPOs”<br />
– primarily are marketed to a targeted group of<br />
institutional investors without public announcement.<br />
The advantages of CMPOs over traditionally marketed<br />
public offerings are similar to the registered direct<br />
offerings:<br />
1) Targeted <strong>and</strong> streamlined marketing efforts allow<br />
companies to complete CMPOs relatively quickly<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
54
Advantages of CMPOs (cont’d)<br />
2) CMPOs allow companies to test the market for an offering without<br />
automatically subjecting the company's stock price to the downward<br />
market pressure typically associated with the announcement of a<br />
material equity offering.<br />
In a fully marketed underwritten offering, the market has advance notice<br />
of the potential offering, <strong>and</strong> market participants may begin shorting the<br />
issuer’s common stock in anticipation of the offering that might dilute<br />
the market price of the issuer’s stock.<br />
By comparison, CMPOs typically involve a very short interval<br />
(typically no more than one evening) or none at all between publicly<br />
announcing the offering <strong>and</strong> pricing it, <strong>and</strong> consequently the market<br />
price for the company's stock is not affected by the offering<br />
announcement.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
55
Elements of CMPOs (cont’d)<br />
Confidentiality considerations<br />
In order to avoid Reg. FD <strong>and</strong> insider trading issues <strong>and</strong> to ensure that a CMPO<br />
actually remains confidential, issuers <strong>and</strong> their financial advisors must carefully<br />
implement procedures to avoid public disclosure of a potential offering until after a<br />
prospective investor has agreed to keep information regarding the offering<br />
confidential.<br />
After a potential investor is "brought over the wall" by agreeing to keep information<br />
about the offering confidential, issuers <strong>and</strong> underwriters can disclose material nonpublic<br />
information about the offering, including the identity of the issuer, to that<br />
investor.<br />
Investors typically request that the issuer file a Form 8-K disclosing the financing<br />
within a certain period of time. Once a press release is issued, the investors <strong>and</strong><br />
other potential investors contacted by the underwriter are released from their<br />
confidentiality undertakings <strong>and</strong> accompanying trading restrictions.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
56
Elements of CMPOs (cont’d)<br />
Due diligence considerations<br />
Underwriters of a CMPO still should conduct<br />
their customary due diligence, including<br />
obtaining accountants' comfort letters <strong>and</strong><br />
opinions of counsel <strong>and</strong> conducting calls with<br />
the company's auditors <strong>and</strong> important<br />
customers <strong>and</strong> suppliers.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
57
Underst<strong>and</strong>ing SEC Registration<br />
Regime for Reporting Companies<br />
What is an “at-the-market” offering?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
58
“At the Market Offerings”<br />
An “at the market”, or ATM, offering allows a company to tap<br />
into the existing secondary market for its shares on an as-<strong>and</strong>when-needed<br />
basis.<br />
Under an ATM offering program, an exchange-listed company<br />
sells newly issued shares into the trading market through a<br />
designated broker-dealer at prevailing market prices, rather than<br />
via a traditional underwritten offering of a fixed number of shares<br />
at a fixed price all at once.<br />
The use <strong>and</strong> attractiveness of ATMs have increased significantly<br />
since the SEC’s 2005 Offering Reforms, which streamlined the<br />
procedural hurdles for conducting an ATM offering.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
59
Elements of<br />
an “at the Market Offering”<br />
Registration Statement. The company files a shelf registration statement<br />
on Form S-3. The base prospectus included in the registration statement<br />
includes disclosure to the effect that sales of common stock may be made<br />
from time to time at prevailing market prices by the issuer directly or<br />
through a designated agent.<br />
Sales Agreement. The company enters into a sales agreement with a<br />
broker-dealer that has agreed to serve as placement agent for the shares<br />
to be sold under the ATM offering program.<br />
The placement agent may be deemed an “underwriter” under the<br />
<strong>Securities</strong> Act, <strong>and</strong> therefore the placement agent will typically conduct<br />
pre-offering due diligence substantially similar to that performed by<br />
underwriters in firm commitment public offerings.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
60
Elements of an<br />
“at the Market Offering” (cont’d)<br />
Program Prospectus Supplement. The company files a prospectus supplement<br />
with the SEC that describes the general terms of the proposed ATM offering<br />
program, including the plan of distribution <strong>and</strong> the maximum number of shares to be<br />
sold, <strong>and</strong> names the designated placement agent as required by SEC guidance.<br />
Sales Orders. After the S-3 is declared effective <strong>and</strong> once all required<br />
documentation has been executed, filed <strong>and</strong> delivered, the company may send sales<br />
orders to the placement agent based on volume or other relevant trading information<br />
available to the company to assess likely dem<strong>and</strong> <strong>and</strong>/or the placement agent may<br />
bring to the attention of the company instances where dem<strong>and</strong> may exist in the<br />
market.<br />
The timing, frequency <strong>and</strong> terms of sales orders (such as minimum required pricing,<br />
volume limitations, etc.) are entirely at the discretion of the company <strong>and</strong> can be<br />
altered (or sales orders revoked before they are executed) by the company at any<br />
time.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
61
Elements of an<br />
“at the Market Offering” (cont’d)<br />
Settlement. Some sales agreements provide the option for a single<br />
settlement at the end of a designated selling period rather than on a<br />
rolling T+3 basis.<br />
Ongoing Disclosure. The company typically will disclose aggregate<br />
sales <strong>and</strong> commission amounts paid on a quarterly basis. Disclosure<br />
can take the form of a very brief prospectus supplement filed under<br />
Rule 424(b) to update the base prospectus <strong>and</strong>/or disclosure as part<br />
of the company’s quarterly report on Form 10-Q.<br />
In some cases, the volume of sales or the terms may be individually<br />
material <strong>and</strong> therefore require prompt disclosure following such<br />
sales.<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
62
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. - International Business Law<br />
July/August 2013<br />
Michael Krebs<br />
JD, Boston University School of Law 1985<br />
Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />
Tel. 617.439.2288 email: mkrebs@nutter.com<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
63
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. in International Business Law<br />
Session 6<br />
July 27, 2013<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Review of Core Principles<br />
1. “<strong>Securities</strong>” broadly defined<br />
2. Investor autonomy (sort of)<br />
3. Every offer/sale must be<br />
registered with SEC if security or<br />
transaction is not exempt<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
2
Core Principles (cont’d)<br />
4. Disclosure of all information about<br />
the issuer <strong>and</strong> the security material to<br />
an investment decision (or access to<br />
all material information) is imperative<br />
5. Financial statements (<strong>and</strong> MD&A)<br />
are essential disclosure elements in<br />
registered offering<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
3
Core Principles (cont’d)<br />
6. “Degree of difficulty” in<br />
registering a sale of securities<br />
varies depending primarily on the<br />
issuer’s market cap <strong>and</strong> reporting<br />
history<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
4
Core Principles (cont’d)<br />
7. Issuers, “control persons” <strong>and</strong>, when<br />
applicable, underwriters <strong>and</strong> “experts”<br />
will have accountability for materially<br />
false or misleading statements<br />
8. Control persons – executive officers,<br />
directors <strong>and</strong> >10% holders – are<br />
subject to extra constraints<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
5
Session 6 Agenda<br />
Part 1<br />
How do investors resell securities?<br />
Part 2<br />
How do publicly traded companies<br />
conduct private placements?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
6
Basic Principle Underlying the<br />
<strong>Securities</strong> Act of 1933<br />
Unless an exemption is available,<br />
1. Every offer or sale of a security must be<br />
registered with the SEC under § 5 of the<br />
<strong>Securities</strong> Act, <strong>and</strong><br />
2. In the registration statement (which<br />
includes the prospectus), all information<br />
material to that investment decision must<br />
be disclosed.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
7
Basic Principle Underlying the<br />
<strong>Securities</strong> Act of 1933<br />
Restated:<br />
If any person sells a non-exempt<br />
security to any other person, the<br />
sale must be registered unless an<br />
exemption can be found for the<br />
transaction.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
8
Resale of <strong>Securities</strong><br />
• How do investors resell securities in the<br />
ordinary course?<br />
• How do investors resell securities purchased<br />
in a private placement?<br />
• How do “insiders” resell securities?<br />
• What is a registration rights agreement?<br />
• What is a “piggyback offering”?<br />
• What is a QIB?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
9
Basic Principle Underlying the<br />
<strong>Securities</strong> Act of 1933<br />
“Unless an exemption is available, . . .”<br />
* * *<br />
Some exemptions focus on the type of<br />
security being offered.<br />
Other exemptions focus on the nature of the<br />
transaction in which the offering is made.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
10
Exempt <strong>Trans</strong>actions –<br />
Key Principle #1<br />
<strong>Securities</strong> offered in exempt<br />
transactions do not become exempt<br />
securities.<br />
For every subsequent offer/sale, the<br />
seller must find an exemption or cause<br />
this issuer to register that offer/sale with<br />
the SEC.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
11
Exempt <strong>Trans</strong>actions - Resales<br />
How do investors resell<br />
securities in the ordinary<br />
course?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
12
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.1<br />
Beantown Biosystems raises $100 million by selling 5 million shares<br />
of common stock at $20 per share in an underwritten initial public<br />
offering (“IPO”) covered by an effective registration statement.<br />
Professor Pennypincher, who has no relationship to Biosystems or<br />
any of its affiliates, purchases 1,000 shares of stock in the IPO<br />
through her trusted brokerage firm Merry Brothers, a brokerage firm<br />
that was not part of the underwriting syndicate.<br />
One month after the IPO, Biosystems’s stock is trading at $30 per<br />
share. Pennypincher’s accountant encourages her to sell one-third of<br />
her Biosystems shares through Merry Brothers.<br />
May Pennypincher do so without causing Biosystems to file with<br />
the SEC a registration statement that registers that sale of<br />
Pennypincher’s stock under §5 of the <strong>Securities</strong> Act?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
13
Primary Resale Exemptions<br />
§ 4(a)(1) – Sales not by an Issuer or<br />
Underwriter or Dealer<br />
Resales under Rule 144 – Safe harbor for nonunderwriter<br />
status<br />
“§ 4(a)(1½)” – Resales of private placement<br />
securities (“restricted securities”) outside of<br />
Rule 144 safe harbor<br />
Resales under Rule 144A – Safe harbor for<br />
non-underwriter status for “QIBs”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
14
Primary Ordinary Course<br />
Trading Exemption<br />
§ 4(a)(1) – transactions by any person other<br />
than<br />
issuer,<br />
underwriter,<br />
or dealer<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
15
Definitions Critical to §<br />
4(a)(1)<br />
Issuer – § 2(a)(4)<br />
Underwriter – § 2(a)(11)<br />
Dealer – § 2(a)(12)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
16
Pivotal Role of “Underwriter”<br />
Concept in § 4(a)(1)<br />
§ 2(a)(11) – "underwriter" means any person who has<br />
purchased from an issuer with a view to, or<br />
offers or sells for an issuer in connection with,<br />
the distribution of any security . . . .<br />
As used in this paragraph . . . "issuer" shall include, in<br />
addition to an issuer, any person . . . controlling or<br />
controlled by the issuer, or any person under . . .<br />
common control with the issuer.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
17
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.1 – Analysis<br />
Pennypincher may sell those shares<br />
without registering the sale under §5 of<br />
the <strong>Securities</strong> Act, because<br />
Pennypincher may rely on the §4(a)(1)<br />
exemption<br />
She is neither an issuer, underwriter,<br />
nor dealer<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
18
Resale of <strong>Securities</strong><br />
How do investors resell securities<br />
purchased in a private<br />
placement?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
19
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.2<br />
One month after the Biosystems IPO, its stock is trading at<br />
$50 per share. Biosystems then has 12 million shares<br />
outst<strong>and</strong>ing.<br />
Faith Frugal, one of the founders’ friends, would like to sell<br />
500 of the Biosystems shares that she acquired 17 months<br />
earlier in a “506” transaction. Neither Faith nor any member<br />
of her family is a Biosystems director or executive officer,<br />
or owns more than 1% of Biosystem stock.<br />
May Faith sell the 500 shares without registration under<br />
§5 of the <strong>Securities</strong> Act?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
20
Pivotal Role of “Underwriter”<br />
Concept in § 4(a)(1)<br />
§ 2(a)(11) – "underwriter" means any<br />
person who has<br />
purchased from an issuer with a view<br />
to . . .<br />
the distribution of any security . . . .<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
21
Pivotal Role of “Underwriter”<br />
Concept in § 4(a)(1)<br />
What’s a “distribution” for<br />
purposes of § 2(a)(11)?<br />
* * *<br />
See pp. 99-100 of course book.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
22
Resale of <strong>Securities</strong><br />
Rule 144 – “Underwriter” Safe Harbor<br />
Restricted <strong>Securities</strong> – Rule 144 Preamble<br />
Any person who sells restricted securities<br />
shall be deemed not to be engaged in a<br />
distribution of such securities <strong>and</strong> therefore<br />
not an underwriter thereof, if sale is made in<br />
accordance with Rule 144.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
23
Resale of <strong>Securities</strong><br />
What is a “restricted” security?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
24
Resale of <strong>Securities</strong><br />
Rule 144(a)(3) – “Restricted <strong>Securities</strong>”<br />
Defined<br />
<strong>Securities</strong> acquired directly or indirectly from the issuer, or<br />
from an affiliate of the issuer, in a transaction or chain of<br />
transactions not involving any public offering;<br />
<strong>Securities</strong> acquired from the issuer that are subject to the resale<br />
limitations of Rule 502(d) under <strong>Regulation</strong> D or Rule 701(g);<br />
<strong>Securities</strong> acquired in a transaction or chain of transactions<br />
meeting the requirements of Rule 144A;<br />
Equity securities of domestic issuers acquired in a transaction<br />
or chain of transactions subject to the conditions of Rule 901<br />
or Rule 903 under <strong>Regulation</strong> S (Rules 901 through 905 <strong>and</strong><br />
Preliminary Notes)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
25
Resale of <strong>Securities</strong><br />
How do “insiders” resell securities?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
26
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.3<br />
Assume that Very Confident purchased Series A preferred stock from<br />
Biosystems six months before the IPO.<br />
Immediately prior to the closing of Biosystems’s IPO, Very Confident’s<br />
Series A preferred stock was converted into Biosystems common stock.<br />
Five months after the Biosystems IPO (<strong>and</strong> 11 months after Very<br />
Confident’s initial investment), Biosystems is trading at $55 per share.<br />
Very Confident wants to sell 500,000 shares, including all 100,000<br />
shares that it purchased in the IPO. Biosystems then has 12 million<br />
shares outst<strong>and</strong>ing. Very Confident owns approximately 15% of<br />
Biosystems common stock. A managing director of Very Confident is a<br />
Biosystems director.<br />
May Very Confident sell all 500,000 shares without registration<br />
under §5 of the <strong>Securities</strong> Act?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
27
Pivotal Role of “Underwriter”<br />
Concept in § 4(a)(1)<br />
§ 2(a)(11) – "underwriter" means any person who has<br />
purchased from an issuer with a view to, or<br />
offers or sells for an issuer in connection with,<br />
the distribution of any security . . . .<br />
IMPORTANT: As used in § 2(a)(11), the definition<br />
of "issuer" includes, “in addition to an issuer, any<br />
person . . . controlling or controlled by the issuer, or<br />
any person under . . . common control with the<br />
issuer.”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
28
Pivotal Role of “Underwriter”<br />
Concept in § 4(a)(1)<br />
Who is a “control person” for<br />
purposes of § 2(a)(11)?<br />
When does a “control person”<br />
engage in a “distribution” for<br />
purposes of § 2(a)(11)?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
29
Resale of <strong>Securities</strong><br />
Rule 144 – “Underwriter” Safe Harbor<br />
Control Person – Rule 144 Preamble<br />
Any person who sells . . . other securities<br />
[i.e., non-restricted securities] on behalf of a<br />
person in a control relationship with the<br />
issuer shall be deemed not to be engaged in a<br />
distribution of such securities <strong>and</strong> therefore<br />
not to be an underwriter thereof, if the sale is<br />
made in accordance with Rule 144.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
30
Who are Control Persons?<br />
Control Persons = Affiliates<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
31
Resale of <strong>Securities</strong><br />
Rule 144 – Who is an Affiliate?<br />
Technical definition of “affiliate” -- Rule 144(a)<br />
An affiliate of an issuer is a person or entity that directly, or<br />
indirectly through one or more intermediaries, controls, or is<br />
controlled by, or is under common control with, such issuer.<br />
Practical definition of affiliate -- The following categories<br />
generally are presumed to be affiliates:<br />
Executive officers of the issuer<br />
Directors of the issuer<br />
Principal shareholders (holders of more than 10 percent<br />
of a class of equity securities)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
32
Control Persons/Affiliates<br />
Rules of Thumb:<br />
Executive officers<br />
Directors<br />
> 10% shareholders<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
33
Resale of <strong>Securities</strong><br />
Rule 144<br />
Safe Harbor – “Underwriter” Status<br />
Two important concepts:<br />
Restricted securities<br />
Control securities<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
34
Resale of <strong>Securities</strong><br />
Rule 144 – Effect of Safe Harbor<br />
If a sale of securities complies with all of the applicable conditions<br />
of Rule 144:<br />
1. Any affiliate or other person who sells restricted securities will<br />
be deemed not to be engaged in a distribution <strong>and</strong> therefore not<br />
an underwriter for that transaction;<br />
2. Any person who sells restricted or other securities on behalf of<br />
an affiliate of the issuer will be deemed not to be engaged in a<br />
distribution <strong>and</strong> therefore not an underwriter for that transaction;<br />
<strong>and</strong><br />
3. The purchaser in such transaction will receive securities that<br />
are not restricted securities.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
35
Resale of <strong>Securities</strong><br />
What are the Rule 144 Conditions?<br />
Holding Period (restricted securities only)<br />
Current public information (sometimes not applicable<br />
to restricted securities)<br />
Volume limitation (i.e., limit on amount of securities<br />
sold during any three month period) (control securities<br />
only)<br />
Manner of sale (securities must be sold through a<br />
broker or to a market maker)<br />
Notice of proposed sale (Form 144 filed with SEC)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
36
Session 6 – Resale of <strong>Securities</strong><br />
Rule 144 – Important 2007 Amendments<br />
“Restricted <strong>Securities</strong>”<br />
Six-month holding period for “restricted securities” of<br />
issuers subject to Exchange Act reporting requirements for at<br />
least 90 days before the Rule 144 sale<br />
After applicable holding period requirement is met, resale of<br />
restricted securities by a non-affiliate is no longer be subject<br />
to any other conditions of Rule 144<br />
Exception: “Current public information” requirement in<br />
Rule 144(c) will apply for an additional six months after<br />
the six-month holding period requirement is met for<br />
resale of securities of a reporting issuer.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
37
Session 6 – Resale of <strong>Securities</strong><br />
Rule 144 – Matrix<br />
Refer to website<br />
Session 6 Reading Materials<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
38
Session 6 – Resale of <strong>Securities</strong><br />
Back to Study Problem 6.2<br />
One month after the Biosystems IPO, its stock is trading at<br />
$50 per share. Biosystems then has 12 million shares<br />
outst<strong>and</strong>ing.<br />
Faith Frugal, one of the founders’ friends, would like to sell<br />
500 of the Biosystems shares that she acquired 17 months<br />
earlier in a “506” transaction. Neither Faith nor any member<br />
of her family is a Biosystems director or executive officer,<br />
or owns more than 1% of Biosystem stock.<br />
May Faith sell the 500 shares without registration under<br />
§5 of the <strong>Securities</strong> Act?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
39
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.2 – Analysis<br />
Faith’s shares are “restricted securities.”<br />
Biosystems’s IPO occurred one month ago <strong>and</strong> therefore it has<br />
not been subject to the reporting requirements of Section 13 or<br />
15(d) of the Exchange Act for at least 90 days, so the one-year<br />
holding period applies<br />
Faith has held the shares for more than one year <strong>and</strong> is not now<br />
<strong>and</strong> never has been an affiliate of Biosystems.<br />
Therefore, the Rule 144 safe harbor is available <strong>and</strong> Faith may<br />
sell the 500 shares in reliance on § 4(a)(1) without complying<br />
with any other provision of Rule 144.<br />
See Rule 144(b)(1)(ii) <strong>and</strong> (d)(1)(ii)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
40
Session 6 – Resale of <strong>Securities</strong><br />
Back to Study Problem 6.3<br />
Assume that Very Confident purchased Series A preferred stock from<br />
Biosystems eight months before the IPO.<br />
Immediately prior to the closing of Biosystems’s IPO, Very Confident’s<br />
Series A preferred stock was converted into Biosystems common stock.<br />
Five months after the Biosystems IPO (<strong>and</strong> 11 months after Very<br />
Confident’s initial investment), Biosystems is trading at $55 per share.<br />
Very Confident wants to sell 500,000 shares, including all 100,000<br />
shares that it purchased in the IPO. Biosystems then has 12 million<br />
shares outst<strong>and</strong>ing. Very Confident owns approximately 15% of<br />
Biosystems common stock. A managing director of Very Confident is a<br />
Biosystems director.<br />
May Very Confident sell all 500,000 shares without registration<br />
under §5 of the <strong>Securities</strong> Act?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
41
Restricted vs. Control <strong>Securities</strong><br />
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.3 – Analysis<br />
Very Confident will likely be deemed to be “affiliate” for purposes of Rule 144.<br />
Holding Period:<br />
Net Effect:<br />
Very Confident affiliate is a director on the Biosystems board<br />
Very Confident owns more than 10 percent of Biosystems stock<br />
Biosystems has been a reporting company for at least 90 days before the proposed Rule 144<br />
sale, so the relevant holding period is 6 months.<br />
Very Confident has held its investment in Biosystems for more 13 months. The 8-month<br />
holding period for the preferred stock is “tacked” onto the 5-month holding period for the<br />
common stock.<br />
Very Confident’s shares purchased in Biosystems’s IPO are not restricted securities <strong>and</strong><br />
therefore the holding period does not apply (SEC allows holder to segregate “restricted” <strong>and</strong><br />
“control” securities.)<br />
As long as Very Confident remains an affiliate of Biosystems, all Very Confident shares will<br />
be subject to “control securities” provisions under Rule 144, even those that have been held<br />
(or are deemed to have been held) for more than six months.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
42
Resale of <strong>Securities</strong><br />
What if Rule 144 is not available?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
43
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.4<br />
George is the President <strong>and</strong> CEO of We Can Do It, Inc. (We Can) <strong>and</strong> one of<br />
the company’s largest shareholders, owning 20 percent of We Can’s outst<strong>and</strong>ing<br />
common stock. Among his holdings are 500,000 shares of We Can Series B<br />
Preferred Stock, which he purchased four months ago as part of an offering<br />
under Rule 506 to accredited investors, including some mutual funds <strong>and</strong> other<br />
large financial institutions. The Series B Preferred Stock is convertible into<br />
common stock.<br />
We Can has been listed on Nasdaq for at least the past ten years.<br />
George tells you that his twin daughters have just turned 18 <strong>and</strong> each is about to<br />
head off to a prestigious (<strong>and</strong> very expensive) private university on the banks of<br />
the Charles River. George would like to sell some or all of his Series B shares<br />
in order to pay the tuition bills.<br />
Can he do so without We Can filing a registration statement registering the<br />
transaction under the <strong>Securities</strong> Act? How? Can he sell all of his shares or<br />
just a portion? What if George has held the Series B for seven months?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
44
Resale of <strong>Securities</strong><br />
Rule 144 – “Underwriter” Safe Harbor<br />
Rule 144 is a nonexclusive safe harbor!<br />
See Rule 144 Preamble<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
45
Session 6 – Resales of <strong>Securities</strong><br />
Study Problem 6.4 – Analysis<br />
Shares of Series B stock are “restricted securities” but are not<br />
“debt securities”<br />
George is an affiliate of We Can<br />
We Can is “listed” <strong>and</strong> therefore likely is a “reporting<br />
company”<br />
George has held the Series B only for four months <strong>and</strong><br />
therefore may not rely on Rule 144<br />
If George held the Series B for seven months, he might be<br />
able to sell under Rule 144 if other conditions are satisfied.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
46
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.5<br />
Same facts as Study Problem 6.4.<br />
Three months later, Thomas, who is George’s college<br />
roommate but has no other relation to We Can, decides<br />
to sell the 250,000 shares of Series B Preferred Stock<br />
that he bought in the same offering. He doesn’t like the<br />
direction that We Can is taking <strong>and</strong> wants out!<br />
Can Thomas sell without We Can filing a registration<br />
statement registering the transaction? Can he use a<br />
brokerage firm?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
47
Session 6 – Resales of <strong>Securities</strong><br />
Study Problem 6.5 – Analysis<br />
Thomas may rely on Rule 144<br />
The shares of Series B Preferred Stock are “restricted<br />
securities” but not “debt securities”<br />
We Can is “listed” <strong>and</strong> therefore likely is a “reporting<br />
company”<br />
Thomas has held the Series B for seven months, <strong>and</strong><br />
therefore can rely on Rule 144 BUT ONLY if there is<br />
“current information” about We Can<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
48
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.6<br />
Same facts as Study Problem 6.5, except assume that<br />
Thomas gave We Can a non-recourse personal note<br />
to finance his purchase of the shares of We Can<br />
preferred stock.<br />
Last month Thomas paid off the note <strong>and</strong> wants to<br />
sell his shares immediately without registration.<br />
Can he?<br />
Do you need to know any additional information?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
49
Session 6 – Resales of <strong>Securities</strong><br />
Study Problem 6.6 – Analysis<br />
Under Rule 144(d), holding period does not begin until the<br />
full purchase price or other consideration is paid<br />
When a promissory note is given to the issuer (or an<br />
affiliate) to pay all or a portion of the purchase price of the<br />
security, the purchaser is not deemed to have paid full<br />
purchase price unless the note:<br />
provides for full recourse against the purchaser; <strong>and</strong><br />
is secured by collateral, other than the securities<br />
purchased, having a fair market value at least equal to<br />
the purchase price of securities purchased; <strong>and</strong><br />
the note is discharged by payment in full prior to sale of<br />
the securities.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
50
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.7<br />
Same facts as Study Problem 6.6, except assume that<br />
Thomas paid We Can cash to purchase the Series B<br />
but borrowed the purchase price from Shadyside<br />
Bank <strong>and</strong> Trust Company. Thomas gave Shadyside<br />
a note for the purchase price, collateralized by a<br />
pledge to the bank of those shares of We Can<br />
preferred stock.<br />
If Thomas defaults on the note seven months after<br />
Thomas purchased the stock, can the bank sell the<br />
preferred stock immediately without registration?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
51
Session 6 – Resales of <strong>Securities</strong><br />
Study Problem 6.7 – Analysis<br />
We Can has been “listed” on Nasdaq for the past 10 years, <strong>and</strong><br />
therefore likely is a “reporting company” at the time of the<br />
proposed Rule 144 sale <strong>and</strong> has been such for the preceding 90<br />
days, <strong>and</strong> therefore the six month holding period applies. Rule<br />
144(d)(1)(i).<br />
Under Rule 144(d)(3)(iv), Shadyside will be able to tack – or add –<br />
Thomas’s holding period to its own, <strong>and</strong> therefore Shadyside<br />
would have a seven month holding period:<br />
If Thomas’s pledge of restricted securities is “bona fide”, <strong>and</strong><br />
If Thomas was personally liable to Shadyside (i.e., there is<br />
“recourse” to Thomas).<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
52
Session 6 – Resales of <strong>Securities</strong><br />
Study Problem 6.7 – Analysis<br />
Let’s continue to assume that We Can is a “reporting company” at the time of the<br />
proposed Rule 144 sale <strong>and</strong> has been such for the preceding 90 days, <strong>and</strong> that<br />
therefore the six month holding period applies. Rule 144(d)(1)(i).<br />
Rule 144(b)(1) states that if the issuer of the securities is, <strong>and</strong> has been for a<br />
period of at least 90 days immediately before the proposed Rule 144 sale, subject<br />
to SEC reporting requirements under the Exchange Act, a seller under Rule 144<br />
who is not an affiliate, <strong>and</strong> has not been an affiliate during the preceding three<br />
months, who sells restricted securities of that issuer for the seller’s own account<br />
shall be deemed not to be an underwriter if:<br />
The seller has held the securities for at least six months (see Rule<br />
144(d)(1)(i));<br />
AND, when the holding period is at least six months but less than one year,<br />
the condition in Rule 144(c)(1) also must be satisfied (i.e., there must be<br />
“adequate current public information with respect to the issuer” as defined<br />
in (c)(1))<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
53
Session 6 – Resales of <strong>Securities</strong><br />
More About Pledges of <strong>Securities</strong><br />
The 1981 Supreme Court decision in Rubin v.<br />
United States held that a pledge may be a sale<br />
for determining application of the anti-fraud<br />
provisions of the federal securities laws.<br />
The SEC’s Division of Corporation finance<br />
continues to take the view that the provisions<br />
of Rule 144(d) expressly permitting the tacking<br />
of holding periods of a pledgor <strong>and</strong> pledgee<br />
continue to apply.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
54
Resale of <strong>Securities</strong><br />
May Rule 144 be used in<br />
conjunction with other<br />
exemptions?<br />
[NOTE: THERE IS NO STUDY<br />
PROBLEM 6.8]<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
55
Session 6 – Exempt <strong>Trans</strong>actions<br />
Study Problem 6.9<br />
Nine months after Biosystems’s IPO, its stock is trading at $50 per<br />
share.<br />
Gary Grateful is one of Great Genome’s founders who acquired a<br />
warrant in lending $1 million to Biosystems. Assume the warrant was<br />
issued five months before the IPO.<br />
Grateful now would like to exercise his Biosystems warrant <strong>and</strong><br />
immediately sell the underlying shares. (As you may recall from Study<br />
Problem 2.6, the warrant includes a customary “net exercise”<br />
provision.)<br />
Grateful is not an officer or director of Biosystems <strong>and</strong> owns less than 5<br />
percent of its common stock.<br />
How could Grateful structure the transaction to accomplish his<br />
objective?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
56
Session 6 – Exempt <strong>Trans</strong>actions<br />
Study Problem 6.9 – Analysis<br />
Grateful would utilize the “net exercise” feature of the warrant<br />
In issuing its shares of common stock to Grateful upon exercise of<br />
the warrant, Biosystems would rely on the §3(a)(9) exemption:<br />
§ 3(a)(9) – Exchanges by the issuer<br />
any security exchanged by the issuer with its existing security<br />
holders exclusively where no commission or other remuneration is<br />
paid or given directly or indirectly for soliciting such exchange<br />
Grateful then could sell shares immediately under §4(a)(1) if he<br />
were not deemed to be an “underwriter”.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
57
Session 6 – Exempt <strong>Trans</strong>actions<br />
Study Problem 6.9 – Analysis (cont’d)<br />
Grateful would utilize the “net exercise” feature of the warrant as follows:<br />
Warrant has exercise price of $10 per share<br />
Therefore, for 100,000 shares, Grateful’s aggregate exercise price is $1<br />
million<br />
With the market price of Biosystems stock at $50 per share, Grateful would<br />
have to deliver 20,000 shares to satisfy the exercise price<br />
On a net exercise basis, Biosystems would withhold (i.e., not issue) 20,000<br />
shares, <strong>and</strong> Grateful would receive 80,000 shares upon exercise without<br />
providing any other consideration to Biosystems . . . so the exchange of<br />
Biosystems common stock would be<br />
exclusively for the warrant, <strong>and</strong><br />
without any commission or other remuneration<br />
<strong>and</strong> therefore would satisfy the criteria for the exemption under §3(a)(9)<br />
Most important, the net exercise will be helpful in allowing Grateful to utilize the<br />
Rule 144 “safe harbor” to avoid the risk that he might be characterized as an<br />
underwriter.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
58
Session 6 – Resales of <strong>Securities</strong><br />
Study Problem 6.9 – Analysis (cont’d)<br />
The warrants are “restricted securities.”<br />
Biosystems has been a “reporting company” for nine months <strong>and</strong><br />
therefore, the relevant holding period is six months. Rule 144(d)(1)(i).<br />
Grateful can “tack” holding period of the warrant (i.e., common stock to<br />
be sold was acquired from Biosystems solely in exchange for the warrant<br />
or “other securities of same issuer” <strong>and</strong> therefore the shares of common<br />
stock or “newly acquired securities” are deemed to have been acquired at<br />
the same time as the warrant. (See Rule 144(d)(3)(ii) & (x).) NB. The<br />
result is the same even if even if the options or warrants exercised<br />
originally did not provide for cashless exercise by their terms.<br />
Grateful held the warrant for 14 months, <strong>and</strong> therefore can rely on Rule<br />
144 without satisfying the other Rule 144 conditions<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
59
Resale of <strong>Securities</strong><br />
Enough about Rule 144!<br />
What if Rule 144 is not available?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
60
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.10<br />
Gee Whiz, Inc. believes that it has developed the “next generation” cell phone. It will take two years<br />
<strong>and</strong> $10 million for the phone to reach the prototype stage. Gee Whiz is not listed on an exchange<br />
<strong>and</strong> its shares are not otherwise publicly traded.<br />
Gee Whiz sells $12 million of convertible preferred stock to its existing VC investors <strong>and</strong> members of<br />
its board of directors <strong>and</strong> advisory board. Sally, one of these advisory directors, invests $500,000.<br />
Three months later Sally learns that she has a potentially life threatening medical condition. Her<br />
doctors recommend that she seek the treatment of a specialist in Australia. The course of treatment<br />
will range from two to three years in Australia, <strong>and</strong> she will not be able to continue teaching or<br />
consulting while “down under.”<br />
Ricardo, a neighbor of Sally’s, hears about her condition <strong>and</strong> wants to help. While speaking with one<br />
of Sally’s children, Riccardo learns that Sally stretched her financial resources to invest in Gee Whiz,<br />
expecting to be able to replenish her savings quickly with income from several new consulting<br />
assignments, which she now must decline. Ricardo teaches art at the local elementary school, but<br />
inherited significant assets from his late wife, a successful entrepreneur who died a year ago. Ricardo<br />
underst<strong>and</strong>s from Sally’s children that the Gee Whiz convertible preferred is “restricted.” He asks<br />
you if he may legally purchase the Gee Whiz preferred stock from Sally to help her fund her medical<br />
<strong>and</strong> relocation expenses.<br />
What is your advice? What additional facts, if any, would you like to know?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
61
Session 6 – Resales of <strong>Securities</strong><br />
Study Problem 6.10 – Analysis<br />
Sally might consider relying on the<br />
so-called § 4(a)(1½) exemption,<br />
which is essentially a secondary<br />
private placement by her to<br />
Ricardo.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
62
Session 6 – Resale of <strong>Securities</strong><br />
So-called § 4(a)(1½) Exemption<br />
§4(a)(2) technically is available only for issuers:<br />
“transactions by an issuer not involving any<br />
public offering.”<br />
§4(a)(1) may not be completely safe because<br />
analysis of “underwriter” status depends on a<br />
subjective assessment of facts <strong>and</strong> the holding<br />
period<br />
In concept, § 4(a)(1½) falls between §4(a)(1) <strong>and</strong><br />
§4(a)(2).<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
63
Session 6 – Resales of <strong>Securities</strong><br />
Study Problem 6.10 – Analysis (cont’d)<br />
Sally would structure the sale as if it were a 506 offering:<br />
Is Ricardo is an accredited investor?<br />
Is Ricardo sophisticated (either alone or with a<br />
purchaser representative)?<br />
Has Sally provided Ricardo with access to information<br />
that she has (or has the right to obtain) about Gee Whiz?<br />
Will Ricardo accept the same restrictions on the resale<br />
of the securities that apply to Sally?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
64
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.11<br />
[Same facts as Study Problem 6.10.]<br />
Eight months after Ricardo acquires the<br />
preferred stock from Sally, he would like to<br />
resell it in a Rule 144 transaction.<br />
May Ricardo rely on Rule 144?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
65
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.11 – Analysis<br />
Rule 144 is a safe harbor both for "restricted securities" <strong>and</strong> securities<br />
sold by affiliates (i.e., control securities).<br />
The SEC takes the position that "individual investors who are not<br />
professionals in the securities business also may be 'underwriters' if they<br />
act as links in a chain of transactions through which securities move<br />
from an issuer to the public." (See Note 2 to preamble to Rule 144.)<br />
Therefore, Rule 144 defines restricted securities as "securities<br />
acquired directly or indirectly from the issuer, or from an affiliate of the<br />
issuer, in a transaction or chain of transactions not involving any public<br />
offering" (Rule 144(a)(3)(i)).<br />
Ricardo's acquisition of securities from Sally would be viewed as part<br />
of a chain of transactions not involving a public offering.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
66
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.11 – Analysis (cont’d)<br />
Remember in Study Problem 6.10 that Ricardo<br />
would accept the same restrictions on the resale of<br />
the securities that applied to Sally.<br />
Under Rule 144(d)(1), Riccardo may “tack”<br />
Sally’s holding period to his own, because Sally is<br />
not an affiliate of Gee Whiz<br />
The holding period began when Sally paid the<br />
full purchase price to Gee Whiz<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
67
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.11 – Analysis (cont’d)<br />
As the combined holding period is less than one year<br />
(three months plus eight months = eleven months),<br />
Ricardo may NOT rely on Rule 144 because Gee Whiz<br />
is not a reporting company.<br />
After Ricardo has held the securities for at least nine<br />
months he will be able to rely on Rule 144.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
68
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.11 – Analysis (cont’d)<br />
What if Gee Whiz was a reporting company at the time of the<br />
proposed Rule 144 sale?<br />
As the combined holding period is greater than six months but less<br />
than one year (three months plus eight months), Ricardo may rely on<br />
Rule 144, provided that Gee Whiz<br />
filed all required reports under section 13 or 15(d) of the<br />
Exchange Act, as applicable, during the 12 months preceding<br />
such sale, other than Form 8–K reports; <strong>and</strong><br />
submitted electronically <strong>and</strong> posted on its corporate Web site<br />
every “Interactive Data File” required to be submitted <strong>and</strong> posted<br />
pursuant to Rule 405 of <strong>Regulation</strong> S–T, during the 12 months<br />
preceding such sale. [NB. This criterion will be discussed in the<br />
second half of the course.]<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
69
Session 6 – Resale of <strong>Securities</strong><br />
More About “Tacking”<br />
Rule 144(d)(1)(i) <strong>and</strong> (ii) indicate generally<br />
that the holding period for restricted securities<br />
acquired from a nonaffiliate may be tacked to<br />
the acquiror’s holding period<br />
BUT the same is not true for securities<br />
purchased from an affiliate.<br />
Other tacking situations are specifically<br />
addressed in Rule 144(d)(3).<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
70
Resale of <strong>Securities</strong><br />
Are there special rules for large<br />
institutional investors?<br />
* * *<br />
What is a “QIB”?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
71
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.12<br />
Three years after the Biosystems IPO, it issues $200 million of<br />
senior unsecured notes in a private placement exempt under<br />
Rule 506. The notes mature <strong>and</strong> are payable in full on the 10 th<br />
anniversary of issuance. Mutual funds <strong>and</strong> other large financial<br />
institutions, including Kinder Gentler Insurance Co., purchase<br />
the notes.<br />
Four months after the placement, Kinder Gentler decides to<br />
change its investment portfolio strategy <strong>and</strong> wishes to sell the<br />
notes.<br />
May it do so without Biosystems filing a registration<br />
statement to register the offer/sale under § 5 of the<br />
<strong>Securities</strong> Act?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
72
Resale of <strong>Securities</strong><br />
Rule 144(a)(3) – “Restricted <strong>Securities</strong>”<br />
Defined<br />
Reminder:<br />
Restricted <strong>Securities</strong> include:<br />
<strong>Securities</strong> acquired in a transaction<br />
or chain of transactions meeting<br />
the requirements of Rule 144A;<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
73
Resale of <strong>Securities</strong><br />
Rule 144A<br />
Private Resales of <strong>Securities</strong> to Institutions<br />
Rule 144A(b):<br />
Any person, other than the issuer or a dealer, who<br />
offers or sells securities in compliance with the<br />
conditions set forth in paragraph (d) of this section<br />
shall be deemed not to be engaged in a<br />
distribution of such securities <strong>and</strong> therefore not<br />
to be an underwriter of such securities within the<br />
meaning of sections 2(a)(11) <strong>and</strong> 4(a)(1) of the Act.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
74
Session 6 – Resales of <strong>Securities</strong><br />
Study Problem 6.12 – Analysis<br />
Kinder Gentler may rely on Rule 144A -- a close relative of<br />
§4(a)(1½) -- if :<br />
Notes are resold only to a qualified institutional buyer or<br />
“QIB”<br />
Biosystems takes reasonable steps to ensure that QIB is<br />
aware that the seller may rely on Rule 144A;<br />
Notes were not, when issued, of the same class as securities<br />
listed on a national securities exchange;<br />
In the case of securities of an issuer that does not file periodic<br />
reports with the SEC, holder <strong>and</strong> a prospective purchaser<br />
have the right to obtain certain information from the issuer,<br />
upon request.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
75
Session 6 – Resale of <strong>Securities</strong><br />
Rule 144A – Elements<br />
Rule 144A -- a close relative of § 4(a)(1½)<br />
Conditions to be met:<br />
<strong>Securities</strong> are offered or sold only to a “qualified<br />
institutional buyer” (“QIB”)<br />
Seller <strong>and</strong> any person acting on its behalf takes<br />
reasonable steps to ensure that purchaser is aware that<br />
seller may rely on exemption from Section 5 provided<br />
by Rule 144A<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
76
Session 6 – Resale of <strong>Securities</strong><br />
Rule 144A – Elements (cont’d)<br />
Conditions to be met (continued):<br />
The securities offered or sold:<br />
Were not, when issued, of the same class as securities listed on a national<br />
securities exchange or quoted in a U.S. automated inter-dealer quotation<br />
system<br />
<strong>Securities</strong> convertible or exchangeable into securities so listed or quoted at<br />
the time of issuance <strong>and</strong> that had an effective conversion premium of less<br />
than 10 percent, treated as securities of the class into which they are<br />
convertible or exchangeable.<br />
Warrants that may be exercised for securities so listed or quoted at the<br />
time of issuance, for a period of less than 3 years from the date of<br />
issuance, or that had an effective exercise premium of less than 10 percent,<br />
shall be treated as securities of the class to be issued upon exercise.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
77
Conditions to be met (continued):<br />
The securities offered or sold:<br />
Session 6 – Resale of <strong>Securities</strong><br />
Rule 144A – Elements (cont’d)<br />
Are not securities of an open-end investment company, unit investment trust<br />
or face-amount certificate company that is or is required to be registered<br />
under the Investment Company Act; <strong>and</strong><br />
In the case of securities of an issuer that is neither subject to section 13 or 15(d) of the<br />
Exchange Act . . . , the holder <strong>and</strong> a prospective purchaser designated by the holder<br />
have the right to obtain from the issuer, upon request of the holder, <strong>and</strong> the<br />
prospective purchaser has received . . . at or prior to the time of sale . . . , the<br />
following information (which shall be reasonably current in relation to the date of<br />
resale under this section): a very brief statement of the nature of the [issuer’s] business<br />
<strong>and</strong> the products <strong>and</strong> services it offers; <strong>and</strong> the issuer's most recent balance sheet <strong>and</strong><br />
profit <strong>and</strong> loss <strong>and</strong> retained earnings statements, <strong>and</strong> similar financial statements for<br />
such part of the two preceding fiscal years as the issuer has been in operation (the<br />
financial statements should be audited to the extent reasonably available).<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
78
Session 6 – Resale of <strong>Securities</strong><br />
Rule 144A – Elements (cont’d)<br />
Fact that purchasers of securities from issuer thereof<br />
may purchase with a view to reselling such<br />
securities pursuant to Rule 144A will not affect<br />
availability to such issuer of an exemption under<br />
§4(a)(2) or <strong>Regulation</strong> D.<br />
<strong>Securities</strong> acquired in a transaction that complies<br />
with Rule 144A are deemed to be restricted<br />
securities within the meaning of Rule 144(a)(3).<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
79
Session 6 – Resale of <strong>Securities</strong><br />
Rule 144A – Recent Changes<br />
How did the 2012 JOBS Act <strong>and</strong><br />
regulations adopted by the SEC<br />
in July 2013 change Rule 144A?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
80
Session 6 Agenda<br />
Part 1<br />
How do investors resell securities?<br />
Part 2<br />
How do publicly traded companies<br />
conduct private placements?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
81
Private Placements by<br />
Publicly Traded Companies<br />
• What is a “PIPE”<br />
• What is an “A/B Exchange<br />
Offer”?<br />
• What is a Reg. S offering?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
82
Basic Principle Underlying the<br />
<strong>Securities</strong> Act of 1933<br />
“Unless an exemption is available, . . .”<br />
* * *<br />
Some exemptions focus on the type of<br />
security being offered.<br />
Other exemptions focus on the nature of the<br />
transaction in which the offering is made.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
83
Session 6 (Part 2) – Private Placements by Publicly<br />
Traded Companies<br />
Study Problem 6.13<br />
2008 Buffet Investment in Goldman Sachs<br />
On September 23, 2008, The Goldman Sachs Group, Inc. announced that in<br />
exchange for a $5 billion cash investment by Berkshire Hathaway, Inc., a<br />
company controlled by Warren Buffet, Goldman Sachs agreed to sell to Berkshire<br />
Hathaway:<br />
Shares of 10% cumulative perpetual Goldman Sachs preferred stock, having<br />
a liquidation preference of $5 billion <strong>and</strong> being “callable” (i.e., subject to<br />
repurchase by Goldman Sachs) at any time at a 10 percent premium;<br />
A warrant to purchase 43.5 million shares of Goldman Sachs common stock<br />
at a price of $115 per share<br />
On September 24, 2008, Goldman Sachs entered into an underwriting agreement<br />
for the sale of 40.65 million shares of Goldman Sachs common stock at a price of<br />
$115 per share (the “Goldman Common Stock Offering”). The Goldman<br />
Common Stock Offering was completed on September 29, 2006.<br />
How would you structure these financings to comply with the <strong>Securities</strong> Act<br />
of 1933?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
84
Session 6 (Part 2) – Private Placements by<br />
Publicly Traded Companies<br />
Study Problem 6.13 — Analysis<br />
Neither the sale of preferred stock or the warrant to Berkshire<br />
Hathaway Sale was registered under the <strong>Securities</strong> Act of 1933.<br />
Instead, they were sold in a private placement pursuant to Section<br />
4(a)(2) of the Act.<br />
Goldman Sachs <strong>and</strong> Berkshire Hathaway entered into a<br />
registration rights agreement<br />
The Common Stock Offering was registered under the Act pursuant<br />
to a “shelf” registration statement on Form S-3ASR (automatic shelf<br />
registration statement of securities of well-known seasoned issuers),<br />
which was originally filed on December 2, 2005.<br />
Goldman Sachs filed a prospectus supplement dated September<br />
25, 2008 related to the Common Stock Offering that describes<br />
the specific terms of the Common Stock Offering <strong>and</strong> adds to <strong>and</strong><br />
updates information contained in a prospectus dated July 16,<br />
2006.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
85
Session 6 (Part 2) – Private Placements by<br />
Publicly Traded Companies<br />
Study Problem 6.14<br />
BeanTown Biosystems completed its IPO five years ago <strong>and</strong> has<br />
timely filed all periodic reports subsequently due under the<br />
Exchange Act.<br />
Biosystems decides to raise additional common equity to fund a<br />
cash acquisition. Biosystems needs to obtain the commitments<br />
relatively quickly (within a few weeks), so it may enter into the<br />
acquisition agreement, but the acquisition will not close for at<br />
least six months.<br />
Biosystems would prefer not to sell its stock at a substantial<br />
discount from the current market price, so it wants to avoid selling<br />
stock that would be subject to material resale restrictions.<br />
Biosystems has a common equity float of $300 million.<br />
What do you recommend?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
86
PIPE—Private Investment in<br />
Public Equities<br />
Step 1 – Investors agree to purchase securities in a<br />
private placement – typically under Rule 506.<br />
Step 2 – Closing of private placement, <strong>and</strong> payment of<br />
funds to issuer, typically is contingent upon<br />
effectiveness of registration statement covering<br />
resales of the privately placed securities.<br />
Alternative Step 2 – Issuer agrees to file registration<br />
promptly after the closing<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
87
PIPE—Private Investment in<br />
Public Equities (cont’d)<br />
Why is this not deemed to be a public<br />
offering under the integration doctrine?<br />
Rule 152: the §4(a)(2) exemption “shall be<br />
deemed to apply to transactions not involving<br />
any public offering at the time of said<br />
transactions although subsequently thereto the<br />
issuer decides to . . . [file] . . . a registration<br />
statement.”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
88
PIPE—Private Investment in<br />
Public Equities (cont’d)<br />
Private placement must be “completed” prior to filing registration<br />
statement, otherwise Rule 152 will not be available.<br />
Private placement is completed when the issuer has commitments<br />
from all investors subject only to conditions outside the investors’<br />
control<br />
The effectiveness of resale registration statement is considered to<br />
be a condition outside the investors’ control<br />
Investors typically are at market risk from the time the private<br />
placement is completed until the registration statement is effective.<br />
Renegotiation of material terms of purchase after registration<br />
statement filing may jeopardize availability of Rule 152 (as it may<br />
constitute a new offering).<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
89
PIPE—Private Investment in<br />
Public Equities (cont’d)<br />
Watch for “toxic convertibles” or “death spirals”!<br />
If a PIPE deal is not structured properly, an issuer may throw the<br />
issuer’s stock into an irreversible “death spiral.”<br />
For example, a small percentage of structured PIPEs involve<br />
convertible securities with floorless reset conversion features.<br />
The floorless price reset features create an incentive for<br />
investors of toxic convertibles to short-sell the stock, driving<br />
the stock price down <strong>and</strong> allowing them to obtain more shares<br />
upon conversion of the toxic convertibles. These potential<br />
issuances of additional shares cause further downward<br />
pressure on stock price, throwing the issuer’s stock into a tailspin.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
90
Session 6 (Part 2) – Private Placements by<br />
Publicly Traded Companies<br />
Nasdaq Rule 5635(d)<br />
Be mindful of Nasdaq Rule 5635(d) – The “20% Rule”<br />
Shareholder approval required prior to issuance of securities in<br />
connection with a transaction other than a public offering if:<br />
issuance or potential issuance of common stock (or securities<br />
convertible into or exercisable for common stock), together with<br />
sales by officers, directors or “Substantial Shareholders,” are ≥ 20%<br />
of common stock or ≥ 20% of voting power outst<strong>and</strong>ing before<br />
issuance; <strong>and</strong><br />
price per share in private placement is < than greater of book or<br />
“market” value<br />
Note also that Nasdaq often will question whether offering registered<br />
with SEC – such as a “registered direct” offering – in fact is a bona fide<br />
“public offering”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
91
Session 6 (Part 2) – Private Placements by<br />
Publicly Traded Companies<br />
Study Problem 6.15<br />
Jumbo Corp., a NYSE-listed company that has been publicly traded for<br />
the past 15 years, seeks to raise $300 million in debt financing by<br />
selling ten-year notes to institutional investors to fund a cash<br />
acquisition.<br />
Jumbo needs to obtain the commitments relatively quickly (within two<br />
weeks), so it may enter into the acquisition agreement. Jumbo will not<br />
be able to file a registration statement for several months while<br />
negotiations for another material acquisition are pending.<br />
Jumbo would prefer not to issue the debt in a Rule 506/Rule 144A<br />
structure, because it believes the illiquidity discount on account of the<br />
resale restrictions would be too great.<br />
Jumbo has a common equity public float of $500 million.<br />
What do you recommend?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
92
Session 6 (Part 2) – Private Placements by<br />
Publicly Traded Companies<br />
Study Problem 6.15 – Analysis<br />
Jumbo does not qualify as a WKSI.<br />
Jumbo’s negotiations for another material<br />
acquisition preclude filing a registration statement<br />
immediately, thus making a traditional PIPE<br />
structure undesirable.<br />
If Jumbo would prefer not to issue the debt in a Rule<br />
506/Rule 144A structure, another approach would<br />
be a transaction known as an “A/B exchange<br />
offer.”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
93
Session 6 (Part 2) – Private Placements by<br />
Publicly Traded Companies<br />
“Exxon Capital” A/B Exchange Offers<br />
In an A/B exchange offer transaction, the issuer sells securities in a<br />
private placement <strong>and</strong>, shortly thereafter, effects a registered<br />
exchange offer for those securities.<br />
The result is that the purchasers of the restricted securities hold<br />
freely tradable securities after the exchange—they can sell them<br />
in the secondary market <strong>and</strong> will not be deemed to be<br />
underwriters.<br />
The transaction may only be used with non-convertible debt<br />
securities, certain types of preferred stock <strong>and</strong> initial public<br />
offerings of common stock of foreign issuers to eliminate a<br />
Rule 144A facility.<br />
The rationale for A/B exchange offers is set forth in the “Exxon<br />
Capital” line of SEC no-action letters.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
94
Session 6 (Part 2) – Private Placements by<br />
Publicly Traded Companies<br />
“Exxon Capital” A/B Exchange Offers<br />
Step 1 – Debt securities are sold in private placement<br />
under an exemption from registration requirements of<br />
the <strong>Securities</strong> Act (e.g., under Rule 506 to accredited<br />
investors – typically QIBs for purposes of Rule 144A).<br />
Step 2 –Issuer registers an exchange offer (on Form S-4)<br />
of debt securities having identical terms <strong>and</strong> conditions<br />
Step 3 – After the S-4 is effective, issuer exchanges the<br />
registered debt securities (i.e., the “B” tranche) for the<br />
privately placed debt securities (i.e., the “A” tranche).<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
95
Session 6 (Part 2) – Private Placements by<br />
Publicly Traded Companies<br />
“Exxon Capital” A/B Exchange Offers<br />
Implications of the Exchange:<br />
Investors now hold registered debt securities that<br />
are freely tradable in the secondary market without<br />
compliance with the <strong>Securities</strong> Act’s registration<br />
<strong>and</strong> prospectus delivery requirements applicable to<br />
underwriters, as long as the securities were acquired<br />
in the ordinary course of business <strong>and</strong> the private<br />
placee has no arrangement with any person for the<br />
distribution of the securities.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
96
Session 6 (Part 2) – Private Placements by<br />
Publicly Traded Companies<br />
“Exxon Capital” A/B Exchange Offers<br />
Reasoning:<br />
SEC has previously opined that an institutional<br />
investor who purchases a large quantity of<br />
securities from an issuer will not be deemed to be<br />
an underwriter when selling the securities in the<br />
secondary market provided that the securities were<br />
acquired in the ordinary course of business <strong>and</strong> the<br />
investor has no arrangement with any person for the<br />
distribution of the securities.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
97
Session 6 (Part 2) – Private Placements by<br />
Publicly Traded Companies<br />
“Exxon Capital” A/B Exchange Offers<br />
Query:<br />
How did the 2007 changes to Rule 144 affect<br />
the role of the A/B exchange offer?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
98
Session 6 (Part 2) – Reg. S<br />
Study Problem 6.16<br />
Five years ago BeanTown Biosystems raised $200 million in<br />
an underwritten IPO. The lead underwriter was the<br />
investment banking firm Gold, Bull & Bear (“GBB”).<br />
GBB now advises Biosystems that there is growing interest<br />
in Europe for Biosystem <strong>and</strong> that an issuance of debt<br />
securities in Europe would enhance Biosystems’s reputation<br />
among institutional money managers in Europe.<br />
Biosystems would like to raise $75 million in Europe, but<br />
does not want to wait for a registration statement to be<br />
declared effective. What is your advice?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
99
Session 6 (Part 2) –<br />
Basic Principle Underlying <strong>Securities</strong> Act of 1933<br />
(Refined)<br />
Unless an exemption is available, it is<br />
unlawful to use any means of interstate<br />
commerce to make any offer or sale of a<br />
security unless the transaction is<br />
registered with the SEC <strong>and</strong> all material<br />
information has been disclosed.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
100
Session 6 (Part 2) – Reg. S<br />
<strong>Regulation</strong> S (Rules 901 – 905)<br />
Rule 901: “offer” <strong>and</strong> “sale” does not<br />
include offers <strong>and</strong> sales solely outside<br />
of United States<br />
Preliminary Notes: A non-exclusive<br />
safe harbor<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
101
Session 6 (Part 2) – Reg. S<br />
<strong>Regulation</strong> S – Rule 903(a):<br />
Offer <strong>and</strong> sale is made in an “offshore”<br />
transaction<br />
No “directed selling efforts” are made in<br />
the U.S.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
102
Session 6 (Part 2) – Reg. S<br />
<strong>Regulation</strong> S – Rule 903(a):<br />
Additional conditions depending on the type of offering:<br />
“Category 1” includes<br />
Foreign issuer reasonably believes at the<br />
commencement of the offering that there is no<br />
substantial U.S. market interest); <strong>and</strong><br />
The securities are offered <strong>and</strong> sold to employees of<br />
issuer or its affiliates pursuant to employee benefit<br />
plan established <strong>and</strong> administered in accordance with<br />
the law of a country other than the United States, <strong>and</strong><br />
customary practices <strong>and</strong> documentation of such<br />
country, provided several other conditions are<br />
satisfied.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
103
Session 6 (Part 2) – Reg. S<br />
<strong>Regulation</strong> S – Rule 903(a):<br />
“Category 2” which includes<br />
Debt securities of a reporting U.S. issuer<br />
Equity securities of a reporting foreign<br />
issuer<br />
Additional conditions<br />
Offering restrictions are implemented<br />
40-day “distribution compliance” period<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
104
Session 6 (Part 2) – Reg. S<br />
<strong>Regulation</strong> S – Rule 903(a):<br />
“Category 3” which applies to any class of securities<br />
not eligible for either category 1 or 2, including<br />
Equity securities of a reporting U.S. issuer<br />
Additional conditions<br />
Offering restrictions are implemented<br />
40-day “distribution compliance” period for debt<br />
six month “distribution compliance” period for<br />
equity for “reporting issuers” (one year period<br />
for non-reporting issuers)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
105
Reg. S<br />
<strong>Regulation</strong> S – Rule 903(a):<br />
Additional conditions for Category 3 equity offerings:<br />
Purchaser (other than a distributor) must certify that it<br />
is not a U.S. person <strong>and</strong> is not acquiring the securities<br />
for the account or benefit of any U.S. person;<br />
Purchaser agrees to resell such securities only in<br />
accordance with <strong>Regulation</strong> S, or pursuant to<br />
registration under the Act, or pursuant to an available<br />
exemption from registration; <strong>and</strong> agrees not to engage<br />
in hedging transactions with regard to such securities<br />
unless in compliance with the Act;<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
106
<strong>Regulation</strong> S – Rule 903(a):<br />
Reg. S<br />
Additional conditions for Category 3 equity<br />
offerings:<br />
<strong>Securities</strong> of a domestic issuer contain restrictive<br />
legend;<br />
The issuer is required, either by contract or a<br />
provision in its bylaws, articles, charter or<br />
comparable document, to refuse to register any<br />
transfer of the securities that does not comply<br />
with the transfer restrictions<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
107
<strong>Regulation</strong> S – Rule 903(a):<br />
Reg. S<br />
Additional conditions for Category 3 equity offerings:<br />
Each distributor, dealer (as defined in section<br />
2(a)(12) of the Act), or a person receiving a selling<br />
concession, fee or other remuneration, prior to the<br />
expiration of the “distribution compliance period”,<br />
sends a confirmation or other notice to the purchaser<br />
stating that the purchaser is subject to the same<br />
restrictions on offers <strong>and</strong> sales that apply to a<br />
distributor.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
108
Reg. S<br />
<strong>Regulation</strong> S – Rules 904 <strong>and</strong> 905:<br />
Resale Restrictions under 904 – Offshore<br />
Similar to basic Reg. S conditions<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
109
Reg. S<br />
<strong>Regulation</strong> S – Rules 904 <strong>and</strong> 905:<br />
Resale Restrictions under 905 – U.S.<br />
Equity securities of domestic issuers<br />
acquired from the issuer, a distributor, or<br />
any of their respective affiliates in a<br />
transaction subject to the conditions of Rule<br />
901 or Rule 903 are deemed to be<br />
"restricted securities" as defined in Rule<br />
144.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
110
Session 6 (Part 2) – Reg. S<br />
<strong>Regulation</strong> S – Rules 904 <strong>and</strong> 905:<br />
Resale Restrictions under 905 – U.S. (cont’d)<br />
Resales of such restricted securities must be made in<br />
accordance with<br />
<strong>Regulation</strong> S, or<br />
the registration requirements of the <strong>Securities</strong> Act, or<br />
an exemption therefrom.<br />
Any "restricted securities," as defined in Rule 144, that are<br />
equity securities of a domestic issuer will continue to be<br />
deemed to be restricted securities, notwithst<strong>and</strong>ing that they<br />
were acquired in a resale transaction made pursuant to Rule<br />
901 or Rule 904.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
111
Same facts as 6.16<br />
Session 6 (Part 2) – Reg. S<br />
Study Problem 6.17<br />
May BioSystems sell $75 million of debt securities<br />
in Europe <strong>and</strong> concurrently sell $50 million of the<br />
same debt securities in the US?<br />
What is your advice?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
112
Session 6 (Part 2) – Reg. S<br />
Study Problem 6.17 Analysis<br />
Yes, Biosystems may sell the debt securities<br />
offshore in reliance on Reg. S <strong>and</strong> concurrently<br />
conduct a private placement of the same securities in<br />
the United States.<br />
According to one source, a majority of international<br />
offerings are concurrent Reg. S offerings <strong>and</strong> Rule<br />
506 private placements in the United States to QIBs<br />
that may resell the securities under Rule 144A.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
113
Session 6 (Part 2) – Reg. S<br />
Study Problem 6.17 Analysis (cont’d)<br />
In determining whether the requirements for an exempt<br />
private placement under Section 4(a)(2) (including Rule<br />
506) have been satisfied, offshore transactions made in<br />
compliance with Reg S will not be integrated with<br />
domestic offerings that are otherwise exempt from<br />
registration under the <strong>Securities</strong> Act. See Preliminary<br />
Note 7 to <strong>Regulation</strong> D.<br />
For Reg. S purposes, it is essential that the issuer not<br />
engage in conduct that could constitute “directed selling<br />
efforts” in the United States.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
114
Note about JOBS Act <strong>and</strong><br />
Foreign Private Issuers<br />
Foreign Private Issuers will be discussed in a<br />
later session.<br />
The JOBS Act contains a number of key<br />
changes that will facilitate U.S. IPOs by<br />
foreign private issuers that are emerging<br />
growth companies.<br />
These changes are relevant to both SECregistered<br />
<strong>and</strong> non-SEC-registered deals.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
115
Note about JOBS Act <strong>and</strong><br />
Foreign Private Issuers<br />
For a client advisory focusing on JOBS Act<br />
changes relevant to foreign private issuers<br />
that are emerging growth companies, see<br />
http://www.davispolk.com/files/Publication/69e8a705a654-486b-b313-<br />
29763590e278/Presentation/PublicationAttachment/6f4c<br />
dcd1-4d3a-41c3-90df-<br />
29801fd8bd2b/042612_finaljobsact.pdf<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
116
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. - International Business Law<br />
July/August 2013<br />
Michael Krebs<br />
JD, Boston University School of Law 1985<br />
Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />
Tel. 617.439.2288 email: mkrebs@nutter.com<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved 117
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. in International Business Law<br />
Session 6 – Study Problem<br />
July 27, 2013<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.1<br />
Beantown Biosystems raises $100 million by selling 5 million shares<br />
of common stock at $20 per share in an underwritten initial public<br />
offering (“IPO”) covered by an effective registration statement.<br />
Professor Pennypincher, who has no relationship to Biosystems or<br />
any of its affiliates, purchases 1,000 shares of stock in the IPO<br />
through her trusted brokerage firm Merry Brothers, a brokerage firm<br />
that was not part of the underwriting syndicate.<br />
One month after the IPO, Biosystems’s stock is trading at $30 per<br />
share. Pennypincher’s accountant encourages her to sell one-third of<br />
her Biosystems shares through Merry Brothers.<br />
May Pennypincher do so without causing Biosystems to file with<br />
the SEC a registration statement that registers that sale of<br />
Pennypincher’s stock under §5 of the <strong>Securities</strong> Act?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
2
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.2<br />
One month after the Biosystems IPO, its stock is trading at<br />
$50 per share. Biosystems then has 12 million shares<br />
outst<strong>and</strong>ing.<br />
Faith Frugal, one of founders’ friends, would like to sell 500<br />
of the Biosystems shares that she acquired 17 months earlier<br />
in a “506” transaction. Neither Faith nor any member of her<br />
family is a Biosystems director or executive officer, or owns<br />
more than 1% of Biosystem stock.<br />
May Faith sell the 500 shares without registration under<br />
§5 of the <strong>Securities</strong> Act?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
3
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.3<br />
Assume that Very Confident purchased Series A preferred stock from<br />
Biosystems six months before the IPO.<br />
Immediately prior to the closing of Biosystems’s IPO, Very Confident’s<br />
Series A preferred stock was converted into Biosystems common stock.<br />
Five months after the Biosystems IPO (<strong>and</strong> 11 months after Very<br />
Confident’s initial investment), Biosystems is trading at $55 per share.<br />
Very Confident wants to sell 500,000 shares, including all 100,000<br />
shares that it purchased in the IPO. Biosystems then has 12 million<br />
shares outst<strong>and</strong>ing. Very Confident owns approximately 15% of<br />
Biosystems common stock. A managing director of Very Confident is a<br />
Biosystems director.<br />
May Very Confident sell all 500,000 shares without registration<br />
under §5 of the <strong>Securities</strong> Act?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved<br />
4
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.4<br />
George is the President <strong>and</strong> CEO of We Can Do It, Inc. (We Can) <strong>and</strong> one of<br />
the company’s largest shareholders, owning 20 percent of We Can’s outst<strong>and</strong>ing<br />
common stock. Among his holdings are 500,000 shares of We Can Series B<br />
Preferred Stock, which he purchased four months ago as part of an offering<br />
under Rule 506 to accredited investors, including some mutual funds <strong>and</strong> other<br />
large financial institutions. The Series B Preferred Stock is convertible into<br />
common stock.<br />
We Can has been listed on Nasdaq for at least the past ten years.<br />
George tells you that his twin daughters have just turned 18 <strong>and</strong> each is about to<br />
head off to a prestigious (<strong>and</strong> very expensive) private university on the banks of<br />
the Charles River. George would like to sell some or all of his Series B shares<br />
in order to pay the tuition bills.<br />
Can he do so without We Can filing a registration statement registering the<br />
transaction under the <strong>Securities</strong> Act? How? Can he sell all of his shares or<br />
just a portion? What if George held the Series B for seven months?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
5
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.5<br />
Same facts as Study Problem 6.4.<br />
Three months later, Thomas, who is George’s old<br />
college roommate <strong>and</strong> has no other relation to We Can,<br />
decides to sell the 250,000 shares of Series B Preferred<br />
Stock that he bought in the same offering. He doesn’t<br />
like the direction that We Can is taking <strong>and</strong> wants out!<br />
Can Thomas sell without We Can filing a registration<br />
statement registering the transaction? Can he use a<br />
brokerage firm?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
6
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.6<br />
Same facts as Study Problem 6.5, except assume that<br />
Thomas gave We Can a non-recourse personal note<br />
to finance his purchase of the shares of We Can<br />
preferred stock.<br />
Last month Thomas paid off the note <strong>and</strong> wants to<br />
sell his shares immediately without registration.<br />
Can he?<br />
Do you need to know any additional information?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
7
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.7<br />
Same facts as Study Problem 6.6, except assume that<br />
Thomas borrowed money from Shadyside Bank <strong>and</strong><br />
Trust Company to fund the purchase of the shares of<br />
We Can preferred stock. He gave Shadyside a note<br />
for the purchase price, collateralized by a pledge to<br />
the bank of those shares of We Can preferred stock.<br />
If Thomas defaults on the note seven months after<br />
Thomas purchased the stock, can the bank sell the<br />
preferred stock immediately without registration?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
8
Resale of <strong>Securities</strong><br />
THERE IS NO 6.8<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
9
Session 6 – Exempt <strong>Trans</strong>actions<br />
Study Problem 6.9<br />
Nine months after Biosystems’s IPO, its stock is trading at $50<br />
per share.<br />
Gary Grateful is one of Great Genome’s founders who acquired a<br />
warrant in lending $1 million to Biosystems. Assume the warrant<br />
was issued five months before the IPO.<br />
Grateful now would like to exercise his Biosystems warrant <strong>and</strong><br />
immediately sell the underlying shares.<br />
Grateful is not an officer or director of Biosystems <strong>and</strong> owns less<br />
than 5 percent of its common stock.<br />
How could Grateful structure the transaction to accomplish<br />
his objective?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
10
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.10<br />
Gee Whiz, Inc. believes that it has developed the “next generation” cell phone. It will take two years<br />
<strong>and</strong> $10 million for the phone to reach the prototype stage. Gee Whiz is not listed on an exchange<br />
<strong>and</strong> its shares are not otherwise publicly traded.<br />
Gee Whiz sells $12 million of convertible preferred stock to its existing VC investors <strong>and</strong> members of<br />
its board of directors <strong>and</strong> advisory board. Sally, one of these advisory directors, invests $500,000.<br />
Three months later Sally learns that she has a potentially life threatening medical condition. Her<br />
doctors recommend that she seek the treatment of a specialist in Australia. The course of treatment<br />
will range from two to three years in Australia, <strong>and</strong> she will not be able to continue teaching or<br />
consulting while “down under.”<br />
Ricardo, a neighbor of Sally’s, hears about her condition <strong>and</strong> wants to help. While speaking with one<br />
of Sally’s children, Riccardo learns that Sally stretched her financial resources to invest in Gee Whiz,<br />
expecting to be able to replenish her savings quickly with income from several new consulting<br />
assignments, which she now must decline. Ricardo teaches art at the local elementary school, but<br />
inherited significant assets from his late wife, a successful entrepreneur who died a year ago. Ricardo<br />
underst<strong>and</strong>s from Sally’s children that the Gee Whiz convertible preferred is “restricted.” He asks<br />
you if he may legally purchase the Gee Whiz preferred stock from Sally to help her fund her medical<br />
<strong>and</strong> relocation expenses.<br />
What is your advice? What additional facts, if any, would you like to know?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
11
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.11<br />
[Same facts as Study Problem 6.10.]<br />
Eight months after Ricardo acquires the<br />
preferred stock from Sally, he would like to<br />
resell it in a Rule 144 transaction.<br />
May Ricardo rely on Rule 144?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
12
Session 6 – Resale of <strong>Securities</strong><br />
Study Problem 6.12<br />
Three years after the Biosystems IPO, it issues $200 million of<br />
senior unsecured notes in a private placement exempt under<br />
Rule 506. The notes mature <strong>and</strong> are payable in full on the 10 th<br />
anniversary of issuance. Mutual funds <strong>and</strong> other large financial<br />
institutions, including Kinder Gentler Insurance Co., purchase<br />
the notes.<br />
Four months after the placement, Kinder Gentler decides to<br />
change its investment portfolio strategy <strong>and</strong> wishes to sell the<br />
notes.<br />
May it do so without Biosystems filing a registration<br />
statement to register the offer/sale under § 5 of the<br />
<strong>Securities</strong> Act?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
13
Session 6 (Part 2) – Private Placements by Publicly<br />
Traded Companies<br />
Study Problem 6.13<br />
2008 Buffet Investment in Goldman Sachs<br />
On September 23, 2008, The Goldman Sachs Group, Inc. announced that in<br />
exchange for a $5 billion cash investment by Berkshire Hathaway, Inc., a<br />
company controlled by Warren Buffet, Goldman Sachs agreed to sell to Berkshire<br />
Hathaway:<br />
Shares of 10% cumulative perpetual Goldman Sachs preferred stock, having<br />
a liquidation preference of $5 billion <strong>and</strong> being “callable” (i.e., subject to<br />
repurchase by Goldman Sachs) at any time at a 10 percent premium;<br />
A warrant to purchase 43.5 million shares of Goldman Sachs common stock<br />
at a price of $115 per share<br />
On September 24, 2008, Goldman Sachs entered into an underwriting agreement<br />
for the sale of 40.65 million shares of Goldman Sachs common stock at a price of<br />
$115 per share (the “Goldman Common Stock Offering”). The Goldman<br />
Common Stock Offering was completed on September 29, 2006.<br />
How would you structure these financings to comply with the <strong>Securities</strong> Act<br />
of 1933?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
14
Session 6 (Part 2) – Private Placements by<br />
Publicly Traded Companies<br />
Study Problem 6.14<br />
BeanTown Biosystems completed its IPO five years ago <strong>and</strong> has<br />
timely filed all periodic reports subsequently due under the<br />
Exchange Act.<br />
Biosystems decides to raise additional common equity to fund a<br />
cash acquisition. Biosystems needs to obtain the commitments<br />
relatively quickly (within a few weeks), so it may enter into the<br />
acquisition agreement, but the acquisition will not close for at<br />
least six months.<br />
Biosystems would prefer not to sell its stock at a substantial<br />
discount from the current market price, so it wants to avoid selling<br />
stock that would be subject to resale restrictions.<br />
Biosystems has a common equity float of $300 million.<br />
What do you recommend?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
15
Session 6 (Part 2) – Private Placements by<br />
Publicly Traded Companies<br />
Study Problem 6.15<br />
Jumbo Corp., a NYSE-listed company that has been publicly traded for<br />
the past 15 years, seeks to raise $300 million in debt financing by<br />
selling ten-year notes to institutional investors to fund a cash<br />
acquisition.<br />
Jumbo needs to obtain the commitments relatively quickly (within two<br />
weeks), so it may enter into the acquisition agreement. Jumbo will not<br />
be able to file a registration statement for several months while<br />
negotiations for another material acquisition are pending.<br />
Jumbo would prefer not to issue the debt in a Rule 506/Rule 144A<br />
structure, because it believes the illiquidity discount on account of the<br />
resale restrictions would be too great.<br />
Jumbo has a common equity public float of $500 million.<br />
What do you recommend?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
16
Session 6 (Part 2) – Reg. S<br />
Study Problem 6.16<br />
Five years ago BeanTown Biosystems raised $200 million in<br />
an underwritten IPO. The lead underwriter was the<br />
investment banking firm Gold, Bull & Bear (“GBB”).<br />
GBB now advises Biosystems that there is growing interest<br />
in Europe for Biosystem <strong>and</strong> that an issuance of debt<br />
securities in Europe would enhance Biosystems’s reputation<br />
among institutional money managers in Europe.<br />
Biosystems would like to raise $75 million in Europe, but<br />
does not want to wait for a registration statement to be<br />
declared effective. What is your advice?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
17
Same facts as 6.16<br />
Session 6 (Part 2) – Reg. S<br />
Study Problem 6.17<br />
May BioSystems sell $75 million of debt securities<br />
in Europe <strong>and</strong> concurrently sell $50 million of the<br />
same debt securities in the US?<br />
What is your advice?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved<br />
18
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. - International Business Law<br />
July/August 2013<br />
Michael Krebs<br />
JD, Boston University School of Law 1985<br />
Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />
Tel. 617.439.2288 email: mkrebs@nutter.com<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved 19
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. in International Business Law<br />
Session 7 – July 29, 2013<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 7 Agenda<br />
Periodic reporting under the<br />
Exchange Act<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act of 1934<br />
Primary Objective:<br />
Maintain integrity of<br />
securities markets<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Exchange Act Overview<br />
Establish SEC (§4 et seq.)<br />
Regulate securities trading markets, including<br />
broker-dealers<br />
Require disclosure of material information<br />
regarding “reporting companies”<br />
Prohibit deceptive <strong>and</strong> manipulative practices<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
<strong>Securities</strong> Exchange Act<br />
Overview (cont’d)<br />
<strong>Regulation</strong> of securities trading markets<br />
The Exchange Act empowers the SEC with broad authority over<br />
all aspects of the securities industry, including the power to<br />
register, regulate, <strong>and</strong> oversee:<br />
brokerage firms,<br />
transfer agents,<br />
clearing agencies<br />
securities self-regulatory organizations (SROs)<br />
various stock exchanges, such as the New York Stock<br />
Exchange, The NASDAQ Stock Market, <strong>and</strong> the American<br />
Stock Exchange are SROs.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
<strong>Securities</strong> Exchange Act<br />
Overview (cont’d)<br />
<strong>Securities</strong> exchanges, Nasdaq <strong>and</strong> SROs -<br />
§§ 5, 6, 15A, 19<br />
Limits on securities related borrowing:<br />
Margin requirements - §7<br />
Limits on borrowing by members, brokers, dealers - §8<br />
Swap agreements (express exclusion thereof) - §3A<br />
“<strong>Securities</strong> information processors” - §11A<br />
<strong>Securities</strong> settlement procedures - §17A<br />
Including DTC<br />
<strong>Regulation</strong> of brokers <strong>and</strong> dealers - §15<br />
<strong>Regulation</strong> of municipal securities dealers - §15B<br />
<strong>Regulation</strong> of government securities brokers <strong>and</strong> dealers - §15C<br />
<strong>Regulation</strong> of securities analysts, research reports - §15D<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
<strong>Securities</strong> Exchange Act<br />
Overview (cont’d)<br />
Disclosure of material information regarding<br />
“reporting companies”, including<br />
Periodic <strong>and</strong> other reports - §§13 <strong>and</strong> 15(d)<br />
Forms 10-K (annual), 10-Q (quarterly)<br />
Form 8-K (episodic)<br />
Schedules 13D <strong>and</strong> 13G (certain shareholders)<br />
Audit <strong>and</strong> non-audit services - §10A<br />
Proxy statements - §14<br />
<strong>Regulation</strong> of trading by “insiders” - §16<br />
Liability for misleading statements - §§ 18, 32<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
<strong>Securities</strong> Exchange Act<br />
Overview (cont’d)<br />
Prohibition of deceptive <strong>and</strong> manipulative<br />
practices, including<br />
Fraud prohibition - §10(b)<br />
Rule 10b-5<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
How does a company become a<br />
“reporting company”?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 7 – Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Study Problem 7.1<br />
Global Yearbook was organized under Delaware<br />
law in 2006 <strong>and</strong> now has its headquarters outside<br />
of San Francisco, California.<br />
As of June 30, 2013, the end of Global's most<br />
recent fiscal year, it had total assets of $15 million.<br />
For FY 2013, it $100 million of revenue.<br />
Global has had three rounds of venture capital<br />
investments, each structured as an exempt private<br />
placement under the Rule 506 safe harbor.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 7 – Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Study Problem 7.1 (cont’d)<br />
Global has been reluctant to issue stock in a public<br />
offering, because it has been able to fund growth<br />
through earnings <strong>and</strong> did not need additional capital. In<br />
the judgment of Global's board of directors, the pricing<br />
in an IPO would result in unacceptable dilution to<br />
existing shareholders.<br />
Global's practice has been to grant stock options to<br />
all employees.<br />
At the end of FY ’13, Global had 300 holders of<br />
common stock, <strong>and</strong> 355 current or former employees<br />
held options to acquire Global common stock.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 7 – Registration <strong>and</strong> Reporting<br />
Under the <strong>Securities</strong> Exchange Act<br />
Study Problem 7.1 (cont’d)<br />
Global's accounting firm asks whether<br />
Global must begin filing reports with the<br />
SEC during its fiscal year ending June 30,<br />
2014.<br />
What is your advice?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
§12(g)(1)(B)<br />
Prior to JOBS Act:<br />
$10 million of assets (Rule 12g-1)<br />
500 “holders of record” of a class<br />
of equity security (see Rule 3a-11)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Underst<strong>and</strong>ing §12(g)<br />
Prior to JOBS Act:<br />
Section 12(g), as modified by Rule 12g-1,<br />
requires a company to register its class of<br />
equity securities with the SEC under the<br />
Exchange Act, within 120 days after the last<br />
day of its fiscal year, if, at the end of the fiscal<br />
year, that class of equity securities is "held of<br />
record" by 500 or more persons <strong>and</strong> the<br />
company has "total assets" exceeding $10<br />
million.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
A few words about “holders of record”<br />
<strong>and</strong> “street name” ownership<br />
Generally speaking, the SEC’s definition of "held of<br />
record" counts as holders of record only persons<br />
identified as owners on records of security holders<br />
maintained by the company in accordance with accepted<br />
practice.<br />
The SEC uses this definition to simplify the process of<br />
determining the applicability of Section 12(g) by allowing<br />
a company to look to the holders of its securities as shown<br />
on records maintained by it or on its behalf, such as<br />
records maintained by the company's transfer agent.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
A few words about “holders of record”<br />
<strong>and</strong> “street name” ownership (cont’d)<br />
But a fundamental shift has occurred in how securities are<br />
held in the United States since the enactment of Section<br />
12(g) in 1964. Today, the vast majority of securities of<br />
publicly-traded companies are held in nominee or “street<br />
name” form.<br />
A security is said to be held in “street name” when the<br />
security is owned by an institutional custodian. The most<br />
prominent custodian in the U.S. is the Depository Trust<br />
Company (DTC), which holds securities through its<br />
nominee Cede & Co.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
A few words about “holders of record”<br />
<strong>and</strong> “street name” ownership (cont’d)<br />
DTC is a central repository or clearinghouse facility through<br />
which members transfer stock <strong>and</strong> bond certificates<br />
electronically (i.e., through a “book entry” system). DTC was<br />
set up to provide an infrastructure for settling trades in<br />
municipal, mortgage-backed <strong>and</strong> corporate securities in a costefficient<br />
<strong>and</strong> timely manner.<br />
DTC is owned indirectly by numerous banks, brokerages,<br />
trading houses <strong>and</strong> trading exchanges (the “Participants”).<br />
For example, one Participant brokerage firm may own a large<br />
position in a publicly traded company on behalf of thous<strong>and</strong>s<br />
of beneficial owners.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
A few words about “holders of record”<br />
<strong>and</strong> “street name” ownership (cont’d)<br />
“Holders of record” Defined<br />
A clearinghouse facility such as DTC is not a single<br />
“holder of record” for purposes of Exchange Act<br />
registration, even though the company’s stock records<br />
will show a single position held by Cede & Co.<br />
Instead, each DTC “participant” (i.e., the banks <strong>and</strong><br />
brokerage firms that own DTC) is a treated as a<br />
single record holder.<br />
Source: Rule 12g5-1(b)(1) <strong>and</strong> SEC Compliance <strong>and</strong><br />
Disclosure Interpretations<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
JOBS Act Change:<br />
Holder of Record Threshold Increased<br />
Section 501 of JOBS Act amends §12(g)(1)(A) of the<br />
Exchange Act to increase “holder of record” threshold for<br />
ALL companies (other than banks <strong>and</strong> bank holding<br />
companies) to<br />
(i) 2,000 persons, or<br />
(ii) 500 persons who are not accredited investors (as<br />
such term is defined by the Commission).<br />
Applies to both EGCs <strong>and</strong> non-EGCs.<br />
Question: How will a company know who is an<br />
accredited investor?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
JOBS Act Change:<br />
Special Rule for Banks <strong>and</strong> Bank<br />
Holding Companies<br />
Section 601 of JOBS Act amends §12(g)(1)(B) of the<br />
Exchange Act to increase “holder of record” threshold<br />
for banks <strong>and</strong> bank holding companies only to<br />
2,000 persons<br />
Whether or not accredited investors.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
JOBS Act Change:<br />
“Holder of Record” Excludes <strong>Securities</strong><br />
issued under Rule 701, etc.<br />
Section 502 of JOBS Act amended §12(g)(5) of the<br />
Exchange Act to provide:<br />
Definition of ‘held of record’ shall not include securities<br />
held by persons who receive securities pursuant to an<br />
employee compensation plan in transactions exempted<br />
from §5 registration.<br />
Examples: Awards under Rule 701. The JOBS Act<br />
directs the SEC to adopt safe harbor rules.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
JOBS Act Change:<br />
“Crowdfunding” <strong>Securities</strong> to be<br />
Excluded for Holder of Record Test<br />
Section 303 of JOBS Act added §12(g)(6) to<br />
the Exchange Act directing SEC to adopt a<br />
rule:<br />
Exempting, conditionally or unconditionally,<br />
securities acquired pursuant to a<br />
“crowdfunding” offering made under §4(6)<br />
SEC rulemaking has not occurred<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 7 – Registration <strong>and</strong> Reporting<br />
Under the <strong>Securities</strong> Exchange Act<br />
Study Problem 7.1<br />
Back to Study Problem 7.1!<br />
Global's accounting firm asks whether<br />
Global must begin filing reports with the<br />
SEC during its current fiscal year ending<br />
June 30, 2014.<br />
Do the option holders count as “holders of<br />
record” of the common stock?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
First, consider Rule 3a-11:<br />
The term equity security is hereby defined to<br />
include any . . . security convertible, with or<br />
without consideration into such a security . . .; or<br />
any . . . warrant or right; or any put, call,<br />
straddle, or other option or privilege of buying<br />
such a security from or selling such a security to<br />
another without being bound to do so.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Next consider Rule 12h-1(f):<br />
In 2007 (i.e., after Google’s IPO), the SEC adopted Rule<br />
12h-1(f), which provides an exemption from the holder<br />
of record threshold for compensatory stock options.<br />
This rule decreased the odds that compensatory stock<br />
options granted by pre-IPO companies to employees,<br />
officers, directors, consultants <strong>and</strong> advisors will cause<br />
the company to have to register a class of equity<br />
securities under the Exchange Act.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
More about Rule 12h-1(f)<br />
Application to Restricted Stock Units<br />
In 2008, in response to a request by<br />
Facebook, Corp Fin issued a “no-action<br />
letter” extending the relief in Rule 12h-<br />
1(f) to restricted stock units. See<br />
Facebook, Inc. (October 14, 2008 no<br />
action letter).<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
But then consider §502 of JOBS Act:<br />
Definition of ‘held of record’ shall not<br />
include securities held by persons who<br />
receive securities pursuant to an employee<br />
compensation plan in transactions exempted<br />
from §5 registration (i.e., equity awards<br />
exempt under Rule 701)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 7 – Registration <strong>and</strong> Reporting<br />
Under the <strong>Securities</strong> Exchange Act<br />
Study Problem 7.1 – Analysis<br />
Global will not have to register under<br />
Section 12(g) in FY 2014.<br />
Per Rule 12h-1(f), Global did not have<br />
more than 500 “holders of record” as of<br />
June 30, 2013 <strong>and</strong> therefore could not<br />
have had more than 500 holders who were<br />
not accredited investors.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 7 – Registration <strong>and</strong> Reporting<br />
Under the <strong>Securities</strong> Exchange Act<br />
Study Problem 7.2<br />
Same facts as Study Problem 7.1<br />
Global plans to raise $500 million by selling shares of its common<br />
stock in a 506 transaction to a so-called “special-purpose vehicle” in<br />
which approximately 250 accredited investors would invest.<br />
Global’s CEO tells you that Global’s investment banking firm, Hook<br />
Line & Sinker, told the CEO that the investors who invest indirectly<br />
through the “special-purpose vehicle” would not be considered<br />
Global “holders of record” for SEC purposes.<br />
The CEO asks you whether this structure presents any<br />
compliance risks for Global. What is your advice.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 7 – Registration <strong>and</strong> Reporting<br />
Under the <strong>Securities</strong> Exchange Act<br />
Study Problem 7.2 – Analysis<br />
It is conceivable the SEC might assert that the structure<br />
proposed by Hook Line & Sinker could raise compliance issues<br />
under Section 12(g).<br />
Consider 12g5-1:<br />
If the issuer knows or has reason to know that the form of<br />
holding securities of record is used primarily to<br />
circumvent the provisions of section 12(g) or 15(d) of the<br />
Act, the beneficial owners of such securities shall be<br />
deemed to be the record owners thereof.<br />
Is the special purpose vehicle being used primarily for another<br />
reason?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
How does “registration” under<br />
the Exchange Act differ from<br />
registration under the<br />
<strong>Securities</strong> Act?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
§12(g)(1)(B) <strong>and</strong> Rule 12g-1<br />
One-time registration of the class of an<br />
equity security (Rule 12d-1)<br />
Registration of a class of equity<br />
securities is effectively registration of<br />
“the company.”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
In addition to Section 12(g), how else<br />
might a company become a<br />
“reporting company”?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
§12(b) – Listing on an Exchange<br />
Registration required to list a security on<br />
an exchange, such as<br />
New York Stock Exchange<br />
The NASDAQ Stock Market<br />
Same effect as Section 12(g) registration<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
§15(d) <strong>and</strong> Rules 15d-1 to 15d-16<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
§15(d)<br />
Each issuer which has filed a registration<br />
statement . . . which has become effective<br />
pursuant to the <strong>Securities</strong> Act . . . shall file with<br />
the [SEC] . . . , such supplementary <strong>and</strong><br />
periodic information, documents, <strong>and</strong><br />
reports as may be required pursuant to § 13<br />
in respect of a security registered pursuant<br />
to § 12.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
§15(d) (continued)<br />
The duty to file under §15(d)<br />
automatically suspended if <strong>and</strong> so long<br />
as any issue of securities of such issuer<br />
is registered pursuant to §12<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Voluntary Registration under §12(g)(1)(B)<br />
Any issuer may register any class of equity<br />
security not required to be registered by filing<br />
a registration statement on Form 10.<br />
See GM’s filing in early 2010.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
§12(g)(2) –§12(g) Registration Exemptions:<br />
security issued by any investment co.<br />
security issued by a mutual or cooperative<br />
organization which supplies a commodity or<br />
service primarily for the benefit of its members<br />
<strong>and</strong> operates not for pecuniary profit<br />
security issued by certain insurance companies<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
§12(g)(2) –§12(g) Registration Exemptions:<br />
collective trust funds maintained by a bank or in a<br />
separate account maintained by an insurance<br />
company which interest or participation is issued<br />
in connection with<br />
a stock bonus, pension, or profit-sharing plan which<br />
meets the requirements for qualification under section<br />
401 of Internal Revenue Code or<br />
an annuity plan which meets the requirements for<br />
deduction of the employer's contribution under section<br />
404(a)(2) of the Internal Revenue Code<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
How does a company cease to be a<br />
“reporting company”?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Termination of registration (Rule 12g-4)<br />
“Going Private”<br />
1) Fewer than 300 holders of record; or<br />
2) Fewer than 500 holders of record <strong>and</strong><br />
less than $10 million of assets<br />
Which test is likely to be more relevant?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Termination of reporting<br />
Don’t forget §15(d)<br />
The duty to file under §15(d)<br />
automatically is reinstated if the issuer<br />
no longer has any securities registered<br />
pursuant to §12<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
§15(d)<br />
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
The duty to file . . . shall also be automatically<br />
suspended as to any fiscal year, other than the fiscal<br />
year within which such registration statement<br />
became effective, if, at the beginning of such fiscal<br />
year, the securities of each class to which the<br />
registration statement relates are held of record by<br />
less than three hundred persons.<br />
See Rule 12h-3 for details.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
How does the disclosure in a “registration”<br />
under Section 12 compare to the<br />
disclosure in an S-1 for an IPO?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
§12(b) <strong>and</strong> §12(g) Registration<br />
Form 10:<br />
www.sec.gov/about/forms/form10.pdf<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
What reports must a reporting<br />
company file?<br />
How are the reports filed?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Periodic Reports:<br />
Form 10-K<br />
Form 10-Q<br />
Form 8-K<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
How Do Investors Access Periodic<br />
Reports?<br />
EDGAR<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Importance of EDGAR System<br />
Electronic Data Gathering<br />
Analysis <strong>and</strong> Retrieval (EDGAR)<br />
All companies, foreign <strong>and</strong> domestic,<br />
are required to file registration<br />
statements, periodic reports, <strong>and</strong><br />
other forms electronically through<br />
EDGAR.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
EDGAR (Cont’d)<br />
Not all documents filed with the SEC by public<br />
companies will be available on EDGAR.<br />
Companies were phased in to EDGAR filing over<br />
a three-year period ended May 6, 1996.<br />
As of that date, all public domestic companies<br />
generally were required to make their filings on<br />
EDGAR.<br />
Third-party filings with respect to these<br />
companies, such as tender offers <strong>and</strong> Schedules<br />
13D, are also filed on EDGAR<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
EDGAR (Cont’d)<br />
Practice point:<br />
All EDGAR filers must have EDGAR codes<br />
issued by the SEC.<br />
For example, a principal shareholder filing a<br />
13D or a Form 3 under Section 16 will<br />
require her own EDGAR codes. (Application<br />
must be made to the SEC for EDGAR codes.)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
When are periodic reports due?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Due date for periodic reports:<br />
Form 10-K<br />
Form 10-Q<br />
Form 8-K Generally 4 business<br />
days after trigger event<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Due date for periodic reports:<br />
Form 10-K Depends upon size of<br />
Form 10-Q<br />
Form 8-K<br />
reporting companies<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Categories of reporting companies:<br />
Large accelerated filer<br />
Accelerated filer<br />
Non-accelerated filer<br />
Smaller reporting company<br />
Emerging growth company<br />
See definitions in Rule 12b-2<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Large accelerated filer<br />
(Similar to WKSI definition)<br />
Criteria include:<br />
Aggregate worldwide “float” ≥ $700 million, as<br />
of the last business day of the issuer's most<br />
recently completed second fiscal quarter;<br />
Subject to section 13(a) or 15(d) reporting for a<br />
period of at least twelve calendar months<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Large accelerated filer<br />
10-K Due 60 days after the end of the<br />
fiscal year covered by the report<br />
10-Q Due 40 days after the end of the<br />
fiscal quarter<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Accelerated filer<br />
(Similar to non-WKSI S-3 issuer)<br />
Criteria include:<br />
Aggregate worldwide “float” ≥ $75 million (but<br />
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Accelerated filer<br />
10-K Due 75 days after the end of the<br />
fiscal year covered by the report<br />
10-Q Due 40 days after the end of the<br />
fiscal quarter<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Smaller Reporting Company<br />
Criteria include:<br />
Public “float” < $75 million, as of the last<br />
business day of the issuer's most recently<br />
completed second fiscal quarter<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Non-accelerated filer <strong>and</strong> Smaller<br />
Reporting Company<br />
10-K Due 90 days after the end of the<br />
fiscal year covered by the report<br />
10-Q Due 45 days after the end of the<br />
fiscal quarter<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Emerging Growth Company<br />
Section 101(b) of JOBS Act adds to definitions in Exchange Act<br />
(§3(a)(80)) “emerging growth company” or EGC.<br />
A company ceases to be an EGC upon the earlier of:<br />
1. Becoming a “Large Accelerated Filer” which could occur as early as<br />
approximately one year after IPO;<br />
2. Last day of FY during which 5 th anniversary of IPO (common<br />
equity) occurred pursuant to an effective registration statement;<br />
3. Last day of FY during which it had total annual gross revenues of<br />
≥$1 billion (indexed for inflation);<br />
4. Date on which the company has, during previous 3-year period,<br />
issued >$1 billion in non-convertible debt.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Special Exchange Act Rules for<br />
Emerging Growth Companies<br />
Title II of the JOBS Act exempts Emerging Growth<br />
Companies from various requirements of Exchange<br />
Act reporting.<br />
Please refer to Goodwin Procter matrix distributed<br />
in class.<br />
http://www.goodwinprocter.com/~/media/E7463DA<br />
9940544CF83D8715CC1E67A98.pdf<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
What are the implications of a<br />
filing under Rule 12b-25<br />
(Notice of Late Filing)?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Rule 12b-25 – Notice of Late Filing<br />
With respect to any report . . . which is not<br />
timely filed because the registrant is unable to<br />
do so without unreasonable effort or expense,<br />
such report shall be deemed to be filed on the<br />
prescribed due date for such report if:<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Rule 12b-25 – Notice of Late Filing (cont’d)<br />
1. The registrant files Form 12b-25 in compliance with<br />
paragraph (a);<br />
2. The registrant represents . . . that the reason(s)<br />
causing the inability to file timely could not be<br />
eliminated by the registrant without unreasonable<br />
effort or expense; <strong>and</strong><br />
3. Form 10-K is filed no later than the fifteenth<br />
calendar day following the prescribed due date; or<br />
Form 10-Q is filed no later than the fifth calendar<br />
day following the prescribed due date<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Rule 12b-25 – Notice of Late Filing (cont’d)<br />
A registrant will not be eligible to use any<br />
registration statement form under the<br />
<strong>Securities</strong> Act of 1933 the use of which is<br />
predicated on timely filed reports (e.g.,<br />
Form S-3) until the subject report is<br />
actually filed pursuant to paragraph (b)(3)<br />
of this section<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
What are the key MD&A<br />
disclosure principals?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
MD&A Overview<br />
Practical Guidance<br />
Past <strong>Trans</strong>gressions<br />
[SEE SEPARATE SLIDE DECK]<br />
Michael Krebs<br />
Nutter, McClennen & Fish, LLP<br />
November 2009<br />
© 2003-2009 Nutter, McClennen & Fish, LLP All Rights Reserved<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
“Forward Looking Statements”<br />
The Private <strong>Securities</strong> Litigation Reform Act (PSLRA),<br />
codified at Section 27A of the <strong>Securities</strong> Act <strong>and</strong> 21E of the<br />
Exchange Act, provides a safe harbor from liability for<br />
forward-looking statements, which immunizes an issuer’s<br />
forward-looking statements from securities law liability if:<br />
(1) the statement is identified as forward-looking <strong>and</strong><br />
is accompanied by meaningful cautionary language; or<br />
(2) plaintiffs fail to establish that defendants that<br />
defendants had actual knowledge of the falsity of the<br />
statement.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Section 21E (<strong>and</strong> 27A) – Safe Harbor<br />
“Forward Looking Statements”<br />
(conceptually related to “bespeaks<br />
caution” doctrine)<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
What is a “Forward Looking Statement”?<br />
What steps are necessary to achieve the<br />
benefit of the safe harbor for forward<br />
looking statements?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Forward Looking Statement:<br />
A statement containing or regarding<br />
Projection of revenues, income, etc.<br />
Plans <strong>and</strong> objectives of management for<br />
future operations<br />
Future economic performance, including<br />
any such statement contained in MD&A<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Section 21E<br />
in any private action . . . based on an untrue<br />
statement of a material fact or omission of a<br />
material fact necessary to make the statement<br />
not misleading . . . a person . . . shall not be<br />
liable with respect to any “forward-looking<br />
statement” if <strong>and</strong> to the extent that –<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Section 21E (cont’d)<br />
the forward-looking statement is--<br />
identified as a forward-looking statement, <strong>and</strong><br />
accompanied by meaningful cautionary<br />
statements identifying important factors that<br />
could cause actual results to differ materially<br />
from those in the forward looking statement; or<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Section 21E (cont’d)<br />
the plaintiff fails to prove that the forward-looking<br />
statement—<br />
If made by a natural person, was made with actual<br />
knowledge by that person that the statement was<br />
false or misleading; or<br />
If made by a business entity, was made by or with<br />
the approval of an executive officer with actual<br />
knowledge by that officer that the statement was<br />
false or misleading.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Section 21E (cont’d)<br />
Oral forward-looking statements:<br />
Oral forward-looking statement must be<br />
accompanied by a cautionary statement<br />
that the particular oral statement is a forwardlooking<br />
statement; <strong>and</strong><br />
that the actual results might differ materially;<br />
<strong>and</strong><br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Section 21E (cont’d)<br />
The oral forward-looking statement is<br />
accompanied by an oral statement that<br />
additional information concerning factors<br />
that could cause actual results to materially<br />
differ is contained in a “readily available<br />
written document,” or portion thereof;<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Section 21E (cont’d)<br />
The accompanying oral statement referred to<br />
identifies the document, or portion thereof, that<br />
contains the additional information about those<br />
factors relating to the forward-looking statement;<br />
<strong>and</strong><br />
The information contained in that written<br />
document is a cautionary statement that satisfies<br />
the st<strong>and</strong>ard for written forward looking<br />
statements<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Forward Looking Statements in the Courts<br />
Can defendant prevail before discovery?<br />
Outside the Seventh Circuit, the prevailing rule is that<br />
the adequacy of defendant’s ‘‘cautionary language’’ can<br />
be resolved at the pleading stage, without discovery, so<br />
long as the language identifies important factors that<br />
could cause results to differ materially from those in the<br />
forward-looking statement.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Forward Looking Statements in the Courts<br />
Can defendant prevail before discovery?<br />
In the Seventh Circuit, if the defendant’s cautionary<br />
language does not identify the negative events that<br />
ultimately occurred, discovery is required to determine if<br />
defendant’s cautionary language was sufficiently<br />
meaningful.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Forward Looking Statements in the Courts<br />
(cont’d)<br />
How specific must cautionary statements be?<br />
Courts generally agree that cautionary language is sufficient if it<br />
warns investors of risks similar in scope to that actually realized so<br />
that the investor is on notice of the danger of the investment<br />
Courts struggle, however, with how specific an issuer’s risk<br />
disclosure must be to avoid the fatal charge that its cautionary<br />
language is mere boilerplate.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Forward Looking Statements in the Courts<br />
(cont’d)<br />
How specific must cautionary statements be?<br />
Courts are especially unlikely to find the safe harbor applicable where the<br />
language is so broad that it could be applied to any business.<br />
For example, a court analyzing a telecommunications company warning that:<br />
‘‘Actual results may differ from the results discussed in the forward-looking<br />
statements. Factors that might cause such a difference include . . . risks associated<br />
with introducing new products, entering new markets, availability of resources,<br />
competitive response, . . . .”<br />
The court rejected this warning as “useless caveat emptor boilerplate,” holding<br />
that the “breadth of these warnings makes it impossible to determine if it<br />
meaningfully described the principal or important risks facing [the defendant].”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Forward Looking Statements in the Courts<br />
(cont’d)<br />
How to draft effective cautionary statements?<br />
First, every issuer should reconsider, on a quarterly basis, whether new<br />
developments in its business or in the markets in which it operates<br />
warrant an update of the cautionary language to reflect any changes to the<br />
description of the nature of the risks facing the company.<br />
Second, in crafting risk disclosures it will often be helpful for the issuer’s<br />
counsel to review the risk disclosures of competitors, suppliers <strong>and</strong><br />
customers.<br />
Third, reviewing recent analyst reports on the company <strong>and</strong> the industry<br />
will often help identify appropriate risk factors to highlight.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Forward Looking Statements in the Courts<br />
(cont’d)<br />
Does the phrase “accompanied by” permit allow<br />
the Company to cross reference to cautionary<br />
statements in another SEC filing?<br />
Recent decisions have found that an issuer does not lose its<br />
safe harbor protection by simply cross referencing, in one<br />
written statement, to cautionary language in one of its SEC<br />
filings.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
What is the Sarbanes-Oxley Act?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Decades Later . . . More<br />
Dramatic Legislation Required!<br />
Nearly 70 years after the adoption of the<br />
<strong>Securities</strong> Act of 1933, Congress again reacted<br />
to a major crisis in the capital markets – this<br />
time resulting from corporate fraud <strong>and</strong><br />
accounting sc<strong>and</strong>als revealed in 2000 <strong>and</strong><br />
2001 – by passing the Sarbanes-Oxley Act of<br />
2002.<br />
SOX has had a HUGE impact on Exchange<br />
Act Reporting.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Origins of Sarbanes-Oxley Act<br />
Intentional misstating of revenue <strong>and</strong>/or expense<br />
WorldCom (n/k/a MCI):<br />
Reduced operating expenses by improperly releasing certain reserves<br />
held against operating expenses<br />
Improperly reduced operating expenses by recharacterizing certain<br />
expenses as capital assets<br />
Tyco: Accused of “Spring-Loading” – Padding earnings growth by<br />
acquiring companies after making them prepay expenses <strong>and</strong> forgo<br />
new revenue<br />
Global Crossing: Accumulated $12.4 billion in debt building a<br />
worldwide fiber optic network. Global Crossing leased space on its<br />
27-nation network to rivals from which it rented capacity at the same<br />
time, helping both parties boost reported revenue.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Origins of Sarbanes-Oxley Act<br />
(cont’d)<br />
Deceptive Related-Party <strong>Trans</strong>actions<br />
Enron: Limited partnerships used as “off-balance sheet”<br />
special purpose entities<br />
Aggressively boosted profits <strong>and</strong> hid debts totaling over $1<br />
billion by using off-the-books partnerships<br />
Adelphia Communications: Fraudulently excluded<br />
billions of dollars in liabilities from its consolidated<br />
financial statements by hiding them on the books of offbalance<br />
sheet affiliates<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Origins of Sarbanes-Oxley Act<br />
(cont’d)<br />
Abuse of Insider Loans<br />
Tyco: $121.1 million -- Including $61 million to CEO<br />
for “relocation costs”<br />
WorldCom: $160.8 million to former CEO<br />
Adelphia Communication: $3.1 billion to Rigas Family<br />
– used money for private purchases <strong>and</strong> investments<br />
including a golf course <strong>and</strong> dealings with a NHL hockey<br />
team<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Origins of Sarbanes-Oxley Act<br />
(cont’d)<br />
Ineffective Corporate Governance<br />
Ineffective oversight by senior-most management <strong>and</strong><br />
especially audit committees of financial reporting <strong>and</strong><br />
internal controls<br />
Enron, WorldCom, etc.<br />
Accounting firms perceived to be insufficiently independent<br />
of management<br />
Enron, WorldCom, etc.<br />
Lawyers perceived to view management <strong>and</strong> not the board<br />
of directors as their client<br />
Enron, Tyco<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Origins of Sarbanes-Oxley Act<br />
(cont’d)<br />
Economic impact of corporate sc<strong>and</strong>als – in the<br />
nine months from early October 2001 to late June<br />
2002<br />
WorldCom stock fell 95% ~ $42 billion decline!<br />
Enron stock declined 99% ~ $25 billion decline!<br />
Adelphia stock fell 99% ~ $3 billion decline!<br />
Tyco stock fell 70% ~ $63 billion decline!<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Sarbanes-Oxley Act of 2002<br />
Overview<br />
Accounting St<strong>and</strong>ards <strong>and</strong> Oversight<br />
Auditor Independence<br />
Management Accountability<br />
CEO/CFO Certifications Under Sections 302 <strong>and</strong> 906<br />
Internal Control Requirements<br />
Ethics Policies Required<br />
Whistle-blower Protection<br />
Limitations on use of Non-GAAP Disclosures<br />
Prohibition on Personal Loans to Executives<br />
Obligation of Lawyers to Report “Up-the-Ladder”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Impact of Sarbanes-Oxley<br />
Certifications under 302 <strong>and</strong> 906<br />
Each CEO <strong>and</strong> CFO of a reporting company must certify the<br />
accuracy of all periodic reports (i.e., 10-Ks <strong>and</strong> 10-Qs) filed<br />
with the SEC.<br />
Each CEO <strong>and</strong> CFO must certify that she has reviewed the<br />
report, <strong>and</strong> to her knowledge the report does not contain any<br />
material misstatements or omissions, <strong>and</strong> the financial<br />
statements <strong>and</strong> other information contained in the report fairly<br />
represent in all material respects the company’s financial<br />
condition <strong>and</strong> results of operations of the issuer for the periods<br />
presented in the reports.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Internal Control Certifications<br />
The CEO <strong>and</strong> CFO must also certify in every quarterly <strong>and</strong> annual report (i.e., 10-Ks <strong>and</strong> 10-<br />
Qs):<br />
that they are responsible for establishing <strong>and</strong> maintaining internal controls <strong>and</strong> have<br />
designed such internal controls to ensure that material information relating to the<br />
company <strong>and</strong> its consolidated subsidiaries is made known to such officers by others<br />
within those entities;<br />
that they have evaluated the effectiveness of the company’s internal controls within<br />
the past 90 days;<br />
that they have presented in the report their conclusions about the effectiveness of their<br />
controls;<br />
that they have disclosed to the company’s auditors <strong>and</strong> the audit committee all<br />
significant deficiencies in the design or operation of internal controls which could<br />
adversely affect the company’s ability to record, process, summarize <strong>and</strong> report financial<br />
data <strong>and</strong> have identified for the auditors any material weaknesses in internal controls <strong>and</strong><br />
any fraud, whether material or not, that involves management or other employees who<br />
have a significant role in the issuer’s internal controls.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
CEO/CFO Certifications – Penalties<br />
Whoever certifies one of the above statements<br />
knowing that the periodic report does not<br />
comport with all the requirements can be fined<br />
up to $1,000,000 <strong>and</strong> imprisoned up to 10 years.<br />
Whoever willfully certifies such a statement<br />
knowing it does not comport with the statute’s<br />
requirements can be fined up to $5,000,000 <strong>and</strong><br />
imprisoned up to 20 years.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
CEO/CFO Certifications<br />
SEC Enforcement Actions<br />
There have been at least eight SEC enforcement actions involving a<br />
CEO or CFO certification under SOX.<br />
In one, the SEC charged that the CEO "signed [the annual report]<br />
<strong>and</strong> the Sarbanes-Oxley certification without having read either<br />
document <strong>and</strong> without having taken any steps to determine their<br />
accuracy or truthfulness,” relying instead on nothing more than a 27year<br />
old EVP’s assurances.<br />
In another, the SEC alleged that the CFO ignored “red flags” of<br />
improper revenue recognition <strong>and</strong> participated in preparing<br />
backdated documentation that was provided to the company’s<br />
auditors to support fictitious fiscal 2006 year-end sales.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Impact of Sarbanes-Oxley (cont’d)<br />
Audit Integrity<br />
Section 303<br />
Section 401<br />
PCAOB<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Impact of Sarbanes-Oxley (cont’d)<br />
Corporate Governance Practices<br />
Section 402 – No Loans to Insiders<br />
Section 404 – Internal Control Certifications<br />
Section 406 – Code of Ethics<br />
Section 409 – “Real Time” Disclosure<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Impact of Sarbanes-Oxley (cont’d)<br />
404 Internal Control Certifications<br />
Section 404 of SOX requires a company’s independent<br />
accounting firm to satisfactorily complete an audit of the<br />
company’s “internal control over financial reporting” (ICOFR).<br />
Effectiveness of a company’s ICOFR is evaluated using<br />
suitable control criteria, such as the COSO (Committee of<br />
Sponsoring Organizations of the Treadway Commission)<br />
criteria.<br />
This is a relatively expensive process, especially for most<br />
companies that are not large accelerated filers.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
404 Internal Control Certifications<br />
Special Rule for EGCs<br />
Section 103 of the JOBS Act amends<br />
Section 404(b) of SOX:<br />
The 404 requirement for audit of the<br />
company’s “internal control over<br />
financial reporting” does not apply to<br />
emerging growth companies<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Trend Toward “Real Time” Disclosure<br />
August 2004 SEC Amends Form 8-K:<br />
Dramatically shortened filing<br />
deadlines:<br />
4 business days for most events<br />
Significantly exp<strong>and</strong>ed scope of<br />
events triggering disclosure<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
2004 Amendment of Form 8-K (cont’d)<br />
Item 1.01 Entry into a Material<br />
Definitive Agreement<br />
Item 1.02 Termination of a Material<br />
Definitive Agreement<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
2004 Amendment of Form 8-K (cont’d)<br />
Item 2.03 Creation of a Direct Financial<br />
Obligation or an Obligation under an Off-<br />
Balance Sheet Arrangement of a Registrant.<br />
Item 2.04 Triggering Events That Accelerate<br />
or Increase a Direct Financial Obligation or<br />
an Obligation under an Off-Balance Sheet<br />
Arrangement.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
2004 Amendment of Form 8-K (cont’d)<br />
Item 2.05 Costs Associated with Exit<br />
or Disposal Activities<br />
Item 2.06 Material Impairments<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
2004 Amendment of Form 8-K (cont’d)<br />
Item 2.06 Material Impairments.<br />
No filing is required under this Item 2.06 if the<br />
conclusion is made in connection with the<br />
preparation, review or audit of financial statements<br />
required to be included in the next periodic report due<br />
to be filed under the Exchange Act, the periodic<br />
report is filed on a timely basis, <strong>and</strong> such conclusion<br />
is disclosed in the report.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
2004 Amendment of Form 8-K (cont’d)<br />
Item 3.01 Notice of Delisting or Failure to<br />
Satisfy a Continued Listing Rule or<br />
St<strong>and</strong>ard; <strong>Trans</strong>fer of Listing.<br />
Item 3.02 Unregistered Sales of Equity<br />
<strong>Securities</strong>.<br />
Item 3.03 Material Modification to Rights<br />
of Security Holders.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
2004 Amendment of Form 8-K (cont’d)<br />
Item 4.02 Non-Reliance on Previously<br />
Issued Financial Statements or a<br />
Related Audit Report or Completed<br />
Interim Review.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
2004 Amendment of Form 8-K (cont’d)<br />
Item 5.02 Departure of Directors or<br />
Principal Officers; Election of<br />
Directors; Appointment of Principal<br />
Officers.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
<strong>Regulation</strong> G – Non-GAAP Disclosure<br />
Pursuant to Section 401(b) of Sarbanes-Oxley:<br />
SEC adopted new <strong>Regulation</strong> G <strong>and</strong> new Item 10<br />
of <strong>Regulation</strong> S-K, governing the use of non-<br />
GAAP financial information in public<br />
communications by SEC registrants <strong>and</strong> filings<br />
made with the SEC.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
<strong>Regulation</strong> G – Non-GAAP Disclosure<br />
(cont’d)<br />
"Non-GAAP financial measure" is defined as a numerical measure of a<br />
company's historical or future financial performance, financial position or<br />
cash flows that:<br />
1) excludes amounts, or is subject to adjustments that have the effect<br />
of excluding amounts, that are included in the most directly<br />
comparable GAAP measure in the statement of income, balance<br />
sheet or statement of cash flows of the company; or<br />
2) includes amounts, or is subject to adjustments that have the effect<br />
of including amounts, that are excluded from the most directly<br />
comparable measure so calculated <strong>and</strong> presented.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
<strong>Regulation</strong> G – Non-GAAP Disclosure<br />
(cont’d)<br />
<strong>Regulation</strong> G requires a company to provide the following<br />
information as part of the disclosure or release of non-GAAP<br />
financial information:<br />
a presentation of the most directly comparable financial<br />
measure calculated <strong>and</strong> presented in accordance with<br />
GAAP; <strong>and</strong><br />
a reconciliation (by schedule or other clearly<br />
underst<strong>and</strong>able method) of the differences between the non-<br />
GAAP measure <strong>and</strong> the most directly comparable GAAP<br />
measure or measures.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
Foreign Corrupt Practices Act<br />
What is scope of FCPA?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Corrupt Practices Act<br />
Enacted in 1977 in the wake of a series of overseas <strong>and</strong><br />
domestic bribery sc<strong>and</strong>als, the FCPA originally<br />
prohibited U.S. corporations <strong>and</strong> nationals from making<br />
improper payments to foreign officials, parties or<br />
c<strong>and</strong>idates, in order to assist a company in obtaining,<br />
retaining or directing business to any person.<br />
The FCPA also imposes record-keeping <strong>and</strong> internal<br />
controls requirements on all SEC reporting<br />
companies.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Corrupt Practices Act (cont’d)<br />
The U.S. Department of Justice (“DOJ”) has primary responsibility<br />
for enforcing the anti-bribery provisions of FCPA.<br />
The SEC typically takes the lead in enforcing the accounting<br />
provisions (e.g., books <strong>and</strong> records, internal controls).<br />
Both the SEC <strong>and</strong> DOJ have authority to seek permanent injunctions<br />
against present <strong>and</strong> future violations. Criminal <strong>and</strong> civil penalties for<br />
violating the FCPA can be severe for corporations as well as<br />
individual officers, employees <strong>and</strong> agents.<br />
In addition to large DOJ <strong>and</strong> SEC monetary sanctions, FCPA<br />
violations can provoke shareholder litigation, as well as government<br />
debarment <strong>and</strong> suspension proceedings <strong>and</strong> parallel investigations in<br />
foreign jurisdictions.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Corrupt Practices Act (cont’d)<br />
Record-keeping Provisions – See p. 127 of Soderquist<br />
Codified in § 13(b)(2) <strong>and</strong> (3) of the Exchange Act, the FCPA record-keeping provisions<br />
state:<br />
Every issuer which has a class of securities registered pursuant to section 12 <strong>and</strong> every<br />
issuer which is required to file reports pursuant to section 15(d) shall—<br />
(A) make <strong>and</strong> keep books, records, <strong>and</strong> accounts, which, in reasonable detail, accurately<br />
<strong>and</strong> fairly reflect the transactions <strong>and</strong> dispositions of the assets of the issuer;<br />
(B) devise <strong>and</strong> maintain a system of internal accounting controls sufficient to provide<br />
reasonable assurances that—<br />
(i) transactions are executed in accordance with management's general or<br />
specific authorization;<br />
(ii) transactions are recorded as necessary (I) to permit preparation of financial<br />
statements in conformity with generally accepted accounting principles or any<br />
other criteria applicable to such statements, <strong>and</strong> (II) to maintain accountability<br />
for assets;<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Corrupt Practices Act (cont’d)<br />
Record-keeping Provisions (cont’d)<br />
FCPA record-keeping <strong>and</strong> internal controls provisions apply<br />
to all reporting companies, whether or not they have any<br />
foreign operations.<br />
FCPA recording keeping <strong>and</strong> internal control rules also<br />
apply to companies with ADRs traded on a U.S. stock<br />
exchange.<br />
FPCA record-keeping nor internal control provisions are not<br />
limited to transactions above a certain amount <strong>and</strong> do not<br />
impose a materiality requirement.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Corrupt Practices Act (cont’d)<br />
Record-keeping Provisions (cont’d)<br />
Inadvertent mistakes will not give rise to<br />
enforcement actions or prosecutions.<br />
An issuer can violate the books <strong>and</strong> records<br />
provisions if a foreign subsidiary creates false<br />
records to conceal an illicit payment, <strong>and</strong> the<br />
issuer parent then incorporates the subsidiary’s<br />
information into its books <strong>and</strong> records.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Corrupt Practices Act (cont’d)<br />
Record-keeping Provisions (cont’d)<br />
Examples of transactions which accounting records may fail to<br />
adequately or accurately disclose:<br />
payments to foreign government officials;<br />
commercial bribes or kickbacks;<br />
political contributions;<br />
smuggling activities;<br />
income tax violations;<br />
customs or currency violations; <strong>and</strong><br />
extraordinary gifts<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Corrupt Practices Act (cont’d)<br />
Bribery Provisions<br />
A U.S. company or issuer can be liable under<br />
the FCPA as amended for the conduct of<br />
overseas employees or agents, even if no<br />
money was transferred from the U.S. <strong>and</strong> no<br />
U.S. person participated in any way in the<br />
foreign bribery.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Corrupt Practices Act (cont’d)<br />
Bribery Provisions<br />
The 1998 amendments exp<strong>and</strong>ed the FCPA’s jurisdiction to cover<br />
corrupt foreign payments outside the U.S. by U.S. persons without any<br />
link to interstate commerce.<br />
The FCPA amendments make it illegal for any U.S. person to violate<br />
the FCPA “irrespective of whether such U.S. person makes use of<br />
interstate commerce in furtherance of the illegal foreign activity.<br />
Until 1998, foreign persons were not subject to the anti-bribery<br />
provisions unless they were issuers or domestic concerns. The 1998<br />
amendments exp<strong>and</strong>ed the FCPA to allow for the prosecution of any<br />
foreign person, whether or not a U.S. resident, who takes any act in<br />
furtherance of a corrupt payment while in the territory of the U.S.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Corrupt Practices Act (cont’d)<br />
What about the ‘Bribery is Accepted <strong>and</strong> Routine There’ Defense<br />
“The argument that a client “conducted business in a foreign country<br />
where corrupt practices are routine <strong>and</strong> long established” <strong>and</strong> “there was<br />
no other practical way to do business <strong>and</strong> compete” is highly unlikely to<br />
succeed, with either the DOJ or the SEC. The uniform government<br />
response is that Congress was fully aware of foreign customs <strong>and</strong><br />
practices where bribery payments were the norm when it enacted the<br />
FCPA three decades ago, <strong>and</strong> it sought to establish ethical business<br />
practices for U.S. companies doing business overseas.”<br />
The Foreign Corrupt Practices Act:<br />
A Primer For Multinational General Counsel<br />
By: Robert W. Tarun<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Corrupt Practices Act (cont’d)<br />
Two noteworthy FCPA enforcement actions during the paste decade:<br />
1. In April 2007, the DOJ <strong>and</strong> SEC entered into an FCPA record setting<br />
$44 million settlement – the largest monetary sanction ever imposed<br />
in an FCPA case – with Baker Hughes Inc. for a subsidiary’s<br />
payment of bribes totaling $4.1 million over a two-year period to<br />
a Kazakh official in order to obtain an oil field services contract.<br />
2. In March 2005, defense contractor Titan Corporation entered into a<br />
$28.5 million settlement with the DOJ <strong>and</strong> SEC for FCPA bribery<br />
violations involving the president of Benin’s reelection campaign.<br />
Titan was required to plead guilty as a result of its submission of<br />
false invoices for consulting services <strong>and</strong> payment of $3.5 million<br />
to an agent, who was in fact the Benin president’s business<br />
advisor.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Registration <strong>and</strong> Reporting<br />
Under <strong>Securities</strong> Exchange Act<br />
What is Reg. FD?<br />
What are the practical<br />
implications?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Overview<br />
Reg. FD – Fair Disclosure<br />
Perceived Abuse:<br />
Selective disclosure of material,<br />
nonpublic information to “Wall<br />
Street” professionals at the expense of<br />
individual investors<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Overview (cont’d)<br />
Reg. FD – Key Elements<br />
1. Disclosure covered by rule:<br />
Statements by issuer or a person<br />
acting on its behalf<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Overview (cont’d)<br />
2. Activity covered:<br />
Selective disclosure of material,<br />
nonpublic information to securities<br />
market professionals or holders of<br />
issuer’s securities, when it is reasonably<br />
foreseeable that recipient will trade on<br />
basis of the material, non-public<br />
information<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Overview (cont’d)<br />
Examples of covered activities:<br />
“Guidance” re: earnings results<br />
One-on-one sessions involving<br />
senior management <strong>and</strong> analysts or<br />
investors<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Overview (cont’d)<br />
Speeches, interviews <strong>and</strong> conferences<br />
Responding to market rumors<br />
Reviewing analyst reports <strong>and</strong> similar<br />
materials<br />
Referring to or distributing analyst<br />
reports about the company<br />
Postings on company website<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Overview (cont’d)<br />
3. Required Disclosure:<br />
Issuer must make public disclosure of<br />
the information –<br />
(1) simultaneously, if the disclosure was<br />
intentional (like a press release), or<br />
(2) promptly thereafter, if the<br />
disclosure was unintentional<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Overview (cont’d)<br />
Public disclosure of the information –<br />
by “furnishing to” or “filing with” the<br />
Commission a Form 8-K disclosing that<br />
information<br />
See Item 7.01 of Form 8-K <strong>and</strong> related<br />
Instruction B.1 regarding “furnishing”<br />
vs. “filing” under Item 8.01 of Form 8-K<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Overview (cont’d)<br />
4. Exceptions:<br />
a. Broad Advance Notice<br />
Issuer exempt from requirement to furnish or file a<br />
Form 8-K if instead it disseminates information<br />
through another method of disclosure that is<br />
reasonably designed to provide broad, nonexclusionary<br />
distribution of the information to the<br />
public<br />
Typically, the alternative scenario is a publicized<br />
conference call in which any party can listen<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Overview (cont’d)<br />
4. Exceptions:<br />
b. “Breach of trust”<br />
Any officer, director, employee, or agent<br />
of an issuer who discloses material,<br />
nonpublic information in breach of a duty<br />
of trust or confidence to the issuer shall<br />
not be considered to be “acting on behalf<br />
of the issuer”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Overview (cont’d)<br />
Examples involving “trust”<br />
(1) a lawyer or an investment banker<br />
engaged by the issuer, or<br />
(2) a party to a confidentiality<br />
agreement<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Overview (cont’d)<br />
4. Exceptions:<br />
c. Violation of Company Policy<br />
If issuer adopts policy that limits which<br />
senior officials are authorized to speak to<br />
securities market professionals, a selective<br />
disclosure by a senior official who is not<br />
authorized to speak under the policy will not<br />
violate <strong>Regulation</strong> FD (but may subject the<br />
person to insider trading liability)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Compliance Programs<br />
Elements of Sample FD Policy:<br />
1. Limit authorize spokespersons<br />
CEO<br />
CFO<br />
Investor Relations Officer<br />
Other persons designated by<br />
“Disclosure Committee”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Compliance Programs<br />
2. Example of Disclosure Committee<br />
Investors Relations<br />
CFO<br />
General Counsel<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Compliance Programs<br />
3. Dissemination of Information<br />
Press release through widely circulated<br />
news <strong>and</strong> wire services<br />
Advance public notice <strong>and</strong> public access<br />
information for each scheduled conference<br />
call<br />
Anyone may listen to call by telephone or<br />
webcast.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Compliance Programs<br />
3. Dissemination of Information (cont’d)<br />
Permissible to allow only a limited group<br />
to ask questions on the conference call, as<br />
long as all listeners can hear the questions<br />
<strong>and</strong> answers<br />
Make an audio recording of the conference<br />
call publicly available through our website<br />
or an outside service for limited period<br />
(e.g., one week following the call)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Enforcement<br />
Who may bring a claim for a<br />
violation of Reg. FD?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Enforcement<br />
Only the SEC may bring a claim for<br />
violation of Reg. FD<br />
Recognizing that private liability could<br />
contribute to a chilling effect on issuer<br />
communications, the SEC has emphasized<br />
that <strong>Regulation</strong> FD contains no private<br />
right of action.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Enforcement<br />
SEC has been viewed as enforcing Reg. FD<br />
zealously.<br />
Most companies <strong>and</strong> insiders against whom<br />
enforcement actions have been brought<br />
have agreed to settle.<br />
BUT the SEC lost decisively in its only<br />
litigated Reg. FD case<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Enforcement – Siebel Case<br />
In September 2005, in SEC v. Siebel<br />
Systems Inc., a federal district court<br />
decisively dismissed the SEC.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Enforcement – Siebel Case<br />
SEC alleged that<br />
1) Siebel’s CFO had commented positively on the<br />
company’s business activity <strong>and</strong> sales transaction<br />
pipeline in a private meeting with an institutional<br />
investor, <strong>and</strong><br />
2) CFO’s statements “materially contrasted” with<br />
allegedly more cautious public statements made by<br />
Siebel’s chairman in a conference calls earlier the<br />
same month<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Enforcement – Siebel Case<br />
Court concluded that Reg. FD does not require that<br />
corporate officials “only utter verbatim statements<br />
that were previously publicly made.” So long as the<br />
private statement communicates the same material<br />
information that the public statement conveyed, the<br />
court concluded that <strong>Regulation</strong> FD is not implicated.<br />
Court ruled that, when viewed in context, the<br />
defendants’ public <strong>and</strong> private disclosures “did not<br />
add, contradict, or significantly alter” the material<br />
information available to the general public.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Reg. FD Enforcement – Siebel Case<br />
Court rejected the SEC’s syntactic parsing of<br />
the Siebel disclosures: “Fair accuracy, not<br />
perfection, is the appropriate st<strong>and</strong>ard.”<br />
Court admonished the SEC for “scrutiniz[ing],<br />
at an extremely heightened level, every<br />
particular word used in [the Siebel statements],<br />
including the tense of verbs <strong>and</strong> the general<br />
syntax of each sentence.”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Attorney Conduct Rules<br />
Under Federal <strong>Securities</strong> Laws<br />
Attorney Conduct Rules –17 CFR Part 205<br />
(pursuant to §307 of Sarbanes-Oxley Act of 2002)<br />
Applies to attorneys who are “appearing<br />
<strong>and</strong> practicing before the Commission in<br />
the representation of an issuer”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Attorney Conduct Rules<br />
Under Federal <strong>Securities</strong> Laws<br />
“Appearing <strong>and</strong> practicing before the<br />
Commission . . . ” is broadly defined to<br />
include<br />
<strong>Trans</strong>acting any business with SEC or otherwise<br />
communicating with SEC;<br />
Representing an issuer in an SEC administrative<br />
proceeding or in connection with any SEC<br />
investigation, inquiry, information request or<br />
subpoena;<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Attorney Conduct Rules<br />
Under Federal <strong>Securities</strong> Laws<br />
Providing advice in respect of federal securities laws<br />
<strong>and</strong> regulations concerning any document that the<br />
attorney has notice will be filed with or submitted to<br />
SEC by a client-issuer, including customary SEC filings<br />
as well documents filed as exhibits or otherwise; <strong>and</strong><br />
Advising an issuer as to whether information,<br />
statements, opinions or other writings are required to<br />
be filed with or submitted to the SEC under the federal<br />
securities laws <strong>and</strong> regulations<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Attorney Conduct Rules<br />
Under Federal <strong>Securities</strong> Laws<br />
Foreign Attorneys:<br />
Foreign attorneys who are not admitted in the United<br />
States, <strong>and</strong> who do not advise clients regarding U.S.<br />
law, are not be covered by the rule<br />
Foreign attorneys who provide legal advice regarding<br />
U.S. law would be covered to the extent they are<br />
appearing <strong>and</strong> practicing before the SEC, unless they<br />
provide such advice in consultation with U.S. counsel<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Attorney Conduct Rules<br />
Under Federal <strong>Securities</strong> Laws<br />
Attorney subject to m<strong>and</strong>atory<br />
“up-the-ladder” reporting<br />
Must report any evidence of<br />
any material violation of federal or state<br />
securities law,<br />
any material breach of a fiduciary duty arising<br />
under federal or state law, or<br />
any other “similar” violation of federal or state<br />
law.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Attorney Conduct Rules<br />
Under Federal <strong>Securities</strong> Laws<br />
Trigger for attorney’s reporting obligation:<br />
“Evidence of a material violation means<br />
credible evidence, based upon which it would<br />
be unreasonable, under the circumstances, for<br />
a prudent <strong>and</strong> competent attorney not to<br />
conclude that it is reasonably likely that a<br />
material violation has occurred, is ongoing, or<br />
is about to occur” (emphasis added).<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Attorney Conduct Rules<br />
Under Federal <strong>Securities</strong> Laws<br />
“Under the circumstances”<br />
Determined at time attorney decides whether he<br />
or she is obligated to report the information.<br />
May include, among others, attorney's<br />
professional skills, background <strong>and</strong> experience,<br />
the time constraints under which attorney is<br />
acting, attorney's previous experience <strong>and</strong><br />
familiarity with client, <strong>and</strong> availability of other<br />
attorneys for consultation.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Attorney Conduct Rules<br />
Under Federal <strong>Securities</strong> Laws<br />
“Reasonably Likely”<br />
To be "reasonably likely" a material<br />
violation must be more than a mere<br />
possibility, but it need not be "more likely<br />
than not."<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved
Attorney Conduct Rules<br />
Under Federal <strong>Securities</strong> Laws<br />
“Up-the-ladder” reporting<br />
Disclosure first to<br />
Chief Legal Officer, or<br />
Chief Legal Officer <strong>and</strong> Chief<br />
Executive Officer<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Attorney Conduct Rules<br />
Under Federal <strong>Securities</strong> Laws<br />
“Up-the-ladder” reporting (cont’d)<br />
Unless attorney believes CLO or CEO has made an<br />
“appropriate response”, the attorney must report the<br />
evidence of a material violation further up-the-ladder<br />
to:<br />
the audit committee of the board of directors,<br />
another independent committee of the board,<br />
or<br />
if no such committees exist, to the entire board.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Attorney Conduct Rules<br />
Under Federal <strong>Securities</strong> Laws<br />
SEC perspective on CLOs:<br />
CLO can play an essential leadership role in assuring an appropriate "tone"<br />
<strong>and</strong> corporate culture that support rigorous compliance with all laws.<br />
CLO generally can "push back" on senior management more forcefully than<br />
other employees when difficult legal issues arise, especially in light of the<br />
greatly heightened awareness among officers <strong>and</strong> directors today of the price<br />
of corporate malfeasance.<br />
CLO can serve as a bridge to the board on difficult legal matters.<br />
CLO also can best assure an appropriate level of protection for<br />
whistleblowers <strong>and</strong> others who identify potential legal problems at the<br />
company, especially given the sometimes difficult task of sorting out<br />
potential cases of whistleblower retaliation from ordinary personnel disputes.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Attorney Conduct Rules<br />
Under Federal <strong>Securities</strong> Laws<br />
In addition to the straight up-the-ladder<br />
reporting, the SEC rules also permit companies<br />
to establish a “qualified legal compliance<br />
committee” (“QLCC”).<br />
Once an attorney reports evidence of a material<br />
violation to pre-existing QLCC, then that<br />
committee is responsible for investigating the<br />
evidence of a material violation <strong>and</strong> formulating<br />
an appropriate <strong>and</strong> timely response.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. - International Business Law<br />
July/August 2013<br />
Michael Krebs<br />
JD, Boston University School of Law 1985<br />
Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />
Tel. 616.439.2288 email: mkrebs@nutter.com<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
MD&A Overview<br />
Practical Guidance<br />
Past <strong>Trans</strong>gressions<br />
Michael Krebs<br />
Nutter, McClennen & Fish, LLP<br />
November 2009<br />
© 2003-2009 Nutter, McClennen & Fish, LLP All Rights Reserved
MD&A Overview<br />
MD&A:<br />
Management’s Discussion <strong>and</strong> Analysis of<br />
Financial Condition, <strong>and</strong><br />
Results of Operations
MD&A Overview<br />
Objective:<br />
“To provide, in one section of a filing,<br />
material historical <strong>and</strong> prospective textual<br />
disclosure enabling investors . . . to assess<br />
the financial condition <strong>and</strong> results of<br />
operations of the registrant, with particular<br />
emphasis on the registrant's prospects for the<br />
future.” (SEC 1989 Release)
MD&A Overview<br />
Key Elements of MD&A<br />
(Item 303 of Reg. S-K <strong>and</strong> Supplemental SEC Guidance)<br />
Executive summary<br />
Critical accounting policies<br />
Liquidity<br />
Capital resources<br />
Off-balance sheet arrangements; contractual<br />
obligations <strong>and</strong> commitments<br />
Operating results
MD&A Overview<br />
Overview of Item 303:<br />
“MD&A is intended to give the investor an<br />
opportunity to look at the company through<br />
the eyes of management by providing both a<br />
short <strong>and</strong> long-term analysis of the business<br />
of the company. [Item 303] asks<br />
management to discuss the dynamics of the<br />
business <strong>and</strong> to analyze the financials.”<br />
(SEC 1989 Release, emphasis added.)
MD&A Overview<br />
Overview of Item 303 (cont’d):<br />
“It is the responsibility of management to<br />
identify <strong>and</strong> address those key variables <strong>and</strong><br />
other qualitative <strong>and</strong> quantitative factors<br />
which are peculiar to <strong>and</strong> necessary for an<br />
underst<strong>and</strong>ing <strong>and</strong> evaluation of the<br />
individual company.” (SEC 1981 Release.)
MD&A Overview<br />
Overview of Item 303 (cont’d):<br />
Several specific provisions in Item 303 require<br />
disclosure of forward-looking information.<br />
MD&A requires discussion of “known trends or<br />
any known dem<strong>and</strong>s, commitments, events or<br />
uncertainties that will result in or that are<br />
reasonably likely to result in the registrant's<br />
liquidity increasing or decreasing in any material<br />
way.”
MD&A Overview<br />
Overview of Item 303 (cont’d):<br />
MD&A also requires discussion of<br />
known material trends in the registrant's capital<br />
resources <strong>and</strong> expected changes in the mix <strong>and</strong> cost<br />
of such resources; <strong>and</strong><br />
known trends or uncertainties that the registrant<br />
reasonably expects will have a material impact on<br />
net sales, revenues, or income from continuing<br />
operations.
MD&A Overview<br />
Overview of Item 303 (cont’d):<br />
Finally, MD&A requires a discussion of<br />
material events <strong>and</strong> uncertainties known to<br />
management that would cause reported financial<br />
information not to be necessarily indicative of<br />
future operating results or of future financial<br />
condition.
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Executive summary (best practice)<br />
Summary identifying what management considers the<br />
most important factors in determining its financial<br />
results <strong>and</strong> conditions, including the principal factors<br />
driving them, the principal trends on which<br />
management focuses <strong>and</strong> the principal risks to the<br />
business<br />
Summary must be balanced <strong>and</strong> include all issues, <strong>and</strong><br />
details must be included in body of MD&A.
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Critical accounting policies<br />
In December 2001, SEC issued "cautionary advice" to<br />
issuers regarding MD&A disclosure of critical accounting<br />
policies.<br />
SEC stated that companies should include in their MD&A<br />
clear, balanced explanations of the effects of “critical<br />
accounting policies,” the judgments made in their<br />
application, <strong>and</strong> the likelihood of materially different<br />
reported results under different assumptions or conditions.
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Critical accounting policies (cont’d)<br />
Working Definition:<br />
A critical accounting policy as one that is both very<br />
important to the portrayal of the company's financial<br />
condition <strong>and</strong> results, <strong>and</strong> requires management's most<br />
difficult, subjective or complex judgments.<br />
(Based upon 2002 remarks by SEC Chief Accountant)
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Critical accounting policies (cont’d)<br />
SEC Objective:<br />
To provide investors with an underst<strong>and</strong>ing about how<br />
management forms its judgments about future events,<br />
including the variables <strong>and</strong> assumptions underlying the<br />
estimates, <strong>and</strong> the sensitivity of those judgments to different<br />
circumstances.<br />
As the complexity <strong>and</strong> subjectivity of judgments increase,<br />
the inherent level of precision in the financial statements<br />
decreases, which is a fact that investors should be told.
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Critical accounting policies (cont’d)<br />
Prior to filing annual reports, the audit committee should<br />
review <strong>and</strong> discuss with senior management <strong>and</strong> outside<br />
auditors the selection, application <strong>and</strong> disclosure of critical<br />
accounting policies.<br />
SEC officials have also advised that critical accounting<br />
policy disclosures be reviewed every quarter.
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Liquidity<br />
Liquidity is defined in Instruction 5 to Item 303(a) as "the<br />
ability of an enterprise to generate adequate amounts of cash<br />
to meet the enterprise's needs for cash."<br />
Item 303(a)(1) requires that the discussion identify "any<br />
known trends or any known dem<strong>and</strong>s, commitments, events<br />
or uncertainties that will result in or that are reasonably likely<br />
to result in the company's liquidity increasing or decreasing in<br />
any material way."
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Liquidity (cont’d)<br />
The scope of the discussion should address liquidity in the<br />
broadest sense, evaluating the amounts <strong>and</strong> certainty of cash<br />
flows from internal operations <strong>and</strong> from outside sources,<br />
current conditions as well as future commitments, known<br />
trends, <strong>and</strong> changes in circumstances <strong>and</strong> uncertainties.
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Liquidity (cont’d)<br />
The scope of the discussion should address liquidity in the broadest<br />
sense, evaluating the amounts <strong>and</strong> certainty of cash flows from<br />
internal operations <strong>and</strong> from outside sources, current conditions as<br />
well as future commitments, known trends, <strong>and</strong> changes in<br />
circumstances <strong>and</strong> uncertainties.<br />
For example, if liquidity is dependent on off-balance sheet<br />
financing, such as securitization of receivables or obtaining access<br />
to assets through special purpose entities, disclosure of factors that<br />
may affect continued use of material off-balance sheet<br />
arrangements is likely to be necessary.
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Liquidity (cont’d)<br />
SEC has identified various items to be considered in preparing the liquidity<br />
section:<br />
(1) Provisions in financial guarantees or commitments, debt or lease<br />
agreements or other arrangements that could trigger a requirement for an<br />
early payment, additional collateral support, changes in terms,<br />
acceleration of maturity, or the creation of an additional financial<br />
obligation, such as adverse changes in the registrant's credit rating,<br />
financial ratios, earnings, cash flows, or stock price, or changes in the<br />
value of underlying, linked or indexed assets;
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Liquidity (cont’d)<br />
(2) Circumstances that could impair the registrant's ability to continue to<br />
engage in transactions that have been integral to historical operations or<br />
are financially or operationally essential, or that could render that activity<br />
commercially impracticable, such as the inability to maintain a specified<br />
investment grade credit rating, level of earnings, earnings per share,<br />
financial ratios, or collateral;<br />
(3) Factors specific to the company <strong>and</strong> its markets that the registrant expects<br />
to be given significant weight in the determination of the registrant's credit<br />
rating or will otherwise affect the registrant's ability to raise short-term<br />
<strong>and</strong> long-term financing;
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Liquidity (cont’d)<br />
(4) Guarantees of debt or other commitments to third parties;<br />
(5) Written options on nonfinancial assets (for example, real estate puts)<br />
(6) Material deficiencies in liquidity <strong>and</strong> any proposed remedies<br />
contemplated, e.g., (i) past due payables to trade <strong>and</strong> other creditors,<br />
negotiations with such creditors <strong>and</strong> steps contemplated to fund<br />
delinquent balances <strong>and</strong> meet ongoing trade obligations <strong>and</strong> (ii) violations<br />
of restrictive maintenance covenants in debt agreements (minimum ratios,<br />
working capital or stockholders' equity) <strong>and</strong> negotiations with lenders to<br />
cure any defaults.
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Liquidity (cont’d)<br />
(7) Cash flows from (i) investing <strong>and</strong> financing activities (e.g., debt<br />
refinancings <strong>and</strong> redemptions <strong>and</strong> financing from customers or suppliers)<br />
<strong>and</strong> (ii) operations (e.g., discretionary operating expenses such as<br />
advertising, research <strong>and</strong> development), including how operating cash<br />
flows may be affected by trends or significant events.<br />
(8) Any limitation on the ability of subsidiaries to upstream funds to the<br />
parent company in the form of cash dividends, loans or advances, or if any<br />
of the parent's debt instruments contain such restrictions, a discussion of<br />
such limitations <strong>and</strong> the expected effect on the ability of the parent to<br />
meet its cash requirements.
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Capital resources<br />
(Companies are permitted to <strong>and</strong> often do combine the discussion of liquidity <strong>and</strong><br />
capital resources whenever the two topics are interrelated. For clarity, this<br />
presentation separately addresses Capital Resources.)<br />
Item 303(a)(2) requires that MD&A describe "the company's material<br />
commitments for capital expenditures" <strong>and</strong> "the general purpose of such<br />
commitments <strong>and</strong> the anticipated source of funds needed to fulfill such<br />
commitments."<br />
Commitments in this context should be construed as planned expenditures, not<br />
simply legal obligations. The discussion should indicate any known material<br />
trends, favorable or unfavorable, in capital resources <strong>and</strong> expected material<br />
changes in the mix <strong>and</strong> relative cost of such resources, such as the mix between<br />
equity, debt, <strong>and</strong> off-balance sheet arrangements.
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Off-Balance Sheet Arrangements; Contractual<br />
Obligations <strong>and</strong> Commitments<br />
As directed by Section 401(a) of the Sarbanes-Oxley Act,<br />
the SEC amended the MD&A requirements to include<br />
specific disclosure m<strong>and</strong>ates with respect to off-balance<br />
sheet arrangements <strong>and</strong> contractual obligations <strong>and</strong><br />
commitments.
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Off-Balance Sheet Arrangements; Contractual<br />
Obligations <strong>and</strong> Commitments (cont’d)<br />
Disclosure of off-balance sheet transactions must be in a<br />
separately-captioned section of MD&A.<br />
Cross-referencing to information in the notes to the financial<br />
statements is allowed if the notes are written in a clear <strong>and</strong><br />
informative manner.<br />
Off-balance sheet arrangements should be aggregated in<br />
categories or groups in a manner that allows investors to<br />
underst<strong>and</strong> the circumstances that would have common effects<br />
with respect to a number of off-balance sheet arrangements.
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Operating results<br />
Companies are required, pursuant to Item 303(a)(3), to<br />
Describe any unusual or infrequent events or transactions . . . that<br />
materially affected the amount of reported income from continuing<br />
operations <strong>and</strong>, in each case, indicate the extent to which income<br />
was so affected; <strong>and</strong><br />
Describe any known trends or uncertainties that have had or that<br />
the company reasonably expects will have a material favorable or<br />
unfavorable impact on net sales or revenues or income from<br />
continuing operations.
MD&A Overview<br />
Elements of MD&A – In Detail<br />
Operating results (cont’d)<br />
Discussion should include a description of matters that might have<br />
an impact on future operating results even if they have not had an<br />
impact in the past, <strong>and</strong> vice versa.<br />
Discussion should include the impact of inflation, if material. In<br />
that case, management need only present its views textually; no<br />
numerical financial data is required.
MD&A Overview<br />
Item 303 of Reg. S-K:<br />
Known Trends, Dem<strong>and</strong>s, Commitments,<br />
Events or Uncertainties<br />
Distinct Three-Step Test<br />
per SEC ’89 Release<br />
Not Probability/Magnitude Assessment<br />
per Basic, Inc. v. Levinson
MD&A Overview<br />
Item 303 of Reg. S-K:<br />
Three-Step Test:<br />
1. Is management aware of any<br />
potential trend, dem<strong>and</strong>,<br />
commitment, event or uncertainty?
MD&A Overview<br />
Item 303 of Reg. S-K:<br />
Three-Step Test:<br />
1. Is there a potential trend, dem<strong>and</strong>, commitment or<br />
uncertainty?<br />
2. If so, is the potential trend,<br />
uncertainty, etc. reasonably unlikely<br />
to occur?
MD&A Overview<br />
Item 303 of Reg. S-K:<br />
Three-Step Test:<br />
1. Is there a known trend, dem<strong>and</strong>, commitment or<br />
uncertainty?<br />
2. Is the known uncertainty, etc.<br />
reasonably unlikely to occur?<br />
If unlikely to occur, no disclosure<br />
required
MD&A Overview<br />
Three-Step Test:<br />
1. Is there a potential trend, dem<strong>and</strong>, commitment or<br />
uncertainty?<br />
2. Is the known uncertainty, etc. reasonably unlikely to<br />
occur?<br />
3. Is it reasonably unlikely that the<br />
occurrence of the known uncertainty,<br />
etc. would have material effect<br />
(negative or positive) on financial<br />
condition or operating results?
MD&A Overview<br />
Three-Step Test:<br />
3. Is it reasonably unlikely that the<br />
occurrence of the known uncertainty,<br />
etc. would have material effect<br />
(negative or positive) on financial<br />
condition or operating results?<br />
If unlikely, no disclosure required
MD&A Overview<br />
When is an effect “material”?<br />
TSC v. Northway:<br />
o Is there a substantial likelihood . . .<br />
o that the . . . fact would have been<br />
viewed by the reasonable investor . . .<br />
o as having significantly altered the<br />
"total mix" of information made<br />
available.
MD&A Overview<br />
When is an effect “material”?<br />
o Reasonable investor test<br />
o No rote percentage test<br />
(i.e., “But it’s less than 5 percent of net<br />
income!”)<br />
Cf. Staff Accounting Bulletin 99<br />
(8.13.99)
MD&A Overview<br />
When is an effect “material”?<br />
o Significant to investors<br />
o No rote %<br />
SAB 99: “exclusive reliance on certain<br />
quantitative benchmarks to assess<br />
materiality in preparing financial<br />
statements <strong>and</strong> performing audits . . . is<br />
inappropriate”
MD&A Overview<br />
More about SAB 99:<br />
To illustrate that a percentage test alone is never defensible, SAB 99<br />
lists qualitative factors that could render material a quantitatively<br />
small misstatement of a financial statement item.<br />
These include:<br />
Whether the misstatement arises from an item capable of precise<br />
measurement or whether it arises from an estimate <strong>and</strong>, if so, the<br />
degree of imprecision inherent in the estimate;<br />
Whether the misstatement masks a change in earnings or other trends;<br />
Whether the misstatement hides a failure to meet analysts' consensus<br />
expectations for the enterprise;
MD&A Overview<br />
More about SAB 99 (cont’d):<br />
Whether the misstatement changes a loss into income or vice versa;<br />
Whether the misstatement concerns a segment or other portion of the<br />
registrant's business that has been identified as playing a<br />
significant role in the registrant's operations or profitability;<br />
Whether the misstatement affects the registrant's compliance with<br />
regulatory requirements;<br />
Whether the misstatement affects the registrant's compliance with loan<br />
covenants or other contractual requirements;
MD&A Overview<br />
More about SAB 99 (cont’d):<br />
Whether the misstatement has the effect of increasing management's<br />
compensation ? for example, by satisfying requirements for the<br />
award of bonuses or other forms of incentive compensation; or<br />
Whether the misstatement involves concealment of an unlawful<br />
transaction.<br />
Other factors that the SEC staff suggests be taken into account include<br />
the volatility of the stock price in response to certain types of<br />
disclosures – a possible indicator of the importance of small<br />
misstatements to investors.
MD&A Overview<br />
Cautionary Tales<br />
Or
MD&A Overview<br />
What You Say (or Choose Not to Say)<br />
Can (<strong>and</strong> Will) Be Used Against You!
MD&A Overview<br />
Cautionary Tale No. 1<br />
• 1990 SEC Enforcement Action re<br />
Bank of New Engl<strong>and</strong><br />
MD&A - Failure to Disclosure Adverse Trends in<br />
Real Estate Market <strong>and</strong> Future Loan Loss Impact<br />
SEC alleged that BNE failed to disclose certain adverse trends<br />
indicating a deterioration in the New Engl<strong>and</strong> real estate market<br />
as well as in BNE's loan portfolio that were reasonably likely to<br />
have material adverse effects on BNE's future loan loss reserve<br />
<strong>and</strong> net income in early 1990.<br />
(SEC brought a similar case against Bank of Boston based upon<br />
its 1989 loan related disclosures.)
MD&A Overview<br />
Cautionary Tale No. 2<br />
• 1992 SEC Enforcement Action re Caterpillar<br />
MD&A - Failure to Disclosure Possible Material<br />
Future Impact of Brazilian Hyperinflation <strong>and</strong><br />
Currency Exchange Issues<br />
SEC alleged that in early ‘90 (before CAT filed ‘89<br />
10-K), CAT management became aware that<br />
Brazilian subsidiary might be significantly less<br />
profitable than in ‘89 <strong>and</strong> this was likely to reduce<br />
materially CAT’s overall ‘90 operating results.
MD&A Overview<br />
Cautionary Tale No. 3<br />
• 1997 re BankAmerica Corp.<br />
Market Risk Disclosure - Disclosure of<br />
securities <strong>and</strong> derivatives trading through joint<br />
venture did not comply with Item 305 (Market<br />
Risk).<br />
SEC alleged that BAC did not disclose the<br />
market risks to which the venture exposed BAC<br />
<strong>and</strong> the potential losses arising from those risks.
MD&A Overview<br />
Cautionary Tale No. 4<br />
• 1998 Sony Corporation<br />
MD&A Disclosure (Prior to Significant<br />
Goodwill Charge) <strong>and</strong> Segment Report for<br />
Foreign Registrant<br />
SEC alleged inadequate disclosures in 6-K <strong>and</strong><br />
MD&A.<br />
SEC also questioned Sony’s “segment<br />
reporting.”
MD&A Overview<br />
Cautionary Tale No. 4 (cont’d)<br />
• 1998 Sony Corporation<br />
SEC alleged that Sony "made inadequate disclosures about the<br />
nature <strong>and</strong> extent of Sony Pictures' net losses <strong>and</strong> their impact<br />
on the consolidated results Sony was reporting."<br />
Sony selectively noted positive developments such as box<br />
office share or the success of individual motion pictures.<br />
SEC took specific issue with MD&A disclosure in Sony's<br />
Annual Report to Shareholders filed with SEC four months<br />
prior to Sony’s November 1994 write-down of approximately<br />
$2.7 billion of goodwill associated with the acquisition of its<br />
motion picture operations.
MD&A Overview<br />
Cautionary Tale No. 4 (cont’d)<br />
• 1998 Sony Corporation<br />
SEC found that Sony’s 1994 Annual Report painted a<br />
generally positive picture of the 1994 results for Sony's<br />
entertainment segment <strong>and</strong> failed to disclose that Sony<br />
Pictures had incurred its first ever operating loss <strong>and</strong> a net loss<br />
of nearly a half billion dollars.<br />
Instead, the MD&A section of that Annual Report discussed<br />
positive results achieved by Sony Pictures – box office share,<br />
Academy Award nominations <strong>and</strong> gross box office receipts –<br />
but simultaneously failed to disclose known negative results<br />
<strong>and</strong> trends in operating income before amortization, net<br />
income <strong>and</strong> operating cash flow.
MD&A Overview<br />
Cautionary Tale No. 4 (cont’d)<br />
• 1998 Sony Corporation<br />
SEC also expressed concerns over the lack of transparency<br />
concerning Sony's motion picture operations.<br />
While not citing Sony for improper accounting, the<br />
Commission specifically noted that "over the expressed<br />
preference of its outside accountants <strong>and</strong> its own U.S.-based<br />
financial officers for separate reporting of Sony's music <strong>and</strong><br />
picture businesses," Sony chose to report the combined results<br />
of these two businesses as a single "entertainment" industry<br />
segment, which resulted in the obscuring of the significant<br />
losses Sony experienced in its motion picture business.
MD&A Overview<br />
Cautionary Tales Nos. 5, 6, 7 Etc.<br />
• 2001-2002: The Corporate Sc<strong>and</strong>al Sheet
MD&A Overview<br />
• Revenue Recognition<br />
Global Crossing: Boosted its reported profits by<br />
“swapping” network capacity with another carrier<br />
Tyco: Accused of “Spring-Loading” -- Padding<br />
earnings growth by acquiring companies after<br />
making them prepay expenses <strong>and</strong> forgo new<br />
revenue<br />
Bristol-Myers Squibb: Inflated 2001 revenue by<br />
$1.5 billion by “channel stuffing” (forcing<br />
wholesalers to accept inventory to get it off the<br />
manufacturer’s books)
MD&A Overview<br />
• Off Balance Sheet <strong>Trans</strong>actions<br />
Enron: Aggressively boosted profits <strong>and</strong> hid<br />
debts totaling over $1 billion by using off-thebooks<br />
partnerships<br />
Adelphia Communications: Fraudulently<br />
excluded billions of dollars in liabilities from its<br />
consolidated financial statements by hiding them<br />
on the books of off-balance sheet affiliates
MD&A Overview<br />
• Operating Expenses vs. Capital Expenses<br />
WorldCom:<br />
• Reduced its operating expenses by improperly<br />
releasing certain reserves held against<br />
operating expenses<br />
• Improperly reduced its operating expenses by<br />
recharacterizing certain expenses as capital<br />
assets<br />
• SEC complaint against WorldCom:<br />
http://www.sec.gov/litigation/complaints/com<br />
p17829.htm
MD&A Overview<br />
Concluding observations:<br />
The MD&A requirements are intentionally flexible<br />
<strong>and</strong> general.<br />
No two companies are identical, <strong>and</strong> therefore<br />
good MD&A disclosure for one company is not<br />
necessarily good for another.<br />
The same is true for MD&A disclosure of the same<br />
registrant in different years.
MD&A Overview<br />
Concluding observations (cont’d):<br />
The Caterpillar <strong>and</strong> Sony decisions highlight SEC's<br />
emphasis on the importance of establishing internal<br />
procedures to ensure compliance with Item 303.<br />
MD&A’s accuracy depends on an effective system for<br />
gathering <strong>and</strong> disseminating information.<br />
The process of MD&A preparation should not be driven by<br />
fixed rules or static checklists, or by simply marking up last<br />
year’s MD&A disclosure.
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. in International Business Law<br />
Session 8 – July 30, 2013<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 8 Agenda<br />
Part 1<br />
Woe to be an insider of a reporting company<br />
Part 2<br />
Proxy Statement <strong>Regulation</strong><br />
Part 3<br />
<strong>Regulation</strong> of Foreign Private Issuers under <strong>Securities</strong> Act <strong>and</strong><br />
Exchange Act<br />
Part 4<br />
Comparative differences between U.S. securities law regime <strong>and</strong> that of<br />
UK, EU <strong>and</strong> Hong Kong<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5<br />
<strong>and</strong> Insider Trading Policies<br />
Limited Trading Windows for Insiders<br />
Role of 10b5-1 Trading Plans<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5<br />
<strong>and</strong> Insider Trading Policies<br />
Reason for policy<br />
Typical elements of policy<br />
Waiting period – 48 to 72 hours – after<br />
release of material information<br />
Blackout period prior to earnings release<br />
Clearance procedures<br />
Section 16 compliance<br />
Acknowledgement of policy by insiders<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rules 10b5-1<br />
Rule 10b5-1(a):<br />
“Manipulative <strong>and</strong> deceptive devices" prohibited by<br />
Section 10(b) <strong>and</strong> Rule 10b-5 include, among other<br />
things, purchase or sale of security of any issuer, on<br />
the basis of material nonpublic information about<br />
that security or issuer, in breach of duty of trust or<br />
confidence owed directly, indirectly, or derivatively,<br />
to issuer of that security or shareholders of that<br />
issuer, or to any other person who is source of<br />
material nonpublic information<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b5-1(b):<br />
Rules 10b5-1 <strong>and</strong> 10b5-2<br />
Trading is "on the basis of" material nonpublic<br />
information if<br />
the person making the purchase or sale was<br />
aware of the material nonpublic information<br />
when the person made the purchase or sale.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rules 10b5-1 <strong>and</strong> 10b5-2<br />
Rule 10b5-2:<br />
Provides a non-exclusive definition of<br />
circumstances in which a person has a duty of<br />
trust or confidence for purposes of the<br />
"misappropriation" theory of insider trading<br />
under Section 10(b) of the Act <strong>and</strong> Rule 10b-5.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b5-1 Plans<br />
Reason for plans –<br />
Rule 10b5-1 establishes affirmative defense<br />
A purchase or sale is not "on the basis of"<br />
material nonpublic information if<br />
the person making the purchase or sale<br />
demonstrates that he or she had adopted a<br />
written plan for trading securities at a time when<br />
he or she was not in possession of material nonpublic<br />
information.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
The plan must either:<br />
1. Specify<br />
Rule 10b5-1 Plans<br />
Amount of securities to be purchased or sold<br />
Price at which <strong>and</strong> date on which securities are to<br />
be purchased or sold; or<br />
2. Include a written formula or algorithm, etc.,<br />
In addition, plan must not permit insider to exercise<br />
any subsequent influence over how, when, or whether<br />
to effect purchases or sales<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Section 16<br />
Reporting <strong>and</strong> Short-Swing Liability<br />
Section 16(a): Reporting<br />
Forms 3, 4 <strong>and</strong> 5<br />
Section 16(b): Liability<br />
Strict Liability<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Section 16<br />
Reporting <strong>and</strong> Short-Swing Liability<br />
Persons covered:<br />
Directors <strong>and</strong> executive officers<br />
Function over form (i.e., title does not<br />
control)<br />
> 10% holders<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved
Section 16<br />
Reporting <strong>and</strong> Short-Swing Liability<br />
Beneficial ownership<br />
Broadly defined<br />
“Pecuniary interest” test<br />
Note: Different than beneficial ownership test<br />
for Schedule 13D/13G purposes<br />
“Presumption” of beneficial ownership of securities<br />
held by immediate family members living at home<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Section 16<br />
Reporting <strong>and</strong> Short-Swing Liability<br />
Any matching Purchase/Sale or<br />
Sale/Purchase within less than 6 months<br />
Regardless of actual inside info.<br />
Matching calculated to yield greatest<br />
profit disgorgement<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Section 16<br />
Reporting <strong>and</strong> Short-Swing Liability<br />
Status at Purchase/Sale or Sale/Purchase<br />
>10% holder – must be > 10% at each stage<br />
Directors <strong>and</strong> officers<br />
<strong>Trans</strong>action before generally not matched<br />
Post-tenure transaction are matched<br />
See Rule 16a-2(c)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Section 16<br />
Reporting <strong>and</strong> Short-Swing Liability<br />
Exemptions – Rule 16b-3<br />
Exercise of option is typically neither<br />
purchase nor sale<br />
Typically employee stock option will be<br />
structured to be exempt from Section 16<br />
liability<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Section 16<br />
Reporting <strong>and</strong> Short-Swing Liability<br />
Reporting on Form 4<br />
Post Sarbanes-Oxley, Form 4 must be filed by<br />
end of second business day after day on which<br />
transaction occurred<br />
Close coordination between company <strong>and</strong><br />
insider required<br />
Filing occurs via EDGAR<br />
Filings closely monitored by “§ 16 Bar”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Section 402 (a/k/a 13(k))<br />
Prohibited Loans<br />
Applicable to companies registered under section 12<br />
or required to file reports under section 15(d), <strong>and</strong><br />
any company that files or has filed a registration<br />
statement that has not yet become effective under the<br />
<strong>Securities</strong> Act of 1933, <strong>and</strong> that it has not withdrawn.<br />
Company may not make personal loans (including<br />
the extension of credit or the arrangement of the<br />
extension of credit) to any of its directors or<br />
executive officers, subject to very limited<br />
exceptions.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Section 402 (a/k/a 13(k))<br />
Prohibited Loans<br />
Two categories of exceptions to the general<br />
prohibition against loans to insiders:<br />
1. Loans by consumer lenders in the ordinary<br />
course of business; <strong>and</strong><br />
2. Loans by banks <strong>and</strong> thrifts that are insured by<br />
the U.S. FDIC (by rule SEC has extended this<br />
exception to apply to foreign banks).<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Section 402 (a/k/a §13(k))<br />
Prohibited Loans<br />
SEC still has not issued guidance in response to questions about<br />
whether certain arrangements between issuers <strong>and</strong> their officers may<br />
violate Section 402.<br />
For example, consider whether the following may violate<br />
Section 402:<br />
Split-dollar life insurance for a director or executive officer<br />
401(k) Plan loans (made by the plan, but “arranged” by the<br />
issuer?)<br />
(See memor<strong>and</strong>um authored by group of 25 law firms for<br />
additional background.)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Section 306 of Sarbanes Oxley<br />
Blackout Period<br />
Insider Trades During Pension Fund Blackout Periods<br />
Unlawful for any director or executive officer of an<br />
issuer of any equity security to purchase, sell, or<br />
otherwise acquire or transfer any equity security of the<br />
issuer during any blackout period with respect to<br />
such equity security if such director or officer acquires<br />
such equity security in connection with his or her<br />
service or employment as a director or executive<br />
officer.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Section 306 of Sarbanes Oxley<br />
Blackout Period (cont’d)<br />
Blackout Period Defined<br />
Any period of more than 3 consecutive business days<br />
during which the ability of not fewer than 50 percent<br />
of the participants or beneficiaries under all<br />
individual account plans maintained by the issuer<br />
to purchase, sell, or otherwise acquire or transfer an<br />
interest in any equity of such issuer held in such an<br />
individual account plan is temporarily suspended by<br />
the issuer or by a fiduciary of the plan<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 8 Agenda<br />
Part 1<br />
Woe to be an insider of a reporting company<br />
Part 2<br />
Proxy Statement <strong>Regulation</strong><br />
Part 3<br />
<strong>Regulation</strong> of Foreign Private Issuers under <strong>Securities</strong> Act <strong>and</strong><br />
Exchange Act<br />
Part 4<br />
Comparative differences between the U.S. securities law regime <strong>and</strong><br />
that of UK, EU <strong>and</strong> Hong Kong<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Proxy regulation: Mix of<br />
State law (jurisdiction of incorporation)<br />
Federal securities law<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Federal proxy regulation applies<br />
only to<br />
“§12 companies”<br />
(i.e., companies with a class of equity<br />
securities registered under §12 of the<br />
Exchange Act)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Caution regarding text on page 132 of Soderquist:<br />
Delaware law is NOT “generally silent”<br />
regarding disclosure in proxy solicitations<br />
Delaware cases have confirmed that corporations<br />
organized under Delaware law must disclose all<br />
material facts when soliciting shareholder approval,<br />
even if the corporation is not registered under §12 of<br />
the Exchange Act.<br />
See, e.g., Stroud v. Grace, Del. Supr., 606 A.2d 75, 84<br />
(1992).<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
What is the meaning of the phrase<br />
“solicitation of proxies” under Section<br />
14(a)?<br />
Are some solicitations exempt?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
“Proxy Solicitation” Broadly Defined:<br />
Any communication reasonably<br />
calculated to result in the<br />
procurement, withholding or<br />
revocation of a proxy<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Two Key Exemptions: Rule 14a-1(l)(2)(iv)<br />
1. Communication by a security holder stating how the security<br />
holder intends to vote <strong>and</strong> the reasons therefor, if the holder<br />
does not otherwise engage in proxy solicitation (other than a<br />
solicitation exempt under Rule 14a-2), <strong>and</strong> if such<br />
communication is:<br />
made by means of speeches in public forums, press<br />
releases, published or broadcast opinions, etc., or<br />
directed to persons to whom the security holder owes a<br />
fiduciary duty in connection with the voting of securities,<br />
or<br />
made in response to unsolicited requests for additional<br />
information with respect to a prior exempt communication.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
2. Rule 14a-2(b)<br />
Various exemptions, including<br />
(2) Any solicitation made otherwise than on behalf of<br />
the registrant where the total number of persons<br />
solicited is not more than ten<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved
Proxy statement as vehicle for social<br />
policy:<br />
Extensive executive compensation disclosure<br />
Exp<strong>and</strong>ed effective for proxy statements after<br />
December 15, 2006<br />
Disclosure of late Form 4s (§16 insiders)<br />
Compensation Disclosure & Analysis (“CD&A”)<br />
Audit Committee/Compensation Committee Reports<br />
Audit Committee/Compensation Committee Charters<br />
Nominating Committee Process<br />
Shareholder Access to Director Nomination (on hold)<br />
Nonbinding “Say-On-Pay”/ “Say-On-Parachute” Votes<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Who controls the proxy mechanism?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Rule 14a-8 –<br />
Security Holder Proposals<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
14a-8(c) – Grounds for exclusion:<br />
“Ordinary course of business”<br />
“Cracker Barrel” No Act<br />
Letters<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
In 2009 the Corp Fin staff indicated in Staff Legal Bulletin<br />
No. 14E that the staff will be less likely in the future to grant<br />
no-action relief to companies seeking to exclude shareholder<br />
proposals under the ordinary business exclusion in Rule 14a-<br />
8(i)(7).<br />
Instead of allowing companies to automatically exclude<br />
any proposal that would require the company to evaluate<br />
risk, the Staff will look at the underlying subject matter<br />
to determine whether or not the proposal should be<br />
allowed.<br />
Proposals relating to CEO succession planning may also<br />
be allowed.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Shareholder Access to Director Nomination<br />
Proposed June 2009<br />
SEC proposes new rules that would require, under<br />
certain circumstances, a company to include in the<br />
company’s proxy materials a shareholder’s, or group<br />
of shareholders’, nominees for director.<br />
Very controversial.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Effective in early 2011,<br />
“say-on-pay”<br />
“say-on-parachute”<br />
nonbinding votes required by Dodd-Frank<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Say-on-Pay<br />
Dodd-Frank amended the <strong>Securities</strong> Exchange Act of 1934<br />
by adding Section 14A, which requires companies to obtain a<br />
separate nonbinding (a/k/a “advisory”) shareholder vote to<br />
approve compensation of executives, as disclosed pursuant<br />
SEC proxy statement disclosure rules<br />
Section 14A also requires companies to conduct a separate<br />
shareholder advisory vote to determine how often an issuer<br />
will conduct a shareholder advisory vote on executive<br />
compensation. In 2011 “proxy season” many <strong>and</strong> perhaps<br />
most companies opted for annual “say-on-pay”<br />
disclosure.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Director Nominating Process:<br />
More robust disclosure of the nominating<br />
committee processes of public companies<br />
More specific disclosure of the processes by<br />
which security holders may communicate with<br />
the directors of the companies in which they<br />
invest<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Where are the disclosure<br />
requirements for proxy statements?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Schedule 14A<br />
Plus Annual Report (if electing<br />
directors)<br />
Form 10-K<br />
(Part III – Instruction G(3))<br />
Reg. S-K<br />
Integrated Disclosure System<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Form 10-K (Part III – Instruction G(3))<br />
Item 10. Directors, Executive Officers <strong>and</strong> Corporate<br />
Governance<br />
Item 11. Executive Compensation<br />
Item 12. Security Ownership of Certain Beneficial Owners<br />
<strong>and</strong> Management <strong>and</strong> Related Stockholder Matters<br />
Item 13. Certain Relationships <strong>and</strong> Related <strong>Trans</strong>actions,<br />
<strong>and</strong> Director Independence<br />
Item 14. Principal Accounting Fees <strong>and</strong> Services<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Form 10-K (Part III – Instruction G(3))<br />
Item 11. Executive Compensation<br />
Who are the “NEOs” (or named executive officers”)?<br />
What is the “summary compensation table”?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Named Executive Officers (NEOs)<br />
S-K Item 402(a)(3)<br />
1. All individuals serving as the registrant's principal executive officer during the last<br />
completed fiscal year ("PEO"), regardless of compensation level;<br />
2. All individuals serving as the registrant's principal financial officer during the last<br />
completed fiscal year ("PFO"), regardless of compensation level;<br />
3. Three most highly compensated executive officers other than the PEO <strong>and</strong> PFO who<br />
were serving as executive officers at the end of the last completed fiscal year; <strong>and</strong><br />
4. Up to two additional individuals for whom disclosure would have been provided<br />
pursuant to paragraph (a)(3)(iii) of this Item but for the fact that the individual was<br />
not serving as an executive officer of the registrant at the end of the last completed<br />
fiscal year.<br />
No disclosure need be provided for any executive officer, other than the PEO <strong>and</strong><br />
PFO, whose total compensation does not exceed $100,000.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Google:<br />
Summary Compensation Table<br />
http://sec.gov/Archives/edgar/data/1288776/000119312511103<br />
802/ddef14a.htm#rom154220_62<br />
General Motors:<br />
http://sec.gov/Archives/edgar/data/1467858/000119312511104<br />
797/ddef14a.htm#toc156829_33<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
“Compensation Discussion & Analysis”<br />
or<br />
CD&A<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
“Compensation Discussion & Analysis”<br />
Objectives of company’s compensation programs?<br />
What is the compensation plan designed to reward?<br />
What is each element of compensation?<br />
Why does company choose to pay each element?<br />
How does company determine amount for each element?<br />
How does each element of company’s decision regarding<br />
that element fit into company’s overall compensation<br />
objectives <strong>and</strong> affect decisions regarding other elements?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
What role do Glass Lewis, RiskMetrics <strong>and</strong> other<br />
proxy advisory firms play in proxy solicitations?<br />
Institutional voting of portfolio stocks generally is no longer in<br />
the h<strong>and</strong>s of institutional money managers, except for votes with<br />
clear economic significance (such as mergers or election<br />
contests).<br />
Instead, the vast majority of institutional investors have delegated<br />
voting decisions to a separate internal voting function or have<br />
outsourced voting decisions to third-party proxy advisory firms.<br />
Glass Lewis <strong>and</strong> RiskMetrics are the two most prominent proxy<br />
advisory firms in the United States.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Changes to exchange rules on broker non-votes<br />
A registered broker holding a customer’s shares in the<br />
name of the broker may vote on the customer’s behalf on<br />
certain routine matters (including ratification of the<br />
company’s auditors).<br />
A “broker non-vote” occurs when the broker has not<br />
received voting instructions on a matter from the<br />
customer <strong>and</strong> is barred from exercising discretionary<br />
authority to vote on the matter, which the broker<br />
indicates on the proxy.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
NYSE Rule 452 applies to stockholder meetings<br />
held on or after January 1, 2010<br />
Under the rule, brokers may vote a customer’s shares on<br />
any routine matter if the broker does not receive voting<br />
instructions at least 10 days prior to the election.<br />
However, election of directors, which was previously<br />
considered a routine matter if the election was<br />
uncontested, is no longer considered routine.<br />
Therefore, a broker is prohibited from voting a<br />
customer’s shares on uncontested director elections<br />
absent specific voting instructions from the customer.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Rule 452 applies to all brokers registered with NYSE,<br />
regardless of whether the company holding the election is a<br />
NYSE listed company<br />
The impact on director elections may be significant.<br />
Disney’s 2004 Annual Meeting: 45% of votes cast on M.<br />
Eisner’s election were “withhold” votes. Without broker<br />
discretionary voting in Mr. Eisner’s favor, 54% of the<br />
votes cast would have been “withhold” votes.<br />
Majority vote campaigns<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
What is difference between<br />
14a-2 // 14a-3, <strong>and</strong><br />
14c-2?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
How quickly can a company act<br />
following distribution of information<br />
statement?<br />
Rule 14c-2(b)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Rule 14c-2(b) –<br />
Information statement shall be sent or given at<br />
least 20 calendar days prior to the meeting date<br />
or, in the case of corporate action taken<br />
pursuant to the consents or authorizations of<br />
security holders, at least 20 calendar days prior<br />
to the earliest date on which the corporate<br />
action may be taken.<br />
60 days for “Roll-ups”<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Does a shareholder have recourse if a<br />
proxy statement is materially false or<br />
misleading?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Rule 14a-9(a) – similar to Rule 10b-5<br />
Private right of action?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
What is definition of materiality?<br />
TSC Industries, Inc. v. Northway, Inc.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Must a shareholder prove causation?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Causation: Mills v. Electric Auto-Lite<br />
proxy solicitation – not the defect in<br />
the proxy materials – must be an<br />
“essential link” in the accomplishment<br />
of the transaction<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
What are the tests?<br />
Cole (2 nd Circuit) compared to<br />
Virginia Bankshares (Supreme Court)<br />
Loss causation under §21D(b)(4)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
What degree of fault must be proved?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Scienter<br />
vs.<br />
Proxy <strong>Regulation</strong><br />
Under <strong>Securities</strong> Exchange Act<br />
Negligence<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 8 Agenda<br />
Part 1<br />
Woe to be an insider of a reporting company<br />
Part 2<br />
Proxy Statement <strong>Regulation</strong><br />
Part 3<br />
<strong>Regulation</strong> of Foreign Private Issuers under <strong>Securities</strong> Act <strong>and</strong><br />
Exchange Act<br />
Part 4<br />
Comparative differences between U.S. securities law regime <strong>and</strong> that of<br />
UK, EU <strong>and</strong> Hong Kong<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Private Issuers –<br />
<strong>Securities</strong> Act <strong>Regulation</strong><br />
Same basic principle:<br />
Unless an exemption is available,<br />
Every offer or sale of a security [in the U.S., whether<br />
by a U.S. issuer or a foreign private issuer,] must be<br />
registered with the SEC under § 5 of the <strong>Securities</strong> Act,<br />
<strong>and</strong><br />
In the registration statement (which includes the<br />
prospectus), all information material to that investment<br />
decision must be disclosed.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Private Issuers –<br />
<strong>Securities</strong> Act <strong>Regulation</strong> (cont’d)<br />
What exemptions are available?<br />
§ 4(2) <strong>and</strong> Private Placement Safe Harbors:<br />
Same exemptions, except Reg. A, which is<br />
available only for U.S. <strong>and</strong> Canadian issuers<br />
§ 4(1) <strong>and</strong> Resale Safe Harbors<br />
Reg. S, Rule 144A, Rule 144<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Private Issuers –<br />
<strong>Securities</strong> Act <strong>Regulation</strong> (cont’d)<br />
What about incidental offers/sales?<br />
Exemptions for Cross-<strong>Border</strong> Rights<br />
Offerings, Exchange Offers <strong>and</strong> Business<br />
Combinations<br />
Rules 800 et seq.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Private Issuers –<br />
<strong>Securities</strong> Act <strong>Regulation</strong> (cont’d)<br />
Rules 800-802 – General Rules<br />
1. These rules exempt only the transaction in which the issuer or other person<br />
offers or sells the securities, not for the securities themselves. <strong>Securities</strong><br />
acquired in a Rule 801 or 802 transaction may be resold in the United States<br />
only if they are registered under the Act or an exemption from registration is<br />
available.<br />
2. Unregistered offers <strong>and</strong> sales made outside the United States will not affect<br />
contemporaneous offers <strong>and</strong> sales made in compliance with §230.801 or<br />
§230.802. A transaction that complies with §230.801 or §230.802 will not<br />
be integrated with offerings exempt under other provisions of the Act, even<br />
if both transactions occur at the same time.<br />
3. The rules do not affect the applicability of the anti-fraud, civil liability or<br />
other provisions of the federal securities laws.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 801 – Cross <strong>Border</strong><br />
Rights Offerings<br />
Rights offering by a foreign private issuer is exempt from Section 5 of the <strong>Securities</strong> Act if<br />
U.S. holders hold no more than 10 percent of the outst<strong>and</strong>ing class of securities that is the<br />
subject of the rights offering, <strong>and</strong> the other conditions of Rule 801 are satisfied, including<br />
Equal treatment of U.S. <strong>and</strong> foreign holders<br />
Information<br />
Any informational documents must be filed in English with the SEC<br />
Informational documents must be provided to U.S. holders in English on a<br />
comparable basis to that provided to security holders in the home jurisdiction.<br />
Eligibility of securities. The securities offered in the rights offering are equity securities<br />
of the same class as the securities held by the offerees in the United States directly or<br />
through American Depositary Receipts.<br />
Limitation on transferability of rights. The terms of the rights prohibit transfers of the<br />
rights by U.S. holders except in accordance with Reg. S<br />
Legends on information documents<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 802 – Exchange Offers<br />
<strong>and</strong> Business Combinations<br />
Exchange offers <strong>and</strong> business combinations are exempt from Section 5 of the<br />
<strong>Securities</strong> Act if in the case of a business combination in which the securities are<br />
to be issued by a successor registrant, U.S. holders may hold no more than 10<br />
percent of the class of securities of the successor registrant, as if measured<br />
immediately after completion of the business combination, <strong>and</strong> the other<br />
conditions of Rule 802 are satisfied, including<br />
Equal treatment of U.S. <strong>and</strong> foreign holders<br />
Information<br />
Any informational documents must be filed in English with the SEC<br />
Informational documents must be provided to U.S. holders in English on a<br />
comparable basis to that provided to security holders in the home<br />
jurisdiction.<br />
Legends on disclosure documents<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Private Issuer<br />
Registration under <strong>Securities</strong> Act<br />
Forms:<br />
F-1, F-3, F-4 etc.<br />
Financial statements:<br />
U.S. GAAP<br />
IFRS<br />
Reconciliation to U.S. GAAP<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Private Issuer Registration<br />
under <strong>Securities</strong> Act (cont’d)<br />
More about financial statements:<br />
According to SEC staff comments in February 2011:<br />
Previously foreign companies would use home-country<br />
GAAP with a U.S. GAAP reconciliation.<br />
More recently, the SEC is seeing more U.S. GAAP<br />
filers in the foreign private issuer community – “a few<br />
hundred.”<br />
There are approximately 170 IFRS filers, <strong>and</strong> soon to<br />
be many more, as Canadians companies move to IFRS<br />
in 2012.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Private Issuer Registration<br />
under <strong>Securities</strong> Act (cont’d)<br />
SEC Review:<br />
Office of International Corporate Finance<br />
Every foreign private issuer is in one of<br />
Corp Fin’s industry groups.<br />
The Office also reviews foreign<br />
governmental offerings<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Private Issuers –<br />
Exchange Act <strong>Regulation</strong><br />
§ 12 Registration <strong>and</strong> Rule 12g3-2<br />
Primary exemption for any foreign private issuer<br />
maintaining a listing of the subject class of<br />
securities on one or more exchanges in one or<br />
more foreign jurisdiction,<br />
Two separate tests.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Private Issuers –<br />
Exchange Act <strong>Regulation</strong><br />
Rule 12g3-2(a)<br />
<strong>Securities</strong> of any class issued by any foreign private issuer are<br />
exempt from § 12(g) if the class has fewer than 300 holders<br />
resident in the U.S.<br />
<strong>Securities</strong> held of record by persons resident in the U.S. is<br />
determined as provided in Rule 12g5–1 except<br />
securities held of record by a broker, dealer, bank or nominee<br />
for any of them for the accounts of customers resident in the<br />
United States shall be counted as held in the United States by<br />
the number of separate accounts for which the securities are<br />
held.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Private Issuers –<br />
Exchange Act <strong>Regulation</strong><br />
Rule 12g3-2(b)<br />
Exemption available where<br />
1. 55 percent or more of trading takes place<br />
outside of the U.S. <strong>and</strong> if traded on two or more<br />
foreign exchanges, at least must have greater<br />
volume in that security than in the U.S.<br />
2. Foreign private issuer satisfies certain<br />
information requirements.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Private Issuers –<br />
Exchange Act <strong>Regulation</strong> (cont’d)<br />
Proxy Statement <strong>and</strong> Section 16 Exemptions<br />
Rule 3a12-3<br />
<strong>Securities</strong> for which the filing of registration statements<br />
on Form 18 are authorized shall be exempt from<br />
Sections 14 <strong>and</strong> 16 of the Exchange Act.<br />
<strong>Securities</strong> registered by a foreign private issuer are<br />
exempt from sections 14(a), 14(b), 14(c), 14(f) <strong>and</strong> 16<br />
of the Exchange Act.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Foreign Private Issuers –<br />
Exchange Act <strong>Regulation</strong> (cont’d)<br />
Underst<strong>and</strong>ing ADRs<br />
The stocks of most foreign companies that trade in the U.S. markets<br />
are traded as American Depositary Receipts (ADRs) issued by U.S.<br />
depositary banks.<br />
Though a U.S. bank issues the ADRs by registering the ADRs on<br />
Form F-6, the foreign private issuer is responsible for Exchange Act<br />
compliance whether or not the ADR is a “sponsored” program.<br />
Exchange traded ADRs must be registered on Form 20-F.<br />
See Pre-Residency material online.<br />
See p. 201 of Soderquist.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Underst<strong>and</strong>ing ADRs (cont’d)<br />
ADRs or ADSs?<br />
Sometimes the terms “ADR” <strong>and</strong> “ADS” (American<br />
Depositary Share) are used interchangeably.<br />
An ADR is actually the negotiable physical certificate that<br />
evidences ADSs (in much the same way a stock certificate<br />
evidences shares of stock), <strong>and</strong> an ADS is the security that<br />
represents an ownership interest in deposited securities (in<br />
much the same way a share of stock represents an ownership<br />
interest in the corporation).<br />
ADRs are the instruments actually traded in the market.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Level I ADRs<br />
Level I ADRs - Traded in the U.S. over-the-counter (OTC) market (i.e., not on an<br />
exchange).<br />
To establish a Level I sponsored ADR program, the following three principal steps<br />
are required:<br />
1) The foreign private issuer must qualify for a Rule 12g3-2(b) exemption (see<br />
above);<br />
2) The foreign private issuer enters into a deposit agreement the depositary bank<br />
<strong>and</strong> the ADR holders that detail the rights <strong>and</strong> responsibilities of each party; <strong>and</strong><br />
3) The parties file a Form F-6 with the SEC to register the ADSs under the 1933<br />
Act.<br />
The Form F-6 is signed by the depositary bank, the issuer <strong>and</strong> its directors <strong>and</strong><br />
officers. Financial statements <strong>and</strong> a description of your business are not required to<br />
be included in a Form F-6 registration statement.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Level II ADRs<br />
“Listing Facility”<br />
Level II ADR programs refer to a company listing its ADRs on a U.S.<br />
exchange.<br />
To qualify a foreign private issuer must comply with the registration <strong>and</strong><br />
reporting requirements of the Exchange Act as well the listing requirements<br />
of the relevant exchange.<br />
A foreign private issuer registers under § 12 of the Exchange Act by filing a<br />
Form 20-F. Annually the foreign private issuer updates its 20-F filing.<br />
The financial statements filed with the 20-F must either be prepared in<br />
accordance with U.S. GAAP or IFRS, or reconciled to U.S. GAAP.<br />
The financial statements must be audited in accordance with U.S. generally<br />
accepted auditing st<strong>and</strong>ards, <strong>and</strong> the auditor must comply with the U.S.<br />
st<strong>and</strong>ards for auditor independence.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Level III ADRs<br />
“Offering Facility”<br />
Level III ADR programs refer to an ADR program used in connection with the<br />
raising of capital through a public offering of securities <strong>and</strong> contemporaneous listing<br />
on a U.S. exchange.<br />
Level III ADR programs require registration of the underlying shares <strong>and</strong> ADRs<br />
under the 1933 Act. The ADRs are registered on Form F-6; the underlying shares<br />
are registered on Form F-1.<br />
The foreign private issuer must register under § 12 of the Exchange Act by filing a<br />
Form 20-F. Annually the foreign private issuer updates its Form 20-F filing. The<br />
financial statements filed with the 20-F must either be prepared in accordance with<br />
U.S. GAAP or IFRS, or reconciled to U.S. GAAP. The financial statements must be<br />
audited in accordance with U.S. generally accepted auditing st<strong>and</strong>ards, <strong>and</strong> the<br />
auditor must comply with the U.S. st<strong>and</strong>ards for auditor independence.<br />
In addition, any material information given to shareholders in the home market,<br />
must be filed with the SEC through Form 6-K. See Rules 13a-16 <strong>and</strong> 15d-16.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Form 6-K<br />
Filing required whenever the foreign private issuer:<br />
(i) makes or is required to make public pursuant to the law of the jurisdiction of its<br />
domicile or in which it is incorporated or organized, or<br />
(ii) files or is required to file with a stock exchange on which its securities are traded<br />
<strong>and</strong> which was made public by that exchange, or<br />
(iii) distributes or is required to distribute to its security holders.<br />
The information required to be furnished pursuant to (i), (ii) or (iii) above is that which is<br />
material with respect to the issuer <strong>and</strong> its subsidiaries concerning: changes in business;<br />
changes in management or control; acquisitions or dispositions of assets; bankruptcy or<br />
receivership; changes in registrant’s certifying accountants; the financial condition <strong>and</strong><br />
results of operations; material legal proceedings; changes in securities or in the security<br />
for registered securities; etc.<br />
The information <strong>and</strong> documents furnished in this report shall not be deemed to be “filed”<br />
for the purposes of Section 18 of the Act or otherwise subject to the liabilities of that<br />
section.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 8 Agenda<br />
Part 1<br />
Woe to be an insider of a reporting company<br />
Part 2<br />
Proxy Statement <strong>Regulation</strong><br />
Part 3<br />
<strong>Regulation</strong> of Foreign Private Issuers under <strong>Securities</strong> Act <strong>and</strong><br />
Exchange Act<br />
Part 4<br />
Comparative differences between U.S. securities law regime <strong>and</strong><br />
that of UK, EU <strong>and</strong> Hong Kong<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Comparative Review<br />
U.S., U.K., EU & Hong Kong<br />
TO BE ADDED<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. - International Business Law<br />
July/August 2013<br />
Michael Krebs<br />
JD, Boston University School of Law 1985<br />
Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />
Tel. 616.439.2288 email: mkrebs@nutter.com<br />
© 2013 Michael K. Krebs<br />
All Rights Reserved
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. in International Business Law<br />
Session 9 – July 31, 2013<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 9 Agenda<br />
Part 1<br />
Mergers <strong>and</strong> Acquisitions under the<br />
Exchange Act, including:<br />
Schedules 13D <strong>and</strong> 13G<br />
Tender Offers<br />
Going Private <strong>Trans</strong>actions<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 9 Agenda<br />
Part 2<br />
Rule 10b-5 Litigation<br />
Insider Trading Liability<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act<br />
<strong>Securities</strong> Act vs. Exchange Act<br />
<strong>Securities</strong> Act: only business combinations<br />
that involve issuance of securities<br />
Exchange Act: most business combinations<br />
involving publicly traded companies, including<br />
Tender or Exchange Offers<br />
Mergers<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
<strong>Regulation</strong> of Public Company Mergers<br />
Stockholder approval<br />
Section 14<br />
Schedule 14A, Item 14<br />
Cash deals v. stock deals<br />
<strong>Regulation</strong> M-A <strong>and</strong> Form S-4<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
<strong>Regulation</strong> of Public Company Mergers<br />
Registration Statement on Form S-4<br />
Disclosure Issues<br />
S-1 Level Disclosure v. S-3 Level Disclosure<br />
SEC Review<br />
Timing Issues<br />
Prospectus Delivery<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
<strong>Regulation</strong> of Public Company Mergers<br />
Shelf Registration<br />
Rule 415<br />
Must be S-3 eligible<br />
Acquisition does not require pro forma<br />
financial information<br />
Duty to update prospectus<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
S-4 Merger Proxy Statement<br />
S-4 for acquiror<br />
Proxy Statement for target <strong>and</strong>/or acquiror<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
Example: Proposed Acquisition of Pennichuck<br />
Philadelphia Suburban Corporation, a<br />
publicly traded water utility, enters into a<br />
definitive agreement to acquire Pennichuck<br />
Corporation, another publicly traded water<br />
utility, in exchange for PSC stock<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
Philadelphia Suburban <strong>and</strong> Pennichuck<br />
execute Merger Agreement<br />
Merger Agreement provides that<br />
Pennichuck will merge into a newly<br />
formed subsidiary of Philadelphia<br />
Suburban, subject to approval of<br />
Pennichuck shareholders <strong>and</strong><br />
satisfaction of customary closing<br />
conditions<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
As a result of the merger, all Pennichuck shares will be<br />
converted into shares of Philadelphia Suburban stock<br />
Philadelphia Suburban agrees to register shares with the<br />
SEC<br />
Pennichuck agrees to seek shareholder approval<br />
What SEC filing will Pennichuck need to make in<br />
order to solicit shareholder approval of the merger?<br />
What SEC filing will Philadelphia Suburban need to<br />
make in order to offer <strong>and</strong> sell its securities to<br />
Pennichuck shareholders?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
Philadelphia Suburban <strong>and</strong> Pennichuck file with<br />
SEC joint Form S-4 Merger Proxy Statement<br />
Level of disclosure: S-3 for Philadelphia<br />
Suburban<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
Creeping Acquisitions, Tender Offers <strong>and</strong><br />
Exchange Offers<br />
Williams Act (1968) amends Exchange Act to close loop holes for open<br />
market purchases <strong>and</strong> tender offers<br />
Section 13(d): Acquisition of more than 5% beneficial ownership<br />
Schedule 13D – provides signal to market <strong>and</strong> issuer<br />
Short Form Schedule 13G – Institutional <strong>and</strong> other passive<br />
investors (until ownership equals or exceeds 20%)<br />
Beneficial Ownership – direct or indirect voting <strong>and</strong>/or<br />
investment power<br />
Section 13(d) “Group” – group for purposes of acquiring,<br />
holding or disposing issuer’s securities<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
Example: Management Buy-Out of Uno<br />
Restaurant Company (UNO)<br />
Aaron Spencer, majority stockholder of Uno,<br />
<strong>and</strong> management team acquire Uno for cash<br />
through the merger of Uno into a new<br />
corporation owned by Spencer <strong>and</strong><br />
management team<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
Aaron Spencer expresses interest in acquiring Uno from public<br />
shareholders, <strong>and</strong> Board of Uno forms Special Committee to consider<br />
offer <strong>and</strong> seek valuation of Uno<br />
Special Committee negotiates <strong>and</strong> enters into Merger Agreement with<br />
Spencer<br />
Merger Agreement provides that (contingent upon approval of a<br />
majority of the minority shareholders of Uno <strong>and</strong> satisfaction of<br />
conditions to closing, including financing) Uno will merge into a new<br />
corporation owned by Spencer <strong>and</strong> management team<br />
Minority Uno shareholders will receive cash in exchange for<br />
cancellation of Uno common stock<br />
Uno agrees to seek shareholder approval <strong>and</strong> files Merger Proxy<br />
Statement with SEC<br />
Uno, Spencer <strong>and</strong> management team file Schedule 13E-3 with SEC<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
UNITED STATES<br />
SECURITIES AND EXCHANGE COMMISSION<br />
Washington, D.C. 20549<br />
SCHEDULE 13D<br />
Under the <strong>Securities</strong> Exchange Act of 1934*<br />
(Amendment No. 6)<br />
Uno Restaurant Corporation<br />
(Name of Issuer)<br />
Common Stock, par value $.01 per share<br />
(Title of Class of <strong>Securities</strong>)<br />
914900-10-5<br />
(CUSIP Number)<br />
Constantine Alex<strong>and</strong>er, Esquire<br />
James E. Dawson, Esquire<br />
Nutter, McClennen & Fish, LLP<br />
One International Place<br />
Boston, MA 02110-2699<br />
(617) 439-2000<br />
(Name, Address <strong>and</strong> Telephone Number of Person Authorized to Receive Notices <strong>and</strong> Communications)<br />
February 28, 2001<br />
(Date of Event which Requires Filing of this Statement)<br />
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the<br />
subject of this Schedule 13D, <strong>and</strong> is filing this schedule because of §§ 240.13d-1(b)(e), 240.13d-1(f) or<br />
240.13d-1(g), check the following box. G<br />
NOTE: Schedules filed in paper format shall include a signed original <strong>and</strong> five copies of the schedule,<br />
including all exhibits. See § 240.13d-7(b) for other parties to whom copies are to be sent.<br />
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with<br />
respect to the subject class of securities, <strong>and</strong> for any subsequent amendment containing information which<br />
would alter disclosures provided in a prior cover page.<br />
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose<br />
of Section 18 of the <strong>Securities</strong> Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that<br />
section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Item 4. Purpose of <strong>Trans</strong>action.<br />
On October 25, 2000, the Reporting Persons submitted to a<br />
Special Committee of the Issuer’s Board of Directors a proposal to<br />
acquire all of the outst<strong>and</strong>ing shares of Common Stock currently not<br />
held by them. During the period from October 25, 2000 to February<br />
28, 2001, the Special Committee <strong>and</strong> the Reporting Persons <strong>and</strong> their<br />
respective advisors negotiated terms of a going private transaction for<br />
the Issuer by the Reporting Persons. On February 28, 2001, the Issuer<br />
announced that the Special Committee <strong>and</strong> the Reporting Persons<br />
reached a tentative agreement on the terms of the going private<br />
transaction at a price of $9.75 in cash for all shares of Common Stock<br />
not held by the Reporting Persons. The transaction will proceed as a<br />
merger <strong>and</strong> will be subject to execution of a definitive merger<br />
agreement, approval by the holders of a majority of the shares not<br />
owned or controlled by the Reporting Persons, receipt of financing <strong>and</strong><br />
customary closing conditions. The transaction has a value of<br />
approximately $41 million to the stockholders other than the Reporting<br />
Persons. The Reporting Persons beneficially own approximately 62%<br />
of the Issuer’s outst<strong>and</strong>ing shares of capital stock. The Reporting<br />
Persons have engaged the investment banking firm of Tucker Anthony<br />
to act as financial advisor in connection with the transaction.
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
<strong>Regulation</strong> of Tender Offers:<br />
Not Defined in Williams Act<br />
SEC generally applies 8 factor test:<br />
1. Broad solicitation of public shareholders<br />
2. Solicitation of substantial or controlling interest<br />
3. Terms are firm rather than negotiable<br />
4. Offer price provides premium to market price<br />
5. Offer contingent on tender of min. number of shares<br />
6. Solicitation provides deadline for tendering<br />
7. Offerees are subject to pressure to tender<br />
8. Solicitation is announced to the public<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
<strong>Regulation</strong> of Tender Offers<br />
Tender Offer v. Exchange Offer<br />
Exchange Offer is a form of tender<br />
offer in which the type of consideration<br />
offered by bidder is securities rather<br />
than cash<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
<strong>Regulation</strong> of Tender Offers<br />
REGULATION 14D v. REGULATION 14E<br />
Section 14(d): filing <strong>and</strong> disclosure<br />
requirements for tender offers for equity<br />
securities registered under Section 12 of<br />
the Exchange Act<br />
Section 14(e): anti-fraud provisions that<br />
apply to all tender offers<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
<strong>Regulation</strong> of Tender Offers<br />
Section 14(d)(1) prohibits tender offer for<br />
equity securities registered under Section 12<br />
If after tender offer, person would be direct or<br />
indirect beneficial owner of more than 5% of equity<br />
securities<br />
Unless at the time of offer person has filed<br />
statement with SEC in accordance with SEC rules<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
<strong>Regulation</strong> of Tender Offers<br />
Schedule TO – Tender Offer Statement<br />
Offer to Purchase vs. Schedule TO<br />
Dissemination requirement<br />
No SEC review prior to mailing<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
Schedule TO incorporates requirements from Reg. M-A<br />
Summary terms sheet (Item 1001 of Reg M-A)<br />
Subject company information (Item 1002 of Reg M-A)<br />
Background about target <strong>and</strong> bidder (Item 1003 of Reg M-A)<br />
Terms of the transaction (Item 1004 of Reg M-A)<br />
Past contacts, transactions, negotiations <strong>and</strong> agreements (Item 1005<br />
of Reg M-A)<br />
Purpose of the transaction <strong>and</strong> plans or proposals (Item 1006 of Reg<br />
M-A)<br />
Sources <strong>and</strong> amount of funds (Item 1007 of Reg M-A)<br />
Interests in subject company securities (Item 1008 of Reg M-A)<br />
Persons retained or compensated (Item 1009 of Reg M-A)<br />
Financial Statements (Item 1010 of Reg M-A)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
<strong>Regulation</strong> of Tender Offers<br />
Material Changes <strong>and</strong> Extension of Offer<br />
Withdrawal Rights<br />
Pro Rata Purchase of Shares<br />
Equal Treatment of Stockholders<br />
Subsequent Offering Period<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
<strong>Regulation</strong> of Tender Offers<br />
Recommendation of Target Company<br />
Rule 14D-9: applies to recommendations by<br />
directors, officers, affiliates <strong>and</strong> subsidiaries<br />
Rule 14e-2: requires target to take a position<br />
within 10 business days<br />
“Stop, look <strong>and</strong> listen” press release<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
Example: Chartwell Acquisition of Carey<br />
International<br />
Chartwell Investments, a private equity<br />
firm, <strong>and</strong> senior management of Carey<br />
International acquire Carey International<br />
through a cash tender offer made to holders<br />
of publicly traded shares<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
Chartwell <strong>and</strong> Carey International Management propose<br />
cash tender offer for all of the outst<strong>and</strong>ing stock of Carey<br />
to Special Committee of Board of Carey<br />
Tender offer is not hostile -- Chartwell chooses to<br />
negotiate tender offer terms with Special Committee<br />
Carey <strong>and</strong> Chartwell enter into acquisition agreement in<br />
which Chartwell agrees to make tender offer at fixed price<br />
<strong>and</strong> Carey agrees to recommend that shareholders<br />
accept tender offer<br />
Bidders <strong>and</strong> Carey put out “stop look <strong>and</strong> listen” press<br />
release regarding agreement<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
CAREY INTERNATIONAL TO BE ACQUIRED BY AN<br />
AFFILIATE OF CHARTWELL AND FORD FOR $18.25 PER SHARE<br />
Washington, D.C. – July 19, 2000 – Carey International, Inc. (Nasdaq:CARY), the world’s<br />
largest chauffeured vehicle services company, announced today that it has entered into a definitive<br />
agreement <strong>and</strong> plan of merger with an entity affiliated with both Chartwell Investments II, LLC, a New<br />
York private-equity firm, <strong>and</strong> Ford Motor Company. The Company’s Board of Directors, with a<br />
recommendation of a special committee comprised of outside directors, unanimously approved the<br />
transaction that provides for the acquisition of all outst<strong>and</strong>ing shares of Carey International stock for<br />
$18.25 per share in cash.<br />
The transaction is structured as a joint tender offer, that will commence within approximately<br />
two weeks, followed by a merger. Consummation of the transaction is subject to certain conditions,<br />
including the tender of at least 50.1 percent of the Company’s outst<strong>and</strong>ing shares <strong>and</strong> the satisfaction of<br />
customary conditions. The Company expects that the transaction will be consummated by the end of<br />
August. Of the $300 million in total financing that will be required to fund the transaction, $100<br />
million will be in equity.<br />
***<br />
This press release is intended for informational purposes only <strong>and</strong> is not an offer to buy or<br />
the solicitation of an offer to sell any shares of Carey International common stock. The<br />
solicitation of offers to sell Carey International’s common stock will only be made pursuant to the<br />
offer to purchase <strong>and</strong> related materials that will be sent out to Carey International’s stockholders<br />
shortly. Stockholders should read those materials carefully because they will contain important<br />
information, including the various terms <strong>and</strong> conditions of the offer. The tender offer documents<br />
(including the offer to purchase, the related letter of transmittal <strong>and</strong> all other offer documents to<br />
be filed with the <strong>Securities</strong> <strong>and</strong> Exchange Commission) will also be available for free at the<br />
Commission’s Web site at www.sec.gov.
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
Reasons for Tender Offer v. Merger<br />
Carey <strong>Trans</strong>action<br />
compared to<br />
Uno <strong>Trans</strong>action<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
<strong>Regulation</strong> of Tender Offers<br />
<strong>Regulation</strong> 14E: Unlawful Tender Offer Practices<br />
Minimum offer period of 20 days <strong>and</strong> 10 days after material<br />
change<br />
Public notice of extension of tender offer<br />
Purchase of securities on the basis of nonpublic information<br />
about tender offer prohibited<br />
Prohibits short tendering <strong>and</strong> hedging tenders<br />
Prohibits purchases outside of tender offer<br />
Prohibits announcement of offer without intent to commence<br />
Recall Rule 14e-2 – position of target<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
<strong>Regulation</strong> of Issuer Tender Offers<br />
Issuer Tender Offers<br />
Rule 13e-4 <strong>Trans</strong>action<br />
Disclosure requirements are similar to third party<br />
tender offers<br />
Going Private <strong>Trans</strong>actions<br />
Rule 13e-3 <strong>Trans</strong>action<br />
Schedule 13E-3: statement re: fairness of transaction<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 13E-4 <strong>Trans</strong>action: Option<br />
Exchange – Microsoft Experience<br />
In October 2003, Microsoft proposed to establish a stock<br />
option transfer program for compensatory purposes to<br />
enable Microsoft employees to realize some value for their<br />
"out of the money" employee stock options.<br />
"Eligible Options" are options that were granted under<br />
certain Microsoft compensatory benefit plans for<br />
employees, had an exercise price per share ≥ $33.00 <strong>and</strong><br />
had an expiration date on or after February 29, 2004.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 13E-4 <strong>Trans</strong>action: Option Exchange<br />
– Microsoft Experience (cont’d)<br />
In requesting a no-action letter from Corp Fin,<br />
Microsoft conceded that the program is subject to<br />
those rules relating to issuer tender offers under Rule<br />
13e-4.<br />
Microsoft argued that its program was very similar to<br />
those previously addressed by the Corp Fin in the<br />
context of employee stock option exchange offers<br />
<strong>and</strong> issuer share repurchase programs for<br />
employee-owned stock.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 13E-4 <strong>Trans</strong>action: Option Exchange<br />
– Microsoft Experience (cont’d)<br />
One of the tender offer issues presented by the Microsoft<br />
program was compliance with the “all holders” requirement<br />
of Rule 13e-4(f)(8)(i), because the Program excludes (i)<br />
options issued under non-qualifying option plans, options with<br />
exercise prices < $33.00 <strong>and</strong> options with expiration dates<br />
earlier than February 29, 2004, (ii) options held by certain<br />
employees who do not meet continued employment criteria,<br />
(iii) options held by persons other than employees, including<br />
directors, advisors <strong>and</strong> consultants of Microsoft <strong>and</strong> (iv)<br />
options held by employees who are employed in certain foreign<br />
jurisdictions.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 13E-4 <strong>Trans</strong>action: Option Exchange<br />
– Microsoft Experience (cont’d)<br />
The SEC granted an exemption from Rule 13e-<br />
4(f)(8)(i) to permit Microsoft to exclude certain<br />
options <strong>and</strong> certain option holders.<br />
* * *<br />
Be mindful of complicated tender offer<br />
compliance issues with option repurchases <strong>and</strong><br />
exchange offers<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
Rule 13E-3 <strong>Trans</strong>action:<br />
Key factors:<br />
Triggering <strong>Trans</strong>action<br />
Triggering Effect<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
Rule 13E-3 Triggering <strong>Trans</strong>actions:<br />
purchase of security,<br />
tender offer,<br />
shareholder solicitation,<br />
sale of substantially all of assets,<br />
reverse stock split<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
Rule 13E-3 Triggering Effect:<br />
Causes fewer than 300 record<br />
shareholders<br />
Causes delisting from an exchange (i.e.,<br />
NYSE, NASDAQ)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
Example: Carey Tender Offer Cont’d<br />
Carey, Chartwell, Management <strong>and</strong> Financing Sources all<br />
considered “Bidders”<br />
Bidders file Schedule TO <strong>and</strong> mail Offer to Purchase to<br />
stockholders<br />
Bidders file Schedule 13E-3<br />
Carey files Schedule 14D-9<br />
Shareholders tender shares in excess of 90% of outst<strong>and</strong>ing<br />
Bidders close tender offer <strong>and</strong> shareholders receive cash for<br />
shares tendered<br />
Carey’s common stock ceases to be traded on NASDAQ<br />
Carey merges into new corporation owned by Bidders<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Mergers <strong>and</strong> Acquisitions under<br />
Exchange Act (cont’d)<br />
Other Rule 13E-4 Considerations:<br />
“Best Price Rule” <strong>and</strong> Management Group<br />
Participation<br />
In 2006 the SEC amended the issuer <strong>and</strong> third-party best-price<br />
rules so that consideration offered <strong>and</strong> paid pursuant to<br />
employment compensation, severance or other employee<br />
benefit arrangements that are entered into with security holders<br />
of the subject company <strong>and</strong> that meet certain substantive<br />
requirements are not prohibited by the best-price rules<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Schedule 13D<br />
Treatment of Derivatives<br />
Under Rule 13d-3(d)(1)(i), beneficial ownership exists<br />
when a derivative gives a person (i) voting or<br />
investment power over the underlying security or (ii)<br />
the right to acquire the underlying security within 60<br />
days or the person holds such right to acquire with the<br />
purpose of changing or influencing control.<br />
Additionally, under anti-evasion prong included in<br />
Rule 13d-3(b), beneficial ownership is deemed to exist<br />
if a derivative is used as part of a plan or scheme to<br />
evade beneficial ownership reporting requirements.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Schedule 13D<br />
Treatment of Derivatives (cont’d)<br />
The SEC, in a broad-ranging “Concept Release”<br />
issued in July 2010, acknowledged that its staff is<br />
in the process of reviewing current disclosure<br />
requirements relating to holdings of financial<br />
instruments, including short sale positions <strong>and</strong><br />
derivatives positions often utilized by activist<br />
investors to magnify their economic return.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Schedule 13D<br />
Recent Developments<br />
1. Beware of “boilerplate” disclosure<br />
Tracinda, an investment fund controlled by Kirk Kerkorian, owned 9.9%<br />
of GM stock prior to its bankruptcy.<br />
Tracinda owned ~ 28.0 million shares but it could sell only 14.0 million<br />
at the price it wanted.<br />
In its 13D amendment for the sale of the 14.0 million shares, Tracinda<br />
included boilerplate disclosure that said, "We may sell additional shares,<br />
but we may also acquire additional shares." The SEC took the position,<br />
upon its investigation, that there was enough evidence to say, "No, you<br />
had a plan to sell all your shares. It was highly unlikely you would<br />
have acquired additional shares. So that disclosure wasn't good<br />
enough. You should have fully disclosed that your intent <strong>and</strong> your<br />
plan were to sell all of your holdings."<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Schedule 13D<br />
Recent Developments (cont’d)<br />
2. Can 13D disclosures go too far <strong>and</strong> constitute a proxy<br />
solicitation necessitating the filing of proxy materials?<br />
Yes. The analysis is whether the information was included<br />
only to comply with Schedule 13D disclosure rules. Of<br />
course, if it is a solicitation, you have to look at whether you<br />
have an exemption for the proxy rules.<br />
In recent years investors who are hesitant to be active but<br />
want to get their point across have used 13D as the<br />
megaphone.<br />
When the 13D starts sounding like a pitch in a sales piece, it<br />
starts sounding like a solicitation.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Schedule 13D<br />
Recent Developments (cont’d)<br />
3. When does an affiliated person (thinking of taking a<br />
company private) need to amend their 13D?<br />
When buying shares in the open market?<br />
When retaining an investment banker to explore the<br />
possibility of taking the company private?<br />
When lining up financing for the potential transaction?<br />
When discussing with the board the possibility of taking<br />
the company private?<br />
Or only subsequently when they have actually<br />
"determined" to take the company private?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Schedule 13D<br />
Recent Developments (cont’d)<br />
3. When does an affiliated person (thinking of taking a<br />
company private) need to amend their 13D? (cont’d)<br />
The Staff's interpretation says that a security holder is<br />
required to promptly amend its 13D to disclose the material<br />
change in the information appearing when it has<br />
“determined” to pursue a plan that would or could<br />
result in a delisting or deregistration of this company's<br />
securities.<br />
The SEC’s Office of Mergers <strong>and</strong> Acquisitions focuses on<br />
the word "determine." When does that person determine to<br />
do something?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Schedule 13D<br />
Recent Developments (cont’d)<br />
4. Is there a “private right of action” for damages<br />
for a material false or misleading 13D or 13G<br />
filing?<br />
Section 13(d) does not explicitly provide a private<br />
right of action.<br />
Courts of Appeals have found an implied private<br />
right of action for both issuers <strong>and</strong> shareholders to<br />
bring claims for injunctive relief.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Schedule 13D<br />
Recent Developments (cont’d)<br />
4. Is there a “private right of action” for damages for a<br />
material false or misleading 13D or 13G filing? (cont’d)<br />
2 nd Circuit has ruled that Section 13(d) also permits a tender<br />
offeror to bring a claim for injunctive relief. The court reasoned<br />
that there is no principled basis not to support a private right of<br />
action for tender offerors seeking solely injunctive relief while<br />
finding that shareholders <strong>and</strong> the issuer have such st<strong>and</strong>ing.<br />
No federal court has granted a private right of action for a<br />
damage claim. However, a Delaware state court judge has<br />
permitted a state law fraud claim based upon materially false or<br />
misleading 13Ds <strong>and</strong> 13Gs.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 9 Agenda<br />
Part 2<br />
Rule 10b-5 Litigation<br />
Insider Trading Liability<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5 <strong>and</strong> Related Matters<br />
Basic elements:<br />
False or misleading statement with<br />
respect to a material fact<br />
TSC Industries v. Northway<br />
“In connection with” the purchase or<br />
sale of a security<br />
includes “fraud on the market”<br />
“Scienter” – Culpability<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5 <strong>and</strong> Related Matters<br />
Basic elements (cont’d):<br />
“Recklessness”<br />
Conduct that is "highly unreasonable,<br />
representing an extreme departure<br />
from the st<strong>and</strong>ards of ordinary care.”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5 <strong>and</strong> Related Matters<br />
Primarily five scenarios:<br />
misleading statement<br />
silence when duty to disclose<br />
insider trading<br />
selective disclosure – “tipping”<br />
inappropriate behavior “in connection<br />
with” sale of securities<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5 <strong>and</strong> Related Matters<br />
Private Right of Action<br />
Kardon v. National Gypsum<br />
Section 21D – heightened pleading<br />
Private Litigation Reform Act of<br />
1995<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5 <strong>and</strong> Related Matters<br />
Liability for misleading statements<br />
Texas Gulf Sulfur<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5 <strong>and</strong> Related Matters<br />
Insider trading<br />
Not “anyone in possession of<br />
material non-public information”<br />
Scope of liability for tippees<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: Basic Elements<br />
False or misleading statement with<br />
respect to a material fact<br />
“In connection with” purchase or<br />
sale of security<br />
Reliance<br />
Loss causation<br />
“Scienter”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “In connection with . . .”<br />
If claim is based upon public statement,<br />
plaintiff must prove that the statement was<br />
material; <strong>and</strong><br />
disseminated in a medium upon which<br />
an investor would presumably rely.<br />
It is irrelevant that statement was not<br />
intended to influence the securities market.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “In connection with . . .”<br />
What if claim is NOT based upon<br />
public statement?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “In connection with . . .”<br />
Superintendent of Insurance (S. Ct. 1971):<br />
10b-5 claim found to be “in connection<br />
with . . .” where issuer of bonds suffered<br />
financial harm as a result of deceptive<br />
practices having a nexus with or<br />
“touching” its sale of bonds to investors<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “In connection with . . .”<br />
Zanford (S. Ct. 2002):<br />
Broker sells securities <strong>and</strong> steals proceeds.<br />
Court finds 10b-5 claim because “it is enough<br />
that scheme to defraud <strong>and</strong> sale of securities<br />
coincide.”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “In connection with . . .”<br />
Ketchum (3 rd Cir. 1977):<br />
Court found dispute was an internal corporate<br />
conflict, not securities fraud, even though a<br />
consequence of the allegedly wrongful conduct<br />
was that plaintiff was required to sell stock under<br />
a pre-existing stockholder agreement.<br />
The real purpose of the internal maneuvers was<br />
to remove plaintiffs as officers <strong>and</strong> employees.<br />
Sale of stock triggered by removal was incidental.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “In connection with . . .”<br />
Santa Fe (S. Ct. 1977):<br />
Short-form merger under Delaware law (i.e.,<br />
cash out merger without shareholder vote)<br />
Court ruled that no 10b-5 claim exists if<br />
allegation is based solely upon a claim involving<br />
breach of a fiduciary duty under state corporate<br />
law that does not involve shareholder action in<br />
reliance upon a on material misrepresentation or<br />
material omission.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “In connection with . . .”<br />
Brown (5 th Cir. 1981):<br />
Allegation that defendants fraudulently induced plaintiff<br />
to enter into 1979 agreement that required plaintiff to sell<br />
stock to corporation if plaintiff were no longer employed<br />
by corporation<br />
Defendants misrepresented reason for new agreement<br />
<strong>and</strong> intent to terminate plaintiff<br />
Court concluded that 10b-5 claim existed because sale of<br />
security (pursuant to the new agreement) was “in<br />
connection with” the fraudulent inducement<br />
Compare with Ketchum<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Compare:<br />
Rule 10b-5: “Reliance . . .”<br />
Failure to Disclose<br />
Fraud on the Market<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “Reliance . . .”<br />
“Failure to Disclose”<br />
Reliance not required<br />
Plaintiff must show<br />
Obligation to disclose<br />
Withholding of material fact<br />
Rule 10b-5 liability may exist whether<br />
counterparty to purchase or sale is known<br />
(Affiliate Ute) or anonymous (Shapiro)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “Reliance . . .”<br />
“Fraud on the Market”<br />
Purchaser of stock on market is<br />
presumed to rely generally on valid<br />
market price <strong>and</strong> indirectly on all<br />
material representations made by a<br />
company, including those in its SEC<br />
filings<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “Reliance . . .”<br />
“Fraud on the Market”<br />
Basic v. Levinson (S. Ct. 1988)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “Reliance . . .”<br />
“Fraud on the Market”<br />
Basic v. Levinson (S. Ct. 1988)<br />
"The fraud on the market theory is based on the hypothesis<br />
that, in an open <strong>and</strong> developed securities market, the price of a<br />
company's stock is determined by the available material<br />
information regarding the company <strong>and</strong> its business. . . .<br />
Misleading statements will therefore defraud purchasers of<br />
stock even if the purchasers do not directly rely on the<br />
misstatements. . . . The causal connection between the<br />
defendants' fraud <strong>and</strong> the plaintiffs' purchase of stock in such<br />
a case is no less significant than in a case of direct reliance on<br />
misrepresentations."<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “Reliance . . .”<br />
“Fraud on the Market”<br />
Basic v. Levinson (S. Ct. 1988) (cont’d)<br />
An investor's reliance on any public material<br />
misrepresentations may be presumed for<br />
purposes of a Rule 10b-5 action, because most<br />
publicly available information is reflected in<br />
market price.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “Reliance . . .”<br />
“Fraud on the Market”<br />
Basic v. Levinson (S. Ct. 1988) (cont’d)<br />
Any showing that severs the link between the alleged misrepresentation <strong>and</strong><br />
either the price received (or paid) by the plaintiff, or his decision to trade at a<br />
fair market price, will be sufficient to rebut the presumption of reliance.<br />
For example, the causal connection could be broken in Basic:<br />
if petitioners could show that the "market makers" were privy to the<br />
truth about the merger discussions here with Combustion, <strong>and</strong> thus that<br />
the market price would not have been affected by their<br />
misrepresentation; or<br />
if news of the merger discussions credibly entered the market <strong>and</strong><br />
dissipated the effects of the misstatements.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “Loss Causation . . .”<br />
“Loss Causation” - Section 21D(b)(4)<br />
In any private action arising under this title,<br />
plaintiff shall have the burden of proving<br />
that the act or omission of defendant<br />
alleged to violate this title caused the loss for<br />
which the plaintiff seeks to recover<br />
damages.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
“Loss Causation . . .” (cont’d)<br />
Reliance <strong>and</strong> loss causation are wholly independent<br />
elements of a Section 10(b) claim.<br />
Fraud-on-the-market theory of reliance focuses on material<br />
misrepresentations that permeate an efficient market <strong>and</strong><br />
thereby affect all purchasers <strong>and</strong> sellers.<br />
“Loss causation, by contrast, requires a plaintiff to show<br />
that a misrepresentation that affected the integrity of the<br />
market price also caused a subsequent economic loss.”<br />
Erica P. John Fund, Inc. v. Halliburton Co., 131 S. Ct. 2179<br />
(2011)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “Purchaser/Seller . . .”<br />
General principle:<br />
Private plaintiff must be<br />
Purchaser or Seller<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “Purchaser/Seller . . .”<br />
Blue Chip Stamps (S. Ct. 1975):<br />
Plaintiff alleged that defendant had intentionally caused<br />
prospectus to include material statements that were<br />
overly pessimistic about company’s prospects, because<br />
defendant wanted to discourage purchase of stock that<br />
defendant was required to offer as part of a settlement.<br />
Plaintiff did not purchase stock. S. Ct. ruled: without a<br />
purchase (or sale), there is no 10b-5 claim!<br />
Very important principle, though very uncommon facts.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “Purchaser/Seller . . .”<br />
Rubin v. U.S. (S. Ct. 1981):<br />
A pledge of stock constitutes a sale for purposes of 10b-5<br />
Pledgor is seller.<br />
Pledgee is purchaser<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “Scienter or Fault”<br />
Hochfelder (S. Ct. 1976) <strong>and</strong> subsequent<br />
cases:<br />
Mere negligence is not enough<br />
Must prove intent (or recklessness??)<br />
Even SEC must show intent or recklessness<br />
Case law affected by subsequent statutory<br />
changes<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: “Scienter or Fault”<br />
Statutory Developments:<br />
Private <strong>Securities</strong> Litigation Reform Act of 1995<br />
(“PSLRA”)<br />
Plaintiff’s complaint must state “with<br />
particularity facts giving rise to a strong<br />
inference” that defendant acted with intent or<br />
recklessness (Section 21D(b)(2) of Exchange Act)<br />
<strong>Securities</strong> Litigation St<strong>and</strong>ards Act of 1998<br />
Class actions involving publicly traded<br />
companies must be brought in federal court<br />
(Section 28(f) of Exchange Act)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: Recklessness?<br />
Post-PSLRA – Cases Split<br />
Supreme Court has not definitively addressed after the<br />
adoption of the PSLRA.<br />
2 nd Circuit – Plaintiff may plead scienter by alleging facts<br />
showing conscious misbehavior or recklessness – a<br />
st<strong>and</strong>ard requiring, “at the least, conduct which is highly<br />
unreasonable <strong>and</strong> which represents an extreme departure<br />
from the st<strong>and</strong>ards of ordinary care to the extent that the<br />
danger was either known to the defendant or so obvious that<br />
the defendant must have been aware of it.”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: Recklessness?<br />
Post-PSLRA – Cases Split<br />
9 th Circuit – “Congress intended to elevate the pleading<br />
requirement above the 2 nd Circuit st<strong>and</strong>ard . . . .”<br />
Put simply, in a securities class action, “the plaintiffs must<br />
show that defendants engaged in ‘knowing’ or ‘intentional’<br />
conduct . . . . [R]eckless conduct can also meet this<br />
st<strong>and</strong>ard ‘to the extent that it reflects some degree of<br />
intentional or conscious misconduct,’ or what we have<br />
called ‘deliberate recklessness.’”<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: Recent Developments<br />
Recent Statutory <strong>and</strong> Regulatory Developments:<br />
Section 20A of Exchange Act<br />
Rule 10b5-2<br />
Rule 10b5-1<br />
Rule 14e-3<br />
Sections 804 <strong>and</strong> 807 of Sarbanes-Oxley Act<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: Recent Developments<br />
Section 20A of Exchange Act<br />
Rule 10b5-2<br />
Person civilly liable to anyone who<br />
“contemporaneously” trades<br />
Presumption regarding relationship of<br />
trust <strong>and</strong> confidence<br />
Non-exclusive!<br />
But consider Mark Cuban case.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: Recent Developments<br />
Section 20A of Exchange Act<br />
Any person who violates [Rule 10b-5, etc.] by<br />
purchasing or selling a security while in possession of<br />
material, nonpublic information shall be liable . . . to<br />
any person who, contemporaneously with the<br />
purchase or sale of securities that is the subject of<br />
such violation, has purchased (where such violation is<br />
based on a sale of securities) or sold (where such<br />
violation is based on a purchase of securities)<br />
securities of the same class.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: Recent Developments<br />
Rule 10b5-1<br />
Rule 14e-3<br />
Presumption regarding “use” of material<br />
non-public information<br />
Refer to Session 8 for more discussion<br />
of so-called “Rule 10b5-1 plans”<br />
Liability for insider trading in tender offer<br />
context; no nexus to “fiduciary duty” to<br />
issuer required<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: Recent Developments<br />
Sarbanes-Oxley<br />
Section 804<br />
Statute of Limitation: 2 years/5 years<br />
When does the limitations period begin to<br />
run?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: Statute of Limitations<br />
When does the limitations period begin to run?<br />
Following the enactment of the Sarbanes Oxley Act, the general rule<br />
is that a securities fraud complaint is timely if filed no more than “2<br />
years after the discovery of the facts constituting the violation” or 5<br />
years after the violation.<br />
In Merck & Co., Inc. v. Reynolds, S. Ct. (April 27, 2010), the<br />
Supreme Court addressed what constitutes “discovery.”<br />
The Court unanimously held that a 10b-5 cause of action accrues<br />
“(1)when the plaintiff did in fact discover, or (2) when a<br />
reasonably diligent plaintiff would have discovered, “the facts<br />
constituting the violation”—whichever comes first.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: Statute of Limitations<br />
Merck & Co., Inc. v. Reynolds, S. Ct. (April 27, 2010) (cont’d)<br />
The Court also held that the “facts constituting the violation” include the fact of scienter,<br />
“a mental state embracing intent to deceive, manipulate, or defraud.” In other words,<br />
the limitations period does not begin to run until the plaintiff discovers or a reasonably<br />
diligent plaintiff would have discovered “the facts constituting the violation,” including<br />
scienter—irrespective of whether the actual plaintiff undertook a reasonably diligent<br />
investigation.<br />
The Court acknowledged that “one might read the statutory words ‘after the discovery of<br />
the facts constituting the violation’ as referring to the time a plaintiff actually discovered<br />
the relevant facts. But in the statute of limitations context, the word ‘discovery’ is often<br />
used as a term of art in connection with the ‘discovery rule,’ a doctrine that delays<br />
accrual of a cause of action until the plaintiff has ‘discovered’ it” (emphasis added). The<br />
Court concluded that “[g]iven the history <strong>and</strong> precedent surrounding the use of the word<br />
‘discovery’ in the [statute of] limitations context generally as well as in this provision in<br />
particular, . . . [w]e . . . hold that “discovery” as used in this statute encompasses not only<br />
those facts the plaintiff actually knew, but also those facts a reasonably diligent plaintiff<br />
would have known” (emphasis added).<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: Issuer Duty to Disclose<br />
Affirmative Duty to Disclose in SEC Filings<br />
MD&A, Reg. FD<br />
Historical Statement – Duty to Correct<br />
Forward Looking Statement – Duty to<br />
Update?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: Issuer Duty to Update<br />
vs. Duty to Correct<br />
Historical Statement – Duty to Correct<br />
Was statement incorrect when report was filed?<br />
Forward Looking Statement – Duty to Update?<br />
Compare<br />
Stansky v. Cummins Engine (7 th Cir. 1995)<br />
with<br />
Weiner v. Quaker Oats (3 rd Cir. 1997)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b-5: Issuer Duty to Disclose<br />
Role of “No Comment”<br />
Basic v. Levinson (S. Ct. 1988)<br />
“Functional equivalent of silence”<br />
Very important principle<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 9 – Rule 10b-5<br />
Study Problem 9.1<br />
Farmer’s Cooperative Corp. (Co-op) helps area farmers finance their farming<br />
operations <strong>and</strong> offers various farming outreach programs. Three years ago the Coop’s<br />
manager, Bill Uppin, started his own company, called Uppin Flames, Inc., to<br />
build <strong>and</strong> operate a gasohol plant that would convert corn into fuel. To fund the<br />
company’s expansion Uppin approached the Co-op board for a loan. The board<br />
approved $2 million in unsecured, low-interest loans by the Co-op to Uppin Flames,<br />
for which Uppin gave personal guarantees.<br />
Problems at the plant developed, causing Uppin Flames to approach<br />
insolvency. Uppin contrived a scheme to sell Uppin Flames to the Co-op in order to<br />
escape his personal guarantees. Uppin, with the help of complicit members of the<br />
Co-op board, convinced the rest of the Co-op board that, while having difficulty<br />
servicing its debt in the short term, Uppin Flames was on the verge of tremendous<br />
growth <strong>and</strong> would be a prudent investment. The Co-op board approved a transaction<br />
whereby the Co-op acquired the stock of Uppin Flames in return for debt<br />
forgiveness, <strong>and</strong> Bill Uppin was relieved of $2 million in personal guarantees.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 9 – Rule 10b-5<br />
Study Problem 9.1 (continued)<br />
The “acquisition” of Uppin Flames, Inc. proved disastrous for the Coop.<br />
Within two years after the acquisition, the Co-op was bankrupt because<br />
of the heavy gasohol liabilities it had assumed. The bankruptcy trustee for<br />
the Co-op considers 10b-5 claims against various participants in the Co-op’s<br />
acquisition of Uppin’s interest the gasohol plant.<br />
1. The trustee begins to draw up a list of potential 10b-5 defendants. Who<br />
should be on the list?<br />
2. From the start Bill Uppin asserted his belief (perhaps naive) that the<br />
gasohol plant would turn itself around with the Co-op’s financial backing<br />
<strong>and</strong> an upturn in gasohol prices. Can Uppin be liable if he had a “clean<br />
heart <strong>and</strong> empty mind”?<br />
3. Even if the Co-op was culpably deceived, can Bill Uppin be liable if the<br />
Uppin Flames investment fizzled because of weakness in gasohol prices?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
TO BE ADDED<br />
Session 9 – Rule 10b-5<br />
Study Problem 9.1 — Analysis<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
TO BE ADDED<br />
Session 9 – Rule 10b-5<br />
Study Problem 9.1 — Analysis (continued)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 9 – Rule 10b-5<br />
Study Problem 9.2<br />
To raise money for its operations, the Co-op sells<br />
promissory notes to its members. The notes, payable on<br />
dem<strong>and</strong>, are uncollateralized <strong>and</strong> uninsured. The Co-op<br />
advertises its dem<strong>and</strong> note program promising that “your<br />
investment is safe, secure, <strong>and</strong> available when you need it.”<br />
1. Do noteholders have st<strong>and</strong>ing to bring a 10b-5 class action<br />
regarding the Co-op’s acquisition of Uppin Flames?<br />
2. Were the noteholders deceived in connection with the<br />
purchase or sale of their notes?<br />
3. Who are potential defendants in a suit by the noteholders?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
TO BE ADDED<br />
Session 9 – Rule 10b-5<br />
Study Problem 9.2 — Analysis<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved
Session 9 – Rule 10b-5<br />
Study Problem 9.2 — Analysis (continued)<br />
TO BE ADDED<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved
Session 9 – Rule 10b-5<br />
Study Problem 9.3<br />
A year after acquiring Uppin Flames, the Co-op hires the well-known<br />
accounting firm Dewey Cheetum & Co. to audit its financial statements. During<br />
their review of the Co-op’s books, Dewey Cheetum accountants notice that the Coop<br />
did not properly account for its investment in Uppin Flames.<br />
In its audit report to the Co-op board, Dewey Cheetum ignores the Uppin<br />
Flames problem. The Dewey Cheetum accountants are aware that the Co-op should<br />
have a negative net worth under generally accepted accounting principals. That bad<br />
news about the Co-op’s financial condition could well trigger a disastrous run on the<br />
dem<strong>and</strong> notes. The only cautionary disclosure came in a footnote to the audit report<br />
in which Dewey Cheetum doubted the recoverability of the Co-op’s investment in<br />
Uppin Flames. Dewey Cheetum attends a meeting of noteholders at which the Coop’s<br />
financial condition is discussed.<br />
Most of the noteholders did not know of the audit report, which Dewey<br />
Cheetum provided only to the Co-op board. Can Arthur Young be liable to the<br />
noteholders despite the absence of any actual reliance?<br />
(c) 2013 Michael K. Krebs All Rights<br />
Reserved
TO BE ADDED<br />
Session 9 – Rule 10b-5<br />
Study Problem 9.3 — Analysis<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Session 9 Agenda<br />
Part 1<br />
Rule 10b-5 Litigation<br />
Part 2<br />
Insider Trading Liability<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Insider Trading Liability<br />
What is the current law?<br />
How did it evolve?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Insider Trading Liability<br />
Statement of Current Law<br />
The purchase or sale of a security of any<br />
issuer, on the basis of material nonpublic<br />
information about that security or the issuer,<br />
in breach of a duty of trust or confidence that<br />
is owed, directly, indirectly or derivatively to<br />
the issuer of that security or the shareholders<br />
of that issuer, or any person who is the source<br />
of the material nonpublic information violates<br />
Rule 10b-5.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Insider Trading Liability<br />
“Classical Theory”<br />
A person purchases or sells securities,<br />
with scienter, while in possession of<br />
material, nonpublic information in<br />
breach of a duty arising out of a<br />
fiduciary relationship to the issuer<br />
of the security<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Insider Trading Liability<br />
“Misappropriate Theory”<br />
A person violates Rule 10b-5 when<br />
she misappropriates <strong>and</strong> trades on the<br />
basis of confidential information in a<br />
breach of a duty of trust or<br />
confidence owed to the source of<br />
the information.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Insider Trading Liability<br />
Evolution of Insider Trading Law<br />
In re Cady Roberts (S. Ct. 1961) (tipper/tippee)<br />
Texas Gulf Sulfur (2 nd Cir. 1971) (accepting options<br />
while in possession of material non-public<br />
information)<br />
Chiarella (S. Ct. 1980)<br />
Dirks (S. Ct. 1983)<br />
O’Hagan (S. Ct. 1997)<br />
SEC Rule 10b5-2 (2000)<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b5-2<br />
Provides a non-exclusive<br />
definition of circumstances in<br />
which a person has a duty of trust<br />
or confidence for purposes of the<br />
"misappropriation" theory of<br />
insider trading under Section<br />
10(b) of the Act <strong>and</strong> Rule 10b-5.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Rule 10b5-2 (cont’d)<br />
(1) A person agrees to maintain information in confidence;<br />
(2) the person communicating the material nonpublic information <strong>and</strong> the person<br />
to whom it is communicated have a history, pattern, or practice of sharing<br />
confidences, such that the recipient of the information knows or reasonably<br />
should know that the person communicating the material nonpublic information<br />
expects that the recipient will maintain its confidentiality; or<br />
(3) A person receives or obtains material nonpublic information from his or<br />
her spouse, parent, child, or sibling, unless the person receiving or obtaining the<br />
information demonstrates that no duty of trust or confidence existed with respect<br />
to the information, by establishing that he or she neither knew nor reasonably<br />
should have known that the person who was the source of the information<br />
expected that the person would keep the information confidential, because of the<br />
parties' history, pattern, or practice of sharing <strong>and</strong> maintaining confidences, <strong>and</strong><br />
because there was no agreement or underst<strong>and</strong>ing to maintain the confidentiality<br />
of the information.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Liability is derivative<br />
Insider Trading:<br />
Tipper/Tippee Liability<br />
Tippee will be liable only if tipper is liable<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Tipper Liability:<br />
Insider Trading:<br />
Tipper/Tippee Liability<br />
(1) Tipper had a duty to keep material non-public<br />
information confidential;<br />
(2) Tipper breached that duty by intentionally or<br />
recklessly relaying the information to a tippee who<br />
could use the information in connection with<br />
securities trading; <strong>and</strong><br />
(3) Tipper received a personal benefit from the tip.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Tippee Liability:<br />
Insider Trading:<br />
Tipper/Tippee Liability<br />
(1) Tipper breached a duty by tipping confidential<br />
information;<br />
(2) Tippee knew or had reason to know that the tippee<br />
improperly obtained the information (i.e., that the<br />
information was obtained through the tipper’s breach);<br />
<strong>and</strong><br />
(3) Tippee, while in knowing possession of the material<br />
non-public information, used the information by trading<br />
or by tipping for his own benefit.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Tipper/Tippee Liability<br />
Study Problem 9.4<br />
Thomas is an employee of GE Capital.<br />
Peter <strong>and</strong> Nelson work at Wynnefield Capital.<br />
Peter is a college friend of Thomas.<br />
Thomas “tips” Peter about the possible acquisition of SunSource<br />
Inc. by Allied Capital Corporation that GE Capital was financing.<br />
Peter passes this information to Nelson, who purchases<br />
SunSource stock based on it.<br />
After an internal investigation, GE Capital did not consider itself<br />
to be a victim of a breach of confidentiality.<br />
Would Thomas, Peter <strong>and</strong>/or Nelson be liable for insider<br />
trading?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
TO BE ADDED<br />
Tipper/Tippee Liability<br />
Study Problem 9.4 - Analysis<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Tipper/Tippee Liability<br />
Study Problem 9.4 – Analysis (cont’d)<br />
TO BE ADDED<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Tipper/Tippee Liability<br />
Study Problem 9.4 – Analysis (cont’d)<br />
TO BE ADDED<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Insider Trading:<br />
Non-Equity <strong>Securities</strong><br />
SEC has brought cases alleging improper<br />
trading in securities other than equities<br />
<strong>and</strong> listed options, such as<br />
credit default swaps,<br />
exchange-traded funds<br />
mutual funds.<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
Insider Trading: Tender Offers<br />
Study Problem 9.5<br />
Kate is drying her hair in the locker room of her very upscale gym.<br />
As she turns off the hair dryer, she overhears the end of a conversation between<br />
two women who Kate knows only casually by their first names – Monica <strong>and</strong><br />
Hillary.<br />
Monica: “I wish could be in the room when Meg learns that Googolplex is<br />
launching a hostile tender for her company.”<br />
Hillary: “I hope Meg can h<strong>and</strong>le the stress. With the premium that ‘Plex<br />
is offering, she will have no choice but to toss in towel.”<br />
Monica <strong>and</strong> Hillary do not know that Kate overhead their conversation.<br />
Making an educated guess regarding the identity of Meg’s company, Kate<br />
purchases shares of its stock before Googolplex launches its tender offer. Her<br />
profit on the trade is $1 million.<br />
Will Kate, Monica <strong>and</strong>/or Hillary have liability for insider trading?<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
TO BE ADDED<br />
Insider Trading:<br />
Study Problem 9.5 - Analysis<br />
(c) 2013 Michael K. Krebs<br />
All Rights Reserved
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
THE END!!<br />
© 2013 Michael K. Krebs<br />
All Rights Reserved
U.S <strong>and</strong> <strong>Trans</strong>-<strong>Border</strong><br />
<strong>Securities</strong> <strong>Regulation</strong><br />
Boston University School of Law<br />
Executive LL.M. - International Business Law<br />
July/August 2013<br />
Michael Krebs<br />
JD, Boston University School of Law 1985<br />
Senior Partner, Nutter, McClennen & Fish, LLP, Boston, MA<br />
Tel. 616.439.2288 email: mkrebs@nutter.com<br />
© 2013 Michael K. Krebs<br />
All Rights Reserved